Single-Counterparty Credit Limits for Large Banking Organizations, 14327-14364 [2016-05386]
Download as PDF
Vol. 81
Wednesday,
No. 51
March 16, 2016
Part IV
Federal Reserve System
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
12 CFR Part 252
Single-Counterparty Credit Limits for Large Banking Organizations;
Proposed Rule
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
PO 00000
Frm 00001
Fmt 4717
Sfmt 4717
E:\FR\FM\16MRP2.SGM
16MRP2
14328
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
FEDERAL RESERVE SYSTEM
12 CFR Part 252
[Regulation YY; Docket No. R–1534]
RIN 7100–AE 48
Single-Counterparty Credit Limits for
Large Banking Organizations
Board of Governors of the
Federal Reserve System (Board).
ACTION: Notice of proposed rulemaking.
AGENCY:
The Board is inviting
comment on proposed rules that would
establish single-counterparty credit
limits for domestic and foreign bank
holding companies with $50 billion or
more in total consolidated assets. The
proposed rules would implement
section 165(e) of the Dodd-Frank Wall
Street Reform and Consumer Protection
Act, which requires the Board to impose
limits on the amount of credit exposure
that such a domestic or foreign bank
holding company can have to an
unaffiliated company in order to reduce
the risks arising from the company’s
failure. The proposed rules, which build
on earlier proposed rules by the Board
to establish single-counterparty credit
limits for large domestic and foreign
banking organizations, would increase
in stringency based on the systemic
importance of the firms to which they
apply.
DATES: Comments should be received by
June 3, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. R–1534 and
RIN No. 7100 AE–48, by any of the
following methods:
• Agency Web site: http://www.
federalreserve.gov. Follow the
instructions for submitting comments at
http://www.federalreserve.gov/
generalinfo/foia/ProposedRegs.cfm.
• Federal eRulemaking Portal: http://
www.regulations.gov. Follow the
instructions for submitting comments.
• Email: regs.comments@federal
reserve.gov. Include the docket number
in the subject line of the message.
• Fax: (202) 452–3819 or (202) 452–
3102.
• Mail: Robert deV. Frierson,
Secretary, Board of Governors of the
Federal Reserve System, 20th Street and
Constitution Avenue NW., Washington,
DC 20551.
All public comments will be made
available on the Board’s Web site at
http://www.federalreserve.gov/general
info/foia/ProposedRegs.cfm as
submitted, unless modified for technical
reasons. Accordingly, your comments
will not be edited to remove any
identifying or contact information.
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
SUMMARY:
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
Public comments may also be viewed
electronically or in paper form in Room
3515, 1801 K Street (between 18th and
19th Streets NW.) Washington, DC
20006 between 9:00 a.m. and 5:00 p.m.
on weekdays.
FOR FURTHER INFORMATION CONTACT:
Jordan Bleicher, Senior Supervisory
Financial Analyst, (202) 973–6123,
Division of Banking Supervision and
Regulation; or Laurie Schaffer, Associate
General Counsel, (202) 452–2272,
Benjamin McDonough, Special Counsel,
(202) 452–2036, Pam Nardolilli, Senior
Counsel, (202) 452–3289, or Lucy
Chang, Attorney, (202) 475–6331, Legal
Division, Board of Governors of the
Federal Reserve System, 20th and C
Streets NW., Washington, DC 20551. For
the hearing impaired only,
Telecommunications Device for the Deaf
(TDD) users may contact (202) 263–
4869.
SUPPLEMENTARY INFORMATION:
Table of Contents
I. Background
A. General Background
B. Summary of Comments on the 2011 and
2012 Proposals
II. Proposed Rule for Domestic Bank Holding
Companies
A. Overview of the Proposed Rule for
Domestic Bank Holding Companies
III. Proposed Rule for Foreign Banking
Organizations
A. Background
B. Overview of the Proposed Rule for
Foreign Banking Organizations
IV. Regulatory Analysis
A. Paperwork Reduction Act
B. Solicitation of Comments on the Use of
Plain Language
C. Regulatory Flexibility Act Analysis
Background
General Background
During the 2007–2008 financial crisis,
some of the largest financial firms in the
world collapsed or experienced material
financial distress. Counterparties of
failing firms were placed under severe
strain when the failing firm could not
meet its financial obligations, in some
cases resulting in the counterparties’
inability to meet their own financial
obligations. Similarly, weakened
financial firms came under increased
stress when counterparties with large
exposures to the firm suddenly
attempted to reduce those exposures.
The effect of a large financial
institution’s failure or near collapse is
amplified by the mutual
interconnectedness of large,
systemically important firms—that is,
the degree to which they extend each
other credit and serve as counterparties
to one another. As demonstrated during
PO 00000
Frm 00002
Fmt 4701
Sfmt 4702
the crisis, financial distress at a banking
organization may materially raise the
likelihood of distress at other firms
given the network of contractual
obligations throughout the financial
system. Accordingly, a large banking
organization’s systemic impact is likely
to be directly related to its
`
interconnectedness vis-a-vis other
financial institutions and the financial
sector as a whole. This
interconnectedness of financial firms
also creates the potential for an increase
in the likelihood of distress at nonfinancial firms that are dependent upon
financial firms for funding.
The financial crisis also revealed
inadequacies in the U.S. regulatory
approach to credit exposure limits,
which limited only some of the
interconnectedness among large
financial companies. For example,
certain commercial banks were subject
to single-borrower lending and
investment limits. However, these limits
often excluded credit exposures
generated by derivatives and some
securities financing transactions, and
did not apply at the consolidated
holding company level.1
Section 165(e) of the Dodd-Frank Wall
Street Reform and Consumer Protection
Act (Dodd-Frank Act) authorizes the
Board to establish single-counterparty
credit limits for bank holding
companies with total consolidated
assets of $50 billion or more (covered
companies) and foreign banking
organizations with total consolidated
assets of $50 billion or more, and any
U.S. intermediate holding company
(covered entities), in order to limit the
risks that the failure of any individual
firm could pose to a covered company.2
This section prohibits covered
companies and covered entities from
having credit exposure to any
unaffiliated company that exceeds 25
percent of the capital stock and surplus
of the covered company, or such lower
amount as the Board may determine by
regulation to be necessary to mitigate
risks to the financial stability of the
United States.3
1 Section 610 of the Dodd-Frank Wall Street
Reform and Consumer Protection Act (Dodd-Frank
Act) amends the term ‘‘loans and extensions of
credit’’ for purposes of the lending limits applicable
to national banks to include any credit exposure
arising from a derivative transaction, repurchase
agreement, reverse repurchase agreement, securities
lending transaction, or securities borrowing
transaction. See Dodd-Frank Act, Public Law 111–
203, 610, 124 Stat. 1376, 1611 (2010), codified at
12 U.S.C. 84(b). As discussed in more detail below,
these types of transactions also are made subject to
the single-counterparty credit limits of section
165(e). 12 U.S.C. 5365(e)(3).
2 See 12 U.S.C. 5365(e)(1).
3 12 U.S.C. 5365(e)(2).
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
Credit exposure to a company is
defined in section 165(e) of the DoddFrank Act to mean all extensions of
credit to the company, including loans,
deposits, and lines of credit; all
repurchase agreements, reverse
repurchase agreements, and securities
borrowing and lending transactions
with the company (to the extent that
such transactions create credit exposure
for the covered company); all
guarantees, acceptances, and letters of
credit (including endorsement or
standby letters of credit) issued on
behalf of the company; all purchases of,
or investments in, securities issued by
the company; counterparty credit
exposure to the company in connection
with derivative transactions between the
covered company and the company; and
any other similar transaction that the
Board, by regulation, determines to be a
credit exposure for purposes of section
165.4
Section 165(e) also grants the Board
authority to issue such regulations and
orders, including definitions consistent
with section 165(e), as may be necessary
to administer and carry out that section.
In addition, it authorizes the Board to
exempt transactions, in whole or in part,
from the definition of the term ‘‘credit
exposure,’’ if the Board finds that the
exemption is in the public interest and
consistent with the purposes of section
165(e).5 Finally, section 165(e)
authorizes the Board to establish singlecounterparty credit limits for nonbank
financial companies designated by the
Financial Stability Oversight Council
(FSOC) for supervision by the Board.
The draft proposed rules would not at
this time apply to any such nonbank
financial company. The Board intends
to apply similar requirements to these
companies separately by rule or order at
a later time.
The proposed framework of credit
exposure limits for covered companies
is similar to existing limits for
depository institutions, including the
investment securities limits and the
lending limits imposed on certain
depository institutions.6 A national
bank generally is limited, subject to
certain exceptions, in the total amount
of investment securities of any one
obligor that it may purchase for its own
account to no more than 10 percent of
its capital stock and surplus.7 In
addition, a national bank’s total
outstanding loans and extensions of
4 See
12 U.S.C. 5365(e)(3).
12 U.S.C. 5365(e)(5)–(6).
6 See, e.g., 12 U.S.C. 24(7); 12 U.S.C. 84; 12 CFR
1 and 32; see also 12 U.S.C. 335 (applying the
provisions of 12 U.S.C. 24(7) to state member
banks).
7 See 12 U.S.C. 24(7); 12 CFR 1.
5 See
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
credit to one borrower may not exceed
15 percent of the bank’s capital stock
and surplus, plus an additional 10
percent of the bank’s capital stock and
surplus, if the amount that exceeds the
bank’s 15 percent general limit is fully
secured by readily-marketable
collateral.8
The requirements in section 165(e)
operate as a separate and independent
limit from the investment securities
limits and lending limits in the National
Bank Act and Federal Reserve Act, and
a covered company or covered entity
must comply with all of the limits that
are applicable to it and its subsidiaries.
A covered company would be required
to ensure that it does not exceed the
single-counterparty credit limits when
all the credit exposures of the
organization are consolidated. Because
the proposed rules would impose limits
on credit transactions by a covered
company or covered entity on a
consolidated basis, including its
subsidiary depository institutions, the
proposed rules may affect the amount of
loans and extensions of credit that
would otherwise be consistent with a
subsidiary depository institution’s
lending limits.
The Board invited public comment on
proposed rules to implement section
165(e) for domestic banking
organizations in December 2011 and for
foreign banking organizations in
December 2012.9 The Board is reproposing rules to implement section
165(e) in order to take account of (1) the
large volume of comments received on
the original 165(e) proposed rules from
banks, trade associations, public interest
groups, and others; (2) the revised
lending limits rules applicable to
national banks; 10 (3) the introduction by
the Basel Committee on Banking
Supervision (BCBS) of a large exposures
standard (LE Standard), which
establishes an international standard for
the maximum amount of credit
exposure that an internationally active
bank is permitted to have to a single
counterparty; 11 and (4) the results of
quantitative impact studies and related
analysis conducted by Board staff to
help gauge the impact of the original
165(e) proposed rules and these revised
rules.
8 See 12 U.S.C. 84; 12 CFR 32.3. State-chartered
banks, as well as state and federally-chartered
savings associations, also are subject to lending
limits imposed by relevant state and federal law.
9 http://www.federalreserve.gov/newsevents/
press/bcreg/20111220a.htm; http://
www.federalreserve.gov/newsevents/press/bcreg/
20121214a.htm.
10 See 78 FR 37930 (June 25, 2013).
11 http://www.bis.org/press/p140415.htm.
PO 00000
Frm 00003
Fmt 4701
Sfmt 4702
14329
Summary of Comments on the 2011 and
2012 Proposals
The Board received 48 comments,
representing approximately 60 parties,
on the 2011 proposal on section 165(e)
as it relates to domestic firms and 35
comments, representing over 45
organizations, on the 2012 proposed
rule as it relates to foreign banking
organizations. The comments were
received from a wide range of
individuals, banking organizations,
industry and trade groups representing
banking, insurance, and the broader
financial services industry, and public
interest groups. Board staff also met
with industry representatives and
government representatives to discuss
issues relating to the proposed rules.
Some commenters expressed support
for the broader goals of the proposed
rules to limit single-counterparty
concentrations at large financial
companies. Numerous commenters
expressed concerns, however, about
various aspects of the proposed rules.
The Board received comments on all
aspects of the proposed rules, and the
Board has taken into consideration these
comments in these revised proposed
rules for section 165(e).
In the 2011 proposed rule, the Board
proposed to limit the aggregate net
credit exposure of a covered company to
a single unaffiliated counterparty to no
more than 25 percent of the
consolidated capital stock and surplus
of the covered company. The Board
further proposed to limit the aggregate
net credit exposure of U.S. bank holding
companies with over $500 billion in
assets to any other unaffiliated bank
holding company of similar size, or to
a nonbank financial company
designated by the FSOC for supervision
by the Board, to 10 percent of the capital
stock and surplus of the covered
company.
Several commenters questioned the
Board’s basis for lowering the 25
percent statutory limit to 10 percent.
These commenters generally questioned
the financial stability need for the lower
limit and questioned whether the 10
percent limit would have disruptive
effects, such as reducing market
liquidity, decreasing loan capacity, and
driving financial services to the shadow
banking sector. Several commenters
questioned the Board’s basis for
selecting a $500 billion asset threshold
as the cutoff for the lower 25 percent
statutory credit limit. Commenters
representing the insurance industry
criticized the proposed standard
because it did not take into account the
unique features of the insurance
business. The Board also received
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
14330
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
several comments that supported
imposing the more stringent limits on
single-counterparty credit exposures
between very large organizations.
Some commenters on the 2011
proposed rule urged the Board to base
single-counterparty credit limits on a
narrower definition of capital. For
example, one commenter noted that a
central finding of the financial crisis
was that only common equity was
reliably loss absorbing, and further
observed that the Basel III capital
standard reflects this through its
redefinition of capital instruments. This
commenter also argued that there are
advantages to coordinating regulatory
capital definitions around a limited
number of capital definitions that
include only instruments that are
reliably loss absorbing.
In its 2011 proposed rule, the Board
proposed to exempt credit exposures
that were direct claims on, and the
portions of claims that were directly and
fully guaranteed as to principal and
interest by, the United States and its
agencies. Many commenters supported
expanding this exemption to include
creditworthy non-U.S. sovereigns.
Several commenters noted that
sovereign entities generally are not
regarded as ‘‘companies,’’ and the
statute covers exposures to companies.
Others argued there is no rationale for
distinguishing between U.S. and other
highly-rated sovereign exposures and
that limiting the amount of exposure
that a covered company can have to a
highly-rated sovereign may increase
systemic risk by limiting the company’s
ability to invest in or accept as collateral
instruments issued by such sovereigns.
Commenters suggested that exposures to
those sovereigns that are assigned a low
risk-weight under the Basel Capital
rules should be exempt.
Commenters questioned the Board’s
approach to measuring the exposures
resulting from derivative transactions.
Under the 2011 proposed rule, a
covered company generally would have
been required to calculate credit
exposure to a derivatives counterparty
using the Current Exposure Method
(CEM). Commenters argued that CEM is
insufficiently risk-sensitive and that it
overstates the realistic economic
exposure of a derivative transaction.
Commenters attributed this issue in
significant part to the fact that CEM
limits the extent to which netting
benefits are taken into account in
calculating counterparty exposures.
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
Some commenters also criticized the
Board’s proposed approach to
measuring exposures from securities
financing transactions.12 These
commenters argued that the collateral
volatility haircuts included in the 2011
proposed rule do not recognize the riskmitigating value of positive correlations
between securities on loan and
securities received as collateral. These
commenters also pointed out that under
the Board’s risk-based capital rules,
collateral volatility haircuts for
securities lending and repurchase
transactions reflect a five-day
liquidation period, rather than the tenday period used in the proposed 165(e)
rule.
Many of the comments received
concerning the proposed rule for foreign
banking organizations were similar to
those filed with respect to the domestic
proposed rule, especially regarding the
2012 proposed rule’s treatment of
foreign sovereign instruments. Some
commenters argued that, in light of the
BCBS’s development of the LE Standard
that would apply to a foreign banking
organization on a consolidated basis, it
was unnecessary for the Board to
develop single-counterparty credit
limits for a foreign banking
organization’s combined U.S.
operations. Some commenters also
expressed concerns related to the
definition of the relevant capital base for
their organizations. For example, some
foreign banking organizations that
expected to form intermediate holding
companies (IHCs) to hold their U.S.
subsidiaries were concerned that their
relevant capital base would be restricted
to the capital of the IHC, and not the
relevant consolidated capital level of
their entire company.
After a review of these comments, the
Board has modified the proposed rules
in a number of key respects. The Board
welcomes comments on all aspects of
the proposed rules, including on the
various questions and alternatives
discussed below.
Proposed Rule for Domestic Bank
Holding Companies
Overview of Proposed Rule for Domestic
Bank Holding Companies
Under the proposed rule to
implement section 165(e) of the Dodd12 ‘‘Securities financing transactions’’ include
repurchase agreements, reverse repurchase
agreements, securities lending transactions, and
securities borrowing transactions.
PO 00000
Frm 00004
Fmt 4701
Sfmt 4702
Frank Act, the aggregate net credit
exposure of a bank holding company
with total consolidated assets of $50
billion or more (covered company) to a
single counterparty would be subject to
one of three increasingly stringent credit
exposure limits. The first category of
limits would apply to covered
companies that have less than $250
billion in total consolidated assets and
less than $10 billion in on-balance-sheet
foreign exposures. Covered companies
that have less than $250 billion in total
consolidated assets and less than $10
billion in on-balance sheet foreign
exposures would be prohibited from
having aggregate net credit exposure to
an unaffiliated counterparty in excess of
25 percent of the covered company’s
total capital stock and surplus, defined
under the rule as the covered company’s
total regulatory capital plus allowance
for loan and lease losses (ALLL).
The second category of exposure
limits would prohibit any covered
company with $250 billion or more in
total consolidated assets or $10 billion
or more in total on-balance-sheet foreign
exposures, but which is not a global
systemically important banking
organization, from having aggregate net
credit exposure to an unaffiliated
counterparty in excess of 25 percent of
the covered company’s tier 1 capital.
The third category of exposure limits
would prohibit any covered company
that is a global systemically important
banking organization (major covered
company) from having aggregate net
credit exposure in excess of 15 percent
of the major covered company’s tier 1
capital to a major counterparty, and 25
percent of the major covered company’s
tier 1 capital to any other counterparty.
A ‘‘major counterparty’’ would be
defined as a global systemically
important banking organization or a
nonbank financial company supervised
by the Board. This framework would be
consistent with the requirement in
section 165(a)(1)(B) of the Dodd-Frank
Act that the enhanced standards
established by the Board under section
165 increase in stringency based on
factors such as the nature, scope, size,
scale, concentration,
interconnectedness, and mix of the
activities of the company.13 The credit
exposure limits are summarized in
Table 1.
13 12
E:\FR\FM\16MRP2.SGM
U.S.C. 5323, 5365(e).
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
14331
TABLE 1—SINGLE-COUNTERPARTY CREDIT LIMITS APPLICABLE TO COVERED COMPANIES
Applicable credit exposure limit
Covered companies that have less than $250 billion in total consolidated assets and less than $10 billion in on-balance-sheet foreign
exposures.
Covered companies that have $250 billion or more in total consolidated
assets or $10 billion or more in on-balance-sheet foreign exposures,
but are not major covered companies.
Major covered companies ........................................................................
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Category of covered company
Aggregate net credit exposure to a counterparty cannot exceed 25 percent of a covered company’s total regulatory capital plus ALLL.
The limits of the proposed rule would
apply to the credit exposures of a
covered company on a consolidated
basis, including any subsidiaries, to any
unaffiliated counterparty. A
‘‘subsidiary’’ of a covered company
would mean a company that is directly
or indirectly controlled by the specified
company for purposes of the Bank
Holding Company Act of 1956, 12
U.S.C. 1841 et seq.14 If an investment
fund or vehicle is not controlled by a
covered company, the exposures of such
fund or vehicle to its counterparties
would not be aggregated with those of
the covered company for purposes of
the proposed single-counterparty credit
limits applicable to that covered
company.
A bank holding company should be
able to monitor and control its credit
exposures on a consolidated basis,
including the credit exposures of its
subsidiaries. Applying the singlecounterparty credit limits in the
proposed rule to bank holding
companies on a consolidated basis,
which would include the credit
exposures of their subsidiaries, would
help to avoid evasion of the rule’s
purposes.
Question 1: As noted, the proposed
rule would apply the singlecounterparty credit limits to covered
companies on a consolidated basis and
could, therefore, impact the level of
credit exposures of subsidiaries of these
covered companies, including
depository institutions. Is application on
a consolidated basis appropriate?
Question 2: Should the definition of a
‘‘subsidiary’’ of a covered company for
purposes of single-counterparty credit
limits be based on the definition in the
Bank Holding Company Act of 1956?
Should a ‘‘subsidiary’’ instead be
defined as any entity that a covered
company (1) owns, controls, or holds
with power to vote 25 percent or more
of a class of voting securities; (2) owns
14 See
proposed rule § 252.71(cc); see also section
252.2(g) of the Board’s Regulation YY (12 CFR
252.2(g)).
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
Aggregate net credit exposure to a counterparty cannot exceed 25 percent of a covered company’s tier 1 capital.
Aggregate net credit exposure to a major counterparty cannot exceed
15 percent of a major covered company’s tier 1 capital.
Aggregate net credit exposure to other counterparties cannot exceed
25 percent of a major covered company’s tier 1 capital.
or controls 25 percent or more of the
total equity; or (3) consolidates for
financial reporting purposes?
Question 3: Should funds or vehicles
that a covered company sponsors or
advises be expressly included as part of
the covered company for purposes of
the proposed rule? Should the proposed
rule’s definition of ‘‘subsidiary’’ be
expanded to include any investment
fund or vehicle advised or sponsored by
a covered company? Should the
proposed rule’s definition of
‘‘subsidiary’’ be expanded to include
any other entity?
The proposed rule would establish
limits on the credit exposure of a
covered company to a single
‘‘counterparty.’’ 15 A counterparty
would be defined to include natural
persons (including the person’s
immediate family); a U.S. State
(including all of its agencies,
instrumentalities, and political
subdivisions); and certain foreign
sovereign entities (including their
agencies, instrumentalities, and political
subdivisions). The Board is proposing to
include individuals and certain
governmental entities within the
definition of a ‘‘counterparty’’ because
credit exposures to such entities create
risks to the covered company that are
similar to those created by large
exposures to companies. The severe
distress or failure of an individual, U.S.
state or municipality, or sovereign entity
could have effects on a covered
company that are comparable to those
caused by the failure of a financial firm
or nonfinancial corporation to which
the covered company has a large credit
exposure. With respect to sovereign
entities, these risks are most acute in the
case of sovereigns that present greater
credit risk. Therefore, the proposed rule
would subject credit exposures to
individuals, U.S. states and
municipalities, and foreign sovereign
governments that do not receive a zero
percent risk weight under the Board’s
15 See
PO 00000
proposed rule § 252.71(e).
Frm 00005
Fmt 4701
Sfmt 4702
Standardized Approach risk-based
capital rules in Regulation Q to the
credit exposure framework in the same
manner as credit exposures to
companies.16
The Board proposes to extend the
single-counterparty credit limits to
individuals, U.S. states, and certain
foreign sovereigns using two authorities.
Under section 165(b)(1)(b) of the DoddFrank Act, the Board may impose such
additional enhanced prudential
standards as the Board of Governors
determines are appropriate.17 In
addition, under section 5(b) of the Bank
Holding Company Act, the Board may to
issue such regulations as may be
necessary to enable it to administer and
carry out the purposes of this chapter
and prevent evasions thereof.18 Such
purposes include examining the
financial, operational, and other risks
within the bank holding company
system that may pose a threat to (1) the
safety and soundness of the bank
holding company or of any depository
institution subsidiary of the bank
holding company; or (2) the stability of
the financial system of the United
States.19 The proposed rule would help
to promote the safety and soundness of
a covered company and mitigate risks to
financial stability by limiting a covered
company’s maximum credit exposure to
an individual, U.S. state, or foreign
sovereign, and thereby reducing the risk
that the failure of such individual or
entity could cause the failure or material
financial distress of a covered company.
For purposes of the proposed credit
exposure limits, a covered company’s
exposures to a ‘‘counterparty’’ would
include not only exposures to that
particular entity but also exposures to
any person with respect to which the
counterparty (1) owns, controls, or
holds with power to vote 25 percent or
more of a class of voting securities; (2)
owns or controls 25 percent or more of
16 See
12 CFR part 217, subpart D.
U.S.C. 5363(b)(1)(B).
18 12 U.S.C. 1844(b).
19 12 U.S.C. 1844(c)(2)(A)(i)(II).
17 12
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
14332
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
the total equity; or (3) consolidates for
financial reporting purposes. To the
extent that one or more of these
conditions are met with respect to a
company’s relationship to an
investment fund or vehicle, exposures
to such fund or vehicle would need to
be aggregated with that counterparty.
Question 4: Under what
circumstances should funds or vehicles
that a counterparty sponsors or advises
be expressly included as part of the
counterparty for purposes of the
proposed rule?
Further, in cases where total
exposures to a single counterparty
exceed five percent of the covered
company’s eligible capital base (i.e.,
total regulatory capital plus ALLL or tier
1 capital), the covered company would
need to add to exposures to that
counterparty all exposures to other
counterparties that are ‘‘economically
interdependent’’ with the first
counterparty. The purpose of this
proposed requirement is to limit a
covered company’s overall credit
exposure to two or more counterparties
where the underlying risk of one
counterparty’s financial distress or
failure would cause the financial
distress or failure of another
counterparty. In particular, under the
proposed rule, two counterparties
would be considered economically
interdependent when it is the case that,
if one of the counterparties were to
experience financial problems, the other
counterparty would be likely to
experience financial problems as a
result. In determining whether two
entities are economically
interdependent, a covered company
would be required to take into account
(1) whether 50 percent of one
counterparty’s gross receipts or gross
expenditures are derived from
transactions with the other
counterparty; (2) whether one
counterparty has fully or partly
guaranteed the exposure of the other
counterparty, or is liable by other
means, and the exposure is significant
enough that the guarantor is likely to
default if a claim occurs; (3) whether a
significant part of one counterparty’s
production or output is sold to the other
counterparty, which cannot easily be
replaced by other customers; (4)
whether one counterparty has made a
loan to the other counterparty and is
relying on repayment of that loan in
order to satisfy its obligations to the
covered company, and the first
counterparty does not have another
source of income that it can use to
satisfy its obligations to the covered
company; (5) whether it is likely that
financial distress of one counterparty
VerDate Sep<11>2014
20:35 Mar 15, 2016
Jkt 238001
would cause difficulties for the other
counterparty in terms of full and timely
repayment of liabilities; and (6) when
both counterparties rely on the same
source for the majority of their funding
and, in the event of the common
provider’s default, an alternative
provider cannot be found.20
Two entities that are economically
interdependent would be expected to
default on their exposures in a highly
correlated manner, and therefore they
would be treated as a single
counterparty for purposes of the
proposed rule. At the same time, there
may be cases in which the burdens of
investigating economic interdependence
would outweigh its credit risk
mitigating benefits to the covered
company. For this reason, a covered
company would only be required to
assess whether counterparties are
economically interdependent if the sum
of the covered company’s exposures to
one individual counterparty exceeds
five percent of the covered company’s
capital stock and surplus, in the case of
a covered company that does not have
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures, and tier 1 capital, in the case
of a covered company with $250 billion
or more in total consolidated assets or
$10 billion or more in total on-balancesheet foreign exposures.
In addition, under the proposed rule,
a covered company would be required
to add to exposures of an unaffiliated
counterparty all exposures to other
counterparties that are connected by
certain control relationships, such as (i)
the presence of voting agreements; (ii)
the ability of one counterparty to
influence significantly the appointment
or dismissal of another counterparty’s
administrative, management or
supervisory body, or the fact that a
majority of members have been
appointed solely as a result of the
exercise of the first entity’s voting
rights; and (iii) the ability of one
counterparty to significantly influence
senior management or to exercise a
controlling influence over the
management or policies of another
counterparty.21 As with cases where two
companies are economically
interdependent, in cases where a
counterparty is subject to some degree
of control by another counterparty, a
covered company’s overall aggregate
credit risk with respect to the two
counterparties may be understated if
such control relationships are not
identified and their credit exposures
20 See
21 See
PO 00000
proposed rule § 252.76(a).
proposed rule § 252.76(b).
Frm 00006
Fmt 4701
Sfmt 4702
added together for purposes of the
proposed rule.
Example: A covered company has credit
exposures to both a bank and a fund that is
sponsored by the bank. The bank does not (1)
own, control, or hold with power to vote 25
percent or more of a class of voting securities
of the fund; (2) own or control 25 percent or
more of the total equity of the fund; or (3)
consolidate the fund for financial reporting
purposes. Thus, the covered company
generally would not be required to aggregate
its exposures to the bank and the fund. The
bank does, however, have the ability to
appoint a majority of the directors of the
fund. Under the proposed rule, a covered
company would be required to add its credit
exposures to the fund to the covered
company’s credit exposures to the bank for
purposes of determining whether the covered
company is in compliance with the proposed
rule.
Question 5: Should covered
companies be required to aggregate
exposures to entities that are
economically interdependent? Are the
criteria for determining whether entities
are economically interdependent
sufficiently clear, and if not, how should
the criteria be further clarified? Should
covered companies only be required to
identify entities as economically
interdependent when exposure to one of
the entities exceeds five percent of the
covered company’s capital stock and
surplus, in the case of a covered
company that does not have $250
billion or more in total consolidated
assets or $10 billion or more in total onbalance-sheet foreign exposures, and
tier 1 capital, in the case of a covered
company with $250 billion or more in
total consolidated assets or $10 billion
or more in total on-balance-sheet
foreign exposures? Should only covered
companies with $250 billion or more in
total consolidated assets or $10 billion
or more in total on-balance-sheet
foreign exposures be required to identify
entities as economically
interdependent? What other threshold(s)
would be appropriate and why?
Question 6: What operational or other
challenges, if any, would covered
companies face in identifying
companies that are economically
interdependent? Will covered
companies have access to all of the
information needed to complete the
analysis of economic interdependence?
Is this type of information collected by
covered companies in the ordinary
course of business as part of
underwriting or other, similar
processes?
Question 7: Should covered
companies be required to aggregate
exposures to entities that are connected
by certain control relationships? Should
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
covered companies only be required to
aggregate exposures to entities that are
connected by certain control
relationships if the exposure exceeds
five percent of the covered company’s
capital stock and surplus, in the case of
a covered company that does not have
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures, and tier 1 capital, in the case
of a covered company with $250 billion
or more in total consolidated assets or
$10 billion or more in total on-balancesheet foreign exposures? Should only
covered companies with $250 billion or
more in total consolidated assets or $10
billion or more in total on-balance-sheet
foreign exposures be required to
aggregate exposures to entities that are
connected by certain control
relationships? Are the criteria for
determining whether entities are
connected by control relationships
sufficiently clear, and if not, how could
the criteria be further clarified? Are
there additional criteria that the Board
should consider?
Section 165(e) of the Dodd-Frank Act
directs the Board to impose singlecounterparty credit limits based on the
‘‘capital stock and surplus’’ of a covered
company, or ‘‘such lower amount as the
Board may determine by regulation to
be necessary to mitigate risks to the
financial stability of the United
States.’’ 22 Under the proposed rule,
‘‘capital stock and surplus’’ of a covered
company would be defined as the sum
of the company’s total regulatory capital
as calculated under the capital adequacy
guidelines applicable to that bank
holding company under Regulation Q
(12 CFR part 217) and the balance of the
bank holding company’s ALLL not
included in tier 2 capital under the
capital adequacy guidelines applicable
to that bank holding company under
Regulation Q (12 CFR part 217).23 This
definition of capital stock and surplus is
conceptually similar to the definition of
the same term in the Board’s
Regulations O and W and the OCC’s
national bank lending limit regulation.24
As indicated, for those covered
companies with $250 billion or more in
total consolidated assets or $10 billion
or more in total on-balance-sheet foreign
exposure, the proposed credit limits
would be calculated by reference to
those companies’ tier 1 capital as
defined under Regulation Q, rather than
their total regulatory capital plus
22 12
U.S.C. 5365(e)(2).
proposed rule § 252.71(d).
24 See 12 CFR 215.3(i), 12 CFR 223.3(d); see also
12 CFR 32.2(b).
ALLL.25 A key financial stability benefit
of single-counterparty credit limits is
that such limits help reduce the
likelihood that the failure of one
financial institution will lead to the
failure of other financial institutions. By
reducing the likelihood of multiple
simultaneous failures arising from
interconnectedness, single-counterparty
credit limits reduce the probability of
future financial crises and the social
costs that would be associated with
such crises. For this benefit to be
realized, single-counterparty credit
limits for firms whose failure is more
likely to have an adverse impact on
financial stability need to be based on
a measure of capital that is available to
absorb losses on a going-concern basis.
Total regulatory capital plus ALLL
includes capital elements that do not
absorb losses on a going-concern basis.
For example, total regulatory capital
includes a covered company’s
subordinated debt, which is senior in
the creditor hierarchy to equity and
therefore only takes losses once a
company’s equity has been wiped out.
In contrast, a company’s tier 1 capital
consists only of equity claims on the
company, such as common equity and
certain preferred shares. By definition,
these equity claims are available to
absorb losses on a going-concern basis.
Therefore, in order to limit the aggregate
net credit exposure that a covered
company with $250 billion or more in
total consolidated assets or $10 billion
or more in total on-balance-sheet foreign
exposures can have to a single
counterparty relative to the covered
company’s ability to absorb losses on a
going-concern basis, single-counterparty
credit limits applicable to such
companies should be based on their tier
1 capital. Basing single-counterparty
credit limits for such companies on tier
1 capital also is consistent with the
direction given in section 165(a)(1)(B) of
the Dodd-Frank Act to impose enhanced
prudential standards that increase in
stringency based on the systemic
footprint of the firms to which they
apply.26
Basing single-counterparty credit
limits for covered companies with total
consolidated assets of $250 billion or
more, or $10 billion or more in onbalance-sheet foreign exposures on tier
1 capital would be consistent with
lessons learned during the financial
crisis of 2007–2009. During the crisis,
counterparties and other creditors of
distressed financial institutions
discounted lower-quality regulatory
capital instruments issued by such
23 See
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
PO 00000
12 CFR 217.2; 12 CFR 217.20.
U.S.C. 5365(a)(1)(B).
institutions, such as trust preferred
shares, hybrid capital instruments, and
other term instruments. Instead, market
participants focused on a financial
institution’s common equity capital and
other simple, perpetual-maturity
instruments that now qualify as tier 1
regulatory capital. For this reason, the
Board’s revised capital framework
introduced a new definition of common
equity tier 1 capital, restricted the set of
instruments that qualify as additional
tier 1 capital, and raised the tier 1
capital regulatory minimum from 4 to 6
percent.27 In contrast, the Board’s
revised capital framework left the total
regulatory capital minimum
requirement unchanged from its precrisis calibration of 8 percent.
Thus, basing single-counterparty
credit limits for such covered
companies on tier 1 capital would be
consistent with the post-crisis focus on
higher-quality forms of capital and,
based on the experience in the crisis
whereby market participants
significantly discounted the value of
capital instruments such as subordinate
debt that count in total regulatory
capital, would provide a more reliable
capital base for the credit limits. In
addition, the analysis that follows
suggests that using a narrower definition
of capital for such covered companies
could help to mitigate risks to U.S.
financial stability.
The marginal impact of basing singlecounterparty credit limits on tier 1
capital for firms with $250 billion or
more in total assets, or $10 billion or
more in on-balance-sheet foreign
exposures, appears to be limited. As of
September 30, 2015, tier 1 capital
represented approximately 82 percent of
the total regulatory capital plus ALLL
for these firms. Further, the quantitative
impact study Board staff conducted to
help gauge the likely effects of the
proposed requirements suggests that
using tier 1 capital as the eligible capital
base for bank holding companies with
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures likely would increase the
total amount of excess exposure among
U.S. bank holding companies by
approximately $30 billion. This
incremental amount of excess credit
exposure could be largely eliminated by
firms through compression of
derivatives, collection of additional
collateral from counterparties, greater
use of central clearing, and modest
rebalancing of portfolios among
counterparties.
25 See
26 12
Frm 00007
Fmt 4701
Sfmt 4702
14333
27 See
E:\FR\FM\16MRP2.SGM
12 CFR part 217.
16MRP2
14334
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
Question 8: Are the proposed
definitions relating to capital stock and
surplus and tier 1 capital clear? Should
the single-counterparty credit limits
applicable to covered companies with
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures be based on a different
capital base than that used for other
firms?
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Credit Exposure Limits
Section 252.72 of the proposed rule
contains the key quantitative limitations
on credit exposure of a covered
company to a single counterparty.28
First, the general limit in proposed
section 252.72 provides that no covered
company may have aggregate net credit
exposure to any unaffiliated
counterparty in excess of 25 percent of
the capital stock and surplus or tier 1
capital, as appropriate, of the covered
company.29 Second, proposed section
252.72 provides that no ‘‘major covered
company,’’ defined as a covered
company that is a U.S. global
systemically important banking
organization, may have aggregate net
credit exposure to a major counterparty
in excess of 15 percent of the major
covered company’s tier 1 capital.30
‘‘Aggregate net credit exposure’’ would
be defined in this section to mean the
sum of all net credit exposures of a
covered company to a single
counterparty.31 As described in detail
below, sections 252.73 and 252.74 of the
proposed rule describe how a covered
company would calculate gross and net
credit exposure in order to arrive at the
aggregate net credit exposure relevant to
the single-counterparty credit limits in
section 252.72.32
A ‘‘major counterparty’’ would be
defined as (1) any major covered
company and all of its subsidiaries,
collectively; (2) any foreign banking
organization and all of its subsidiaries,
collectively, that would be considered a
global systemically important foreign
banking organization; and (3) any
nonbank financial company supervised
by the Board.33
The Board’s proposed rule regarding
the single-counterparty credit limits that
should apply to credit exposures of a
major covered company to a major
28 See
proposed rule § 252.72.
proposed rule §§ 252.72(a)–(b).
30 See proposed rule § 252.72(c).
31 See proposed rule § 252.71(b).
32 See proposed rule §§ 252.73–252.74.
33 See proposed rule § 252.72(v). The Financial
Stability Board maintains and periodically
publishes a list of entities that have the
characteristics of a global systemically important
banking organization: http://www.fsb.org/.
29 See
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
counterparty reflects the financial
stability consequences associated with
such credit extensions. A credit
extension between a major covered
company and a major counterparty is
expected to result in a heightened
degree of credit risk to the major
covered company relative to the case in
which a major covered company
extends credit to a counterparty that is
not a major counterparty. The
heightened credit risk arises because
major covered companies and major
counterparties are often engaged in
common business lines and often have
common counterparties and common
funding sources. This creates a
significant degree of commonality in
their economic performance. In
particular, factors that would likely
cause the distress of a major
counterparty would also likely be
expected to simultaneously adversely
affect a major covered company that has
extended credit to the major
counterparty. As a result, such credit
extensions would be expected to present
more credit risk, and greater potential
for financial instability, than a credit
extension made by a major covered
company to a counterparty that is not a
major counterparty.
In a white paper that has been
released in conjunction with these
proposed rules, Board staff has analyzed
data on the default correlation between
systemically important financial
institutions (SIFIs) as well as data on the
default correlation between SIFIs and a
sample of non-SIFI companies.34 The
analysis supports the view that the
correlation between SIFIs, and hence
the correlation between major covered
companies and major counterparties, is
measurably higher than the correlation
between SIFIs and other companies.
This finding further supports the view
that credit extensions between SIFIs,
and hence by a major covered company
to a major counterparty, present a higher
degree of risk and the potential for
greater financial instability than credit
extensions of a major covered company
to a non-major counterparty.
Because credit extensions of a major
covered company to a major
counterparty present a heightened
degree of credit risk and a greater
potential for heightened financial
instability, the Board is proposing to set
a more stringent single-counterparty
credit limit for credit extensions
between a major covered company and
34 See Calibrating the Single-Counterparty Credit
Limit between Systemically Important Financial
Institutions. For purposes of the white paper, SIFIs
include global systemically important banking
organizations and nonbank financial companies
designated by FSOC for supervision by the Board.
PO 00000
Frm 00008
Fmt 4701
Sfmt 4702
a major counterparty of 15 percent
rather than the statutory limit of 25
percent. The more stringent credit limit
of 15 percent is informed by the results
of a credit risk model that is described
in detail in the white paper. More
specifically, data on correlations, as
described above, is used to calibrate a
credit risk model. The credit risk model
is then used to set the singlecounterparty credit limit between SIFIs
such that the amount of credit risk that
a SIFI is permitted to incur through
extensions of credit to another SIFI is no
greater than the amount of credit risk
that the SIFI would be permitted to
incur through extensions of credit to a
non-SIFI under the 25 percent limit
applicable to such exposures. The
resulting calibrated model produces
inter-SIFI single-counterparty credit
limits that are in line with the proposed
limit of 15 percent.
An additional consideration that is
not considered explicitly in the context
of the white paper’s credit risk model,
but which should influence the
calibration of the credit limit between
major covered companies and major
counterparties, is the relative difference
in adverse consequences arising from
multiple SIFI defaults relative to the
default of a SIFI and non-SIFI
counterparty. The financial stability
consequences of multiple SIFI defaults
caused by the default of a SIFI borrower
and the resulting default of a SIFI lender
are likely substantially greater than the
adverse consequences that would result
from the default of a single SIFI lender
and a single non-SIFI borrower. As a
result, there is a compelling rationale to
require that credit risk posed by interSIFI credit extensions be materially
smaller than that posed by credit
extensions between a SIFI lender and
non-SIFI borrower. This consideration
suggests that an appropriate inter-SIFI
single-counterparty credit limit would
be even lower than the 15 percent limit
suggested by the calibrated credit risk
model that is presented in the white
paper.
Accordingly, the more stringent 15
percent single-counterparty credit limit
on credit exposures of a major covered
company to a major counterparty should
help to mitigate risks to U.S. financial
stability. The Board seeks comment on
the analytical rationale that has been
presented for a tighter singlecounterparty credit limit for exposures
of a major covered company to a major
counterparty. The Board also invites
comment on the data, analysis, and
economic model that is used in the
white paper to support the proposed
more stringent limit. Commenters are
encouraged to provide any specific
E:\FR\FM\16MRP2.SGM
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
analyses that could be used to support
an alternative view on the appropriate
level of the single-counterparty credit
limit between major covered companies
and major counterparties.
Question 9: Should more stringent
credit exposure limits apply to credit
exposures of a major covered company
to a major counterparty than would
apply to other credit exposures?
Question 10: Are the proposed
definitions of a ‘‘major covered
company’’ and a ‘‘major counterparty’’
appropriate? What alternative
definitions should the Board consider?
Question 11: Should more stringent
credit exposure limits apply to
exposures of major covered companies
to a nonbank financial company that
has been designated by FSOC for Board
supervision? Should more stringent
limits also apply to exposures of a major
covered company to other entities that
have been designated as global
systemically important financial
institutions by the Financial Stability
Board ( e.g., global systemically
important insurance companies)? If so,
what limits should apply?
Question 12: What other limits or
modifications to the proposed limits on
aggregate net credit exposure should the
Board consider? For example, should
the Board consider developing aggregate
exposure limits to certain categories of
firms (e.g., a limit on the aggregate
amount of credit exposure that a major
covered company can have to all major
counterparties)? How should the Board
identify any such categories and the
applicable exposure thresholds?
Gross Credit Exposure
As noted, the proposed rule would
impose limits on a covered company’s
aggregate net credit exposure, rather
than aggregate gross credit exposure, to
a counterparty. The key difference
between these two amounts is that a
company’s net credit exposure would
take into account any available credit
risk mitigants, such as collateral,
guarantees, credit or equity derivatives,
and other hedges, provided the credit
risk mitigants meet certain requirements
in the rule, as discussed more fully
below. For example, if a covered
company had $100 in gross credit
exposure to a counterparty with respect
to a particular credit transaction, and
the counterparty pledged collateral with
an adjusted market value of $50, the full
amount of which qualified as ‘‘eligible
collateral’’ under the rule, the covered
company’s net credit exposure to the
counterparty on the transaction would
be $50.
In order to calculate its aggregate net
credit exposure to a counterparty, a
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
covered company first would calculate
its gross credit exposure to the
counterparty on each credit transaction
in accordance with certain valuation
and other requirements under the rule.
Second, the covered company would
reduce its gross credit exposure amount
based on eligible credit risk mitigants to
determine its net credit exposure for
each credit transaction with the
counterparty. Third and finally, the
covered company would sum all of its
net credit exposures to the counterparty
to calculate the covered company’s
aggregate net credit exposure to the
counterparty. It is this final amount, the
aggregate net credit exposure, that
would be subject to a credit exposure
limit under the rule.
With respect to a credit exposure
involving eligible collateral or an
eligible protection provider, the
proposed rule would apply a ‘‘riskshifting’’ approach. In general, any
reduction in the exposure amount to the
original counterparty relating to the
eligible collateral or eligible protection
provider would result in a dollar-fordollar increase in exposure to the
eligible collateral issuer or eligible
protection provider (as applicable). For
example, in the case discussed above
where a covered company had $100 in
gross credit exposure to a counterparty
and the counterparty pledged collateral
with an adjusted market value of $50,
the covered company would have net
credit exposure to the counterparty on
the transaction of $50 and net credit
exposure to the issuer of the collateral
of $50.
However, in cases where a covered
company hedges its exposure to an
entity that is not a ‘‘financial entity’’ (a
non-financial entity) using an eligible
credit or equity derivative, and the
underlying exposure is subject to the
Board’s market risk capital rule (12 CFR
part 217, subpart F), the covered
company would calculate its exposure
to the eligible protection provider using
methodologies that it is permitted to use
under the Board’s risk-based capital
rules. For these purposes, a ‘‘financial
entity’’ would include regulated U.S.
financial institutions, such as insurance
companies, broker-dealers, banks,
thrifts, and futures commission
merchants, as well as foreign banking
organizations and a non-U.S.-based
securities firm or a non-U.S.-based
insurance company subject to
consolidated supervision and regulation
comparable to that imposed on U.S.
depository institutions, securities
broker-dealers, or insurance
companies.35 ‘‘Financial entities’’
35 See
PO 00000
proposed rule § 252.71(q).
Frm 00009
Fmt 4701
Sfmt 4702
14335
would also include companies whose
primary business includes the
management of financial assets, lending,
factoring, leasing, provision of credit
enhancements, securitization,
investments, financial custody, central
counterparty services, proprietary
trading, insurance, and other financial
services.36
Question 13: Is the definition of a
‘‘financial entity’’ sufficiently clear? If
not, what further guidance should be
provided?
Section 252.73 of the proposed rule
explains in detail how a covered
company would calculate its ‘‘gross
credit exposure’’ with respect to a
counterparty. Gross credit exposure
would be defined to mean, with respect
to any credit transaction, the credit
exposure of the covered company to the
counterparty before adjusting for the
effect of any qualifying master netting
agreements, eligible collateral, eligible
guarantees, eligible credit derivatives
and eligible equity derivatives, and
other eligible hedges (i.e., a short
position in the counterparty’s debt or
equity securities).37 Consistent with the
statutory definition of credit exposure,
the proposed rule defines ‘‘credit
transaction’’ to mean, with respect to a
counterparty, any (i) extension of credit
to the counterparty, including loans,
deposits, and lines of credit, but
excluding advised or other
uncommitted lines of credit; (ii)
repurchase or reverse repurchase
agreement with the counterparty; (iii)
securities lending or securities
borrowing transaction with the
counterparty; (iv) guarantee, acceptance,
or letter of credit (including any
confirmed letter of credit or standby
letter of credit) issued on behalf of the
counterparty; (v) purchase of, or
investment in, securities issued by the
counterparty; (vi) credit exposure to the
counterparty in connection with a
derivative transaction between the
covered company and the counterparty;
(vii) credit exposure to the counterparty
in connection with a credit derivative or
equity derivative transaction between
the covered company and a third party,
the reference asset of which is an
obligation or equity security issued by
the counterparty; 38 and (viii) any
transaction that is the functional
equivalent of the above, and any similar
transaction that the Board determines to
36 Id.
37 See proposed rule § 252.71(r). Section 252.74 of
the proposed rule explains how these adjustments
are made.
38 ‘‘Credit derivative’’ and ‘‘equity derivative’’ are
defined in sections 252.71(g) and (p) of the
proposed rule, respectively.
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
14336
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
be a credit transaction for purposes of
this subpart.39
Section 252.73 describes how the
gross credit exposure of a covered
company to a counterparty should be
calculated for each type of credit
transaction described above.40 In
general, the methodologies contained in
the proposed rule are similar to those
used to calculate credit exposure under
the standardized risk-based capital rules
for bank holding companies.41 More
specifically, section 252.73(a) of the
proposed rule provides that, for
purposes of calculating gross credit
exposure:
(1) The value of loans by a covered
company to a counterparty (and leases
in which the covered company is the
lessor and the counterparty is the lessee)
would be equal to the amount owed by
the counterparty to the covered
company under the transaction;
(2) The value of debt securities held
by the covered company that are issued
by the counterparty would be equal to
the market value of the securities (in the
case of trading and available-for-sale
securities) or the amortized purchase
price of the securities (in the case of
securities that are held to maturity);
(3) The value of equity securities held
by the covered company that are issued
by the counterparty would be equal to
the market value of such securities;
(4) The value of repurchase
agreements would be equal to the
adjusted market value of the securities
transferred by the covered company to
the counterparty;
(5) The value of reverse repurchase
agreements would be equal to the
amount of cash transferred by the
covered company to the counterparty;
(6) The value of securities borrowing
transactions would be equal to the sum
of the amount of cash collateral
transferred by the covered company to
the counterparty and the adjusted
market value of the securities collateral
transferred to the counterparty;
(7) The value of securities lending
transactions would be equal to the
adjusted market value of the securities
lent by the covered company to the
counterparty;
(8) Committed credit lines extended
by a covered company to the
counterparty would be valued at the
face amount of the credit line;
(9) Guarantees and letters of credit
issued by a covered company on behalf
39 See proposed rule § 252.71(h). The definition of
‘‘credit transaction’’ in the proposed rule is similar
to the definition of ‘‘credit exposure’’ in section
165(e) of the Dodd-Frank Act. See 12 U.S.C.
5365(e)(3).
40 See proposed rule § 252.73(a)(1)–(12).
41 12 CFR part 217, subpart D.
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
of the counterparty would be equal to
the maximum potential loss to the
covered company on the transaction;
(10) Derivative transactions between
the covered company and the
counterparty not subject to a qualifying
master netting agreement would be
valued in an amount equal to the sum
of the current exposure of the
derivatives contract and the potential
future exposure of the derivatives
contract, calculated using
methodologies that the covered
company is permitted to use under
Regulation Q (12 CFR part 217, subparts
D and E);
(11) Derivative transactions between
the covered company and the
counterparty subject to a qualifying
master netting agreement would be
valued in an amount equal to the
exposure at default amount calculated
using methodologies that the covered
company is permitted to use under
subpart E of Regulation Q (12 CFR part
217); and
(12) Credit or equity derivative
transactions between the covered
company and a third party where the
covered company is the protection
provider and the reference asset is an
obligation or equity security of the
counterparty, would be valued in an
amount equal to the maximum potential
loss to the covered company on the
transaction.
Under the proposed rule, trading and
available-for-sale debt securities held by
the covered company, as well as equity
securities, would be valued for purposes
of single-counterparty credit limits
based on their market value. This
approach would require a covered
company to revalue upwards the
amount of an investment in such
securities when the market value of the
securities increases. In these
circumstances, the re-valuation would
reflect the covered company’s greater
financial exposure to the counterparty
and would reduce the covered
company’s ability to engage in
additional transactions with the
counterparty. In circumstances where
the market value of the securities falls,
however, a covered company under the
proposal would revalue downwards its
exposure to the issuer of the securities.
This reflects the fact that, just as an
increase in the value of a security
results in greater exposure to the issuer
of that security, a decrease in the value
of the security leaves a firm with less
exposure to that issuer.
Question 14: Should the Board
provide further guidance regarding the
calculation of the ‘‘market value’’ of a
debt or equity security, particularly for
securities that are illiquid or otherwise
PO 00000
Frm 00010
Fmt 4701
Sfmt 4702
hard-to-value? If so, what guidance
should be provided?
In the context of repurchase
agreements, securities borrowing
transactions, and securities lending
transactions, the ‘‘adjusted market
value’’ of a security would mean the
sum of (i) the market value of the
security and (ii) the market value of the
security multiplied by the product of (a)
the collateral haircut set forth in Table
1 to section 217.132 of the Board’s
Regulation Q (12 CFR 217.132) that is
applicable to the security and (b) the
square root of 1⁄2.42 The purpose of
adjusting the value of a security in this
manner is to capture the market
volatility (and associated potential
increase in counterparty credit
exposure) of the securities transferred or
lent by the covered company in these
transactions. Multiplying the values in
Table 1 to section 217.132 of the Board’s
Regulation Q by the square root of 1⁄2
would align with the requirements in
the Board’s risk-based capital rules,
which assume a 5-day liquidation
period for ‘‘repo-style’’ transactions,43
rather than the 10-day liquidation
period that is assumed for other
transactions. With respect to derivative
transactions between a covered
company and a counterparty that are not
subject to a qualifying master netting
agreement, the gross credit exposure of
a covered company to the counterparty
would be valued as the sum of the
current exposure and the potential
future exposure of the contract.44 With
respect to derivative transactions
between a covered company and a
counterparty that are subject to a
qualifying master netting agreement, the
proposed rule would require covered
companies to calculate gross credit
exposure to a counterparty as the
amount that would be calculated using
any methodologies that the covered
company is permitted to use under the
Board’s risk-based capital rules (12 CFR
part 217, subpart D and E).45 This
approach would allow certain covered
companies to calculate counterparty
exposures for derivatives transactions
subject to a qualifying master netting
agreement using the internal model
method in the Board’s Regulation Q (12
CFR part 217, subpart E). The Board is
42 See
proposed rule § 252.71(a).
‘‘repo-style’’ transaction is a repurchase or
reverse repurchase transaction, or a securities
borrowing or lending transaction, that meets certain
criteria. See 12 CFR 217.2.
44 See proposed rule § 252.73(a)(10). ‘‘Qualifying
master netting agreement’’ is defined in section
252.71(z) of the proposed rule in a manner
consistent with the Board’s advanced risk-based
capital rules for bank holding companies.
45 See proposed rule § 252.73(a)(11).
43 A
E:\FR\FM\16MRP2.SGM
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
proposing this approach, rather than
proposing to require all covered
companies to use CEM because of
concerns that CEM may not take fully
into account correlations and netting
relationships, and therefore, under
certain circumstances, may overstate
counterparty credit risk.
The Board notes, however, that the
BCBS has recently finalized a revised
standardized approach (SA–CCR) for
measuring credit exposure to a
derivatives counterparty.46 The Board
expects to consider the benefits of
incorporating SA–CCR in the singlecounterparty credit limit rule at such
time as the Board considers the benefits
of SA–CCR for risk-based capital
purposes.
With respect to derivative
transactions between a covered
company and a third party, where the
covered company is the protection
provider and the reference asset is an
obligation or equity security of the
counterparty, the credit exposure of the
covered company to the counterparty
would be equal to the maximum
potential loss to the covered company
on the transaction.47
With respect to cleared and uncleared
derivatives, the amount of initial margin
and excess variation margin (i.e.,
variation margin in excess of that
needed to secure the mark-to-market
value of a derivative) posted to a
bilateral or central counterparty would
be treated as credit exposure to the
counterparty unless the margin is held
in a segregated account at a third party
custodian.
Section 252.73(c) of the proposed rule
includes the statutory attribution rule,
which provides that a covered company
must treat a transaction with any person
as a credit exposure to a counterparty to
the extent the proceeds of the
transaction are used for the benefit of,
or transferred to, that counterparty.48
This attribution rule seeks to prevent
firms from evading the singlecounterparty credit limits by using
intermediaries and thereby avoiding a
direct credit transaction with a
particular counterparty. It is the Board’s
intention to avoid interpreting the
attribution rule in a manner that would
impose undue burden on covered
companies by requiring firms to monitor
46 See
http://www.bis.org/publ/bcbs279.htm.
proposed rule § 252.73(a)(12). ‘‘Credit
derivative’’ is defined in § 252.71(g) of the proposed
rule, and ‘‘equity derivative’’ is defined in
§ 252.71(p) of the proposed rule. ‘‘Derivative
transaction’’ is defined in § 252.71(j) of the
proposed rule in the same manner as it is defined
in the National Bank Act, as amended by section
610 of the Dodd-Frank Act. See 12 U.S.C. 84(b)(3).
48 See proposed rule § 252.73(c); see also 12
U.S.C. 5365(e)(4).
47 See
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
and trace the proceeds of transactions
made in the ordinary course of business.
In general, credit exposures resulting
from transactions made in the ordinary
course of business will not be subject to
the attribution rule.
Question 15: The Board invites
comment on all aspects of the proposed
approaches for calculating gross credit
exposures.
Question 16: With respect to
derivative transactions, the Board
invites comment on the proposed
reliance on the methodologies covered
companies are permitted to use under
the risk-based capital rules. Should
covered companies instead be required
to use CEM? Should the singlecounterparty credit limits rule
ultimately require use of SA–CCR or a
similar standardized approach to
measure a covered company’s credit
exposure to derivatives counterparties?
Question 17: With respect to credit or
equity derivative transactions between
the covered company and a third party,
where the covered company is the
protection provider and the reference
asset is an obligation or equity security
of the counterparty, is it sufficiently
clear how a covered company would
calculate its ‘‘maximum potential loss’’?
What additional guidance, if any,
should the Board provide?
Question 18: With respect to credit
derivatives, equity derivatives,
guarantees, and letters of credit, are
there cases in which ‘‘maximum
potential loss to the covered company’’
arising from the transaction is
indeterminate? How should singlecounterparty credit limits apply in those
instances?
Question 19: The Board invites
comment on ways to apply the statutory
attribution rule in a manner that would
be consistent with the goal of preventing
evasion of the single-counterparty credit
limits without imposing undue burden
on covered companies. Is additional
regulatory clarity around the attribution
rule necessary? What is the potential
cost or burden of applying the
attribution rule as proposed?
Net Credit Exposure
As noted, the proposed rule would
impose limits on a covered company’s
net credit exposure to a counterparty.
‘‘Net credit exposure’’ would be defined
to mean, with respect to any credit
transaction, the gross credit exposure of
a covered company calculated under
section 252.73, as adjusted in
accordance with section 252.74.49
Section 252.74 of the proposed rule
explains how a covered company would
49 See
PO 00000
proposed rule § 252.71(x).
Frm 00011
Fmt 4701
Sfmt 4702
14337
convert gross credit exposure amounts
to net credit exposure amounts by
taking into account eligible collateral,
eligible guarantees, eligible credit and
equity derivatives, other eligible hedges
(for example, a short position in the
counterparty’s debt or equity securities),
and for securities financing transactions,
the effect also of bilateral netting
agreements.50
Calculation of Net Credit Exposure for
Securities Financing Transactions
With respect to any repurchase
transaction, reverse repurchase
transaction, securities lending
transaction, and securities borrowing
transaction with a counterparty that is
subject to a bilateral netting agreement
with that counterparty and that meets
the definition of ‘‘repo-style
transaction’’ in section 217.2 of the
Board’s Regulation Q (12 CFR 217.2), a
covered company’s net credit exposure
to a counterparty generally would be
equal to the exposure at default amount
calculated under section 217.37(c)(2) of
the Board’s Regulation Q (12 CFR
217.37(c)(2)), applying standardized
supervisory haircuts as provided in 12
CFR 217.37(c)(3)(iii).51 A covered
company would not be permitted to
apply its own internal estimates for
haircuts. Further, in calculating its net
credit exposure to a counterparty as a
result of such transactions, a covered
company would be required to disregard
any collateral received from that
counterparty that does not meet the
definition of ‘‘eligible collateral’’ in
§ 252.71(k).
The proposal would also require a
covered company to recognize a credit
exposure to any issuer of eligible
collateral that is used to reduce the
covered company’s gross credit
exposure from a transaction described
in the preceding paragraph. The amount
of credit exposure that a covered
company would be required to
recognize to an issuer of such collateral
would be equal to the market value of
the collateral minus the standardized
supervisory haircuts provided in 12 CFR
217.37(c)(2)(ii). However, in no event
would the amount of credit exposure
that a covered company is required to
recognize to such a collateral issuer be
in excess of its gross credit exposure to
the counterparty on the original credit
transaction.
Some commenters on the 2011 section
165(e) proposed rule objected to the
50 See
proposed rule § 252.74.
to 12 CFR 217.37(c)(3)(iii), a bank that
is engaged in a repo-style transaction may multiply
the standardized supervisory haircuts that would
otherwise apply pursuant to Table 1 to § 217.37 of
the Board’s Regulation Q by the square root of 1⁄2.
51 Pursuant
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
14338
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
proposed methodology for netting
securities financing transactions as
overly conservative. The commenters
generally argued that the proposed
approach implied unrealistic
assumptions about correlations among
securities that a covered company
transfers to its counterparty and
received from that counterparty. For
example, if a covered company loans
equity securities to a counterparty and
receives equity securities from the
counterparty as collateral, the proposed
methodology implied that, upon the
counterparty’s default, the value of the
equities transferred to the counterparty
would increase in value while the value
of the equities received would decrease
in value.
In developing this proposed rule, the
Board considered several alternatives to
address these concerns. First, the Board
considered allowing covered firms only
to apply valuation adjustments to one
side of a securities financing transaction
where the securities transferred and
received from a counterparty are of the
same asset class. For example, if a
covered company loans equity securities
to a counterparty and receives equity
securities from the counterparty as
collateral, the covered company could
be permitted to apply valuation
adjustments only to the value of the
equity securities that have been
transferred to the counterparty. This
would be a relatively simple way of
taking account of the fact that securities
in the same asset class tend to be
somewhat positively correlated.
Second, the Board considered a
methodology similar to the one recently
proposed by the BCBS in its second
consultative document on potential
revisions to the standardized approach
to credit risk.52 Under the formula
proposed by the Basel Committee, an
entity’s exposure for repo-style
transactions would be equal to 40
percent of its ‘‘net exposure’’ from the
transaction plus 60 percent of its ‘‘gross
exposure’’ divided by the square root of
the number of security issues in the
netting set. In this formula, the ‘‘net
exposure’’ term is intended to reflect the
effect of netting long positions and short
positions because the volatility haircuts
that would apply to long positions
would be allowed to offset those that
apply to short positions. Although
volatility haircuts would not offset
when calculating gross exposure, gross
exposure would reflect the effect of
diversification by dividing the gross
exposure amount by the square root of
the number of exposures.
52 http://www.bis.org/bcbs/publ/d347.pdf.
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
Third, the Board considered allowing
credit exposure from repo-style
transactions to be measured using
standardized correlation matrices.
Under this approach, securities would
be divided into a handful of asset
classes (for example, sovereign
securities, corporate and municipal
debt, and equities). Based on
distinctions between asset classes,
specific assumptions about correlations
within portfolios of securities
transferred to or received from a
counterparty, as well as assumptions
about correlations across portfolios of
securities transferred and received,
would be provided. These standardized
correlation assumptions, together with
standardized volatility haircuts for the
relevant securities, would serve as
inputs into a formula that would yield
an estimate of a covered company’s
credit exposure to its counterparty.
Again, this could provide a more
accurate way of taking into account
correlations among securities.
The first alternative would permit a
covered company to apply valuation
adjustments to only one side of a
securities financing transaction where
the securities transferred and received
from a counterparty are of the same
asset class. While this approach is
meant to reflect the fact that securities
in the same asset class are generally
positively correlated, some securities in
the same asset class may also be
negative correlated. In addition,
assumptions about asset correlations
based on observations during normal
times may break down during periods of
extreme market turbulence, when large
credit exposures of financial institutions
to their counterparties could pose the
greatest risk to financial stability. The
second and third alternatives would
increase the complexity of the
framework and potentially make the
framework susceptible to arbitrage. For
the foregoing reasons, the proposed rule
does not include these alternatives.
Question 20: Should the Board
consider alternative approaches to
measuring the net credit exposure from
securities financing transactions? What
are the advantages and disadvantages of
such alternative measurement
approaches relative to the proposed
approach?
Collateral
Section 252.74(c) of the proposed rule
describes how eligible collateral would
be taken into account in the calculation
of net credit exposure.53 ‘‘Eligible
collateral’’ would be defined to include
cash on deposit with a covered
53 See
PO 00000
proposed rule § 252.74(c).
Frm 00012
Fmt 4701
Sfmt 4702
company (including cash held for the
covered company by a third-party
custodian or trustee); debt securities
(other than mortgage- or asset-backed
securities 54) that are bank-eligible
investments and that have an
investment grade rating; equity
securities that are publicly traded; or
convertible bonds that are publicly
traded.55 For any of these asset types to
count as eligible collateral for a credit
transaction, the covered company
generally would be required to have a
perfected, first priority security interest
in the collateral or the legal equivalent
thereof, if outside of the United States.
This list of eligible collateral would be
similar to the list of eligible collateral in
Regulation Q.56
In computing its net credit exposure
to a counterparty with respect to a credit
transaction, a covered company would
be required to reduce its gross credit
exposure on the transaction by the
adjusted market value of any eligible
collateral.57 Other than in the context of
repo-style transactions, the ‘‘adjusted
market value’’ of eligible collateral
would be defined in section 252.71(a) of
the proposed rule to mean the fair
market value of the eligible collateral
after application of the applicable
haircut specified in Table 1 to section
217.132 of the Board’s Regulation Q for
that type of eligible collateral.58
The net credit exposure of a covered
company to a counterparty on a credit
transaction is the gross credit exposure
of the covered company on the
transaction minus the adjusted market
value of any eligible collateral related to
the transaction.59 In addition, under the
54 The proposed rule generally would exclude
mortgage-backed securities and other asset-backed
securities from the definition of ‘‘eligible collateral’’
because of concerns that those securities may be
more likely than other securities to become illiquid
and lose value during periods of financial
instability. However, asset-backed securities
guaranteed by a U.S. government sponsored entity,
such as Ginnie Mae, Fannie Mae, or Freddie Mac,
would qualify as eligible collateral under the
proposed rule.
55 See proposed rule § 252.71(k); see also 12 CFR
252.2(p) (defining ‘‘publicly traded’’).
56 See 12 CFR 217.2.
57 See proposed rule § 252.74(c).
58 Table 1 to section 217.132 of the Board’s
Regulation Q (12 CFR 217.132) provides haircuts for
multiple collateral types, including some types that
do not meet the proposed definition of ‘‘eligible
collateral.’’ Notwithstanding the inclusion of those
collateral types in the reference table, a company
cannot reduce its gross credit exposure for a
transaction with a counterparty based on the
adjusted market value of collateral that does not
meet the definition of ‘‘eligible collateral.’’
59 The Board is proposing to treat eligible
collateral as a gross credit exposure to the collateral
issuer under the Board’s authority under section
165(e) to determine that any other similar
transaction is a credit exposure. See 12 U.S.C.
5365(e)(3)(F).
E:\FR\FM\16MRP2.SGM
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
proposed rule, a covered company
generally must recognize a credit
exposure to the collateral issuer in an
amount equal to the adjusted market
value of the collateral. As such, the
amount of credit exposure to the
original counterparty and the issuer of
the eligible collateral would fluctuate
over time based on the adjusted market
value of the eligible collateral. Collateral
that previously met the definition of
eligible collateral under the proposed
rule but over time ceases to do so would
no longer be eligible to reduce gross
credit exposure.
In effect, the proposed treatment of
eligible collateral would require a
covered company to shift its credit
exposure from the original counterparty
to the issuer of such collateral. This
approach would help to promote a
covered company’s careful monitoring
of its direct and indirect credit
exposures. So as not to discourage
overcollateralization, however, a
covered company’s maximum credit
exposure to the collateral issuer would
be limited to the credit exposure to the
original counterparty.60
A covered company would continue
to have credit exposure to the original
counterparty to the extent that the
adjusted market value of the eligible
collateral does not equal the full amount
of the credit exposure to the original
counterparty.
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Example: A covered company (Company
A) makes a $1,000 loan to a counterparty
(Company B), creating $1,000 of gross credit
exposure to that counterparty, and the
counterparty provides eligible collateral
issued by a third party (Company C) that has
an adjusted market value of $700 on day 1.
Company A would be required to reduce its
credit exposure to Company B by the
adjusted market value of the eligible
collateral. As a result, on day 1, Company A
would have gross credit exposure of $700 to
Company C and $300 net credit exposure to
Company B.
As noted, the amount of credit
exposure to the original counterparty
and the issuer of the eligible collateral
will fluctuate over time based on
movements in the adjusted market value
of the eligible collateral. If the adjusted
market value of the eligible collateral
decreased to $400 on day 2 in the
previous example, on day 2 Company
A’s net credit exposure to Company B
would increase to $600, and its gross
credit exposure to Company C would
decrease to $400. By contrast, if on day
3 the adjusted market value of the
eligible collateral increased to $800, on
day 3 Company A’s net credit exposure
to Company B would decrease to $200,
60 See
proposed rule § 252.74(c)(2).
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
and its gross credit exposure to
Company C would increase to $800. In
each case, the covered company’s total
credit exposure would be capped at the
original amount of the exposure created
by the loan or $1,000—even if the
adjusted market value of the eligible
collateral exceeded $1,000.
Finally, in cases where eligible
collateral is issued by an issuer covered
by one of the exemptions in section
252.76 of the proposed rule or that is
excluded from the proposed definition
of a ‘‘counterparty,’’ the requirement to
recognize an exposure to the collateral
issuer would have no effect.
Example: A covered company makes a
$1,000 loan to a counterparty and that
counterparty has pledged as collateral U.S.
government bonds with an adjusted market
value of $1,000. In this case, the covered
company would not have any net credit
exposure to the original counterparty because
the value of loan and the adjusted market
value of the U.S. government bonds are
equal. Although the covered company would
have $1,000 of exposure to the U.S.
government, single-counterparty credit limits
would not apply to that exposure because
U.S. government bonds are excluded from
the single-counterparty credit limits of the
proposed rule.
Question 21: Should the list of eligible
collateral be broadened or narrowed?
What items should be added or deleted?
Question 22: Should covered
companies have the option of whether
to reduce their gross credit exposures by
recognizing eligible collateral in some or
all cases? If so, should covered
companies nevertheless have to
recognize gross credit exposures to the
issuers of the eligible collateral? Are
there situations in which full shifting of
exposures would not be appropriate?
Question 23: Are the market volatility
haircuts in Table 1 to section 217.132 of
the Board’s Regulation Q (12 CFR
217.132) appropriate for the valuation
of eligible collateral for purposes of this
rule? Should these haircuts be
calibrated differently for purposes of
this rule?
Eligible Guarantees
Section 252.74(d) of the proposed rule
describes how to reflect eligible
guarantees in calculations of net credit
exposure to a counterparty.61 Eligible
guarantees would be defined as
guarantees that meet certain conditions,
including having been written by an
eligible protection provider.62 The
definition of ‘‘eligible protection
provider’’ would be the same as the
proposed rule § 252.74(d).
proposed rule § 252.71(n) for the definition
of ‘‘eligible guarantee’’ and for a description of the
requirements of an eligible guarantee.
definition of ‘‘eligible guarantor’’ in
section 217.2 of Regulation Q. As such,
an eligible protection provider would
include a sovereign, the Bank for
International Settlements, the
International Monetary Fund, the
European Central Bank, the European
Commission, a Federal Home Loan
Bank, the Federal Agricultural Mortgage
Corporation (Farmer Mac), a multilateral
development bank (MDB), a depository
institution, a bank holding company, a
savings and loan holding company, a
credit union, a foreign bank, or a
qualifying central counterparty. An
eligible protection provider also would
include any entity, other than a special
purpose entity, (i) that at the time the
guarantee is issued or anytime
thereafter, has issued and maintains
outstanding an unsecured debt security
without credit enhancement that is
investment grade, (ii) whose
creditworthiness is not positively
correlated with the credit risk of the
exposures for which it has provided
guarantees, and (iii) that is not an
insurance company engaged
predominantly in the business of
providing credit protection (such as a
monoline bond insurer or re-insurer).
In calculating its net credit exposure
to the counterparty, a covered company
would be required to reduce its gross
credit exposure to the counterparty by
the amount of any eligible guarantee
from an eligible protection provider.63
The covered company would then have
to include the amount of the eligible
guarantee when calculating its gross
credit exposure to the eligible protection
provider.64 Also, as is the case with
eligible collateral, a covered company’s
gross credit exposure to an eligible
protection provider (with respect to an
eligible guarantee) could not exceed its
gross credit exposure to the original
counterparty on the credit transaction
prior to the recognition of the eligible
guarantee.65 Accordingly, the exposure
to the eligible protection provider
would be capped at the amount of the
credit exposure to the original
counterparty even if the amount of the
eligible guarantee is larger than the
original exposure. A covered company
would continue to have credit exposure
to the original counterparty to the extent
that the eligible guarantee does not
equal the full amount of the credit
exposure to the original counterparty.
Example: A covered company makes a
$1,000 loan to an unaffiliated counterparty
and obtains a $700 eligible guarantee on the
loan from an eligible protection provider.
61 See
62 See
PO 00000
Frm 00013
Fmt 4701
Sfmt 4702
14339
63 See
proposed rule § 252.74(d).
proposed rule §§ 252.74(d)(1)–(2).
65 See proposed rule § 252.74(d)(2).
64 See
E:\FR\FM\16MRP2.SGM
16MRP2
14340
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
The covered company would have gross
credit exposure of $700 to the protection
provider as a result of the eligible guarantee
and $300 net credit exposure to the original
counterparty.
Example: A covered company makes a
$1,000 loan to an unaffiliated counterparty
and obtains a $1,500 eligible guarantee from
an eligible protection provider. The covered
company would have $1,000 gross credit
exposure to the protection provider (capped
at the amount of the exposure to the
unaffiliated counterparty), but the covered
company would have no net credit exposure
to the original counterparty as a result of the
eligible guarantee.
As with eligible collateral, a covered
company would be required to reduce
its gross exposure to a counterparty by
the amount of an eligible guarantee in
order to ensure that concentrations in
exposures to guarantors are captured by
the risk-shifting approach. This
requirement is meant to limit the ability
of a covered company to extend loans or
other forms of credit to a large number
of high risk borrowers that are
guaranteed by a single guarantor.
Question 24: Should the definition of
eligible guarantee or eligible protection
provider be expanded or narrowed? Are
there any additional or alternative
requirements the Board should place on
eligible protection providers to ensure
their capacity to perform on their
guarantee obligations?
Question 25: Under what
circumstances, if any, should covered
companies have the option of whether
(1) to fully shift exposures to eligible
protection providers in the case of
eligible guarantees or (2) divide an
exposure between the original
counterparty and the eligible protection
provider in some manner? If so, should
covered companies nevertheless have to
recognize gross credit exposures to the
issuers of the eligible collateral? Are
there situations in which full shifting of
exposures would not be appropriate?
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Eligible Credit and Equity Derivative
Hedges
Section 252.74(e) sets forth the
proposed treatment of eligible credit
and equity derivatives in the case where
the covered company is the protection
purchaser.66 In the case where a covered
company is a protection purchaser, such
derivatives can be used to mitigate gross
credit exposure. A covered company
may only recognize credit and equity
derivative hedges that qualify as eligible
credit and equity derivative hedges for
purposes of calculating net credit
exposure under the proposed rule.67
66 See
proposed rule § 252.74(e).
67 By contrast, in section 252.73(a)(12) of the
proposed rule, where the covered company is the
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
These derivatives would be required to
meet certain criteria, including having
been written by an eligible protection
provider.68 An eligible credit derivative
hedge would need to be simple in form,
meaning a single-name or standard,
non-tranched index credit derivative.
An eligible equity derivative hedge must
be in the form of an equity-linked total
return swap and would not include
other, more complex forms of equity
derivatives, such as purchased equitylinked options.
The proposed treatment of eligible
credit and equity derivatives would be
similar to the proposed treatment of
eligible guarantees. A covered company
would be required to reduce its gross
credit exposure to a counterparty by the
notional amount of any eligible credit or
equity derivative hedge that references
the counterparty if the covered company
obtains the derivative from an eligible
protection provider.69 In these
circumstances, the covered company
generally would be required to include
the notional amount of the eligible
credit or equity derivative hedge in
calculating its gross credit exposure to
the eligible protection provider.70 As is
the case for eligible collateral and
eligible guarantees, the gross exposure
to the eligible protection provider
would in no event be greater than it was
to the original counterparty prior to
recognition of the eligible credit or
equity derivative.71
For eligible credit and equity
derivatives that are used to hedge
covered positions subject to the Board’s
market risk rule (12 CFR part 217,
subpart F), the approach would be the
same as that explained above, except in
the case of credit derivatives where the
counterparty on the hedged transaction
is not a financial entity. In this case, a
covered company would be required to
reduce its gross credit exposure to the
counterparty on the hedged transaction
by the notional amount of the eligible
credit derivative that references the
counterparty if the covered company
obtains the derivative from an eligible
protection provider. In addition, the
protection provider, any credit or equity derivative
written by the covered company is included in the
calculation of the covered company’s gross credit
exposure to the reference obligor.
68 See proposed rule §§ 252.71(l) and (m) defining
‘‘eligible credit derivative’’ and ‘‘eligible equity
derivative,’’ respectively. ‘‘Eligible protection
provider’’ is defined in § 252.71(o) of the proposed
rule. The same types of organizations that are
eligible protection providers for the purposes of
eligible guarantees are eligible protection providers
for purposes of eligible credit and equity
derivatives.
69 See proposed rule § 252.74(e).
70 See proposed rule §§ 252.74(e)(1)–(2).
71 See proposed rule § 252.74(e)(2)(i).
PO 00000
Frm 00014
Fmt 4701
Sfmt 4702
covered company would be required to
recognize a credit exposure to the
eligible protection provider that is
measured using methodologies that the
covered company is authorized to use
under the Board’s risk-based capital
rules (12 CFR part 217, subparts D and
E), rather than the notional amount.72
Example: A covered company holds a
$1,000 bond issued by a non-financial entity
(for example, a commercial firm or sovereign)
that is a covered position subject to the
Board’s market risk rule, and the covered
company purchases an eligible credit
derivative in a notional amount of $800 from
Protection Provider X, which is an eligible
protection provider, to hedge its exposure to
the non-financial entity. The covered
company would continue to have $200 in net
credit exposure to the non-financial entity. In
addition, the covered company would treat
Protection Provider X as a counterparty, and
would measure its exposure to Protection
Provider X using any methodology that the
covered company is permitted to use under
Regulation Q to calculate its risk-based
capital requirements.
Example: A covered company holds as a
covered position subject to the Board’s
market risk rule a $1,000 bond issued by a
financial entity (for example, a banking
organization), and the covered company
purchases an eligible credit derivative in a
notional amount of $800 from Protection
Provider X, which is an eligible protection
provider, to hedge its exposure to the
financial entity. The covered company would
continue to have credit exposure of $200 to
the underlying financial entity. In addition,
the covered company would now treat
Protection Provider X as a counterparty, and
would have an $800 credit exposure to
Protection Provider X.
As with eligible collateral and eligible
guarantees, a covered company would
be required to reduce its gross exposure
to a counterparty by the amount of an
eligible equity or credit derivative, and
to recognize an exposure to an eligible
protection provider, in order to ensure
that concentrations in exposures to
eligible protection providers are
captured in the regime. However, many
commenters on the 2011 proposed rule
argued that requiring a full notional
shifting of risk in the context of credit
derivatives was overly conservative,
since a covered company would only
experience losses in cases where both
the original counterparty and the
protection provider default. As such,
these commenters recommended
allowing covered companies to measure
exposures from credit derivative hedges
using the methodologies permitted for
derivatives more generally.
72 At such time as the Board may consider
incorporation of SA–CCR into the U.S. risk-based
capital rules, the Board may consider requiring SA–
CCR to be used for this purpose as well.
E:\FR\FM\16MRP2.SGM
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
The proposed rule includes this
modification for credit derivatives that
are used to hedge covered positions
subject to the market risk rule, where
the credit derivative is used to hedge an
exposure to an entity that is not a
financial entity. The proposed rule
would require full notional risk-shifting
for credit derivatives used to hedge
exposures to financial entities because
most protection providers are financial
entities, and when both the protection
provider and the reference entity are
financial entities, the probability of
correlated defaults generally is
substantially greater than when
protection is sold on non-financial
reference entities.
In cases where a covered company is
required to shift its credit exposure from
the counterparty to an eligible
protection provider pursuant to section
252.74(e), the covered company would
be permitted to exclude the relevant
equity or credit derivative when
calculating its gross exposure to the
eligible protection provider under
sections 252.74(a)(10) and 252.94(a)(11).
This is to avoid requiring covered
companies to double count the same
exposures.
Question 26: Should the proposed
definitions of eligible credit derivative or
eligible equity derivative be expanded or
narrowed? In particular, are there more
complex forms of derivatives that
should be eligible hedges?
Question 27: Under what
circumstances, if any, should covered
companies be permitted not to recognize
an eligible credit or equity derivative
hedge, or to apportion the exposure
between the original counterparty and
the eligible protection provider?
Question 28: To the extent that
covered companies will be required to
shift exposures to protection providers
in the case of eligible credit or equity
derivative hedges, would the proposed
approach result in recognition of the
proper amount of exposure by a covered
company to an eligible protection
provider? If not, what modifications
should the Board consider?
Other Eligible Hedges
Under the proposed rule, a covered
company would be allowed to reduce its
credit exposure to a counterparty by the
face amount of a short sale of the
counterparty’s debt or equity securities,
provided that the instrument in which
the covered company has a short
position is junior to, or pari passu with,
the instrument in which the covered
company has the long position.73 This
restriction on the set of short positions
73 See
proposed rule § 252.74(f).
VerDate Sep<11>2014
20:35 Mar 15, 2016
Jkt 238001
permitted to offset long positions would
help to ensure that any loss arising from
the covered company’s long exposure is
offset by a gain in the covered
company’s short exposure.
Example: A covered company holds $100
of bonds issued by Company X. If the
covered company sells short $100 of equity
shares issued by Company X, the covered
company would not have any net credit
exposure to Company X. Similarly, the
covered company would not have any net
credit exposure to Company X if it sells short
$100 of Company X’s debt obligations,
provided that those obligations are junior to,
or pari passu with, the Company X bonds
that the covered company holds.
Question 29: Should the Board permit
short positions to offset long positions
only if the short position is in an
instrument that is junior to, or pari
passu with, the instrument that gives
rise to the firm’s long exposure?
Question 30: Should the Board place
any additional requirements, including
maturity match requirements, on short
positions that are eligible to offset long
positions? To the extent that there is a
maturity mismatch between the
positions, should the value of the short
position be subject to application of the
maturity mismatch adjustment
approach of § 217.36(d) of the Board’s
Regulation Q?
Treatment of Maturity Mismatches
The above discussion of credit risk
mitigation techniques (collateral,
guarantees, equity and credit
derivatives, and offsetting short
positions) assumes that the residual
maturity of the credit risk mitigant is
greater than or equal to that of the
underlying exposure. If the residual
maturity of the credit risk mitigant is
less than that of the underlying
exposure, the credit risk mitigant would
only be recognized under the proposed
rule if the credit risk mitigant’s original
maturity is equal to or greater than one
year and its residual maturity is not less
than three months from the current date.
In that case, the reduction in the
underlying exposure would be adjusted
based on the same approach that is used
in the Board’s Regulation Q (12 CFR
part 217) to address a maturity
mismatch.74
With respect to the amount of
exposure that a covered company would
need to recognize to the issuer of
74 A
credit risk mitigant would be adjusted using
the formula Pa = P × (t¥0.25)/(T¥0.25), where Pa
is the value of the credit protection adjusted for
maturity mismatch; P is the credit protection
adjusted for any haircuts; t is the lesser of (1) T or
(2) the residual maturity of the credit protection,
expressed in years; and T is the lesser of (1) 5 or
(2) the residual maturity of the exposure, expressed
in years. See 12 CFR 217.36(d).
PO 00000
Frm 00015
Fmt 4701
Sfmt 4702
14341
eligible collateral or to an eligible
protection provider in cases of maturity
mismatch, such amount generally
would be equal to the amount by which
the relevant form of credit risk
mitigation has reduced the exposure to
the original counterparty. However, in
the case of credit and equity derivatives
used to hedge exposures subject to the
Board’s market risk rule (12 CFR 217,
subpart F) that are to counterparties that
are non-financial entities, the covered
company would be permitted to
recognize a credit exposure with regard
to the eligible protection provider
measured using methodologies that the
covered company is authorized to use
under the Board’s risk-based capital
rules, including CEM for all covered
companies and approaches that rely on
internal models for companies subject to
the Board’s advanced approaches riskbased capital rules (12 CFR 217,
subparts D and E).
Example: A covered company makes a loan
to a counterparty and hedges the resulting
exposure by obtaining an eligible guarantee
from an eligible protection provider. If the
residual maturity of the guarantee is less than
that of the loan, the covered company would
adjust the value assigned to the guarantee
using the formula in the Board’s Regulation
Q (12 CFR part 217). The covered company
would then reduce its gross credit exposure
to the underlying counterparty by the
adjusted value of the guarantee and would
set its exposure to the eligible guarantor
equal to the adjusted value of the guarantee.
Example: A covered company holds bonds
issued by a non-financial entity that are
subject to the Board’s market risk rule, and
hedges the exposure using an eligible credit
derivative obtained from an eligible
protection provider. If the residual maturity
of the eligible credit derivative is less than
that of the bonds, the covered company
would reduce its exposure to the issuer of the
bonds by the adjusted value of the credit
derivative using the formula in the Board’s
Regulation Q. The covered company would
measure its exposure to the eligible
protection provider using methodologies that
the covered company is permitted to use
under the Board’s risk-based capital rules (12
CFR part 217, subparts D and E), without any
specific adjustment to reflect the maturity
mismatch between the bonds and the credit
derivative.
Question 31: The Board invites
comment on the proposed treatment of
maturity mismatches in the context of
credit risk mitigation.
Unused Credit Lines
Section 252.74(g) of the proposed rule
addresses the treatment of any unused
portion of certain extensions of credit.
In computing its net credit exposure to
a counterparty for a credit line or
revolving credit facility, a covered
company would be permitted to reduce
E:\FR\FM\16MRP2.SGM
16MRP2
14342
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
its gross credit exposure by the amount
of the unused portion of the credit
extension to the extent that the covered
company does not have any legal
obligation to advance additional funds
under the facility until the counterparty
provides collateral that qualifies under
the credit line or revolving credit
facility equal to or greater than the
entire used portion of the facility.75 To
qualify for this reduction, the contract
governing the extension of credit would
be required to specify that any used
portion of the credit extension must be
fully secured at all times by collateral
that is either (i) cash; (ii) obligations of
the United States or its agencies; (iii)
obligations directly and fully guaranteed
as to principal and interest by, the
Federal National Mortgage Association
or the Federal Home Loan Mortgage
Corporation, but only while operating
under the conservatorship or
receivership of the Federal Housing
Finance Agency; or (iv) any additional
obligations issued by a U.S. government
sponsored entity, as determined by the
Board.76
Question 32: What alternative
approaches should the Board consider
concerning the unused portion of
certain credit facilities?
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Credit Transactions Involving Exempt
and Excluded Persons
Section 252.74(h) 77 provides that, if a
covered company has reduced its credit
exposure to a counterparty that would
be exempt under the proposed rule by
obtaining eligible collateral from that
entity, or by obtaining an eligible
guarantee or an eligible credit or equity
derivative from an eligible protection
provider, the covered company must
recognize an exposure to the collateral
issuer or eligible protection provider to
the same extent as if the underlying
exposure were to an entity that is not
exempt. Similarly, if a covered company
has reduced its exposure to an entity
that is excluded from the definition of
a ‘‘counterparty’’ (e.g., the U.S.
government or a foreign sovereign entity
that receives a zero percent risk weight
under Regulation Q) by obtaining
eligible collateral from that entity, or by
obtaining an eligible guarantee or an
eligible credit or equity derivative from
an eligible protection provider, the
covered company must recognize an
exposure to the collateral issuer or
eligible protection provider to the same
extent as if the underlying exposure
75 See
proposed rule § 252.74(g).
76 Id.
77 See
proposed rule § 252.74(h).
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
were to an entity that is not excluded
from the definition of a counterparty.
Example: A covered company has
purchased a credit derivative from an eligible
protection provider to hedge the credit risk
on a portfolio of U.S. government bonds. The
covered company would need to recognize
an exposure to the credit protection provider
equal to the full notional of the credit
derivative (if the bonds are subject to the
Board’s risk-based capital rules in 12 CFR
part 217, subparts D and E) or to the
counterparty credit risk measurements
obtained by using methodologies that the
covered company is permitted to use under
the market risk capital rules (if the bonds are
subject to the Board’s market risk rule in 12
CFR part 217, subpart F).
Question 33: If a covered company
has an exempted credit exposure but
either (1) receives non-exempt eligible
collateral in support of the exempted
transaction or (2) obtains a non-exempt
eligible guarantee or eligible credit or
equity derivative referencing the
exempted credit exposure from an
eligible protection provider, should the
covered company be required to
recognize an exposure to the issuer(s) of
the collateral or eligible protection
provider even though the original credit
exposure was exempt? Should the Board
consider any alternative treatment in
such situations?
Exposures to Funds and Securitizations
Special considerations arise in
connection with measuring credit
exposure of a covered company to a
securitization fund, investment fund or
other special purpose vehicle
(collectively, SPVs). In some cases, a
covered company’s failure to recognize
an exposure to the issuers of the
underlying assets held by an SPV may
understate the covered company’s credit
exposure to those issuers. In other cases,
a covered company’s credit exposure to
the issuers of the underlying assets held
by an SPV may be insignificant and, in
such cases, requiring a covered
company to recognize an exposure to
each issuer of underlying assets for
every SPV in which a covered company
invests could be unduly burdensome.
Under the proposed rule, covered
companies that have $250 billion or
more in total consolidated assets or $10
billion or more in total on-balance-sheet
foreign exposures would be required to
analyze their credit exposure to the
issuers of the underlying assets in an
SPV in which the covered company
invests or to which the covered
company otherwise has credit exposure.
If a covered company cannot
demonstrate that its exposure to the
issuer of each underlying asset held by
an SPV is less than 0.25 percent of the
covered company’s tier 1 capital
PO 00000
Frm 00016
Fmt 4701
Sfmt 4702
(considering only exposures that arise
from the SPV), the covered company
would be required to apply a ‘‘lookthrough approach’’ and recognize an
exposure to each issuer of the assets
held by the SPV.78 Conversely, if a
covered company with $250 billion or
more in total consolidated assets or $10
billion or more in total on-balance-sheet
foreign exposures can demonstrate that
its exposure to each underlying asset in
an SPV is less than 0.25 percent of the
covered company’s tier 1 capital
(considering only exposures that arise
from the SPV), the covered company
would be allowed to recognize an
exposure solely to the SPV and not to
the underlying assets.79 The proposed
0.25 percent threshold for requiring the
use of the look-through approach is
intended to strike a balance between the
goals of limiting a covered company’s
exposures to underlying assets in an
SPV and avoiding excessive burden. If
a covered company with $250 billion or
more in total consolidated assets or $10
billion or more in total on-balance-sheet
foreign exposures would be required to
apply the look-through approach, but is
unable to identify an issuer of assets
underlying an SPV, the covered
company would be required to attribute
the exposure to a single ‘‘unknown
counterparty.’’ The covered company
would then be required to aggregate all
exposures to an unknown counterparty
as if they related to a single
counterparty.
The application of the look-through
approach would depend on the nature
of the investment of the covered
company in the SPV. Where all
investors in an SPV are pari passu, the
covered company would calculate its
exposure to an issuer of assets held by
the SPV as an amount equal to the
covered company’s pro rata share in the
SPV multiplied by the value of the
SPV’s underlying assets issued by that
issuer.
Example: An SPV holds $10 of bonds
issued by Company A and $20 of bonds
issued by Company B. Assuming that all
investors in the SPV are pari passu and that
a covered company’s pro rata share in the
SPV is 50 percent, a covered company (with
$250 billion or more in total consolidated
assets or $10 billion or more in total onbalance-sheet foreign exposures) would need
78 See proposed rule § 252.75. The calculation of
a covered company’s exposure to an issuer of assets
held by an SPV is discussed in more detail in the
following paragraphs.
79 A covered company’s exposure to each
underlying asset in an SPV necessarily would be
less than 0.25 percent of the covered company’s
eligible capital base where the covered company’s
entire investment in the SPV is less than 0.25
percent of the covered company’s eligible capital
base.
E:\FR\FM\16MRP2.SGM
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
to recognize a $5 exposure to Company A
(i.e., 50 percent of $10) and a $10 exposure
to Company B (i.e., 50 percent of $20) if the
look-through approach is required.
If all investors in an SPV are not pari
passu, a covered company that is
required to use the look-through
approach would measure its exposure to
an issuer of assets held by the SPV for
each tranche in the SPV in which the
covered company invests. The covered
company would do this using a two-step
process. First, the covered company
would assume that the total exposure to
an issuer of assets held by the SPV
among all investors in a given SPV
tranche is equal to the lesser of the
value of the tranche and the value of the
assets issued by the issuer that are held
by the SPV. Second, the covered
company would multiply this exposure
amount by the percentage of the SPV
tranche that the covered company
holds.
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Example: An SPV holds $10 of bonds
issued by Company A. The SPV has issued
$4 of junior notes and $6 of senior notes to
the SPV’s investors. A covered company with
$250 billion or more in total consolidated
assets or $10 billion or more in total onbalance-sheet foreign exposures holds 50
percent of the junior notes and 50 percent of
the senior notes. With respect to the junior
tranche of the SPV, the lesser of the value of
the tranche (i.e., $4) and the value of the
underlying assets issued by Company A (i.e.,
$10) is $4. With respect to the senior tranche
of the SPV, the lesser of the value of the
tranche (i.e., $6) and the value of the
underlying assets issued by Company A (i.e.,
$10) is $6. Because the covered company has
$250 billion or more in total consolidated
assets or $10 billion or more in total onbalance-sheet foreign exposures and its pro
rata share of each tranche is 50 percent, it
would need to recognize $2 of exposure to
Company A because of its investment in the
junior tranche (i.e., 50 percent of $4), and $3
of exposure to Company A because of its
investment in the senior tranche (i.e., 50
percent of $6), assuming the look-through
approach is required.
In addition, a covered company with
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures would be required to identify
third parties whose failure or distress
would likely result in a loss in the value
of the covered company’s investment in
the SPV. For example, the value of an
investment by the covered company in
an SPV might be reliant on various
forms of credit support provided by a
financial institution to the SPV. The
failure or distress of the credit support
provider would then lead to loss in the
value of the investment of the covered
company in the SPV. Other examples of
third parties whose failure or distress
could potentially lead to a loss in the
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
value of the covered company’s
investment in the SPV are originators of
assets held by the SPV, liquidity
providers to the SPV, and (potentially)
fund managers. In such cases, the
covered company would be required to
recognize an exposure to the relevant
third party that is equal to the value of
the covered company’s investment in
the SPV. This requirement would be in
addition to the requirements described
above to recognize an exposure to the
SPV and, if needed, to the issuers of
assets held by the SPV.
These proposed requirements for
covered companies with $250 billion or
more in total consolidated assets or $10
billion or more in total on-balance-sheet
foreign exposures would be appropriate
in light of the larger systemic footprint
of those firms, and is consistent with the
direction in section 165(a)(1)(B) of the
Dodd-Frank Act to tailor enhanced
prudential standards based on factors
such as the nature, scope, size, scale,
concentration, interconnectedness, and
mix of the activities of the company to
which the standards apply.80
Question 34: Is the proposed
treatment of a covered company that
has less than $250 billion or more in
total consolidated assets and less than
$10 billion or more in total on-balancesheet foreign exposures with respect to
its exposures related to SPVs
appropriate? What alternatives should
the Board consider?
Question 35: Is the proposed
treatment of a covered company with
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures with respect to its exposures
related to SPVs appropriate? Are there
situations in which the proposed
treatment would result in recognition of
inappropriate amounts of credit
exposure concerning an SPV? What
alternative approaches should the
Board consider?
Question 36: Is the proposed
treatment of exposures related to SPVs
sufficiently clear? Would further
clarification or simplification be
appropriate? What modifications should
the Board consider? For example,
should the Board modify the approach
such that a covered company would
only be required to use the look-through
approach with respect to particular
underlying exposures rather than all
underlying exposures in the event that
the covered company is able to
demonstrate that its credit exposure to
some of the underlying assets in an SPV
is less than 0.25 percent of the covered
company’s tier 1 capital but not able to
80 12
PO 00000
U.S.C. 5365(a)(1)(B).
Frm 00017
Fmt 4701
Sfmt 4702
14343
make this demonstration with respect to
all the underlying assets?
Exemptions
Under the proposal, singlecounterparty credit limits would not
apply to exposures to the U.S.
government or a foreign sovereign entity
that receives a zero percent risk weight
under Regulation Q because such
entities are not included in the
definition of a ‘‘counterparty.’’ Section
252.77 of the proposed rule sets forth
additional exemptions from the singlecounterparty credit limits.81 Section
165(e)(6) of the Dodd-Frank Act states
that the Board may, by regulation or
order, exempt transactions, in whole or
in part, from the definition of the term
‘‘credit exposure’’ for purposes of this
subsection, if the Board finds that the
exemption is in the public interest and
is consistent with the purposes of this
subsection.82
The first exemption from the
proposed rule would be for direct
claims on, and the portions of claims
that are directly and fully guaranteed as
to principal and interest by, the Federal
National Mortgage Association and the
Federal Home Loan Mortgage
Corporation, while these entities are
operating under the conservatorship or
receivership of the Federal Housing
Finance Agency.83 This proposed
exemption reflects a policy decision that
credit exposures to these governmentsponsored entities should not be subject
to a regulatory limit for so long as the
entities are in the conservatorship or
receivership of the U.S. government.
This approach is consistent with the
approach that the Board used in its risk
retention rules.84 As determined by the
Board, obligations issued by another
U.S. government sponsored entity
would also be exempt. The Board
requests comment on whether these
exemptions are appropriate.
The second exemption from the
proposed rule would be for intraday
credit exposure to a counterparty.85
This exemption would help minimize
the impact of the rule on the payment
and settlement of financial transactions.
The third exemption from the
proposed rule would be for trade
exposures to a central counterparty that
meet the definition of a qualified central
counterparty under Regulation Q
(QCCPs).86 These exposures would
81 See
proposed rule § 252.77.
12 U.S.C. 5365(e)(6).
83 See proposed rule § 252.77(a)(1).
84 See 12 CFR 244.8.
85 See proposed rule § 252.77(a)(2).
86 See proposed rule § 252.71(y); see also 12 CFR
217.2.
82 See
E:\FR\FM\16MRP2.SGM
16MRP2
14344
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
include potential future exposure
arising from transactions cleared by a
QCCP and pre-funded default fund
contributions.87 The proposed rule
would exempt these exposures to
QCCPs from single-counterparty credit
limits because of the concern that
application of single-counterparty credit
limits to these exposures would require
firms to spread activity across a greater
number of CCPs, which could lead to a
reduction in multilateral netting
benefits.88
The fourth exemption category would
implement section 165(e)(6) of the
Dodd-Frank Act and provide a catch-all
category to exempt any transaction
which the Board determines to be in the
public interest and consistent with the
purposes of section 165(e).89
Section 252.77(b) of the proposed rule
would implement section 165(e)(6) of
the Dodd-Frank Act, which provides a
statutory exemption for credit exposures
to the Federal Home Loan Banks.
Question 37: Should all trade
exposures to QCCPs be exempt from the
proposed rules? Is the definition of
‘‘QCCP’’ sufficiently clear? Should the
Board consider exempting any different
or additional exposures to QCCPs?
Would additional clarification on these
issues be appropriate?
Question 38: Should the Board
exempt any additional credit exposures
from the limitations of the proposed
rule? If so, please explain why.
Compliance
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Under section 252.78(a) of the
proposed rule, covered companies with
less than $250 billion in total
consolidated assets and less than $10
billion in total on-balance-sheet foreign
exposures would be required to
demonstrate compliance with the
requirements of the proposed rule as of
the end of each calendar quarter.90
These companies would, however, need
to have systems in place that would
allow them to calculate compliance on
a daily basis and would be required to
calculate compliance on a more frequent
basis than quarterly if directed to do so
by the Board. A covered company with
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures would be required to comply
87 As
initial margin and excess variation margin
posted to the QCCP and held in a segregated
account by a third party custodian are not subject
to counterparty risk, these amounts would not be
considered credit exposures under the proposed
rule.
88 See proposed rule § 252.77(a)(3).
89 See 12 U.S.C. 5365(e)(6); proposed rule
§ 252.76(a)(4).
90 See proposed rule § 252.78(a).
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
with the requirements of the proposed
rule on a daily basis as of the end of
each business day. Such covered
companies also would be required to
submit a monthly compliance report to
the Board.91
Section 252.78(c) of the proposed rule
would address the consequences if a
covered company fails to comply with
the credit exposure limits.92 This
section states that if a covered company
is not in compliance with respect to a
counterparty due to a decrease in the
covered company’s capital, the merger
of a covered company with another
covered company, or the merger of two
unaffiliated counterparties of the
covered company, the covered company
would not be subject to enforcement
actions with respect to such
noncompliance for a period of 90 days
(or such shorter or longer period
determined by the Board to be
appropriate to maintain the safety and
soundness of the covered company or
financial stability), so long as the
company uses reasonable efforts to
return to compliance with the proposed
rule during this period. The covered
company would be prohibited from
engaging in any additional credit
transactions with such a counterparty in
contravention of this rule during the
non-compliance period, except in cases
where the Board determines that such
additional credit transactions are
necessary or appropriate to preserve the
safety and soundness of the covered
company or financial stability.93 In
granting approval for any such special
temporary exceptions, the Board may
impose supervisory oversight and
reporting measures that it determines
are appropriate to monitor compliance
with the foregoing standards.94
The Board plans to develop reporting
forms for covered companies to use to
report credit exposures to their
counterparties as those credit exposures
would be measured under section
165(e). In addition, section 165(d)(2) of
the Dodd-Frank Act directs the Board to
require bank holding companies with
$50 billion or more in total consolidated
assets and nonbank financial companies
that are supervised by the Board to
prepare period exposure reports.95 The
Board anticipates that 165(d)(2) credit
exposure reporting obligations will be
informed by the requirements of the
165(e) framework and by any forms that
91 See
92 See
proposed rule § 252.78(a).
proposed rule § 252.78(c).
are developed for covered companies to
use in reporting their 165(e) exposures.
Question 39: Should the rule provide
a cure period for covered companies
that fall out of compliance? Under what
circumstances should such a cure
period be provided, and how long
should such a period be?
Question 40: If a cure period is
provided, would it be appropriate to
generally prohibit additional credit
transactions with the affected
counterparty during the cure period?
Are there additional situations in which
additional credit transactions with the
affected counterparty would be
appropriate? What additional
modifications or clarifications should
the Board consider with respect to any
cure period?
Timing
Under the proposed rule, covered
companies with total consolidated
assets of less than $250 billion in total
consolidated assets and less than $10
billion or more in total on-balance-sheet
foreign exposures would be required to
comply initially with the proposed rules
two years from the effective date of the
proposed rules, unless that time is
extended by the Board in writing.96
Covered companies that have $250
billion or more in total consolidated
assets or $10 billion or more in total onbalance-sheet foreign exposures would
be required to comply initially with the
proposed rules one year from the
effective date of the rule, unless that
time is extended by the Board in
writing.97
Any company that becomes a covered
company after the effective date of the
rule would be required to comply with
the requirements of the rule beginning
on the first day of the fifth calendar
quarter after it becomes a covered
company, unless that time is accelerated
or extended by the Board in writing.98
Question 41: Should the Board
consider a longer or shorter phase-in
period for all or a subset of covered
companies? Is a shorter phase-in period
for covered companies with $250 billion
or more in total consolidated exposures,
or $10 billion or more in total onbalance-sheet foreign exposures,
compared to firms below these
thresholds, appropriate?
Proposed Rule for Foreign Banking
Organizations
Background
In February 2014, the Board adopted
a final rule establishing enhanced
93 Id.
96 See
94 See
97 See
proposed rule § 252.78(d).
95 12 U.S.C. 5365(d)(2).
PO 00000
Frm 00018
Fmt 4701
Sfmt 4702
proposed rule § 252.70(g)(1).
proposed rule § 252.70(g)(2).
98 See proposed rule § 252.70(h).
E:\FR\FM\16MRP2.SGM
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
prudential standards for foreign banking
organizations with U.S. banking
operations and total consolidated assets
of $50 billion or more.99 Under that
rule, a foreign banking organization
with U.S. non-branch assets of $50
billion or more will be required to form
an intermediate holding company (U.S.
intermediate holding company) to hold
its interests in U.S. bank and nonbank
subsidiaries.100 A foreign banking
organization’s U.S. intermediate holding
company will be subject to enhanced
prudential standards on a consolidated
basis, including risk-based and leverage
capital requirements, liquidity
requirements, and risk management
standards. Certain enhanced prudential
standards also will apply to a foreign
banking organization’s ‘‘combined U.S.
operations,’’ which would include a
foreign banking organization’s U.S.
branches and agencies as well as U.S.
subsidiaries.
Like the enhanced prudential
standards for foreign banking
organizations that the Board previously
has adopted, the single-counterparty
credit limits in this proposed rule
would apply to a foreign banking
organization with U.S. banking
operations and $50 billion or more in
total consolidated assets, and to the U.S.
intermediate holding company of such a
foreign banking organization.
Overview of the Proposed Rule for
Foreign Banking Organizations
Similar to the proposed rule to
implement section 165(e) of the DoddFrank Act for domestic companies, the
aggregate net credit exposure of a
foreign banking organization or U.S.
intermediate holding company with
total consolidated assets of $50 billion
or more (each a covered entity) to a
single counterparty would be subject to
one of three increasingly stringent credit
exposure limits. Credit exposure limits
as applied to foreign banking
organizations, as opposed to
intermediate holding companies, would
only apply with respect to credit
exposures of that foreign banking
organization’s combined U.S. operations
(i.e., any U.S. intermediate holding
company, including its subsidiaries,
plus any U.S. branches or agencies of
the foreign banking organization),
although the foreign banking
organization’s total consolidated assets
on a worldwide basis would determine
whether the credit exposure limits
apply.
The first category of limits would
apply to covered entities that have less
than $250 billion in total consolidated
assets and less than $10 billion in onbalance-sheet foreign exposures.
Covered entities that have less than
$250 billion in total consolidated assets
and less than $10 billion in on-balance
sheet foreign exposures would be
prohibited from having aggregate net
credit exposure to an unaffiliated
counterparty in excess of 25 percent of
the covered entity’s total capital stock
and surplus, defined under the rule as
(1) in the case of a U.S. intermediate
holding company, the sum of the U.S.
intermediate holding company’s total
regulatory capital, as calculated under
the risk-based capital adequacy
guidelines applicable to that U.S.
intermediate holding company, plus the
balance of the ALLL of the U.S.
intermediate holding company not
included in tier 2 capital under the
capital adequacy guidelines, and (2) in
the case of a foreign banking
organization, the total regulatory capital
of the foreign banking organization on a
consolidated basis, as determined in
accordance with section 252.171(d) of
the proposed rule.101 The different
definition of ‘‘capital stock and surplus’’
with respect to a foreign banking
organization reflects differences in
international accounting standards.
The second category of exposure
limits would prohibit any covered entity
with $250 billion or more in total
14345
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures, but less than $500 billion in
total consolidated assets, from having
aggregate net credit exposure to an
unaffiliated counterparty in excess of 25
percent of the covered entity’s tier 1
capital. For the same reasons as
described above with respect to the
portion of the proposed rule applicable
to covered companies, the proposed
single-counterparty credit limits
applicable to a covered entity, including
both a foreign banking organization and
any U.S. intermediate holding company,
with $250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures would be based on tier 1
capital.
The third category of exposure limits
would prohibit any covered entity with
total consolidated assets of $500 billion
or more (major foreign banking
organization or major U.S. intermediate
holding company) from having
aggregate net credit exposure in excess
of 15 percent of the tier 1 capital of the
major foreign banking organization or
major U.S. intermediate holding
company to a major counterparty, and
25 percent of the tier 1 capital of the
major foreign banking organization or
major U.S. intermediate holding
company to any other counterparty. A
‘‘major counterparty’’ would be defined
as a global systemically important
banking organization or a nonbank
financial company supervised by the
Board. This framework would be
consistent with the requirement in
section 165(a)(1)(B) of the Dodd-Frank
Act that the enhanced standards
established by the Board under section
165 increase in stringency based on
factors such as the nature, scope, size,
scale, concentration,
interconnectedness, and mix of the
activities of the company.102 The credit
exposure limits are summarized in
Table 2.
TABLE 2—SINGLE-COUNTERPARTY CREDIT LIMITS APPLICABLE TO COVERED ENTITIES
Applicable credit exposure limit
U.S. intermediate holding companies or foreign banking organizations
with less than $250 billion in total consolidated assets and less than
$10 billion in on-balance-sheet foreign exposures..
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Category of covered entities
Aggregate net credit exposure of a U.S. intermediate holding company
cannot exceed 25 percent of the U.S. intermediate holding company’s total regulatory capital plus the balance of its ALLL not included in tier 2 capital under the capital adequacy guidelines in 12
CFR part 252.
Aggregate net credit exposure of a foreign banking organization, with
respect to its U.S. combined operations, to a counterparty cannot exceed 25 percent of the foreign banking organization’s total regulatory
capital on a consolidated basis.
99 See
79 FR 17240 (Mar. 27, 2014).
foreign banking organization’s intermediate
holding company is not required to hold the foreign
100 A
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
banking organization’s interest in any company
held under section 2(h)(2) of the Bank Holding
Company Act, 12 U.S.C. 1841(h)(2).
PO 00000
Frm 00019
Fmt 4701
Sfmt 4702
101 See
102 12
E:\FR\FM\16MRP2.SGM
12 CFR part 252, subpart L.
U.S.C. 5323, 5365(e).
16MRP2
14346
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
TABLE 2—SINGLE-COUNTERPARTY CREDIT LIMITS APPLICABLE TO COVERED ENTITIES—Continued
Category of covered entities
Applicable credit exposure limit
U.S. intermediate holding companies or foreign banking organizations
with $250 billion or more in total consolidated assets or $10 billion or
more in on-balance-sheet foreign exposures..
Aggregate net credit exposure of a U.S. intermediate holding company
to a counterparty cannot exceed 25 percent of the U.S. intermediate
holding company’s tier 1 capital.
Aggregate net credit exposure of a foreign banking organization, with
respect to its U.S. combined operations, to a counterparty cannot exceed 25 percent of the foreign banking organization’s worldwide tier
1 capital.
Aggregate net credit exposure of a major U.S. intermediate holding
company or, with respect to its combined U.S. operations, of a foreign banking organization to a major counterparty cannot exceed 15
percent of the covered entity’s tier 1 capital.
Aggregate net credit exposure of a major U.S. intermediate holding
company or, with respect to its combined U.S. operations, of a foreign banking organization to other counterparties cannot exceed 25
percent of the covered entity’s tier 1 capital.
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Major U.S. intermediate holding companies and major foreign banking
organizations..
Question 42: Should the Board apply
these single-counterparty credit limits to
all foreign banking organizations that
have $50 billion or more in total
consolidated assets, regardless of the
size of these organizations’ combined
operations in the United States? Is this
application appropriate?
The more stringent limit for major
U.S. intermediate holding companies
and, with respect to their combined U.S.
operations, major foreign banking
organizations would be consistent with
the Board’s discretion under the DoddFrank Act to impose such lower singlecounterparty credit limits as the Board
may determine by regulation to be
necessary to mitigate risks to the
financial stability of the United States,
as well as with the standard in section
165(a)(1)(B) of the Dodd-Frank Act that
the Board establish enhanced prudential
standards that increase in stringency
based on the systemic footprint of the
firms to which they apply. The rationale
for proposing to apply a 15 percent limit
to such exposures is set out in more
detail in the discussion in the
SUPPLEMENTARY INFORMATION concerning
the credit exposure limits of the
domestic proposed rule.
The proposed approach to identifying
a major U.S. intermediate holding
company and major foreign banking
organization is based only on size, and
the Board recognizes that size is only a
rough proxy for the systemic footprint of
a company. By contrast, the domestic
proposed rule would only subject a U.S.
banking organization to a 15 percent
limit on its exposures to major
counterparties if that U.S. banking
organization has been identified as a
global systemically important banking
organization under Method 1 of the
Board’s G–SIB surcharge rule.103 These
determinations are based on multiple
103 12
CFR 217.402.
VerDate Sep<11>2014
18:55 Mar 15, 2016
factors, including size, complexity,
interconnectedness, cross-border
exposure, and substitutability. Imposing
stricter limits on exposures of the
combined U.S. operations of major
foreign banking organizations or major
U.S. intermediate holding companies to
their respective major counterparties
based on a simple asset threshold may
not take into account nuances that
might be captured by other approaches.
Question 43: Should the Board adopt
a different approach in determining
which foreign banking organizations,
with respect to their combined U.S.
operations, and U.S. intermediate
holding companies should be treated as
major foreign banking organizations or
major U.S. intermediate holding
companies?
Question 44: Should the Board adopt
a different approach to the definition of
a ‘‘major counterparty’’?
In determining whether a U.S.
intermediate holding company complies
with these limits, exposures of the U.S.
intermediate holding company itself
and its subsidiaries would need to be
taken into account. Exposures of a
foreign banking organization’s
combined U.S. operations would
include exposures of any branch or
agency of the foreign banking
organization; exposures of the U.S.
subsidiaries of the foreign banking
organization, including any U.S.
intermediate holding company; and any
subsidiaries of such subsidiaries (other
than any companies held under section
2(h)(2) of the Bank Holding Company
Act of 1956).104 ‘‘Subsidiary’’ would be
defined in the same manner as under
the proposed requirements for domestic
covered companies: any company that a
parent company directly or indirectly
controls for purposes of the Bank
104 12
Jkt 238001
PO 00000
105 12 U.S.C. 1841 et seq.; see proposed rule
§ 252.171(dd).
U.S.C. 1841(h)(2).
Frm 00020
Fmt 4701
Holding Company Act of 1956.105 For
purposes of the proposed rule
applicable to covered entities, the
definitions of subsidiary, counterparty,
and related terms and the economic
interdependence, control relationship,
and attribution requirements would be
the same as under the portions of the
proposed rule applicable to covered
companies.
Although the major components of
the proposed single-counterparty credit
limits for foreign banking organizations
would be the same as the proposed
requirements for domestic covered
companies, there are also some
differences between the proposed rules.
For example, as discussed in more
detail below, the proposed singlecounterparty credit limits would not
apply to exposures of a U.S.
intermediate holding company or a
foreign banking organization’s
combined U.S. operations to the foreign
banking organization’s home country
sovereign, regardless of the risk weight
assigned to that sovereign under the
Board’s Regulation Q (12 CFR part 217).
Question 45: As noted, the proposed
rule would apply the singlecounterparty credit limits to covered
entities on a consolidated basis and
could, therefore, impact the level of
credit exposures of subsidiaries of these
covered entities, including depository
institutions. Is application on a
consolidated basis appropriate?
Question 46: What challenges, if any,
would a foreign banking organization
face in implementing the requirement
that all subsidiaries of the U.S.
intermediate holding company and the
combined U.S. operations be subject to
the proposed single-counterparty credit
limit?
Sfmt 4702
E:\FR\FM\16MRP2.SGM
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Question 47: What other alternatives
to the proposed capital bases should the
Board consider in applying singlecounterparty credit limits to U.S.
intermediate holding companies and the
combined U.S. operations of foreign
banking organizations?
Question 48: Should tier 1 capital be
used as the capital base in applying
single-counterparty credit limits to U.S.
intermediate holding companies and the
combined U.S. operations of foreign
banking organizations with $250 billion
or more in total consolidated assets, or
$10 billion or more in total on-balancesheet foreign exposures?
Question 49: Should singlecounterparty credit limits apply to a
foreign banking organization’s
combined U.S. operations, or is
application of single-counterparty credit
limits to a foreign banking
organization’s combined U.S.
operations unnecessary in light of the
Basel Committee’s adoption of a Large
Exposures standard?
Gross Credit Exposure
The proposed valuation rules for
measuring gross credit exposure to a
counterparty would be the same as
those set forth in the proposed rule for
domestic bank holding companies, other
than the proposed valuation rules for
derivatives exposures of U.S. branches
and agencies that are subject to a
qualifying master netting agreement.
When calculating a U.S. branch or
agency’s gross credit exposure to a
counterparty for a derivative contract
that is subject to a qualifying master
netting agreement, a foreign banking
organization could choose either to use
the exposure at default calculation set
forth in the Board’s advanced
approaches capital rules (12 CFR
217.132(c)) provided that the collateral
recognition rules of the proposed rule
would apply, or use the gross valuation
methodology for derivatives not subject
to a qualified master netting
agreements.106 Under this approach, a
foreign banking organization would be
able to rely on a qualified master netting
agreement to which the U.S. branch or
agency is subject that covers exposures
of the foreign banking organization
outside of the U.S. branch and agency
network.
Question 50: Is the proposed
treatment of derivatives exposures of
U.S. branches and agencies that are
subject to a qualifying master netting
agreement appropriate? What
alternatives should the Board consider?
Question 51: Should there be any
other differences between the treatment
of derivative exposures of a foreign
banking organization’s combined U.S.
operations or U.S. intermediate holding
company and the treatment derivative
exposures of U.S. covered companies?
Question 52: Should the rule provide
a separate process that allows foreign
banking organizations to receive Board
approval to use internal models to value
derivative transactions solely for the
purpose of complying with this rule?
Net Credit Exposure
The proposed rule describes how a
covered entity would convert gross
credit exposure amounts to net credit
exposure amounts by taking into
account eligible collateral, eligible
guarantees, eligible credit and equity
derivatives, other eligible hedges (that
is, a short position in the counterparty’s
debt or equity securities), and for
securities financing transactions, the
effect also of bilateral netting
agreements. The proposed treatment
described below is generally consistent
with the proposed treatment for
domestic bank holding companies.
However, the definition of ‘‘eligible
collateral’’ for covered entities would
exclude debt or equity securities
(including convertible bonds) issued by
an affiliate of the U.S. intermediate
holding company or the combined U.S.
operations of a foreign banking
organization, and the definition of
‘‘eligible protection provider’’ would
exclude the foreign banking
organization or any affiliate thereof.107
Question 53: Does the proposed
approach to the calculation of net credit
exposure pose particular concerns for
U.S. intermediate holding companies or
foreign banking organizations, with
respect to their U.S. operations?
Exposures to Funds and Securitizations
The proposed rule’s treatment for a
covered entity’s exposures to funds and
securitizations would be the same as the
proposed treatment for a domestic
covered company’s exposures to such
entities.108
Question 54: Does the proposed
treatment of exposures related to SPVs
pose particular concerns for foreign
banking organizations, with respect to
its combined U.S. operations, or U.S.
intermediate holding companies?
Exemptions
As noted, section 165(e)(6) of the
Dodd-Frank Act permits the Board to
exempt transactions from the definition
of the term ‘‘credit exposure’’ for
purposes of this subsection, if the Board
proposed rule § 252.173(a)(11).
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
finds that the exemption is in the public
interest and is consistent with the
purposes of this subsection. The
proposed rule would provide the same
exemptions for the credit exposures of
covered entities as the proposed rule
provides for credit exposures of
domestic covered companies.109 In
addition, the proposed rule would
include an additional exemption for a
foreign banking organization’s
exposures to its home country
sovereign, notwithstanding the risk
weight assigned to that sovereign entity
under the Board’s Regulation Q (12 CFR
part 217).110 This exemption would
recognize that a foreign banking
organization’s U.S. operations may have
exposures to its home country sovereign
entity that are required by home country
laws or are necessary to facilitate the
normal course of business for the
consolidated company. This proposed
exemption would be in the public
interest and consistent with the
treatment of credit exposures of covered
companies to the U.S. government.
Question 55: Would additional
exemptions for foreign banking
organizations or the U.S. intermediate
holding companies of foreign banking
organizations be appropriate? Why or
why not?
Compliance
Under the proposed rule, an U.S.
intermediate holding company or the
combined U.S. operations of a foreign
banking organization with less than
$250 billion in total consolidated assets,
and less than $10 billion in total onbalance-sheet foreign exposures, would
be required to comply with the
requirements of the proposed rule as of
the end of each quarter.111 Other
intermediate holding companies and
foreign banking organizations would be
required to comply with the proposed
rule on a daily basis as of the end of
each business day and submit a monthly
compliance report demonstrating its
daily compliance.112 A foreign banking
organization would be required to
ensure the compliance of its U.S.
intermediate holding company and its
combined U.S. operations. If either the
U.S. intermediate holding company or
the combined U.S. operations were not
in compliance with respect to a
counterparty, both of the U.S.
intermediate holding company and the
combined U.S. operations would be
prohibited from engaging in any
additional credit transactions with such
109 See
proposed rule § 252.177(a).
proposed rule § 252.177(a)(4).
111 See proposed rule § 252.178(a).
112 Id.
110 See
107 See
106 See
108 See
PO 00000
proposed rule § 252.171(k).
proposed rule § 252.175.
Frm 00021
Fmt 4701
Sfmt 4702
14347
E:\FR\FM\16MRP2.SGM
16MRP2
14348
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
a counterparty, except in cases when the
Board determines that such additional
credit transactions are necessary or
appropriate to preserve the safety and
soundness of the foreign banking
organization or financial stability.113 In
considering special temporary
exceptions, the Board could impose
supervisory oversight and reporting
measures that it determines are
appropriate to monitor compliance with
the foregoing standards.114
Question 56: Should the rule provide
a cure period for covered entities that
are not compliant? Under what
circumstances should such a cure
period be provided, and how long
should such a period be?
Question 57: If a cure period is
provided, would it be appropriate to
generally prohibit additional credit
transactions with the affected
counterparty during the cure period?
Are there additional situations in which
additional credit transactions with the
affected counterparty would be
appropriate? What additional
modifications or clarifications should
the Board consider with respect to any
cure period?
Question 58: Should the Board
consider any temporary exceptions
particularly for foreign banking
organizations or the U.S. intermediate
holding companies of foreign banking
organizations? In what situations would
a temporary exception be appropriate?
Timing
The proposed rule is designed to be
less stringent for those foreign banking
organizations and U.S. intermediate
holding companies whose failure or
distress would be less likely to pose a
risk to U.S. financial stability. Foreign
banking organizations and U.S.
intermediate holding companies with
less than $250 billion in total
consolidated assets and less than $10
billion in total on-balance-sheet foreign
assets would be required to comply
initially with the proposed rule two
years from the effective date of the
proposed rule, unless that time is
extended by the Board in writing.115
Foreign banking organizations and U.S.
intermediate holding companies with
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
assets would be required to comply
initially with the proposed rule one year
from the effective date of the rule,
unless that time is extended by the
proposed rule § 252.178(c).
proposed rule § 252.178(d).
115 See proposed rule §§ 252.170(c)(1)(i) and
252.170(c)(2)(i).
Board in writing.116 Any company that
becomes a covered company after the
effective date of the rule would be
required to comply with the
requirements of the rule beginning on
the first day of the fifth calendar quarter
after it becomes a covered entity, unless
that time is accelerated or extended by
the Board in writing.117
Regulatory Analysis
Paperwork Reduction Act
Certain provisions of the proposed
rules contain ‘‘collection of
information’’ requirements within the
meaning of the Paperwork Reduction
Act (PRA) of 1995 (44 U.S.C. 3501
through 3521). The Board has reviewed
the reporting requirements in sections
252.78(a) and 252.178(a) of the
proposed rules under the authority
delegated to the Board by Office of
Management and Budget (OMB). The
Board will address these requirements
in a separate notice, such as when the
Board proposes reporting forms for
companies subject to these rules to use
to report credit exposures to their
counterparties as those credit exposures
would be measured under the proposed
rules.
Solicitation of Comments on the Use of
Plain Language
Section 722 of the Gramm-Leach
Bliley Act (Pub. L. 106–102, 113 Stat.
1338, 1471, 12 U.S.C. 4809) requires the
Federal banking agencies to use plain
language in all proposed and final rules
published after January 1, 2000. The
Board has sought to present the
proposed rules in a simple and
straightforward manner, and invites
comment on the use of plain language.
For example:
• Have the agencies organized the
material to suit your needs? If not, how
could they present the proposed rules
more clearly?
• Are the requirements in the
proposed rules clearly stated? If not,
how could the proposed rules be more
clearly stated?
• Do the regulations contain technical
language or jargon that is not clear? If
so, which language requires
clarification?
• Would a different format (grouping
and order of sections, use of headings,
paragraphing) make the regulation
easier to understand? If so, what
changes would achieve that?
• Is the section format adequate? If
not, which of the sections should be
changed and how?
• What other changes can the Board
incorporate to make the regulation
easier to understand?
Regulatory Flexibility Act Analysis
In accordance with section 3(a) of the
Regulatory Flexibility Act 118 (RFA), the
Board is publishing an initial regulatory
flexibility analysis of the proposed
rules. The RFA requires an agency
either to provide an initial regulatory
flexibility analysis with a proposed rule
for which a general notice of proposed
rulemaking is required or to certify that
the proposed rule will not have a
significant economic impact on a
substantial number of small entities.
Based on its analysis and for the reasons
stated below, the Board believes that
these proposed rules will not have a
significant economic impact on a
substantial number of small entities.
Nevertheless, the Board is publishing an
initial regulatory flexibility analysis. A
final regulatory flexibility analysis will
be conducted after comments received
during the public comment period have
been considered.
In accordance with section 165 of the
Dodd-Frank Act, the Board is proposing
to amend Regulation YY to establish
single-counterparty credit limits for
bank holding companies, foreign
banking organizations, and U.S.
intermediate holding companies with
total consolidated assets of $50 billion
or more in order to limit the risks that
the failure of any individual firm could
pose to those organizations.119
Under regulations issued by the Small
Business Administration (SBA), a
‘‘small entity’’ includes a depository
institution, bank holding company, or
savings and loan holding company with
assets of $550 million or less (small
banking organizations).120 As discussed
in the SUPPLEMENTARY INFORMATION, the
proposed rules generally would apply to
bank holding companies, foreign
banking organizations, and U.S.
intermediate holding companies with
total consolidated assets of $50 billion
or more. Companies that are subject to
the proposed rule have consolidated
assets that substantially exceed the $550
million asset threshold at which a
banking entity is considered a ‘‘small
entity’’ under SBA regulations. Because
the proposed rules would not apply to
any company with assets of $550
million or less, if adopted in final form,
the proposed rules would not apply to
any ‘‘small entity’’ for purposes of the
RFA. The Board does not believe that
the proposed rules duplicate, overlap, or
113 See
114 See
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
116 See proposed rule §§ 252.170(c)(1)(ii) and
252.170(c)(2)(ii).
117 See proposed rule § 252.170(d).
PO 00000
Frm 00022
Fmt 4701
Sfmt 4702
118 5
U.S.C. 601 et seq.
12 U.S.C. 5365(e).
120 See 13 CFR 121.201.
119 See
E:\FR\FM\16MRP2.SGM
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
conflict with any other Federal rules. In
light of the foregoing, the Board does
not believe that the proposed rules, if
adopted in final form, would have a
significant economic impact on a
substantial number of small entities
supervised. Nonetheless, the Board
seeks comment on whether the
proposed rules would impose undue
burdens on, or have unintended
consequences for, small organizations,
and whether there are ways such
potential burdens or consequences
could be minimized in a manner
consistent with section 165(e) of the
Dodd-Frank Act.
List of Subjects in 12 CFR Part 252
Administrative practice and
procedure, Banks, Banking, Federal
Reserve System, Holding companies,
Reporting and recordkeeping
requirements, Securities.
Authority and Issuance
For the reasons stated in the
preamble, the Board of Governors of the
Federal Reserve System proposes to
amend 12 CFR part 252 as follows:
PART 252—ENHANCED PRUDENTIAL
STANDARDS (REGULATION YY)
1. The authority citation for part 252
continues to read as follows:
■
Authority: 12 U.S.C. 321–338a, 1467a(g),
1818, 1831p–1, 1844(b), 1844(c), 5361, 5365,
5366.
■
2. Add subpart H to read as follows:
Subpart H—Single-Counterparty Credit
Limits
Sec.
252.70 Applicability.
252.71 Definitions.
252.72 Credit exposure limits.
252.73 Gross credit exposure.
252.74 Net credit exposure.
252.75 Investments in and exposures to
securitization vehicles, investment
funds, and other special purpose
vehicles.
252.76 Aggregation of exposures to more
than one counterparty due to economic
interdependence or control
relationships.
252.77 Exemptions.
252.78 Compliance.
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
§ 252.70
Applicability.
(a) In general. A covered company is
subject to the general credit exposure
limit set forth in § 252.72(a).
(b) Covered companies with $250
billion or more in total consolidated
assets or $10 billion or more in total onbalance-sheet foreign exposures. A
covered company with $250 billion or
more in total consolidated assets or $10
billion or more in total on-balance-sheet
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
foreign exposures is subject to the credit
exposure limit set forth in § 252.72(b).
(c) Major covered companies. A major
covered company is subject to the credit
exposure limit set forth in § 252.72(c).
(d) Total consolidated assets. For
purposes of this section, total
consolidated assets are determined
based on:
(1) The average of the bank holding
company’s total consolidated assets in
the four most recent consecutive
quarters as reported quarterly on the FR
Y–9C; or
(2) If the bank holding company has
not filed an FR Y–9C for each of the
most recent four quarters, the average of
the bank holding company’s total
consolidated assets in the most recent
consecutive quarters as reported
quarterly on the bank holding
company’s FR Y–9Cs.
(e) Cessation of requirements. Once a
covered company meets the
requirements described in paragraphs
(a) or (b) of this section, the company
shall remain a covered company for
purposes of this subpart unless and
until the company has less than $50
billion in total consolidated assets as
determined based on each of the bank
holding company’s four most recent FR
Y–9Cs.
(1) A bank holding company that has
ceased to be a major covered company
for purposes of paragraph (c) of this
section shall no longer be subject to the
requirements of § 252.70(c) beginning
on the first day of the calendar quarter
following the reporting date on which it
ceased to be a major covered company.
(2) Nothing in paragraph (c) of this
section shall preclude a company from
becoming a covered company pursuant
to paragraphs (a) or (b) of this section.
(f) Measurement date. For purposes of
this section, total consolidated assets are
measured on the last day of the quarter
used in calculation of the average.
(g) Initial applicability.
(1) A covered company that is subject
to this subpart under paragraph (a) of
this section as of [INSERT EFFECTIVE
DATE], must comply with the
requirements of this subpart, including
§ 252.72(a), beginning on [INSERT
DATE TWO YEARS FROM EFFECTIVE
DATE], unless that time is extended by
the Board in writing.
(2) A covered company that is subject
to this subpart under paragraph (b) of
this section as of [INSERT EFFECTIVE
DATE], must comply with the
requirements of this subpart, including
§§ 252.72(b)–(c), as applicable,
beginning on [INSERT DATE ONE
YEAR FROM EFFECTIVE DATE], unless
that time is extended by the Board in
writing.
PO 00000
Frm 00023
Fmt 4701
Sfmt 4702
14349
(3) A company that becomes a
covered company subject to this subpart
under paragraphs (a), (b), or (c) of this
section after the effective date of this
part will be subject to the requirements
of this subpart in accordance with
paragraph (h) of this section.
(h) Ongoing applicability. Except as
provided in paragraph (g)(1) or (g)(2) of
this section, a covered company that is
subject to this subpart under paragraphs
(a), (b), or (c) of this section must
comply with the requirements of
§§ 252.72(a)–(c), as applicable,
beginning on the first day of the fifth
calendar quarter after it becomes a
covered company, unless that time is
accelerated or extended by the Board in
writing.
§ 252.71
Definitions.
For purposes of this subpart:
(a) Adjusted market value means:
(1) With respect to the value of
securities transferred by the covered
company to a counterparty, the sum of:
(i) The market value of the securities;
and
(ii) The product of the market value
of the securities multiplied by the
applicable collateral haircut in Table 1
to § 217.132 of the Board’s Regulation Q
(12 CFR 217.132); and
(2) With respect to eligible collateral
received by the covered company from
a counterparty:
(i) The market value of the securities;
minus
(ii) The market value of the securities
multiplied by the applicable collateral
haircut in Table 1 to § 217.132 of the
Board’s Regulation Q (12 CFR 217.132).
(3) Prior to calculating the adjusted
market value pursuant to paragraphs (1)
and (2) of this section, with regard to a
transaction that meets the definition of
‘‘repo-style transaction’’ in § 217.2 the
Board’s Regulation Q (12 CFR 217.2),
the covered company would first
multiply the applicable collateral
haircuts in Table 1 to § 217.132 of the
Board’s Regulation Q (12 CFR 217.132)
by the square root of 1⁄2.
(b) Aggregate net credit exposure
means the sum of all net credit
exposures of a covered company to a
single counterparty.
(c) Bank-eligible investments means
investment securities that a national
bank is permitted to purchase, sell, deal
in, underwrite, and hold under 12
U.S.C. 24 (Seventh) and 12 CFR part 1.
(d) Capital stock and surplus means,
with respect to a bank holding
company, the sum of the following
amounts in each case as reported by the
bank holding company on the most
recent FR Y–9C report:
(1) The company’s tier 1 and tier 2
capital, as calculated under the capital
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
14350
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
adequacy guidelines applicable to that
bank holding company under the
Board’s Regulation Q (12 CFR part 217);
and
(2) The balance of the allowance for
loan and lease losses of the bank
holding company not included in its tier
2 capital under the capital adequacy
guidelines applicable to that bank
holding company under the Board’s
Regulation Q (12 CFR part 217).
(e) Counterparty means:
(1) With respect to a natural person,
the person, and members of the person’s
immediate family;
(2) With respect to a company, the
company and all persons that that
counterparty
(i) Owns, controls, or holds with
power to vote 25 percent or more of a
class of voting securities of the person;
(ii) Owns or controls 25 percent or
more of the total equity of the person;
or
(iii) Consolidates for financial
reporting purposes, as described in
§ 252.72(d), collectively;
(3) With respect to a State, the State
and all of its agencies, instrumentalities,
and political subdivisions (including
any municipalities) collectively;
(4) With respect to a foreign sovereign
entity that is not assigned a zero percent
risk weight under the standardized
approach in the Board’s Regulation Q
(12 CFR part 217, subpart D), the foreign
sovereign entity and all of its agencies
and instrumentalities (but not including
any political subdivision), collectively;
and
(5) With respect to a political
subdivision of a foreign sovereign entity
such as states, provinces, and
municipalities, any political subdivision
of a foreign sovereign entity and all of
such political subdivision’s agencies
and instrumentalities, collectively.
(f) Covered company means any bank
holding company (other than a foreign
banking organization that is subject to
subpart Q of the Board’s Regulation YY),
that has $50 billion or more in total
consolidated assets, calculated pursuant
to § 252.70(d), and all of its subsidiaries.
(g) Credit derivative has the same
meaning as in § 217.2 of the Board’s
Regulation Q (12 CFR 217.2).
(h) Credit transaction means, with
respect to a counterparty:
(1) Any extension of credit to the
counterparty, including loans, deposits,
and lines of credit, but excluding
uncommitted lines of credit;
(2) Any repurchase transaction or
reverse repurchase transaction with the
counterparty;
(3) Any securities lending or
securities borrowing transaction with
the counterparty;
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
(4) Any guarantee, acceptance, or
letter of credit (including any
endorsement, confirmed letter of credit,
or standby letter of credit) issued on
behalf of the counterparty;
(5) Any purchase of, or investment in,
securities issued by the counterparty;
(6) Any credit exposure to the
counterparty in connection with a
derivative transaction between the
covered company and the counterparty;
(7) Any credit exposure to the
counterparty in connection with a credit
derivative or equity derivative
transaction between the covered
company and a third party, the
reference asset of which is an obligation
or equity security of the counterparty;
and
(8) Any transaction that is the
functional equivalent of the above, and
any other similar transaction that the
Board, by regulation, determines to be a
credit transaction for purposes of this
subpart.
(i) Depository institution has the same
meaning as in section 3 of the Federal
Deposit Insurance Act (12 U.S.C.
1813(c)).
(j) Derivative transaction means any
transaction that is a contract, agreement,
swap, warrant, note, or option that is
based, in whole or in part, on the value
of, any interest in, or any quantitative
measure or the occurrence of any event
relating to, one or more commodities,
securities, currencies, interest or other
rates, indices, or other assets.
(k) Eligible collateral means collateral
in which the covered company has a
perfected, first priority security interest
or the legal equivalent thereof, if outside
of the United States (with the exception
of cash on deposit and notwithstanding
the prior security interest of any
custodial agent) and is in the form of:
(1) Cash on deposit with the covered
company (including cash held for the
covered company by a third-party
custodian or trustee);
(2) Debt securities (other than
mortgage- or asset-backed securities and
resecuritization securities, unless those
securities are issued by a U.S.
government-sponsored enterprise) that
are bank-eligible investments and that
are investment grade;
(3) Equity securities that are publicly
traded; or
(4) Convertible bonds that are
publicly traded.
(l) Eligible credit derivative means a
single-name credit derivative or a
standard, non-tranched index credit
derivative, provided that:
(1) The derivative contract is subject
to an eligible guarantee and has been
confirmed by the protection purchaser
and the protection provider;
PO 00000
Frm 00024
Fmt 4701
Sfmt 4702
(2) Any assignment of the derivative
contract has been confirmed by all
relevant parties;
(3) If the credit derivative is a credit
default swap, the derivative contract
includes the following credit events:
(i) Failure to pay any amount due
under the terms of the reference
exposure, subject to any applicable
minimal payment threshold that is
consistent with standard market
practice and with a grace period, if any,
that is in line with the grace period of
the reference exposure; and
(ii) Receivership, insolvency,
liquidation, conservatorship, or inability
of the reference exposure issuer to pay
its debts, or its failure or admission in
writing of its inability generally to pay
its debts as they become due and similar
events;
(4) The terms and conditions dictating
the manner in which the derivative
contract is to be settled are incorporated
into the contract;
(5) If the contract allows for cash
settlement, the contract incorporates a
robust valuation process to estimate loss
reliably and specifies a reasonable
period for obtaining post-credit event
valuations of the reference exposure;
(6) If the contract requires the
protection purchaser to transfer an
exposure to the protection provider at
settlement, the terms of at least one of
the exposures that is permitted to be
transferred under the contract provides
that any required consent to transfer
may not be unreasonably withheld; and
(7) If the credit derivative is a credit
default swap, the contract clearly
identifies the parties responsible for
determining whether a credit event has
occurred, specifies that this
determination is not the sole
responsibility of the protection
provider, and gives the protection
purchaser the right to notify the
protection provider of the occurrence of
a credit event.
(m) Eligible equity derivative means
an equity derivative, provided that:
(1) The derivative contract has been
confirmed by the counterparties;
(2) Any assignment of the derivative
contract has been confirmed by all
relevant parties; and
(3) The terms and conditions dictating
the manner in which the derivative
contract is to be settled are incorporated
into the contract.
(n) Eligible guarantee has the same
meaning as in § 217.2 of the Board’s
Regulation Q (12 CFR 217.2) that is
provided by an eligible protection
provider.
(o) Eligible protection provider has the
same meaning as ‘‘eligible guarantor’’ in
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
§ 217.2 of the Board’s Regulation Q (12
CFR 217.2).
(p) Equity derivative has the same
meaning as ‘‘equity derivative contract’’
in § 217.2 of the Board’s Regulation Q
(12 CFR 217.2).
(q) Financial entity means:
(1) A depository institution;
(2) A bank holding company;
(3) A savings and loan holding
company (as defined in 12 U.S.C.
1467a);
(4) A securities broker or dealer
registered with the U.S. Securities and
Exchange Commission under the
Securities Exchange Act of 1934 (15
U.S.C. 78o et seq.);
(5) An insurance company that is
subject to the supervision by a State
insurance regulator;
(6) A foreign banking organization;
(7) A non-U.S.-based securities firm or
a non-U.S.-based insurance company
that is subject to consolidated
supervision and regulation comparable
to that applicable to U.S. depository
institutions, securities broker-dealers, or
insurance companies;
(8) A central counterparty; and
(9) A legal entity whose main
business includes the management of
financial assets, lending, factoring,
leasing, provision of credit
enhancements, securitization,
investments, financial custody,
proprietary trading, and other financial
services.
(r) Gross credit exposure means, with
respect to any credit transaction, the
credit exposure of the covered company
before adjusting, pursuant to section
252.74, for the effect of any qualifying
master netting agreement, eligible
collateral, eligible guarantee, eligible
credit derivative, eligible equity
derivative, other eligible hedge, and any
unused portion of certain extensions of
credit.
(s) Immediate family means the
spouse of an individual, the individual’s
minor children, and any of the
individual’s children (including adults)
residing in the individual’s home.
(t) Intraday credit exposure means
credit exposure of a covered company to
a counterparty that by its terms is to be
repaid, sold, or terminated by the end of
its business day in the United States.
(u) Investment grade has the same
meaning as in § 217.2 of the Board’s
Regulation Q (12 CFR 217.2).
(v) Major counterparty means any:
(1) Major covered company and all of
its subsidiaries, collectively;
(2) Any foreign banking organization
(and all of its subsidiaries, collectively)
that meets one of the following
conditions:
(i) The foreign banking organization
has the characteristics of a global
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
systemically important banking
organization under the assessment
methodology and the higher loss
absorbency requirement for global
systemically important banks issued by
the Basel Committee on Banking
Supervision, as updated from time to
time; or
(ii) The Board, using information
reported by the foreign banking
organization or its U.S. subsidiaries,
information that is publicly available,
and confidential supervisory
information, determines:
(A) That the foreign banking
organization would be a global
systemically important banking
organization under the global
methodology;
(B) That the foreign banking
organization, if it were subject to the
Board’s Regulation Q, would be
identified as a global systemically
important bank holding company under
§ 217.402 of the Board’s Regulation Q;
or
(C) That the U.S. intermediate holding
company, if it were subject to the
Board’s Regulation Q, would be
identified as a global systemically
important bank holding company.
(iii) A foreign banking organization
that prepares or reports for any purpose
the indicator amounts necessary to
determine whether the foreign banking
organization is a global systemically
important banking organization under
the assessment methodology and the
higher loss absorbency requirement for
global systemically important banks
issued by the Basel Committee on
Banking Supervision, as updated from
time to time, must use the data to
determine whether the foreign banking
organization has the characteristics of a
global systemically important banking
organization under the global
methodology; and
(3) Any nonbank financial company
supervised by the Board.
(w) Major covered company means
any U.S. bank holding company
identified as a global systemically
important bank holding company
pursuant to 12 CFR 217.402, and all of
its subsidiaries.
(x) Net credit exposure means, with
respect to any credit transaction, the
gross credit exposure of a covered
company calculated under § 252.73, as
adjusted in accordance with § 252.74.
(y) Qualifying central counterparty
has the same meaning as in § 217.2 of
the Board’s Regulation Q (12 CFR
217.2).
(z) Qualifying master netting
agreement has the same meaning as in
§ 217.2 of the Board’s Regulation Q (12
CFR 217.2).
PO 00000
Frm 00025
Fmt 4701
Sfmt 4702
14351
(aa) Short sale means any sale of a
security which the seller does not own
or any sale which is consummated by
the delivery of a security borrowed by,
or for the account of, the seller.
(bb) Sovereign entity means a central
national government (including the U.S.
government) or an agency, department,
ministry, or central bank, but not
including any political governmental
subdivision such as a state, province, or
municipality.
(cc) Subsidiary of a specified
company means a company that is
directly or indirectly controlled by the
specified company.
(dd) Tier 1 capital means common
equity tier 1 capital and additional tier
1 capital, as defined in the Board’s
Regulation Q (12 CFR part 217).
§ 252.72
Credit exposure limits.
(a) General limit on aggregate net
credit exposure. No covered company
shall have an aggregate net credit
exposure to any unaffiliated
counterparty that exceeds 25 percent of
the consolidated capital stock and
surplus of the covered company.
(b) Limit on aggregate net credit
exposure for covered companies with
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures. No covered company that
has $250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures shall have an aggregate net
credit exposure to any unaffiliated
counterparty that exceeds 25 percent of
the covered company’s tier 1 capital.
(c) Limit on aggregate net credit
exposure of major covered companies to
major counterparties. No major covered
company shall have aggregate net credit
exposure to any unaffiliated major
counterparty that exceeds 15 percent of
the tier 1 capital of the major covered
company.
(d) For purposes of this subpart, a
counterparty and major counterparty
shall include any person that the
counterparty or major counterparty
(1) Owns, controls, or holds with
power to vote 25 percent or more of a
class of voting securities of the person;
(2) Owns or controls 25 percent or
more of the total equity of the person;
or
(3) Consolidates for financial
reporting purposes.
§ 252.73
Gross credit exposure.
(a) Calculation of gross credit
exposure. Except as provided in
paragraph (b), the amount of gross credit
exposure of a covered company to a
counterparty with respect to a credit
transactions is, in the case of:
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
14352
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
(1) Loans by a covered company to the
counterparty and leases in which the
covered company is the lessor and the
counterparty is the lessee, equal to the
amount owed by the counterparty to the
covered company under the transaction.
(2) Debt securities held by the covered
company that are issued by the
counterparty, equal to:
(i) The market value of the securities,
for trading and available-for-sale
securities; and
(ii) The amortized purchase price of
the securities, for securities held to
maturity.
(3) Equity securities held by the
covered company that are issued by the
counterparty, equal to the market value.
(4) Repurchase transactions, equal to
the adjusted market value of securities
transferred by the covered company to
the counterparty.
(5) Reverse repurchase transactions,
equal to the amount of cash transferred
by the covered company to the
counterparty.
(6) Securities borrowing transactions,
equal to:
(i) The amount of cash collateral
transferred by the covered company to
the counterparty; plus
(ii) The adjusted market value of
securities collateral transferred by the
covered company to the counterparty.
(7) Securities lending transactions,
equal to the adjusted market value of
securities lent by the covered company
to the counterparty.
(8) Committed credit lines extended
by a covered company to a counterparty,
equal to the face amount of the credit
line.
(9) Guarantees and letters of credit
issued by a covered company on behalf
of a counterparty, equal to the
maximum potential loss to the covered
company on the transaction.
(10) Derivative transactions between
the covered company and the
counterparty not subject to a qualifying
master netting agreement:
(i) Valued at an amount equal to the
sum of
(A) The current exposure of the
derivatives contract equal to the greater
of the mark-to-market value of the
derivative contract or zero; and
(B) The potential future exposure of
the derivatives contract, calculated by
multiplying the notional principal
amount of the derivative contract by the
applicable conversion factor in Table 2
to § 217.132 of the Board’s Regulation Q
(12 CFR 217.132); and
(ii) In cases where a covered company
is required to recognize an exposure to
an eligible protection provider pursuant
to § 252.74(e), the covered company
must exclude the relevant derivative
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
transaction when calculating its gross
exposure to the original counterparty
under this section.
(11) Derivative transactions between
the covered company and the
counterparty subject to a qualifying
master netting agreement:
(i) The derivative transaction shall be
valued using any of the methods that
the covered company is authorized to
use under the Board’s Regulation Q (12
CFR part 217, subparts D and E) to value
such transactions; and
(ii) In cases where a covered company
is required to recognize an exposure to
an eligible protection provider pursuant
to § 252.74(e), the covered company
must exclude the relevant derivative
transaction when calculating its gross
exposure to the original counterparty
under this section.
(12) Credit or equity derivative
transactions between the covered
company and a third party where the
covered company is the protection
provider and the reference asset is an
obligation or equity security of the
counterparty, equal to the maximum
potential loss to the covered company
on the transaction.
(b) Investments in and Exposures to
Securitization Vehicles, Investment
Funds, and Other Special Purpose
Vehicles. A covered company that has
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures shall calculate its gross credit
exposure for investments in and
exposures to a securitization vehicle,
investment fund, and other special
purpose vehicle pursuant to § 252.75.
(c) Attribution rule. A covered
company must treat any credit
transaction with any person as a credit
transaction with a counterparty, to the
extent that the proceeds of the
transaction are used for the benefit of,
or transferred to, that counterparty.
§ 252.74
Net Credit Exposure.
(a) In general. For purposes of this
subpart, a covered company shall
calculate its net credit exposure to a
counterparty by adjusting its gross
credit exposure to that counterparty in
accordance with the rules set forth in
this section.
(b) Calculation of net credit exposure
for repurchase transactions, reverse
repurchase transactions, securities
lending transactions, and securities
borrowing transactions. With respect to
any repurchase transaction, reverse
repurchase transaction, securities
lending transaction, and securities
borrowing transaction with a
counterparty that is subject to a bilateral
netting agreement with that
PO 00000
Frm 00026
Fmt 4701
Sfmt 4702
counterparty and that meets the
definition of ‘‘repo-style transaction’’ in
§ 217.2 of the Board’s Regulation Q (12
CFR 217.2), a covered company’s net
credit exposure to a counterparty shall
be equal to the exposure at default
amount calculated under § 217.37(c)(2)
of the Board’s Regulation Q (12 CFR
217.37(c)(2)); provided that:
(1) The covered company shall apply
the standardized supervisory haircuts as
provided in 12 CFR 217.37(c)(3)(iii) of
the Board’s Regulation (12 CFR
217.37(c)(3)(iii), and is not permitted to
use its own internal estimates for
haircuts;
(2) The covered company shall, in
calculating its net credit exposure to a
counterparty as a result of the
transactions described in paragraph (b)
of this section, disregard any collateral
received from that counterparty that
does not meet the definition of ‘‘eligible
collateral’’ in § 252.71(k); and
(3) The covered company shall
include the adjusted market value of
any eligible collateral, as further
adjusted by the application of the
maturity mismatch adjustment approach
of § 217.36(d) of the Board’s Regulation
Q (12 CFR 217.36(d)), if applicable,
when calculating its gross credit
exposure to the collateral issuer,
including in instances where the
underlying repurchase transaction,
reverse repurchase transaction,
securities lending transaction, or
securities borrowing transaction would
not be subject to the credit limits of
§ 272.72.
(c) Eligible collateral.
(1) In computing its net credit
exposure to a counterparty for any
credit transaction other than
transactions described in paragraph (b)
of this section, a covered company must
reduce its gross credit exposure on the
transaction by:
(i) The adjusted market value of any
eligible collateral, in cases where the
eligible collateral has the same or
greater maturity as the credit
transactions; or
(ii) The adjusted market value of any
eligible collateral, as further adjusted by
application of the maturity mismatch
adjustment approach of § 217.36(d) of
the Board’s Regulation Q (12 CFR
217.36(d)), if the eligible collateral has
an original maturity equal to or greater
than one year and a residual maturity of
not less than three months, in cases
where the eligible collateral has a
shorter maturity than the credit
transaction.
(2) A covered company that reduces
its gross credit exposure to a
counterparty as required under
paragraph (c)(1) of this section must
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
include the adjusted market value of the
eligible collateral, as further adjusted by
the application of the maturity
mismatch adjustment approach of
§ 217.36(d) of the Board’s Regulation Q
(12 CFR 217.36(d)), if applicable, when
calculating its gross credit exposure to
the collateral issuer, including in
instances where the underlying credit
transaction would not be subject to the
credit limits of § 272.72.
Notwithstanding the foregoing, in no
event will the covered company’s gross
credit exposure to the issuer of
collateral be in excess of its gross credit
exposure to the counterparty on the
credit transaction.
(d) Eligible guarantees.
(1) In calculating net credit exposure
to a counterparty for any credit
transaction, a covered company must
reduce its gross credit exposure to the
counterparty by any eligible guarantees
from an eligible protection provider that
covers the transaction by:
(i) The amount of any eligible
guarantees from an eligible protection
provider that covers the transaction, in
cases where the eligible guarantee has
the same or greater maturity as the
credit transaction; or
(ii) The amount of any eligible
guarantees from an eligible protection
provider that covers the transaction as
further adjusted by application of the
maturity mismatch adjustment approach
of § 217.36(d) of the Board’s Regulation
Q (12 CFR 217.36(d)), if the eligible
guarantees have an original maturity
equal to or greater than one year and a
residual maturity of not less than three
months, in cases where the eligible
guarantee has a shorter maturity than
the credit transaction.
(2) A covered company that reduces
its gross credit exposure to a
counterparty as required under
paragraph (d)(1) must include the
amount of eligible guarantees when
calculating its gross credit exposure to
the eligible protection provider,
including in instances where the
underlying credit transaction would not
be subject to the credit limits of
§ 272.72. Notwithstanding the foregoing,
in no event will the covered company’s
gross credit exposure to an eligible
protection provider with respect to an
eligible guarantee be in excess of its
gross credit exposure to the
counterparty on the credit transaction
prior to recognition of the eligible
guarantee.
(e) Eligible credit and equity
derivatives. (1) In calculating net credit
exposure to a counterparty for a credit
transaction, a covered company must
reduce its gross credit exposure to the
counterparty by:
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
(i) The notional amount of any
eligible credit or equity derivative from
an eligible protection provider, in cases
where the eligible credit or equity
derivative has a maturity that is the
same or greater than the maturity of the
credit transaction; or
(ii) The notional amount of any
eligible credit or equity derivative from
an eligible protection provider, as
further adjusted by application of the
maturity mismatch adjustment approach
of § 217.36(d) of the Board’s Regulation
Q (12 CFR 217.36(d)), if the eligible
credit or equity derivative has an
original maturity equal to or greater than
one year and a residual maturity of not
less than three months, in cases where
the eligible credit or equity derivative
has a shorter maturity than the credit
transaction.
(2)(i) In general, a covered company
that reduces its gross credit exposure to
a counterparty as provided under
paragraph (e)(1) must include the
notional amount of the eligible credit or
equity derivative from an eligible
protection provider, as further adjusted
by the application of the maturity
mismatch adjustment approach of
§ 217.36(d) of the Board’s Regulation Q
(12 CFR 217.36(d)), as applicable, when
calculating its gross credit exposure to
the eligible protection provider,
including in instances where the
underlying credit transaction would not
be subject to the credit limits of
§ 272.72. Notwithstanding the foregoing,
in no event will the covered company’s
gross credit exposure to an eligible
protection provider with respect to an
eligible credit or equity derivative be in
excess of its gross credit exposure to
that counterparty on the credit
transaction prior to recognition of the
eligible credit or equity derivative; and
(ii) In cases where the eligible credit
or equity derivative is used to hedge
covered positions and available-for-sale
exposures that are subject to the Board’s
market risk rule (12 CFR part 217,
subpart F) and the counterparty on the
hedged transaction is not a financial
entity, the amount of credit exposure
that a company must recognize to the
eligible protection provider is the
amount that would be calculated
pursuant to § 252.73(a), including in
instances where the underlying credit
transaction would not be subject to the
credit limits of § 272.72.
(f) Other eligible hedges. In
calculating net credit exposure to a
counterparty for a credit transaction, a
covered company may reduce its gross
credit exposure to the counterparty by
the face amount of a short sale of the
counterparty’s debt or equity security,
provided that:
PO 00000
Frm 00027
Fmt 4701
Sfmt 4702
14353
(1) The instrument in which the
covered company has a short position is
junior to, or pari passu with, the
instrument in which the covered
company has the long position; and
(2) The instrument in which the
covered company has a short position
and the instrument in which the
covered company has the long position
are either both treated as trading or
available-for-sale exposures or both
treated as held-to-maturity exposures.
(g) Unused portion of certain
extensions of credit. (1) In computing its
net credit exposure to a counterparty for
a credit line or revolving credit facility,
a covered company may reduce its gross
credit exposure by the amount of the
unused portion of the credit extension
to the extent that the covered company
does not have any legal obligation to
advance additional funds under the
extension of credit, until the
counterparty provides the amount of
adjusted market value of collateral
required with respect to the entire used
portion of the extension of credit.
(2) To qualify for this reduction, the
credit contract must specify that any
used portion of the credit extension
must be fully secured by collateral that
is:
(i) Cash;
(ii) Obligations of the United States or
its agencies; or
(iii) Obligations directly and fully
guaranteed as to principal and interest
by, the Federal National Mortgage
Association and the Federal Home Loan
Mortgage Corporation, while operating
under the conservatorship or
receivership of the Federal Housing
Finance Agency, and any additional
obligations issued by a U.S.
government-sponsored enterprise as
determined by the Board.
(h) Credit transactions involving
exempt and excluded persons. If a
covered company has a credit
transaction with any person that is
exempt from this subpart under
§ 252.75, or is otherwise excluded from
this subpart, and the covered company
has reduced its credit exposure on the
credit transaction with that person by
obtaining collateral from that person or
a guarantee or credit or equity derivative
from an eligible protection provider, the
covered company shall calculate its
credit exposure to the issuer of the
collateral or protection provider, as
applicable, in accordance with the rules
set forth in this section to the same
extent as if the credit transaction with
the person were subject to the
requirements in this subpart, including
§ 252.72.
E:\FR\FM\16MRP2.SGM
16MRP2
14354
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
§ 252.75 Investments in and exposures to
securitization vehicles, investment funds,
and other special purpose vehicles.
(a) In general. (1) This section applies
only to covered companies with $250
billion or more in total consolidated
assets or $10 billion or more in onbalance-sheet foreign exposures, subject
to paragraph (d) of this section.
(2)(i) If a covered company can satisfy
the requirements of paragraph (a)(3) of
this section, a covered company must
calculate its gross credit exposure to
each securitization vehicle, investment
fund, and other special purpose vehicle
in which it invests pursuant to
§ 252.73(a), and the covered company is
not required to calculate its gross credit
exposure to each issuer of assets held by
a securitization vehicle, investment
fund, or other special purpose vehicle.
(ii) If a covered company cannot
satisfy the requirements of paragraph
(a)(3), the covered company must
calculate its gross credit exposure to
each issuer of assets held by a
securitization vehicle, investment fund,
or other special purpose vehicle using
the look-through approach in paragraph
(b) of this section.
(3) A covered company is not required
to calculate its gross credit exposure to
each issuer of assets held by a
securitization vehicle, investment fund,
or other special purpose vehicle, as
applicable, if the covered company can
demonstrate that its gross credit
exposure to each issuer, considering
only the credit exposures to that issuer
arising from the covered company’s
investment in a particular securitization
vehicle, investment fund, or other
special purpose vehicle, is less than
0.25 percent of the covered company’s:
(i) Capital stock and surplus in the
case of a covered company subject to the
credit exposure limit of § 252.72(a); or
(ii) Tier 1 capital in the case of a
covered company subject to the credit
exposure limit of § 252.72(b).
(b) Look-through Approach. (1) A
covered company that cannot satisfy the
requirements of paragraph (a)(3) must
calculate its gross credit exposure, for
purposes of § 252.73(a), to each issuer of
assets held by a securitization vehicle,
investment fund, or other special
purpose vehicle pursuant to paragraph
(b)(3).
(2) If a covered company that cannot
satisfy the requirements of paragraph
(a)(3) of this section is unable to identify
each issuer of assets held by a
securitization vehicle, investment fund,
or other special purpose vehicle, the
covered company, for purposes of
paragraph (b)(3) of this section, must
attribute the gross credit exposure to a
single unknown counterparty, and the
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
limits of § 252.72 shall apply to that
counterparty as a single counterparty.
(3) A covered company that is
required to calculate its gross credit
exposure to an issuer of assets held by
a securitization vehicle, investment
fund, or other special purpose vehicle
pursuant to paragraph (b)(1) of this
section, or to an unknown counterparty
pursuant to paragraph (b)(2) of this
section, must calculate the gross credit
exposure as follows:
(i) Where all investors in the
securitization vehicle, investment fund,
or other special purpose vehicle rank
pari passu, the gross credit exposure is
equal to the covered company’s pro rata
share multiplied by the value of the
assets attributed to the issuer or the
unknown counterparty, as applicable,
that are held within the structure; and
(ii) Where all investors in the
securitization vehicle, investment fund,
or other special purpose vehicle do not
rank pari passu, the gross credit
exposure is equal to:
(A) The lower of the value of the
tranche in which the covered company
has invested, calculated pursuant to
§ 252.73(a), and the value of each asset
attributed to the issuer or the unknown
counterparty, as applicable, that are
held by the securitization vehicle,
investment fund, or other special
purpose vehicle; multiplied by
(B) The pro rata share of the covered
company’s investment in the tranche.
(c) Exposures to Third Parties. (1)
Notwithstanding any other requirement
in this section, a covered company must
recognize, for purposes of this subpart,
a gross credit exposure to each third
party that has a contractual or other
business relationship with a
securitization vehicle, investment fund,
or other special purpose vehicle, such as
a fund manager or protection provider
to such securitization vehicle,
investment fund, or other special
purpose vehicle, whose failure or
material financial distress would cause
a loss in the value of the covered
company’s investment in or exposure to
the securitization vehicle, investment
fund, or other special purpose vehicle.
(2) For purposes of § 252.72, with
respect to a covered company’s gross
credit exposure to a third party that a
covered company must recognize
pursuant to paragraph (c)(1) of this
section, the covered company shall
recognize an exposure to the third party
in an amount equal to the covered
company’s gross credit exposure to the
associated securitization vehicle,
investment fund, or other special
purpose vehicle, in addition to the
covered company’s gross credit
exposure to the associated securitization
PO 00000
Frm 00028
Fmt 4701
Sfmt 4702
vehicle, investment fund, or other
special purpose vehicle.
(d) Notwithstanding paragraph (a)(1)
of this section, in order to avoid evasion
of this subpart, the Board may
determine, after notice to the covered
company and opportunity for hearing,
that a covered company with less than
$250 billion in total consolidated assets
and less than $10 billion in total onbalance-sheet foreign exposures must
apply the look-through approach or
recognize exposures to third parties that
have a contractual or other business
relationship for purposes of this
subpart.
§ 252.76 Aggregation of exposures to
more than one counterparty due to
economic interdependence or control
relationships.
(a) Aggregation of Exposures to More
than One Counterparty due to Economic
Interdependence. (1)(i) If a covered
company has an aggregate net credit
exposure to any unaffiliated
counterparty that exceeds 5 percent of
the consolidated capital stock and
surplus of the covered company, or 5
percent of its tier 1 capital in the case
of a covered company with $250 billion
or more in total consolidated assets or
$10 billion or more in total foreign
exposures, the covered company shall
analyze its relationship with the
unaffiliated counterparty under
paragraph (a)(2) of this section to
determine whether the unaffiliated
counterparty is economically
interdependent with one or more other
unaffiliated counterparties of the
covered company.
(ii) For purposes of this paragraph,
two counterparties are economically
interdependent if the failure, default,
insolvency, or material financial distress
of one counterparty would cause the
failure, default, insolvency, or material
financial distress of the other
counterparty, taking into account the
factors in paragraph (a)(2) of this
section.
(iii) If a covered company or the
Board determines pursuant to paragraph
(a)(2) or (a)(3) of this section, as
applicable, that one or more other
unaffiliated counterparties of a covered
company are economically dependent,
the covered company shall aggregate its
net credit exposure to the unaffiliated
counterparties for all purposes under
this subpart, including but not limited
to, § 252.72.
(2) In making a determination as to
whether any two counterparties are
economically interdependent, a covered
company shall consider the following
factors:
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
(i) Whether 50 percent or more of one
counterparty’s gross revenue or gross
expenditures are derived from
transactions with the other
counterparty;
(ii) Whether one counterparty
(counterparty A) has fully or partly
guaranteed the credit exposure of the
other counterparty (counterparty B), or
is liable by other means, and the credit
exposure is significant enough that
counterparty B is likely to default if
presented with a claim relating to the
guarantee or liability;
(iii) Whether 25 percent or more of
one counterparty’s production or output
is sold to the other counterparty, which
cannot easily be replaced by other
customers;
(iv) Whether the expected source of
funds to repay any credit exposure
between the counterparties is the same
and at least one of the counterparties
does not have another source of income
from which the extension of credit may
be fully repaid;
(v) Whether the financial distress of
one counterparty (counterparty A) is
likely to impair the ability of the other
counterparty (counterparty B) to fully
and timely repay counterparty B’s
liabilities;
(vi) Whether one counterparty
(counterparty A) has made a loan to the
other counterparty (counterparty B) and
is relying on repayment of that loan in
order to satisfy its obligations to the
covered company, and counterparty A
does not have another source of income
that it can use to satisfy its obligations
to the covered company; and
(vii) Any other indicia of
interdependence that the covered
company determines to be relevant to
this analysis.
(3) In order to avoid evasion of this
subpart, the Board may determine, after
notice to the covered company and
opportunity for hearing, that one or
more unaffiliated counterparties of a
covered company are economically
dependent for purposes of this subpart.
In making any such determination, the
Board shall consider the factors in
paragraph (a)(2) of this section as well
as any other indicia of economic
interdependence that the Board
determines to be relevant.
(b) Aggregation of exposures to more
than one counterparty due to certain
control relationships. (1) A covered
company shall assess whether
counterparties are connected by control
relationships due to the following
factors:
(i) The presence of voting agreements;
(ii) Ability of one counterparty to
significantly influence the appointment
or dismissal of another counterparty’s
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
administrative, management or
governing body, or the fact that a
majority of members of such body have
been appointed solely as a result of the
exercise of the first counterparty’s
voting rights; and
(iii) Ability of one counterparty to
exercise a controlling influence over the
management or policies of another
counterparty.
(2) If a covered company or the Board
determines pursuant to paragraph (b)(1)
or (b)(3) of this section that one or more
other unaffiliated counterparties of a
covered company are connected by
control relationships, the covered
company shall aggregate its net credit
exposure to the unaffiliated
counterparties for all purposes under
this subpart, including but not limited
to, § 252.72.
(3) In order to avoid evasion of this
subpart, the Board may determine, after
notice to the covered company and
opportunity for hearing, that one or
more unaffiliated counterparties of a
covered company are connected by
control relationships for purposes of
this subpart. In making any such
determination, the Board shall consider
the factors in paragraph (b)(1) of this
section as well as any other control
relationships that the Board determines
to be relevant.
§ 252.77
Exemptions.
(a) Exempted exposure categories.
The following categories of credit
transactions are exempt from the limits
on credit exposure under this subpart:
(1) Direct claims on, and the portions
of claims that are directly and fully
guaranteed as to principal and interest
by, the Federal National Mortgage
Association and the Federal Home Loan
Mortgage Corporation, only while
operating under the conservatorship or
receivership of the Federal Housing
Finance Agency, and any additional
obligations issued by a U.S.
government-sponsored entity as
determined by the Board.
(2) Intraday credit exposure to a
counterparty.
(3) Trade exposures to a qualifying
central counterparty related to the
covered company’s clearing activity,
including potential future exposure
arising from transactions cleared by the
qualifying central counterparty and prefunded default fund contributions.
(4) Any transaction that the Board
exempts if the Board finds that such
exemption is in the public interest and
is consistent with the purpose of this
section.
(b) Exemption for Federal Home Loan
Banks. For purposes of this subpart, a
PO 00000
Frm 00029
Fmt 4701
Sfmt 4702
14355
covered company does not include any
Federal Home Loan Bank.
(c) Additional Exemptions by the
Board. The Board may, by regulation or
order, exempt transactions, in whole or
in part, from the definition of the term
‘‘credit exposure,’’ if the Board finds
that the exemption is in the public
interest and is consistent with the
purpose of § 165(e) of the Dodd-Frank
Wall Street Reform and Consumer
Protection Act (12 U.S.C. 5365(e)).
§ 252.78
Compliance.
(a) Scope of compliance. A covered
company with $250 billion or more in
total consolidated assets or $10 billion
or more in total on-balance-sheet foreign
exposures must comply with the
requirements of this section on a daily
basis at the end of each business day
and submit on a monthly basis a report
demonstrating its daily compliance. A
covered company with less than $250
billion in total consolidated assets and
less than $10 billion in total on-balancesheet foreign exposures must comply
with the requirements of this section on
a quarterly basis and submit on a
quarterly basis a report demonstrating
its quarterly compliance, unless the
Board determines and notifies that
company that more frequent compliance
and reporting is required.
(b) Qualifying Master Netting
Agreement. A covered company must
establish and maintain procedures that
meet or exceed the requirements of
§ 217.3(d) of the Board’s Regulation Q
(12 CFR 217.3(d)) to monitor possible
changes in relevant law and to ensure
that the agreement continues to satisfy
the requirements of a qualifying master
netting agreement.
(c) Noncompliance. Except as
otherwise provided in this section, if a
covered company is not in compliance
with this subpart with respect to a
counterparty solely due to the
circumstances listed in paragraphs
(c)(1)–(4) of this section, the covered
company will not be subject to
enforcement actions for a period of 90
days (or such other period determined
by the Board to be appropriate to
preserve the safety and soundness of the
covered company or U.S. financial
stability) if the company uses reasonable
efforts to return to compliance with this
subpart during this period. The covered
company may not engage in any
additional credit transactions with such
a counterparty in contravention of this
rule during the compliance period,
except in cases where the Board
determines that such credit transactions
are necessary or appropriate to preserve
the safety and soundness of the covered
company or U.S. financial stability. In
E:\FR\FM\16MRP2.SGM
16MRP2
14356
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
granting approval for such a special
temporary credit exposure limit, the
Board will consider the following:
(1) A decrease in the covered
company’s capital stock and surplus;
(2) The merger of the covered
company with another covered
company;
(3) A merger of two unaffiliated
counterparties; or
(4) Any other circumstance the Board
determines is appropriate.
(d) Other measures. The Board may
impose supervisory oversight and
reporting measures that it determines
are appropriate to monitor compliance
with this subpart.
■ 3. Add subpart Q to read as follows:
Subpart Q—Single-Counterparty Credit
Limits
Sec.
252.170 Applicability.
252.171 Definitions.
252.172 Credit exposure limits.
252.173 Gross credit exposure.
252.174 Net credit exposure.
252.175 Investments in and exposures to
securitization vehicles, investment
funds, and other special purpose
vehicles.
252.176 Aggregation of exposures to more
than one counterparty due to economic
interdependence or control
relationships.
252.177 Exemptions.
252.178 Compliance.
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
§ 252.170
Applicability.
(a) Foreign banking organizations
with total consolidated assets of $50
billion or more.
(1) In general. A foreign banking
organization with total consolidated
assets of $50 billion or more is subject
to the general credit exposure limit set
forth in § 252.173(a).
(2) Foreign banking organizations
with $250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures. A foreign banking
organization with $250 billion or more
in total consolidated assets or $10
billion or more in total on-balance-sheet
foreign exposures is subject to the credit
exposure limit set forth in § 252.172(b).
(3) Major foreign banking
organizations. A foreign banking
organization with total consolidated
assets of $500 billion or more is subject
to the credit exposure limit set forth in
§ 252.172(c).
(4) Total consolidated assets. For
purposes of this section, total
consolidated assets are determined
based on:
(i) The average of the foreign banking
organization’s total consolidated assets
in the four most recent consecutive
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
quarters as reported quarterly on the FR
Y–7Q; or
(ii) If the foreign banking organization
has not filed the FR Y–7Q for each of
the four most recent consecutive
quarters, the average of the foreign
banking organization’s total
consolidated assets in the most recent
consecutive quarters as reported
quarterly on the foreign banking
organization’s FR Y–7Qs; or
(iii) If the foreign banking
organization has not yet filed an FR Y–
7Q, as determined under applicable
accounting standards.
(5) Cessation of requirements. A
foreign banking organization will
remain subject to the requirements of
this subpart, including § 252.172(a) and,
as applicable, the credit exposure limits
of §§ 252.172(b) and (c), unless and
until total assets are less than $50
billion (with respect to the requirements
in paragraphs (a) and (b)) or $500 billion
(with respect to the requirement in
paragraph (c)) for each of the four most
recent consecutive calendar quarters,
either as reported on the foreign banking
organization’s FR Y–7Q or as
determined under applicable accounting
standards, to the extent the foreign
banking organization has not yet filed
an FR Y–7Q.
(i) Nothing in paragraph (a)(3) shall
preclude a company from becoming a
covered company pursuant to
paragraphs (a)(1) or (a)(2) of this section.
(6) Measurement date. For purposes
of this section, total consolidated assets
are measured on the last day of the
quarter used in calculation of the
average.
(b) U.S. intermediate holding
companies.
(1) In general. A U.S. intermediate
holding company is subject to the
general credit exposure limit set forth in
§ 252.172(a).
(2) U.S. intermediate holding
companies with $250 billion or more in
total consolidated assets or $10 billion
or more in total on-balance-sheet
foreign exposures. A U.S intermediate
holding company with $250 billion or
more in total consolidated assets or $10
billion or more in total on-balance-sheet
foreign exposures is subject to the credit
exposure limit set forth in § 252.172(b).
(3) Major U.S. intermediate holding
companies. A U.S. intermediate holding
company that has total consolidated
assets of $500 billion or more is subject
to the credit exposure limit set forth in
§ 252.172(c)..
(4) Total consolidated assets. For
purposes of this paragraph, total
consolidated assets are determined
based on:
PO 00000
Frm 00030
Fmt 4701
Sfmt 4702
(i) The average of the total
consolidated assets for the four most
recent consecutive quarters as reported
by the U.S. intermediate holding
company on its FR Y–9C, or
(ii) If the U.S. intermediate holding
company has not filed the FR Y–9C for
each of the four most recent consecutive
quarters, for the most recent quarter or
consecutive quarters as reported on the
FR Y–9C, or
(iii) If the U.S. intermediate holding
company has not yet filed an FR Y–9C,
as determined under applicable
accounting standards.
(5) Cessation of requirements. A major
U.S. intermediate holding company will
remain subject to the requirements of
this subpart, including § 252.172(a) and,
as applicable, the credit exposure limits
set forth in §§ 252.172(b) and (c), unless
and until total assets are less than $50
billion (with respect to the requirements
in paragraphs (a) or (b) of this section)
or $500 billion (with respect to the
requirement in paragraph (c) of this
section) for each of the four most recent
consecutive calendar quarters either as
reported on its FR Y–9C or as
determined under applicable accounting
standards, to the extent the foreign
banking organization has not yet filed
an FR Y–9C.
(i) Nothing in paragraph (b)(3) shall
preclude a company from becoming a
covered company pursuant to
paragraphs (b)(1) or (b)(2) of this
section.
(5) Measurement date. For purposes
of this section, total consolidated assets
are measured on the last day of the
quarter used in calculation of the
average.
(c) Initial applicability.
(1) Foreign banking organizations. (i)
A foreign banking organization that is
subject to this subpart under paragraph
(a)(1) of this section as of [INSERT
EFFECTIVE DATE], must comply with
the requirements of this subpart
beginning on [INSERT DATE TWO
YEARS FROM EFFECTIVE DATE],
unless that time is extended by the
Board in writing.
(ii) A foreign banking organization
that is subject to this subpart under
paragraphs (a)(2) or (3) of this section as
of [INSERT EFFECTIVE DATE], must
comply with the requirements of this
subpart, as applicable, beginning on
[INSERT DATE ONE YEAR FROM
EFFECTIVE DATE].
(2) U.S. intermediate holding
companies. (i) A U.S. intermediate
holding company that is subject to the
requirements of this subpart under
paragraph (b)(1) of this section as of
[INSERT EFFECTIVE DATE], must
comply with the requirements of this
E:\FR\FM\16MRP2.SGM
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
subpart beginning on [INSERT DATE
TWO YEARS FROM EFFECTIVE
DATE], unless that time is extended by
the Board in writing.
(ii) A U.S. intermediate holding
company that is subject to this subpart
under paragraphs (b)(2) or (3) of this
section as of [INSERT EFFECTIVE
DATE], must comply with the
requirements of this subpart, including
§§ 252.172(b)–(c), beginning on [INSERT
DATE ONE YEAR FROM EFFECTIVE
DATE].
(3) A foreign banking organization or
U.S. intermediate holding company that
becomes subject to the requirements of
this subpart after the effective date of
the subpart will be subject to the
requirements of this subpart in
accordance with paragraph (d) of this
section.
(d) Ongoing applicability.
(1) Foreign banking organizations.
Except as provided in paragraphs (c)(1)
or (c)(2) of this section, a foreign
banking organization that becomes
subject to the requirements of this
subpart after [INSERT EFFECTIVE
DATE], must comply with the
requirements of this subpart, as
applicable, beginning on the first day of
the fifth calendar quarter after it
becomes subject to those requirements,
unless that time is accelerated or
extended by the Board in writing.
(2) U.S. intermediate holding
companies. Except as provided in
paragraph (c)(2) of this section, a U.S.
intermediate holding company that
becomes subject to the requirements of
this subpart after [INSERT EFFECTIVE
DATE], must comply with the
requirements of this subpart, as
applicable, on the later of:
(i) The first day of the fifth calendar
quarter after it becomes subject to those
requirements, or
(ii) The date on which the U.S.
intermediate holding company is
required to be established, unless that
time is accelerated or extended by the
Board in writing.
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
§ 252.171
Definitions.
For purposes of this subpart:
(a) Adjusted market value means:
(1) With respect to the value of
securities transferred by the covered
company to a counterparty, the sum of:
(i) Market value of the securities and
(ii) The product of the market value
of the securities multiplied by the
applicable collateral haircut in Table 1
to § 217.132 of the Board’s Regulation Q
(12 CFR 217.132); and
(2) With respect to eligible collateral
received by the covered company from
a counterparty:
(i) The market value of the securities
minus
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
(ii) The market value of the securities
multiplied by the applicable collateral
haircut in Table 1 to § 217.132 of the
Board’s Regulation Q (12 CFR 217.132).
(3) Prior to calculating the adjusted
market value pursuant to paragraphs (1)
and (2) of this section, with regard to a
transaction that meets the definition of
‘‘repo-style transaction’’ in § 217.2 the
Board’s Regulation Q (12 CFR 217.2),
the covered company would first
multiply the applicable collateral
haircuts in Table 1 to § 217.132 of the
Board’s Regulation Q (12 CFR 217.132)
by the square root of 1⁄2.
(b) Aggregate net credit exposure
means the sum of all net credit
exposures of a covered entity to a single
counterparty.
(c) Bank-eligible investments means
investment securities that a national
bank is permitted to purchase, sell, deal
in, underwrite, and hold under 12
U.S.C. 24 (Seventh) and 12 CFR part 1.
(d) Capital stock and surplus means:
(1) With respect to a U.S. intermediate
holding company, the sum of the
following amounts in each case as
reported by a U.S. intermediate holding
company on the most recent FR Y–9C:
(i) The tier 1 and tier 2 capital of the
U.S. intermediate holding company, as
calculated under the capital adequacy
guidelines applicable to that U.S.
intermediate holding company under
subpart O of the Board’s Regulation YY
(12 CFR part 252); and
(ii) The excess allowance for loan and
lease losses of the U.S. intermediate
holding company not included in tier 2
capital under the capital adequacy
guidelines applicable to that U.S.
intermediate holding company under
subpart O of the Board’s Regulation YY
(12 CFR part 252); and
(2) With respect to a foreign banking
organization, the total regulatory capital
as reported on the foreign banking
organization’s most recent FR Y–7Q or
other reporting form specified by the
Board.
(e) Counterparty means:
(1) With respect to a natural person,
the person, and members of the person’s
immediate family;
(2) With respect to a company, the
company and all persons that that
counterparty
(i) Owns, controls, or holds with
power to vote 25 percent or more of a
class of voting securities of the person;
(ii) Owns or controls 25 percent or
more of the total equity of the person;
or
(iii) Consolidates for financial
reporting purposes, as described in
§ 252.172(d), collectively;
(3) With respect to a State, the State
and all of its agencies, instrumentalities,
PO 00000
Frm 00031
Fmt 4701
Sfmt 4702
14357
and political subdivisions (including
any municipalities) collectively;
(4) With respect to a foreign sovereign
entity that is not assigned a zero percent
risk weight under the standardized
approach in the Board’s Regulation Q
(12 CFR part 217, subpart D), the foreign
sovereign entity and all of its agencies
and instrumentalities (but not including
any political subdivision), collectively;
and
(5) With respect to a political
subdivision of a foreign sovereign entity
such as states, provinces, and
municipalities, any political
subdivisions of a foreign sovereign
entity and all such political
subdivision’s agencies and
instrumentalities, collectively.
(f) Covered entity means:
(1) Any entity that is part of the
combined U.S. operations of a foreign
banking organization with total
consolidated assets of $50 billion or
more, calculated pursuant to
§ 252.170(a), and all of its subsidiaries;
and
(2) Any U.S. intermediate holding
company of a foreign banking
organization with total consolidated
assets of $50 billion or more, calculated
pursuant to § 252.170(b), and all of its
subsidiaries.
(g) Credit derivative has the same
meaning as in § 217.2 of the Board’s
Regulation Q (12 CFR 217.2).
(h) Credit transaction means:
(1) Any extension of credit, including
loans, deposits, and lines of credit, but
excluding uncommitted lines of credit;
(2) Any repurchase transaction or
reverse repurchase transaction;
(3) Any securities lending or
securities borrowing transaction;
(4) Any guarantee, acceptance, or
letter of credit (including any
endorsement, confirmed letter of credit,
or standby letter of credit) issued on
behalf of a counterparty;
(5) Any purchase of, or investment in,
securities issued by a counterparty;
(6) Any credit exposure to the
counterparty in connection with a
derivative transaction between the
covered company and the counterparty;
(7) Any credit exposure to the
counterparty in connection with a credit
derivative or equity derivative
transaction between the covered
company and a third party, the
reference asset of which is an obligation
or equity security of the counterparty;
and
(8) Any transaction that is the
functional equivalent of the above, and
any other similar transaction that the
Board, by regulation, determines to be a
credit transaction for purposes of this
subpart.
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
14358
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
(i) Depository institution has the same
meaning as in section 3 of the Federal
Deposit Insurance Act (12 U.S.C.
1813(c)).
(j) Derivative transaction means any
transaction that is a contract, agreement,
swap, warrant, note, or option that is
based, in whole or in part, on the value
of, any interest in, or any quantitative
measure or the occurrence of any event
relating to, one or more commodities,
securities, currencies, interest or other
rates, indices, or other assets.
(k) Eligible collateral means collateral
in which a U.S. intermediate holding
company or any part of the foreign
banking organization’s combined U.S.
operations has a perfected, first priority
security interest or the legal equivalent
thereof, if outside of the United States
(with the exception of cash on deposit
and notwithstanding the prior security
interest of any custodial agent) and is in
the form of:
(1) Cash on deposit with the U.S.
intermediate holding company or any
part of the U.S. operations, the U.S.
branch, or the U.S. agency (including
cash held for the foreign banking
organization or U.S. intermediate
holding company by a third-party
custodian or trustee);
(2) Debt securities (other than
mortgage- or asset-backed securities and
resecuritization securities, unless those
securities are issued by a U.S.
government-sponsored enterprise) that
are bank-eligible investments and that
are investment grade;
(3) Equity securities that are publicly
traded; or
(4) Convertible bonds that are
publicly traded; and
(5) Does not include any debt or
equity securities (including convertible
bonds), issued by an affiliate of the U.S.
intermediate holding company or by
any part of the foreign banking
organization’s combined U.S.
operations.
(l) Eligible credit derivative means a
single-name credit derivative or a
standard, non-tranched index credit
derivative, provided that:
(1) The derivative contract is subject
to an eligible guarantee and has been
confirmed by the protection purchaser
and the protection provider;
(2) Any assignment of the derivative
contract has been confirmed by all
relevant parties;
(3) If the credit derivative is a credit
default swap, the derivative contract
includes the following credit events:
(i) Failure to pay any amount due
under the terms of the reference
exposure, subject to any applicable
minimal payment threshold that is
consistent with standard market
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
practice and with a grace period that is
closely in line with the grace period of
the reference exposure; and
(ii) Receivership, insolvency,
liquidation, conservatorship, or inability
of the reference exposure issuer to pay
its debts, or its failure or admission in
writing of its inability generally to pay
its debts as they become due and similar
events;
(4) The terms and conditions dictating
the manner in which the derivative
contract is to be settled are incorporated
into the contract;
(5) If the contract allows for cash
settlement, the contract incorporates a
robust valuation process to estimate loss
reliably and specifies a reasonable
period for obtaining post-credit event
valuations of the reference exposure;
(6) If the contract requires the
protection purchaser to transfer an
exposure to the protection provider at
settlement, the terms of at least one of
the exposures that is permitted to be
transferred under the contract provides
that any required consent to transfer
may not be unreasonably withheld; and
(7) If the credit derivative is a credit
default swap, the contract clearly
identifies the parties responsible for
determining whether a credit event has
occurred, specifies that this
determination is not the sole
responsibility of the protection
provider, and gives the protection
purchaser the right to notify the
protection provider of the occurrence of
a credit event.
(m) Eligible equity derivative means
an equity-linked total return swap,
provided that:
(1) The derivative contract has been
confirmed by the counterparties;
(2) Any assignment of the derivative
contract has been confirmed by all
relevant parties; and
(3) The terms and conditions dictating
the manner in which the derivative
contract is to be settled are incorporated
into the contract.
(n) Eligible guarantee has the same
meaning as in § 217.2 of the Board’s
Regulation Q (12 CFR 217.2) that is
provided by an eligible protection
provider.
(o) Eligible protection provider has the
same meaning as ‘‘eligible guarantor’’ in
§ 217.2 of the Board’s Regulation Q (12
CFR 217.2), but does not include the
foreign banking organization or any
entity that is an affiliate of either the
U.S. intermediate holding company or
of any part of the foreign banking
organization’s combined U.S.
operations.
(p) Equity derivative has the same
meaning as ‘‘equity derivative contract’’
PO 00000
Frm 00032
Fmt 4701
Sfmt 4702
in § 217.2 of the Board’s Regulation Q
(12 CFR 217.2).
(q) Financial entity means:
(1) A depository institution;
(2) A bank holding company;
(3) A savings and loan holding
company (as defined in 12 U.S.C.
1467a);
(4) A securities broker or dealer
registered with the U.S. Securities and
Exchange Commission under the
Securities Exchange Act of 1934 (15
U.S.C. 78o et seq.);
(5) An insurance company that is
subject to the supervision by a State
insurance regulator;
(6) A foreign banking organization;
(7) A non-U.S.-based securities firm or
a non-U.S.-based insurance company
that is subject to consolidated
supervision and regulation comparable
to that imposed on U.S. depository
institutions, securities broker-dealers, or
insurance companies;
(8) A central counterparty; and
(9) A legal entity whose main
business includes the management of
financial assets, lending, factoring,
leasing, provision of credit
enhancements, securitization,
investments, financial custody,
proprietary trading, and other financial
services.
(r) Gross credit exposure means, with
respect to any credit transaction, the
credit exposure of the covered company
before adjusting, pursuant to section
252.174, for the effect of any qualifying
master netting agreement, eligible
collateral, eligible guarantee, eligible
credit derivative, eligible equity
derivative, other eligible hedge, and any
unused portion of certain extensions of
credit.
(s) Immediate family means the
spouse of an individual, the individual’s
minor children, and any of the
individual’s children (including adults)
residing in the individual’s home.
(t) Intraday credit exposure means
credit exposure of the U.S. intermediate
holding company or any part of the
combined U.S. operations to a
counterparty that by its terms is to be
repaid, sold, or terminated by the end of
its business day in the United States.
(u) Investment grade has the same
meaning as in § 217.2 of the Board’s
Regulation Q (12 CFR 217.2).
(v) Major counterparty means:
(1) A U.S. company identified as a
global systemically important bank
holding company pursuant to 12 CFR
217.402;
(2) Any foreign banking organization
(and all of its subsidiaries, collectively)
that meets one of the following
conditions:
(i) The foreign banking organization
has the characteristics of a global
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
systemically important banking
organization under the assessment
methodology and the higher loss
absorbency requirement for global
systemically important banks issued by
the Basel Committee on Banking
Supervision, as updated from time to
time; or
(ii) The Board, using information
reported by the foreign banking
organization or its U.S. subsidiaries,
information that is publicly available,
and confidential supervisory
information, determines:
(A) That the foreign banking
organization would be a global
systemically important banking
organization under the global
methodology;
(B) That the foreign banking
organization, if it were subject to the
Board’s Regulation Q, would be
identified as a global systemically
important bank holding company under
§ 217.402 of the Board’s Regulation Q;
or
(C) That the U.S. intermediate holding
company, if it were subject to the
Board’s Regulation Q, would be
identified as a global systemically
important bank holding company.
(iii) A foreign banking organization
that prepares or reports for any purpose
the indicator amounts necessary to
determine whether the foreign banking
organization is a global systemically
important banking organization under
the assessment methodology and the
higher loss absorbency requirement for
global systemically important banks
issued by the Basel Committee on
Banking Supervision, as updated from
time to time, must use the data to
determine whether the foreign banking
organization has the characteristics of a
global systemically important banking
organization under the global
methodology; and
(3) Any nonbank financial company
supervised by the Board.
(w) Major foreign banking
organization means any foreign banking
organization that has total consolidated
assets of $500 billion or more,
calculated pursuant to § 252.170(a)(4).
(x) Major U.S. intermediate holding
company means a U.S. intermediate
holding company that has total
consolidated assets of $500 billion or
more, calculated pursuant to
§ 252.170(b)(3).
(y) Net credit exposure means, with
respect to any credit transaction, the
gross credit exposure of a covered
company calculated under § 252.173, as
adjusted in accordance with § 252.174.
(z) Qualifying central counterparty
has the same meaning as in § 217.2 of
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
the Board’s Regulation Q (12 CFR
217.2).
(aa) Qualifying master netting
agreement has the same meaning as in
§ 217.2 of the Board’s Regulation Q (12
CFR 217.2).
(bb) Short sale means any sale of a
security which the seller does not own
or any sale which is consummated by
the delivery of a security borrowed by,
or for the account of, the seller.
(cc) Sovereign entity means a central
national government (including the U.S.
government) or an agency, department,
ministry, or central bank, but not
including any political governmental
subdivision such as a state, province, or
municipality.
(dd) Subsidiary of a specified
company means a company that is
directly or indirectly controlled by the
specified company.
(ee) Tier 1 capital means common
equity tier 1 capital and additional tier
1 capital, as defined in subpart O of the
Board’s Regulation YY (12 CFR part
252).
§ 252.172
Credit exposure limits.
(a) General limit on aggregate net
credit exposure.
(1) No U.S. intermediate holding
company shall have an aggregate net
credit exposure to any unaffiliated
counterparty in excess of 25 percent of
the consolidated capital stock and
surplus of the U.S. intermediate holding
company.
(2) No foreign banking organization
may permit its combined U.S.
operations, including, but not limited
to, any U.S. intermediate holding
company and any subsidiary of any U.S.
intermediate holding company, to have
an aggregate net credit exposure to any
unaffiliated counterparty in excess of 25
percent of the consolidated capital stock
and surplus of the foreign banking
organization.
(b) Limit on aggregate net credit
exposure for U.S. intermediate holding
companies and foreign banking
organizations with $250 billion or more
in total consolidated assets or $10
billion or more in total on-balance-sheet
foreign exposures.
(1) No U.S. intermediate holding
company that has $250 billion or more
in total consolidated assets or $10
billion or more in total on-balance-sheet
foreign exposures shall have an
aggregate net credit exposure to any
unaffiliated counterparty that exceeds
25 percent of the tier 1 capital of the
U.S. intermediate holding company.
(2) No foreign banking organization
that has $250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
PO 00000
Frm 00033
Fmt 4701
Sfmt 4702
14359
exposures shall permit its combined
U.S. operations, including, but not
limited to, any U.S. intermediate
holding company and any subsidiary of
any U.S. intermediate holding company,
to have an aggregate net credit exposure
to any unaffiliated counterparty in
excess of 25 percent of the tier 1 capital
of the foreign banking organization.
(c) Major U.S. intermediate holding
company and major foreign banking
organization limits on aggregate net
credit exposure to each other.
(1) No U.S. intermediate holding
company shall have an aggregate net
credit exposure to any unaffiliated
major counterparty in excess of 15
percent of the tier 1 capital of the U.S.
intermediate holding company.
(2) No major foreign banking
organization may permit its combined
U.S. operations to have an aggregate net
credit exposure to any unaffiliated
major counterparty in excess of 15
percent of the tier 1 capital of the major
foreign banking organization.
(d) For purposes of this subpart, a
counterparty and major counterparty
shall include any person that the
counterparty or major counterparty:
(1) owns, controls, or holds with
power to vote 25 percent or more of a
class of voting securities of the person;
(2) owns or controls 25 percent or
more of the total equity of the person;
or
(3) consolidates for financial reporting
purposes.
§ 252.173
Gross credit exposure.
(a) Calculation of gross credit
exposure for U.S. intermediate holding
companies and foreign banking
organizations. Except as provided in
paragraph (b) of this section, the amount
of gross credit exposure of a U.S.
intermediate holding company or, with
respect to any part of its combined U.S.
operations, a foreign banking
organization (each a covered entity), to
a counterparty is, in the case of:
(1) Loans by a covered entity to a
counterparty and leases in which a
covered entity is the lessor and a
counterparty is the lessee, an amount
equal to the amount owed by the
counterparty to the covered entity under
the transaction.
(2) Debt securities held by a covered
entity that is issued by the counterparty,
equal to:
(i) The market value, for trading and
available-for-sale securities; and
(ii) The amortized purchase price, for
securities held to maturity.
(3) Equity securities held by a covered
entity that is issued by the counterparty,
equal to the market value.
(4) Repurchase transactions, equal to
the adjusted market value of securities
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
14360
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
transferred by a covered entity to the
counterparty.
(5) Reverse repurchase transactions,
equal to the amount of cash transferred
by the covered company to the
counterparty.
(6) Securities borrowing transactions,
equal to:
(i) The amount of cash collateral
transferred by the covered entity to the
counterparty; plus
(ii) The adjusted market value of
securities collateral transferred by the
covered entity to the counterparty.
(7) Securities lending transactions,
equal to the adjusted market value of
securities lent by the covered entity to
the counterparty.
(8) Committed credit lines extended
by a covered entity to a counterparty,
equal to the face amount of the credit
line.
(9) Guarantees and letters of credit
issued by a covered entity on behalf of
a counterparty, equal to the maximum
potential loss to the covered entity on
the transaction.
(10) Derivative transactions between
the covered entity and the counterparty
that is not subject to a qualifying master
netting agreement:
(i) The derivative transaction shall be
valued at an amount equal to the sum
of:
(A) The current exposure of the
derivatives contract equal to the greater
of the mark-to-market value of the
derivative contract or zero; and
(B) The potential future exposure of
the derivatives contract, calculated by
multiplying the notional principal
amount of the derivative contract by the
applicable conversion factor in Table 2
to § 217.132 of the Board’s Regulation Q
(12 CFR 217.132).
(ii) In cases where a covered entity is
required to recognize an exposure to an
eligible protection provider pursuant to
section 252.174(e), the covered entity
must exclude the relevant derivative
transaction when calculating its gross
exposure to the original counterparty
under this section.
(11) Derivative transactions:
(i) Between a U.S. intermediate
holding company and a counterparty
that is subject to a qualifying master
netting agreement:
(A) The derivative transaction shall be
valued using any of the methods that
the U.S. intermediate holding company
is authorized to use under the Board’s
Regulation Q (12 CFR part 217, subparts
D and E) to value such transactions
(provided that the rules governing the
recognition of collateral set forth in this
subpart shall apply).
(B) In cases where the U.S.
intermediate holding company is
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
required to recognize an exposure to an
eligible protection provider pursuant to
section 252.174(e), the U.S. intermediate
holding company must exclude the
relevant derivative transaction when
calculating its gross exposure to the
original counterparty under this section.
(ii) Between an entity within the
combined U.S. operations of a foreign
banking organization and a counterparty
that is subject to a qualifying master
netting agreement between an entity
within the combined U.S. operations
and the counterparty:
(A) The derivative transaction shall be
valued at an amount equal to either (1)
the exposure at default amount
calculated under any of the methods
that the covered company is authorized
to use under the Board’s Regulation Q
(12 CFR part 217, subparts D and E) to
value such transactions (provided that
the rules governing the recognition of
collateral set forth in this subpart shall
apply); or (2) the gross credit exposure
amount calculated under
§ 252.173(a)(10) of this subpart.
(B) In cases where, the foreign
banking organization is required to
recognize an exposure to an eligible
protection provider pursuant to
§ 252.174(e), the foreign banking
organization must exclude the relevant
derivative transaction when calculating
its gross exposure to the original
counterparty under this section.
(12) Credit or equity derivative
transactions between the covered entity
and a third party where the covered
entity is the protection provider and the
reference asset is an obligation or equity
security of the counterparty, equal to the
maximum potential loss to the covered
entity on the transaction.
(b) Investments in and Exposures to
Securitization Vehicles, Investment
Funds, and Other Special Purpose
Vehicles. A U.S. intermediate holding
company or a foreign banking
organization that has $250 billion or
more in total consolidated assets or $10
billion or more in total on-balance-sheet
foreign exposures shall calculate its
gross credit exposure for investments in
and exposures to a securitization
vehicle, investment fund, and other
special purpose vehicle pursuant to
§ 252.175.
(c) Attribution rule. A U.S.
intermediate holding company or, with
respect to its combined U.S. operations,
a foreign banking organization must
treat any credit transaction with any
person as a credit transaction with a
counterparty, to the extent that the
proceeds of the transaction are used for
the benefit of, or transferred to, that
counterparty.
PO 00000
Frm 00034
Fmt 4701
Sfmt 4702
§ 252.174
Net credit exposure.
(a) In general. For purposes of this
subpart, a U.S. intermediate holding
company, or with respect to its
combined U.S. operations, a foreign
banking organization, shall calculate its
net credit exposure to a counterparty by
adjusting its gross credit exposure to
that counterparty in accordance with
the rules set forth in this section.
(b) Calculation of net credit exposure
for repurchase transactions, reverse
repurchase transactions, securities
lending transactions, and securities
borrowing transactions. With respect to
any repurchase transaction, reverse
repurchase transaction, securities
lending transaction, and securities
borrowing transaction with a
counterparty that is subject to a bilateral
netting agreement with that
counterparty and that meets the
definition of ‘‘repo-style transaction’’ in
section 217.2 of the Board’s Regulation
Q (12 CFR 217.2), the net credit
exposure of a U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization to a counterparty
shall be equal to the exposure at default
amount calculated under § 217.37(c)(2)
of the Board’s Regulation Q (12 CFR
217.37(c)(2)); provided that:
(1) The U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization shall apply the
standardized supervisory haircuts as
provided in 12 CFR 217.37(c)(3)(iii) of
the Board’s Regulation (12 CFR
217.37(c)(3)(iii), and is not permitted to
use its own internal estimates for
haircuts;
(2) The U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization shall, in
calculating its net credit exposure to a
counterparty as a result of the
transactions described in paragraph (b),
disregard any collateral received from
that counterparty that does not meet the
definition of ‘‘eligible collateral’’ in
§ 252.171(k); and
(3) The U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization shall include the
adjusted market value of any eligible
collateral, as further adjusted by the
application of the maturity mismatch
adjustment approach of § 217.36(d) of
the Board’s Regulation Q (12 CFR
217.36(d)), if applicable, when
calculating its gross credit exposure to
the collateral issuer, including in
instances where the underlying
repurchase transaction, reverse
repurchase transaction, securities
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
lending transaction, or securities
borrowing transaction would not be
subject to the credit limits of § 272.172.
(c) Eligible collateral.
(1) In computing its net credit
exposure to a counterparty for any
credit transaction other than
transactions described in paragraph (b)
of this section, a U.S. intermediate
holding company or, with respect to its
combined U.S. operations, a foreign
banking organization must reduce its
gross credit exposure on the transaction
by:
(i) The adjusted market value of any
eligible collateral, in cases where the
eligible collateral has the same or
greater maturity as the credit
transactions; or
(ii) The adjusted market value of any
eligible collateral, as further adjusted by
application of the maturity mismatch
adjustment approach of § 217.36(d) of
the Board’s Regulation Q (12 CFR
217.36(d)), but only if the eligible
collateral has an original maturity equal
to or greater than one year and a
residual maturity of not less than three
months, in cases where the eligible
collateral has a shorter maturity than the
credit transaction.
(2) A U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization that reduces its
gross credit exposure to a counterparty
as required under paragraph (c)(1) must
include the adjusted market value of the
eligible collateral, as further adjusted by
the application of the maturity
mismatch adjustment approach of
§ 217.36(d) of the Board’s Regulation Q
(12 CFR 217.36(d)), if applicable, when
calculating its gross credit exposure to
the collateral issuer, including in
instances where the underlying credit
transaction would not be subject to the
credit limits of § 272.172.
Notwithstanding the foregoing, in no
event will the gross credit exposure of
the U.S. intermediate holding company
or, with respect to its combined U.S.
operations, of the foreign banking
organization to the issuer of collateral be
in excess of its gross credit exposure to
the counterparty on the credit
transaction.
(d) Eligible guarantees.
(1) In calculating net credit exposure
to a counterparty for any credit
transaction, a U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization must reduce its
gross credit exposure to the
counterparty by any eligible guarantees
from an eligible protection provider that
covers the transaction by:
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
(i) The amount of any eligible
guarantees from an eligible protection
provider that covers the transaction, in
cases where the eligible guarantee has
the same or greater maturity as the
credit transaction; or
(ii) The amount of any eligible
guarantees from an eligible protection
provider that covers the transaction as
further adjusted by application of the
maturity mismatch adjustment approach
of § 217.36(d) of the Board’s Regulation
Q (12 CFR 217.36(d)), if the eligible
guarantees have an original maturity
equal to or greater than one year and a
residual maturity of not less than three
months, in cases where the eligible
guarantee has a shorter maturity than
the credit transaction.
(2) A U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization that reduces its
gross credit exposure to a counterparty
as required under paragraph (d)(1) must
include the amount of eligible
guarantees when calculating its gross
credit exposure to the eligible protection
provider, including in instances where
the underlying credit transaction would
not be subject to the credit limits of
§ 272.172. Notwithstanding the
foregoing, in no event will the gross
credit exposure of the U.S. intermediate
holding company or, with respect to its
combined U.S. operations, of the foreign
banking organization to an eligible
protection provider with respect to an
eligible guarantee be in excess of its
gross credit exposure to the
counterparty on the credit transaction
prior to recognition of the eligible
guarantee.
(e) Eligible credit and equity
derivatives.
(1) In calculating net credit exposure
to a counterparty for a credit
transaction, a U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization must reduce its
gross credit exposure to the
counterparty by:
(i) The notional amount of any
eligible credit or equity derivative from
an eligible protection provider, in cases
where the eligible credit or equity
derivative has a maturity that is the
same or greater than the maturity of the
credit transaction; or
(ii) The notional amount of any
eligible credit or equity derivative from
an eligible protection provider, as
further adjusted by application of the
maturity mismatch adjustment approach
of § 217.36(d) of the Board’s Regulation
Q (12 CFR 217.36(d)), but only if the
eligible credit or equity derivative has
an original maturity equal to or greater
PO 00000
Frm 00035
Fmt 4701
Sfmt 4702
14361
than one year and a residual maturity of
not less than three months, in cases
where the eligible credit or equity
derivative has a shorter maturity than
the credit transaction.
(2)(i) In general, a U.S. intermediate
holding company or, with respect to its
combined U.S. operations, a foreign
banking organization that reduces its
gross credit exposure to a counterparty
as provided under paragraph (e)(1) must
include the notional amount of the
eligible credit or equity derivative from
an eligible protection provider, as
further adjusted by the application of
the maturity mismatch adjustment
approach of § 217.36(d) of the Board’s
Regulation Q (12 CFR 217.36(d)), as
applicable, when calculating its gross
credit exposure to the eligible protection
provider, including in instances where
the underlying credit transaction would
not be subject to the credit limits of
§ 272.172. Notwithstanding the
foregoing, in no event will the gross
credit exposure of the U.S. intermediate
holding company or, with respect to its
combined U.S. operations, of the foreign
banking organization to an eligible
provider with respect to an eligible
credit or equity derivative be in excess
of its gross credit exposure to that
counterparty on the credit transaction
prior to recognition of the eligible credit
or equity derivative; and
(ii) In cases where the eligible credit
or equity derivative is used to hedge
covered positions and available-for-sale
exposures that are subject to the Board’s
market risk rule (12 CFR part 217,
subpart F) and the counterparty on the
hedged transaction is not a financial
entity, the amount of credit exposure
that a company must recognize to the
eligible protection provider is the
amount that would be calculated
pursuant to § 252.173(a), including in
instances where the underlying credit
transaction would not be subject to the
credit limits of § 272.172.
(f) Other eligible hedges. In
calculating net credit exposure to a
counterparty for a credit transaction, a
U.S. intermediate holding company or,
with respect to its combined U.S.
operations, a foreign banking
organization may reduce its gross credit
exposure to the counterparty by the face
amount of a short sale of the
counterparty’s debt or equity security,
provided that:
(1) The instrument in which the
covered company has a short position is
junior to, or pari passu with, the
instrument in which the covered
company has the long position; and
(2) The instrument in which the
covered company has a short position
and the instrument in which the
E:\FR\FM\16MRP2.SGM
16MRP2
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
14362
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
covered company has the long position
are either both treated as trading or
available-for-sale exposures or both
treated as held-to-maturity exposures.
(g) Unused portion of certain
extensions of credit.
(1) In computing its net credit
exposure to a counterparty for a credit
line or revolving credit facility, a U.S.
intermediate holding company or, with
respect to its combined U.S. operations,
a foreign banking organization may
reduce its gross credit exposure by the
amount of the unused portion of the
credit extension to the extent that the
U.S. intermediate holding company or
any part of the combined U.S.
operations of the foreign banking
organization does not have any legal
obligation to advance additional funds
under the extension of credit, until the
counterparty provides the amount of
adjusted market value of collateral of
the type described in paragraph (g)(2) of
this section in the amount (calculated in
accordance with § 252.171 of this
subpart) required with respect to the
entire used portion of the extension of
credit.
(2) To qualify for this reduction, the
credit contract must specify that any
used portion of the credit extension
must be fully secured by collateral that
is:
(i) Cash;
(ii) Obligations of the United States or
its agencies;
(iii) Obligations directly and fully
guaranteed as to principal and interest
by, the Federal National Mortgage
Association and the Federal Home Loan
Mortgage Corporation, while operating
under the conservatorship or
receivership of the Federal Housing
Finance Agency, and any additional
obligations issued by a U.S.
government-sponsored enterprise as
determined by the Board; or
(iv) Obligations of the foreign banking
organization’s home country sovereign
entity.
(h) Credit transactions involving
exempt and excluded persons. If a U.S.
intermediate holding company or, with
respect to its combined U.S. operations,
a foreign banking organization has a
credit transaction with any person,
exposures to which are exempt from
this subpart under § 252.175 or
otherwise excluded from the limits in
this subpart, and the U.S. intermediate
holding company or foreign banking
organization has reduced its credit
exposure on the credit transaction with
that person by obtaining collateral from
that person or a guarantee or credit or
equity derivative from an eligible
protection provider, the U.S.
intermediate holding company or
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
foreign banking organization shall
calculate its credit exposure to the
issuer of the collateral or protection
provider, as applicable, in accordance
with the rules set forth in this section
to the same extent as if the credit
transaction with the person were subject
to the requirements in this subpart,
including § 252.172.
§ 252.175 Investments in and exposures to
securitization vehicles, investment funds,
and other special purpose vehicles.
(a) In general. (1) This section applies
only to covered entities with $250
billion or more in total consolidated
assets or $10 billion or more in onbalance-sheet foreign exposures, subject
to paragraph (d) of this section.
(2)(i) If a covered entity can satisfy the
requirements of paragraph (a)(3), a
covered company must calculate its
gross credit exposure to each
securitization vehicle, investment fund,
and other special purpose vehicle in
which it invests pursuant to
§ 252.173(a), and the covered entity is
not required to calculate its gross credit
exposure to each issuer of assets held by
a securitization vehicle, investment
fund, or other special purpose vehicle.
(ii) If a covered entity cannot satisfy
the requirements of paragraph (a)(3), the
covered entity must calculate its gross
credit exposure to each issuer of assets
held by a securitization vehicle,
investment fund, or other special
purpose vehicle using the look-through
approach in paragraph (b) of this
section.
(2) A covered entity is not required to
calculate its gross credit exposure to
each issuer of assets held by a
securitization vehicle, investment fund,
or other special purpose vehicle, as
applicable, if the covered entity can
demonstrate that its gross credit
exposure to each such issuer,
considering only the credit exposures to
that issuer arising from the covered
entity’s investment in a particular
securitization vehicle, investment fund,
or other special purpose vehicle, is less
than 0.25 percent of the covered
entity’s:
(i) Capital stock and surplus in the
case of a covered entity subject to the
credit exposure limit of § 252.172(a); or
(ii) Tier 1 capital in the case of a
covered company subject to the credit
exposure limit of § 252.172(b).
(b) Look-Through Approach. (1) A
covered entity that cannot satisfy the
requirements of paragraph (a)(3) must
calculate its gross credit exposure, for
purposes of § 252.173(a), to each issuer
of assets held by a securitization
vehicle, investment fund, or other
PO 00000
Frm 00036
Fmt 4701
Sfmt 4702
special purpose vehicle, pursuant to
paragraph (b)(3) of this section.
(2) If a covered entity that cannot
satisfy the requirements of paragraph
(a)(3) is unable to identify each issuer of
assets held by a securitization vehicle,
investment fund, or other special
purpose vehicle, the covered entity, for
purposes of paragraph (b)(3) of this
section, must attribute the gross credit
exposure to a single unknown
counterparty, and the limits of § 252.172
shall apply to that counterparty as a
single counterparty.
(3) A covered entity that is required
to calculate its gross credit exposure to
an issuer of assets held by a
securitization vehicle, investment fund,
or other special purpose vehicle
pursuant to paragraph (b)(1), or to an
unknown counterparty pursuant to
paragraph (b)(2), must calculate the
gross credit exposure as follows:
(i) Where all investors in the
securitization vehicle, investment fund,
or other special purpose vehicle rank
pari passu, the gross credit exposure is
equal to the covered entity’s pro rata
share multiplied by the value of the
assets attributed to the issuer or the
unknown counterparty, as applicable,
that are held within the structure; and
(ii) Where all investors in the
securitization vehicle, investment fund,
or other special purpose vehicle do not
rank pari passu, the gross credit
exposure is equal to:
(A) The lower of the value of the
tranche in which the covered entity has
invested, calculated pursuant to
§ 252.173(a), and the value of each asset
attributed to the issuer or the unknown
counterparty, as applicable, that are
held by the securitization vehicle,
investment fund, or other special
purpose vehicle; multiplied by
(B) The pro rata share of the covered
entity’s investment in the tranche.
(c) Exposures to Third Parties. (1)
Notwithstanding any other requirement
in this section, a covered entity must
recognize, for purposes of this subpart,
a gross credit exposure to each third
party that has a contractual or other
business relationship with a
securitization vehicle, investment fund,
or other special purpose vehicle, such as
a fund manager or protection provider,
whose failure or material financial
distress would cause a loss in the value
of the covered entity’s investment in or
exposure to the securitization vehicle,
investment fund, or other special
purpose vehicle.
(2) For purposes of § 252.172, with
respect to a covered entity’s gross credit
exposure to a third party that a covered
entity must recognize pursuant to
paragraph (c)(1), the covered entity shall
E:\FR\FM\16MRP2.SGM
16MRP2
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
recognize an exposure to the third party
in an amount equal to the covered
entity’s gross credit exposure to the
associated securitization vehicle,
investment fund, or other special
purpose vehicle, in addition to the
covered entity’s gross credit exposure to
the associated securitization vehicle,
investment fund, or other special
purpose vehicle.
(d) Notwithstanding paragraph (a)(1)
of this section, in order to avoid evasion
of this subpart, the Board may
determine, after notice to the covered
entity and opportunity for hearing, that
a covered entity with less than $250
billion in total consolidated assets and
less than $10 billion in total on-balancesheet foreign exposures must apply the
look-through approach or recognize
exposures to third parties that have a
contractual or other business
relationship for purposes of this
subpart.
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
§ 252.176 Aggregation of exposures to
more than one counterparty due to
economic interdependence or control
relationships.
(a) Aggregation of Exposures to More
than One Counterparty due to Economic
Interdependence.
(1)(i) If a U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization that has less than
$250 billion in total consolidated assets
and less than $10 billion in total onbalance-sheet foreign exposures has an
aggregate net credit exposure to any
unaffiliated counterparty that exceeds 5
percent of the consolidated capital stock
and surplus of the covered company, or
5 percent of its tier 1 capital in the case
of a U.S. intermediate holding company
with $250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures, the U.S. intermediate
holding company or, with respect to its
combined U.S. operations, the foreign
banking organization shall analyze its
relationship with the unaffiliated
counterparty under paragraph (a)(2) of
this section to determine whether the
unaffiliated counterparty is
economically interdependent with one
or more other unaffiliated
counterparties of the covered company.
(ii) For purposes of this paragraph,
two counterparties are economically
interdependent if the failure, default,
insolvency, or material financial distress
of one counterparty would cause the
failure, default, insolvency, or material
financial distress of the other
counterparty, taking into account the
factors in paragraph (a)(2) of this
section.
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
(iii) If a U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization or the Board
determines pursuant to paragraph (a)(2)
or (a)(3) of this section, as applicable,
that one or more other unaffiliated
counterparties of a U.S. intermediate
holding company or, with respect to its
combined U.S. operations, of a foreign
banking organization are economically
dependent, the U.S. intermediate
holding company or, with respect to its
combined U.S. operations, the foreign
banking organization shall aggregate its
net credit exposure to the unaffiliated
counterparties for all purposes under
this subpart, including but not limited
to § 252.172.
(2) In making a determination as to
whether any two counterparties are
economically interdependent, a U.S.
intermediate holding company or, with
respect to its combined U.S. operations,
a foreign banking organization shall
consider the following factors:
(i) Whether 50 percent or more of one
counterparty’s gross revenue or gross
expenditures are derived from
transactions with the other
counterparty;
(ii) Whether one counterparty
(counterparty A) has fully or partly
guaranteed the credit exposure of the
other counterparty (counterparty B), or
is liable by other means, and the credit
exposure is significant enough that
counterparty B is likely to default if
presented with a claim relating to the
guarantee or liability;
(iii) Whether 25 percent or more of
one counterparty’s production or output
is sold to the other counterparty, which
cannot easily be replaced by other
customers;
(iv) Whether the expected source of
funds to repay any credit exposure
between the counterparties is the same
and at least one of the counterparties
does not have another source of income
from which the extension of credit may
be fully repaid;
(v) Whether the financial distress of
one counterparty (counterparty A) is
likely to impair the ability of the other
counterparty (counterparty B) to fully
and timely repay counterparty B’s
liabilities;
(vi) Whether one counterparty
(counterparty A) has made a loan to the
other counterparty (counterparty B) and
is relying on repayment of that loan in
order to satisfy its obligations to the
covered company, and counterparty A
does not have another source of income
that it can use to satisfy its obligations
to the covered company; and
(vii) Any other indicia of
interdependence that the covered
PO 00000
Frm 00037
Fmt 4701
Sfmt 4702
14363
company determines to be relevant to
this analysis.
(3) In order to avoid evasion of this
section, the Board may determine, after
notice to the company and opportunity
for hearing, that one or more
unaffiliated counterparties of a U.S.
intermediate holding company or, with
respect to its combined U.S. operations,
of a foreign banking organization are
economically dependent for purposes of
this subpart. In making any such
determination, the Board shall consider
the factors in paragraph (a)(2) of this
section as well as any other indicia of
economic interdependence that the
Board determines to be relevant.
(b) Aggregation of exposures to more
than one counterparty due to certain
control relationships.
(1) A U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization shall assess
whether counterparties are connected
by control relationships due to the
following factors:
(i) The presence of voting agreements;
(ii) Ability of one counterparty to
significantly influence the appointment
or dismissal of another counterparty’s
administrative, management or
governing body, or the fact that a
majority of members of such body have
been appointed solely as a result of the
exercise of the first counterparty’s
voting rights; and
(iii) Ability of one counterparty to
exercise a controlling influence over the
management or policies of another
counterparty.
(2) If a U.S. intermediate holding
company or, with respect to its
combined U.S. operations, a foreign
banking organization or the Board
determines pursuant to paragraph (b)(1)
or (b)(3) of this section that one or more
other unaffiliated counterparties of the
U.S. intermediate holding company or,
with respect to its combined U.S.
operations, of the foreign banking
organization are connected by control
relationships, the U.S. intermediate
holding company or, with respect to its
combined U.S. operations, the foreign
banking organization shall aggregate its
net credit exposure to the unaffiliated
counterparties for all purposes under
this subpart, including but not limited
to, § 252.172.
(3) In order to avoid evasion of this
section, the Board may determine, after
notice to the company and opportunity
for hearing, that one or more
unaffiliated counterparties of a U.S.
intermediate holding company or, with
respect to its combined U.S. operations,
of a foreign banking organization are
connected by control relationships for
E:\FR\FM\16MRP2.SGM
16MRP2
14364
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Proposed Rules
purposes of this subpart. In making any
such determination, the Board shall
consider the factors in paragraph (b)(1)
of this section as well as any other
control relationships that the Board
determines to be relevant.
§ 252.177
Exemptions.
mstockstill on DSK4VPTVN1PROD with PROPOSALS2
(a) Exempted exposure categories.
The following categories of credit
transactions are exempt from the limits
on credit exposure under this subpart:
(1) Direct claims on, and the portions
of claims that are directly and fully
guaranteed as to principal and interest
by, the Federal National Mortgage
Association and the Federal Home Loan
Mortgage Corporation, only while
operating under the conservatorship or
receivership of the Federal Housing
Finance Agency, and any additional
obligations issued by a U.S.
government-sponsored entity as
determined by the Board.
(2) Intraday credit exposure to a
counterparty.
(3) Trade exposures to a qualifying
central counterparty related to the
covered entity’s clearing activity,
including potential future exposure
arising from transactions cleared by the
qualifying central counterparty and prefunded default fund contributions.
(4) Direct claims on, and the portions
of claims that are directly and fully
guaranteed as to principal and interest
by, the foreign banking organization’s
home country sovereign entity,
notwithstanding the risk weight
assigned to that sovereign entity under
the Board’s Regulation Q (12 CFR part
217).
(5) Any transaction that the Board
exempts if the Board finds that such
exemption is in the public interest and
consistent with the purpose of this
section.
(b) Additional Exemptions by the
Board. The Board may, by regulation or
order, exempt transactions, in whole or
in part, from the definition of the term
‘‘credit exposure,’’ if the Board finds
VerDate Sep<11>2014
18:55 Mar 15, 2016
Jkt 238001
that the exemption is in the public
interest and is consistent with the
purpose of § 165(e) of the Dodd-Frank
Wall Street Reform and Consumer
Protection Act (12 U.S.C. 5365(e)).
§ 252.178
Compliance.
(a) Scope of compliance. A foreign
banking organization or U.S.
intermediate holding company with
$250 billion or more in total
consolidated assets or $10 billion or
more in total on-balance-sheet foreign
exposures must ensure its compliance
with the requirements of this section on
a daily basis at the end of each business
day and submit to the Board on a
monthly basis a report demonstrating its
daily compliance. A foreign banking
organization or U.S. intermediate
holding company with less than $250
billion in total consolidated assets or
$10 billion in total on-balance-sheet
foreign exposures must comply with the
requirements of this section on a
quarterly basis and submit on a
quarterly basis a report demonstrating
its quarterly compliance, unless the
Board determines and notifies that
company that more frequent compliance
and reporting is required.
(b) Qualifying Master Netting
Agreement. A foreign banking
organization must ensure that its U.S.
intermediate holding company and
combined U.S. operations establish and
maintain procedures that meet or
exceed the requirements of § 217.3(d) of
the Board’s Regulation Q (12 CFR
217.3(d)) to monitor possible changes in
relevant law and to ensure that the
agreement continues to satisfy the
requirements of a qualifying master
netting agreement.
(c) Noncompliance. Except as
otherwise provided in this section,
either the U.S. intermediate holding
company or the foreign banking
organization is not in compliance with
this subpart solely due to the
circumstances listed in §§ 252.178(c)
(1)–(4) below, the covered entity will
PO 00000
Frm 00038
Fmt 4701
Sfmt 9990
not be subject to enforcement actions for
a period of 90 days (or such other period
determined by the Board to be
appropriate to preserve the safety and
soundness of the covered company or
U.S. financial stability) if the covered
entity uses reasonable efforts to return
to compliance with this subpart during
this period. Neither the U.S.
intermediate holding company nor the
combined U.S. operations may engage
in any additional credit transactions
with such a counterparty in
contravention of this subpart, unless the
Board determines that such credit
transactions are necessary or
appropriate to preserve the safety and
soundness of the foreign banking
organization or U.S. financial stability.
In considering this determination, the
Board will consider whether any of the
following circumstances exist:
(1) A decrease in the U.S.
intermediate holding company’s or
foreign banking organization’s capital
stock and surplus;
(2) The merger of the U.S.
intermediate holding company or
foreign banking organization with a
bank holding company with total
consolidated assets of $50 billion or
more, a nonbank financial company
supervised by the Board, a foreign
banking organization, or U.S.
intermediate holding company;
(3) A merger of two unaffiliated
counterparties; or
(4) Any other circumstance the Board
determines is appropriate.
(d) Other measures. The Board may
impose supervisory oversight and
reporting measures that it determines
are appropriate to monitor compliance
with this subpart.
By order of the Board of Governors of the
Federal Reserve System, March 4, 2016.
Robert deV. Frierson,
Secretary of the Board.
[FR Doc. 2016–05386 Filed 3–15–16; 8:45 am]
BILLING CODE P
E:\FR\FM\16MRP2.SGM
16MRP2
Agencies
[Federal Register Volume 81, Number 51 (Wednesday, March 16, 2016)]
[Proposed Rules]
[Pages 14327-14364]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05386]
[[Page 14327]]
Vol. 81
Wednesday,
No. 51
March 16, 2016
Part IV
Federal Reserve System
-----------------------------------------------------------------------
12 CFR Part 252
Single-Counterparty Credit Limits for Large Banking Organizations;
Proposed Rule
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 /
Proposed Rules
[[Page 14328]]
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
12 CFR Part 252
[Regulation YY; Docket No. R-1534]
RIN 7100-AE 48
Single-Counterparty Credit Limits for Large Banking Organizations
AGENCY: Board of Governors of the Federal Reserve System (Board).
ACTION: Notice of proposed rulemaking.
-----------------------------------------------------------------------
SUMMARY: The Board is inviting comment on proposed rules that would
establish single-counterparty credit limits for domestic and foreign
bank holding companies with $50 billion or more in total consolidated
assets. The proposed rules would implement section 165(e) of the Dodd-
Frank Wall Street Reform and Consumer Protection Act, which requires
the Board to impose limits on the amount of credit exposure that such a
domestic or foreign bank holding company can have to an unaffiliated
company in order to reduce the risks arising from the company's
failure. The proposed rules, which build on earlier proposed rules by
the Board to establish single-counterparty credit limits for large
domestic and foreign banking organizations, would increase in
stringency based on the systemic importance of the firms to which they
apply.
DATES: Comments should be received by June 3, 2016.
ADDRESSES: You may submit comments, identified by Docket No. R-1534 and
RIN No. 7100 AE-48, by any of the following methods:
Agency Web site: http://www.federalreserve.gov. Follow the
instructions for submitting comments at http://www.federalreserve.gov/generalinfo/foia/ProposedRegs.cfm.
Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments.
Email: regs.comments@federalreserve.gov. Include the
docket number in the subject line of the message.
Fax: (202) 452-3819 or (202) 452-3102.
Mail: Robert deV. Frierson, Secretary, Board of Governors
of the Federal Reserve System, 20th Street and Constitution Avenue NW.,
Washington, DC 20551.
All public comments will be made available on the Board's Web site
at http://www.federalreserve.gov/generalinfo/foia/ProposedRegs.cfm as
submitted, unless modified for technical reasons. Accordingly, your
comments will not be edited to remove any identifying or contact
information. Public comments may also be viewed electronically or in
paper form in Room 3515, 1801 K Street (between 18th and 19th Streets
NW.) Washington, DC 20006 between 9:00 a.m. and 5:00 p.m. on weekdays.
FOR FURTHER INFORMATION CONTACT: Jordan Bleicher, Senior Supervisory
Financial Analyst, (202) 973-6123, Division of Banking Supervision and
Regulation; or Laurie Schaffer, Associate General Counsel, (202) 452-
2272, Benjamin McDonough, Special Counsel, (202) 452-2036, Pam
Nardolilli, Senior Counsel, (202) 452-3289, or Lucy Chang, Attorney,
(202) 475-6331, Legal Division, Board of Governors of the Federal
Reserve System, 20th and C Streets NW., Washington, DC 20551. For the
hearing impaired only, Telecommunications Device for the Deaf (TDD)
users may contact (202) 263-4869.
SUPPLEMENTARY INFORMATION:
Table of Contents
I. Background
A. General Background
B. Summary of Comments on the 2011 and 2012 Proposals
II. Proposed Rule for Domestic Bank Holding Companies
A. Overview of the Proposed Rule for Domestic Bank Holding
Companies
III. Proposed Rule for Foreign Banking Organizations
A. Background
B. Overview of the Proposed Rule for Foreign Banking
Organizations
IV. Regulatory Analysis
A. Paperwork Reduction Act
B. Solicitation of Comments on the Use of Plain Language
C. Regulatory Flexibility Act Analysis
Background
General Background
During the 2007-2008 financial crisis, some of the largest
financial firms in the world collapsed or experienced material
financial distress. Counterparties of failing firms were placed under
severe strain when the failing firm could not meet its financial
obligations, in some cases resulting in the counterparties' inability
to meet their own financial obligations. Similarly, weakened financial
firms came under increased stress when counterparties with large
exposures to the firm suddenly attempted to reduce those exposures.
The effect of a large financial institution's failure or near
collapse is amplified by the mutual interconnectedness of large,
systemically important firms--that is, the degree to which they extend
each other credit and serve as counterparties to one another. As
demonstrated during the crisis, financial distress at a banking
organization may materially raise the likelihood of distress at other
firms given the network of contractual obligations throughout the
financial system. Accordingly, a large banking organization's systemic
impact is likely to be directly related to its interconnectedness vis-
[agrave]-vis other financial institutions and the financial sector as a
whole. This interconnectedness of financial firms also creates the
potential for an increase in the likelihood of distress at non-
financial firms that are dependent upon financial firms for funding.
The financial crisis also revealed inadequacies in the U.S.
regulatory approach to credit exposure limits, which limited only some
of the interconnectedness among large financial companies. For example,
certain commercial banks were subject to single-borrower lending and
investment limits. However, these limits often excluded credit
exposures generated by derivatives and some securities financing
transactions, and did not apply at the consolidated holding company
level.\1\
---------------------------------------------------------------------------
\1\ Section 610 of the Dodd-Frank Wall Street Reform and
Consumer Protection Act (Dodd-Frank Act) amends the term ``loans and
extensions of credit'' for purposes of the lending limits applicable
to national banks to include any credit exposure arising from a
derivative transaction, repurchase agreement, reverse repurchase
agreement, securities lending transaction, or securities borrowing
transaction. See Dodd-Frank Act, Public Law 111-203, 610, 124 Stat.
1376, 1611 (2010), codified at 12 U.S.C. 84(b). As discussed in more
detail below, these types of transactions also are made subject to
the single-counterparty credit limits of section 165(e). 12 U.S.C.
5365(e)(3).
---------------------------------------------------------------------------
Section 165(e) of the Dodd-Frank Wall Street Reform and Consumer
Protection Act (Dodd-Frank Act) authorizes the Board to establish
single-counterparty credit limits for bank holding companies with total
consolidated assets of $50 billion or more (covered companies) and
foreign banking organizations with total consolidated assets of $50
billion or more, and any U.S. intermediate holding company (covered
entities), in order to limit the risks that the failure of any
individual firm could pose to a covered company.\2\ This section
prohibits covered companies and covered entities from having credit
exposure to any unaffiliated company that exceeds 25 percent of the
capital stock and surplus of the covered company, or such lower amount
as the Board may determine by regulation to be necessary to mitigate
risks to the financial stability of the United States.\3\
---------------------------------------------------------------------------
\2\ See 12 U.S.C. 5365(e)(1).
\3\ 12 U.S.C. 5365(e)(2).
---------------------------------------------------------------------------
[[Page 14329]]
Credit exposure to a company is defined in section 165(e) of the
Dodd-Frank Act to mean all extensions of credit to the company,
including loans, deposits, and lines of credit; all repurchase
agreements, reverse repurchase agreements, and securities borrowing and
lending transactions with the company (to the extent that such
transactions create credit exposure for the covered company); all
guarantees, acceptances, and letters of credit (including endorsement
or standby letters of credit) issued on behalf of the company; all
purchases of, or investments in, securities issued by the company;
counterparty credit exposure to the company in connection with
derivative transactions between the covered company and the company;
and any other similar transaction that the Board, by regulation,
determines to be a credit exposure for purposes of section 165.\4\
---------------------------------------------------------------------------
\4\ See 12 U.S.C. 5365(e)(3).
---------------------------------------------------------------------------
Section 165(e) also grants the Board authority to issue such
regulations and orders, including definitions consistent with section
165(e), as may be necessary to administer and carry out that section.
In addition, it authorizes the Board to exempt transactions, in whole
or in part, from the definition of the term ``credit exposure,'' if the
Board finds that the exemption is in the public interest and consistent
with the purposes of section 165(e).\5\ Finally, section 165(e)
authorizes the Board to establish single-counterparty credit limits for
nonbank financial companies designated by the Financial Stability
Oversight Council (FSOC) for supervision by the Board. The draft
proposed rules would not at this time apply to any such nonbank
financial company. The Board intends to apply similar requirements to
these companies separately by rule or order at a later time.
---------------------------------------------------------------------------
\5\ See 12 U.S.C. 5365(e)(5)-(6).
---------------------------------------------------------------------------
The proposed framework of credit exposure limits for covered
companies is similar to existing limits for depository institutions,
including the investment securities limits and the lending limits
imposed on certain depository institutions.\6\ A national bank
generally is limited, subject to certain exceptions, in the total
amount of investment securities of any one obligor that it may purchase
for its own account to no more than 10 percent of its capital stock and
surplus.\7\ In addition, a national bank's total outstanding loans and
extensions of credit to one borrower may not exceed 15 percent of the
bank's capital stock and surplus, plus an additional 10 percent of the
bank's capital stock and surplus, if the amount that exceeds the bank's
15 percent general limit is fully secured by readily-marketable
collateral.\8\
---------------------------------------------------------------------------
\6\ See, e.g., 12 U.S.C. 24(7); 12 U.S.C. 84; 12 CFR 1 and 32;
see also 12 U.S.C. 335 (applying the provisions of 12 U.S.C. 24(7)
to state member banks).
\7\ See 12 U.S.C. 24(7); 12 CFR 1.
\8\ See 12 U.S.C. 84; 12 CFR 32.3. State-chartered banks, as
well as state and federally-chartered savings associations, also are
subject to lending limits imposed by relevant state and federal law.
---------------------------------------------------------------------------
The requirements in section 165(e) operate as a separate and
independent limit from the investment securities limits and lending
limits in the National Bank Act and Federal Reserve Act, and a covered
company or covered entity must comply with all of the limits that are
applicable to it and its subsidiaries. A covered company would be
required to ensure that it does not exceed the single-counterparty
credit limits when all the credit exposures of the organization are
consolidated. Because the proposed rules would impose limits on credit
transactions by a covered company or covered entity on a consolidated
basis, including its subsidiary depository institutions, the proposed
rules may affect the amount of loans and extensions of credit that
would otherwise be consistent with a subsidiary depository
institution's lending limits.
The Board invited public comment on proposed rules to implement
section 165(e) for domestic banking organizations in December 2011 and
for foreign banking organizations in December 2012.\9\ The Board is re-
proposing rules to implement section 165(e) in order to take account of
(1) the large volume of comments received on the original 165(e)
proposed rules from banks, trade associations, public interest groups,
and others; (2) the revised lending limits rules applicable to national
banks; \10\ (3) the introduction by the Basel Committee on Banking
Supervision (BCBS) of a large exposures standard (LE Standard), which
establishes an international standard for the maximum amount of credit
exposure that an internationally active bank is permitted to have to a
single counterparty; \11\ and (4) the results of quantitative impact
studies and related analysis conducted by Board staff to help gauge the
impact of the original 165(e) proposed rules and these revised rules.
---------------------------------------------------------------------------
\9\ http://www.federalreserve.gov/newsevents/press/bcreg/20111220a.htm; http://www.federalreserve.gov/newsevents/press/bcreg/20121214a.htm.
\10\ See 78 FR 37930 (June 25, 2013).
\11\ http://www.bis.org/press/p140415.htm.
---------------------------------------------------------------------------
Summary of Comments on the 2011 and 2012 Proposals
The Board received 48 comments, representing approximately 60
parties, on the 2011 proposal on section 165(e) as it relates to
domestic firms and 35 comments, representing over 45 organizations, on
the 2012 proposed rule as it relates to foreign banking organizations.
The comments were received from a wide range of individuals, banking
organizations, industry and trade groups representing banking,
insurance, and the broader financial services industry, and public
interest groups. Board staff also met with industry representatives and
government representatives to discuss issues relating to the proposed
rules.
Some commenters expressed support for the broader goals of the
proposed rules to limit single-counterparty concentrations at large
financial companies. Numerous commenters expressed concerns, however,
about various aspects of the proposed rules. The Board received
comments on all aspects of the proposed rules, and the Board has taken
into consideration these comments in these revised proposed rules for
section 165(e).
In the 2011 proposed rule, the Board proposed to limit the
aggregate net credit exposure of a covered company to a single
unaffiliated counterparty to no more than 25 percent of the
consolidated capital stock and surplus of the covered company. The
Board further proposed to limit the aggregate net credit exposure of
U.S. bank holding companies with over $500 billion in assets to any
other unaffiliated bank holding company of similar size, or to a
nonbank financial company designated by the FSOC for supervision by the
Board, to 10 percent of the capital stock and surplus of the covered
company.
Several commenters questioned the Board's basis for lowering the 25
percent statutory limit to 10 percent. These commenters generally
questioned the financial stability need for the lower limit and
questioned whether the 10 percent limit would have disruptive effects,
such as reducing market liquidity, decreasing loan capacity, and
driving financial services to the shadow banking sector. Several
commenters questioned the Board's basis for selecting a $500 billion
asset threshold as the cutoff for the lower 25 percent statutory credit
limit. Commenters representing the insurance industry criticized the
proposed standard because it did not take into account the unique
features of the insurance business. The Board also received
[[Page 14330]]
several comments that supported imposing the more stringent limits on
single-counterparty credit exposures between very large organizations.
Some commenters on the 2011 proposed rule urged the Board to base
single-counterparty credit limits on a narrower definition of capital.
For example, one commenter noted that a central finding of the
financial crisis was that only common equity was reliably loss
absorbing, and further observed that the Basel III capital standard
reflects this through its redefinition of capital instruments. This
commenter also argued that there are advantages to coordinating
regulatory capital definitions around a limited number of capital
definitions that include only instruments that are reliably loss
absorbing.
In its 2011 proposed rule, the Board proposed to exempt credit
exposures that were direct claims on, and the portions of claims that
were directly and fully guaranteed as to principal and interest by, the
United States and its agencies. Many commenters supported expanding
this exemption to include creditworthy non-U.S. sovereigns. Several
commenters noted that sovereign entities generally are not regarded as
``companies,'' and the statute covers exposures to companies. Others
argued there is no rationale for distinguishing between U.S. and other
highly-rated sovereign exposures and that limiting the amount of
exposure that a covered company can have to a highly-rated sovereign
may increase systemic risk by limiting the company's ability to invest
in or accept as collateral instruments issued by such sovereigns.
Commenters suggested that exposures to those sovereigns that are
assigned a low risk-weight under the Basel Capital rules should be
exempt.
Commenters questioned the Board's approach to measuring the
exposures resulting from derivative transactions. Under the 2011
proposed rule, a covered company generally would have been required to
calculate credit exposure to a derivatives counterparty using the
Current Exposure Method (CEM). Commenters argued that CEM is
insufficiently risk-sensitive and that it overstates the realistic
economic exposure of a derivative transaction. Commenters attributed
this issue in significant part to the fact that CEM limits the extent
to which netting benefits are taken into account in calculating
counterparty exposures.
Some commenters also criticized the Board's proposed approach to
measuring exposures from securities financing transactions.\12\ These
commenters argued that the collateral volatility haircuts included in
the 2011 proposed rule do not recognize the risk-mitigating value of
positive correlations between securities on loan and securities
received as collateral. These commenters also pointed out that under
the Board's risk-based capital rules, collateral volatility haircuts
for securities lending and repurchase transactions reflect a five-day
liquidation period, rather than the ten-day period used in the proposed
165(e) rule.
---------------------------------------------------------------------------
\12\ ``Securities financing transactions'' include repurchase
agreements, reverse repurchase agreements, securities lending
transactions, and securities borrowing transactions.
---------------------------------------------------------------------------
Many of the comments received concerning the proposed rule for
foreign banking organizations were similar to those filed with respect
to the domestic proposed rule, especially regarding the 2012 proposed
rule's treatment of foreign sovereign instruments. Some commenters
argued that, in light of the BCBS's development of the LE Standard that
would apply to a foreign banking organization on a consolidated basis,
it was unnecessary for the Board to develop single-counterparty credit
limits for a foreign banking organization's combined U.S. operations.
Some commenters also expressed concerns related to the definition of
the relevant capital base for their organizations. For example, some
foreign banking organizations that expected to form intermediate
holding companies (IHCs) to hold their U.S. subsidiaries were concerned
that their relevant capital base would be restricted to the capital of
the IHC, and not the relevant consolidated capital level of their
entire company.
After a review of these comments, the Board has modified the
proposed rules in a number of key respects. The Board welcomes comments
on all aspects of the proposed rules, including on the various
questions and alternatives discussed below.
Proposed Rule for Domestic Bank Holding Companies
Overview of Proposed Rule for Domestic Bank Holding Companies
Under the proposed rule to implement section 165(e) of the Dodd-
Frank Act, the aggregate net credit exposure of a bank holding company
with total consolidated assets of $50 billion or more (covered company)
to a single counterparty would be subject to one of three increasingly
stringent credit exposure limits. The first category of limits would
apply to covered companies that have less than $250 billion in total
consolidated assets and less than $10 billion in on-balance-sheet
foreign exposures. Covered companies that have less than $250 billion
in total consolidated assets and less than $10 billion in on-balance
sheet foreign exposures would be prohibited from having aggregate net
credit exposure to an unaffiliated counterparty in excess of 25 percent
of the covered company's total capital stock and surplus, defined under
the rule as the covered company's total regulatory capital plus
allowance for loan and lease losses (ALLL).
The second category of exposure limits would prohibit any covered
company with $250 billion or more in total consolidated assets or $10
billion or more in total on-balance-sheet foreign exposures, but which
is not a global systemically important banking organization, from
having aggregate net credit exposure to an unaffiliated counterparty in
excess of 25 percent of the covered company's tier 1 capital.
The third category of exposure limits would prohibit any covered
company that is a global systemically important banking organization
(major covered company) from having aggregate net credit exposure in
excess of 15 percent of the major covered company's tier 1 capital to a
major counterparty, and 25 percent of the major covered company's tier
1 capital to any other counterparty. A ``major counterparty'' would be
defined as a global systemically important banking organization or a
nonbank financial company supervised by the Board. This framework would
be consistent with the requirement in section 165(a)(1)(B) of the Dodd-
Frank Act that the enhanced standards established by the Board under
section 165 increase in stringency based on factors such as the nature,
scope, size, scale, concentration, interconnectedness, and mix of the
activities of the company.\13\ The credit exposure limits are
summarized in Table 1.
---------------------------------------------------------------------------
\13\ 12 U.S.C. 5323, 5365(e).
[[Page 14331]]
Table 1--Single-Counterparty Credit Limits Applicable to Covered
Companies
------------------------------------------------------------------------
Applicable credit exposure
Category of covered company limit
------------------------------------------------------------------------
Covered companies that have less than Aggregate net credit exposure
$250 billion in total consolidated to a counterparty cannot
assets and less than $10 billion in on- exceed 25 percent of a covered
balance-sheet foreign exposures. company's total regulatory
capital plus ALLL.
Covered companies that have $250 Aggregate net credit exposure
billion or more in total consolidated to a counterparty cannot
assets or $10 billion or more in on- exceed 25 percent of a covered
balance-sheet foreign exposures, but company's tier 1 capital.
are not major covered companies.
Major covered companies................ Aggregate net credit exposure
to a major counterparty cannot
exceed 15 percent of a major
covered company's tier 1
capital.
Aggregate net credit exposure
to other counterparties cannot
exceed 25 percent of a major
covered company's tier 1
capital.
------------------------------------------------------------------------
The limits of the proposed rule would apply to the credit exposures
of a covered company on a consolidated basis, including any
subsidiaries, to any unaffiliated counterparty. A ``subsidiary'' of a
covered company would mean a company that is directly or indirectly
controlled by the specified company for purposes of the Bank Holding
Company Act of 1956, 12 U.S.C. 1841 et seq.\14\ If an investment fund
or vehicle is not controlled by a covered company, the exposures of
such fund or vehicle to its counterparties would not be aggregated with
those of the covered company for purposes of the proposed single-
counterparty credit limits applicable to that covered company.
---------------------------------------------------------------------------
\14\ See proposed rule Sec. 252.71(cc); see also section
252.2(g) of the Board's Regulation YY (12 CFR 252.2(g)).
---------------------------------------------------------------------------
A bank holding company should be able to monitor and control its
credit exposures on a consolidated basis, including the credit
exposures of its subsidiaries. Applying the single-counterparty credit
limits in the proposed rule to bank holding companies on a consolidated
basis, which would include the credit exposures of their subsidiaries,
would help to avoid evasion of the rule's purposes.
Question 1: As noted, the proposed rule would apply the single-
counterparty credit limits to covered companies on a consolidated basis
and could, therefore, impact the level of credit exposures of
subsidiaries of these covered companies, including depository
institutions. Is application on a consolidated basis appropriate?
Question 2: Should the definition of a ``subsidiary'' of a covered
company for purposes of single-counterparty credit limits be based on
the definition in the Bank Holding Company Act of 1956? Should a
``subsidiary'' instead be defined as any entity that a covered company
(1) owns, controls, or holds with power to vote 25 percent or more of a
class of voting securities; (2) owns or controls 25 percent or more of
the total equity; or (3) consolidates for financial reporting purposes?
Question 3: Should funds or vehicles that a covered company
sponsors or advises be expressly included as part of the covered
company for purposes of the proposed rule? Should the proposed rule's
definition of ``subsidiary'' be expanded to include any investment fund
or vehicle advised or sponsored by a covered company? Should the
proposed rule's definition of ``subsidiary'' be expanded to include any
other entity?
The proposed rule would establish limits on the credit exposure of
a covered company to a single ``counterparty.'' \15\ A counterparty
would be defined to include natural persons (including the person's
immediate family); a U.S. State (including all of its agencies,
instrumentalities, and political subdivisions); and certain foreign
sovereign entities (including their agencies, instrumentalities, and
political subdivisions). The Board is proposing to include individuals
and certain governmental entities within the definition of a
``counterparty'' because credit exposures to such entities create risks
to the covered company that are similar to those created by large
exposures to companies. The severe distress or failure of an
individual, U.S. state or municipality, or sovereign entity could have
effects on a covered company that are comparable to those caused by the
failure of a financial firm or nonfinancial corporation to which the
covered company has a large credit exposure. With respect to sovereign
entities, these risks are most acute in the case of sovereigns that
present greater credit risk. Therefore, the proposed rule would subject
credit exposures to individuals, U.S. states and municipalities, and
foreign sovereign governments that do not receive a zero percent risk
weight under the Board's Standardized Approach risk-based capital rules
in Regulation Q to the credit exposure framework in the same manner as
credit exposures to companies.\16\
---------------------------------------------------------------------------
\15\ See proposed rule Sec. 252.71(e).
\16\ See 12 CFR part 217, subpart D.
---------------------------------------------------------------------------
The Board proposes to extend the single-counterparty credit limits
to individuals, U.S. states, and certain foreign sovereigns using two
authorities. Under section 165(b)(1)(b) of the Dodd-Frank Act, the
Board may impose such additional enhanced prudential standards as the
Board of Governors determines are appropriate.\17\ In addition, under
section 5(b) of the Bank Holding Company Act, the Board may to issue
such regulations as may be necessary to enable it to administer and
carry out the purposes of this chapter and prevent evasions
thereof.\18\ Such purposes include examining the financial,
operational, and other risks within the bank holding company system
that may pose a threat to (1) the safety and soundness of the bank
holding company or of any depository institution subsidiary of the bank
holding company; or (2) the stability of the financial system of the
United States.\19\ The proposed rule would help to promote the safety
and soundness of a covered company and mitigate risks to financial
stability by limiting a covered company's maximum credit exposure to an
individual, U.S. state, or foreign sovereign, and thereby reducing the
risk that the failure of such individual or entity could cause the
failure or material financial distress of a covered company.
---------------------------------------------------------------------------
\17\ 12 U.S.C. 5363(b)(1)(B).
\18\ 12 U.S.C. 1844(b).
\19\ 12 U.S.C. 1844(c)(2)(A)(i)(II).
---------------------------------------------------------------------------
For purposes of the proposed credit exposure limits, a covered
company's exposures to a ``counterparty'' would include not only
exposures to that particular entity but also exposures to any person
with respect to which the counterparty (1) owns, controls, or holds
with power to vote 25 percent or more of a class of voting securities;
(2) owns or controls 25 percent or more of
[[Page 14332]]
the total equity; or (3) consolidates for financial reporting purposes.
To the extent that one or more of these conditions are met with respect
to a company's relationship to an investment fund or vehicle, exposures
to such fund or vehicle would need to be aggregated with that
counterparty.
Question 4: Under what circumstances should funds or vehicles that
a counterparty sponsors or advises be expressly included as part of the
counterparty for purposes of the proposed rule?
Further, in cases where total exposures to a single counterparty
exceed five percent of the covered company's eligible capital base
(i.e., total regulatory capital plus ALLL or tier 1 capital), the
covered company would need to add to exposures to that counterparty all
exposures to other counterparties that are ``economically
interdependent'' with the first counterparty. The purpose of this
proposed requirement is to limit a covered company's overall credit
exposure to two or more counterparties where the underlying risk of one
counterparty's financial distress or failure would cause the financial
distress or failure of another counterparty. In particular, under the
proposed rule, two counterparties would be considered economically
interdependent when it is the case that, if one of the counterparties
were to experience financial problems, the other counterparty would be
likely to experience financial problems as a result. In determining
whether two entities are economically interdependent, a covered company
would be required to take into account (1) whether 50 percent of one
counterparty's gross receipts or gross expenditures are derived from
transactions with the other counterparty; (2) whether one counterparty
has fully or partly guaranteed the exposure of the other counterparty,
or is liable by other means, and the exposure is significant enough
that the guarantor is likely to default if a claim occurs; (3) whether
a significant part of one counterparty's production or output is sold
to the other counterparty, which cannot easily be replaced by other
customers; (4) whether one counterparty has made a loan to the other
counterparty and is relying on repayment of that loan in order to
satisfy its obligations to the covered company, and the first
counterparty does not have another source of income that it can use to
satisfy its obligations to the covered company; (5) whether it is
likely that financial distress of one counterparty would cause
difficulties for the other counterparty in terms of full and timely
repayment of liabilities; and (6) when both counterparties rely on the
same source for the majority of their funding and, in the event of the
common provider's default, an alternative provider cannot be found.\20\
---------------------------------------------------------------------------
\20\ See proposed rule Sec. 252.76(a).
---------------------------------------------------------------------------
Two entities that are economically interdependent would be expected
to default on their exposures in a highly correlated manner, and
therefore they would be treated as a single counterparty for purposes
of the proposed rule. At the same time, there may be cases in which the
burdens of investigating economic interdependence would outweigh its
credit risk mitigating benefits to the covered company. For this
reason, a covered company would only be required to assess whether
counterparties are economically interdependent if the sum of the
covered company's exposures to one individual counterparty exceeds five
percent of the covered company's capital stock and surplus, in the case
of a covered company that does not have $250 billion or more in total
consolidated assets or $10 billion or more in total on-balance-sheet
foreign exposures, and tier 1 capital, in the case of a covered company
with $250 billion or more in total consolidated assets or $10 billion
or more in total on-balance-sheet foreign exposures.
In addition, under the proposed rule, a covered company would be
required to add to exposures of an unaffiliated counterparty all
exposures to other counterparties that are connected by certain control
relationships, such as (i) the presence of voting agreements; (ii) the
ability of one counterparty to influence significantly the appointment
or dismissal of another counterparty's administrative, management or
supervisory body, or the fact that a majority of members have been
appointed solely as a result of the exercise of the first entity's
voting rights; and (iii) the ability of one counterparty to
significantly influence senior management or to exercise a controlling
influence over the management or policies of another counterparty.\21\
As with cases where two companies are economically interdependent, in
cases where a counterparty is subject to some degree of control by
another counterparty, a covered company's overall aggregate credit risk
with respect to the two counterparties may be understated if such
control relationships are not identified and their credit exposures
added together for purposes of the proposed rule.
---------------------------------------------------------------------------
\21\ See proposed rule Sec. 252.76(b).
Example: A covered company has credit exposures to both a bank
and a fund that is sponsored by the bank. The bank does not (1) own,
control, or hold with power to vote 25 percent or more of a class of
voting securities of the fund; (2) own or control 25 percent or more
of the total equity of the fund; or (3) consolidate the fund for
financial reporting purposes. Thus, the covered company generally
would not be required to aggregate its exposures to the bank and the
fund. The bank does, however, have the ability to appoint a majority
of the directors of the fund. Under the proposed rule, a covered
company would be required to add its credit exposures to the fund to
the covered company's credit exposures to the bank for purposes of
determining whether the covered company is in compliance with the
---------------------------------------------------------------------------
proposed rule.
Question 5: Should covered companies be required to aggregate
exposures to entities that are economically interdependent? Are the
criteria for determining whether entities are economically
interdependent sufficiently clear, and if not, how should the criteria
be further clarified? Should covered companies only be required to
identify entities as economically interdependent when exposure to one
of the entities exceeds five percent of the covered company's capital
stock and surplus, in the case of a covered company that does not have
$250 billion or more in total consolidated assets or $10 billion or
more in total on-balance-sheet foreign exposures, and tier 1 capital,
in the case of a covered company with $250 billion or more in total
consolidated assets or $10 billion or more in total on-balance-sheet
foreign exposures? Should only covered companies with $250 billion or
more in total consolidated assets or $10 billion or more in total on-
balance-sheet foreign exposures be required to identify entities as
economically interdependent? What other threshold(s) would be
appropriate and why?
Question 6: What operational or other challenges, if any, would
covered companies face in identifying companies that are economically
interdependent? Will covered companies have access to all of the
information needed to complete the analysis of economic
interdependence? Is this type of information collected by covered
companies in the ordinary course of business as part of underwriting or
other, similar processes?
Question 7: Should covered companies be required to aggregate
exposures to entities that are connected by certain control
relationships? Should
[[Page 14333]]
covered companies only be required to aggregate exposures to entities
that are connected by certain control relationships if the exposure
exceeds five percent of the covered company's capital stock and
surplus, in the case of a covered company that does not have $250
billion or more in total consolidated assets or $10 billion or more in
total on-balance-sheet foreign exposures, and tier 1 capital, in the
case of a covered company with $250 billion or more in total
consolidated assets or $10 billion or more in total on-balance-sheet
foreign exposures? Should only covered companies with $250 billion or
more in total consolidated assets or $10 billion or more in total on-
balance-sheet foreign exposures be required to aggregate exposures to
entities that are connected by certain control relationships? Are the
criteria for determining whether entities are connected by control
relationships sufficiently clear, and if not, how could the criteria be
further clarified? Are there additional criteria that the Board should
consider?
Section 165(e) of the Dodd-Frank Act directs the Board to impose
single-counterparty credit limits based on the ``capital stock and
surplus'' of a covered company, or ``such lower amount as the Board may
determine by regulation to be necessary to mitigate risks to the
financial stability of the United States.'' \22\ Under the proposed
rule, ``capital stock and surplus'' of a covered company would be
defined as the sum of the company's total regulatory capital as
calculated under the capital adequacy guidelines applicable to that
bank holding company under Regulation Q (12 CFR part 217) and the
balance of the bank holding company's ALLL not included in tier 2
capital under the capital adequacy guidelines applicable to that bank
holding company under Regulation Q (12 CFR part 217).\23\ This
definition of capital stock and surplus is conceptually similar to the
definition of the same term in the Board's Regulations O and W and the
OCC's national bank lending limit regulation.\24\
---------------------------------------------------------------------------
\22\ 12 U.S.C. 5365(e)(2).
\23\ See proposed rule Sec. 252.71(d).
\24\ See 12 CFR 215.3(i), 12 CFR 223.3(d); see also 12 CFR
32.2(b).
---------------------------------------------------------------------------
As indicated, for those covered companies with $250 billion or more
in total consolidated assets or $10 billion or more in total on-
balance-sheet foreign exposure, the proposed credit limits would be
calculated by reference to those companies' tier 1 capital as defined
under Regulation Q, rather than their total regulatory capital plus
ALLL.\25\ A key financial stability benefit of single-counterparty
credit limits is that such limits help reduce the likelihood that the
failure of one financial institution will lead to the failure of other
financial institutions. By reducing the likelihood of multiple
simultaneous failures arising from interconnectedness, single-
counterparty credit limits reduce the probability of future financial
crises and the social costs that would be associated with such crises.
For this benefit to be realized, single-counterparty credit limits for
firms whose failure is more likely to have an adverse impact on
financial stability need to be based on a measure of capital that is
available to absorb losses on a going-concern basis.
---------------------------------------------------------------------------
\25\ See 12 CFR 217.2; 12 CFR 217.20.
---------------------------------------------------------------------------
Total regulatory capital plus ALLL includes capital elements that
do not absorb losses on a going-concern basis. For example, total
regulatory capital includes a covered company's subordinated debt,
which is senior in the creditor hierarchy to equity and therefore only
takes losses once a company's equity has been wiped out. In contrast, a
company's tier 1 capital consists only of equity claims on the company,
such as common equity and certain preferred shares. By definition,
these equity claims are available to absorb losses on a going-concern
basis. Therefore, in order to limit the aggregate net credit exposure
that a covered company with $250 billion or more in total consolidated
assets or $10 billion or more in total on-balance-sheet foreign
exposures can have to a single counterparty relative to the covered
company's ability to absorb losses on a going-concern basis, single-
counterparty credit limits applicable to such companies should be based
on their tier 1 capital. Basing single-counterparty credit limits for
such companies on tier 1 capital also is consistent with the direction
given in section 165(a)(1)(B) of the Dodd-Frank Act to impose enhanced
prudential standards that increase in stringency based on the systemic
footprint of the firms to which they apply.\26\
---------------------------------------------------------------------------
\26\ 12 U.S.C. 5365(a)(1)(B).
---------------------------------------------------------------------------
Basing single-counterparty credit limits for covered companies with
total consolidated assets of $250 billion or more, or $10 billion or
more in on-balance-sheet foreign exposures on tier 1 capital would be
consistent with lessons learned during the financial crisis of 2007-
2009. During the crisis, counterparties and other creditors of
distressed financial institutions discounted lower-quality regulatory
capital instruments issued by such institutions, such as trust
preferred shares, hybrid capital instruments, and other term
instruments. Instead, market participants focused on a financial
institution's common equity capital and other simple, perpetual-
maturity instruments that now qualify as tier 1 regulatory capital. For
this reason, the Board's revised capital framework introduced a new
definition of common equity tier 1 capital, restricted the set of
instruments that qualify as additional tier 1 capital, and raised the
tier 1 capital regulatory minimum from 4 to 6 percent.\27\ In contrast,
the Board's revised capital framework left the total regulatory capital
minimum requirement unchanged from its pre-crisis calibration of 8
percent.
---------------------------------------------------------------------------
\27\ See 12 CFR part 217.
---------------------------------------------------------------------------
Thus, basing single-counterparty credit limits for such covered
companies on tier 1 capital would be consistent with the post-crisis
focus on higher-quality forms of capital and, based on the experience
in the crisis whereby market participants significantly discounted the
value of capital instruments such as subordinate debt that count in
total regulatory capital, would provide a more reliable capital base
for the credit limits. In addition, the analysis that follows suggests
that using a narrower definition of capital for such covered companies
could help to mitigate risks to U.S. financial stability.
The marginal impact of basing single-counterparty credit limits on
tier 1 capital for firms with $250 billion or more in total assets, or
$10 billion or more in on-balance-sheet foreign exposures, appears to
be limited. As of September 30, 2015, tier 1 capital represented
approximately 82 percent of the total regulatory capital plus ALLL for
these firms. Further, the quantitative impact study Board staff
conducted to help gauge the likely effects of the proposed requirements
suggests that using tier 1 capital as the eligible capital base for
bank holding companies with $250 billion or more in total consolidated
assets or $10 billion or more in total on-balance-sheet foreign
exposures likely would increase the total amount of excess exposure
among U.S. bank holding companies by approximately $30 billion. This
incremental amount of excess credit exposure could be largely
eliminated by firms through compression of derivatives, collection of
additional collateral from counterparties, greater use of central
clearing, and modest rebalancing of portfolios among counterparties.
[[Page 14334]]
Question 8: Are the proposed definitions relating to capital stock
and surplus and tier 1 capital clear? Should the single-counterparty
credit limits applicable to covered companies with $250 billion or more
in total consolidated assets or $10 billion or more in total on-
balance-sheet foreign exposures be based on a different capital base
than that used for other firms?
Credit Exposure Limits
Section 252.72 of the proposed rule contains the key quantitative
limitations on credit exposure of a covered company to a single
counterparty.\28\ First, the general limit in proposed section 252.72
provides that no covered company may have aggregate net credit exposure
to any unaffiliated counterparty in excess of 25 percent of the capital
stock and surplus or tier 1 capital, as appropriate, of the covered
company.\29\ Second, proposed section 252.72 provides that no ``major
covered company,'' defined as a covered company that is a U.S. global
systemically important banking organization, may have aggregate net
credit exposure to a major counterparty in excess of 15 percent of the
major covered company's tier 1 capital.\30\ ``Aggregate net credit
exposure'' would be defined in this section to mean the sum of all net
credit exposures of a covered company to a single counterparty.\31\ As
described in detail below, sections 252.73 and 252.74 of the proposed
rule describe how a covered company would calculate gross and net
credit exposure in order to arrive at the aggregate net credit exposure
relevant to the single-counterparty credit limits in section
252.72.\32\
---------------------------------------------------------------------------
\28\ See proposed rule Sec. 252.72.
\29\ See proposed rule Sec. Sec. 252.72(a)-(b).
\30\ See proposed rule Sec. 252.72(c).
\31\ See proposed rule Sec. 252.71(b).
\32\ See proposed rule Sec. Sec. 252.73-252.74.
---------------------------------------------------------------------------
A ``major counterparty'' would be defined as (1) any major covered
company and all of its subsidiaries, collectively; (2) any foreign
banking organization and all of its subsidiaries, collectively, that
would be considered a global systemically important foreign banking
organization; and (3) any nonbank financial company supervised by the
Board.\33\
---------------------------------------------------------------------------
\33\ See proposed rule Sec. 252.72(v). The Financial Stability
Board maintains and periodically publishes a list of entities that
have the characteristics of a global systemically important banking
organization: http://www.fsb.org/.
---------------------------------------------------------------------------
The Board's proposed rule regarding the single-counterparty credit
limits that should apply to credit exposures of a major covered company
to a major counterparty reflects the financial stability consequences
associated with such credit extensions. A credit extension between a
major covered company and a major counterparty is expected to result in
a heightened degree of credit risk to the major covered company
relative to the case in which a major covered company extends credit to
a counterparty that is not a major counterparty. The heightened credit
risk arises because major covered companies and major counterparties
are often engaged in common business lines and often have common
counterparties and common funding sources. This creates a significant
degree of commonality in their economic performance. In particular,
factors that would likely cause the distress of a major counterparty
would also likely be expected to simultaneously adversely affect a
major covered company that has extended credit to the major
counterparty. As a result, such credit extensions would be expected to
present more credit risk, and greater potential for financial
instability, than a credit extension made by a major covered company to
a counterparty that is not a major counterparty.
In a white paper that has been released in conjunction with these
proposed rules, Board staff has analyzed data on the default
correlation between systemically important financial institutions
(SIFIs) as well as data on the default correlation between SIFIs and a
sample of non-SIFI companies.\34\ The analysis supports the view that
the correlation between SIFIs, and hence the correlation between major
covered companies and major counterparties, is measurably higher than
the correlation between SIFIs and other companies. This finding further
supports the view that credit extensions between SIFIs, and hence by a
major covered company to a major counterparty, present a higher degree
of risk and the potential for greater financial instability than credit
extensions of a major covered company to a non-major counterparty.
---------------------------------------------------------------------------
\34\ See Calibrating the Single-Counterparty Credit Limit
between Systemically Important Financial Institutions. For purposes
of the white paper, SIFIs include global systemically important
banking organizations and nonbank financial companies designated by
FSOC for supervision by the Board.
---------------------------------------------------------------------------
Because credit extensions of a major covered company to a major
counterparty present a heightened degree of credit risk and a greater
potential for heightened financial instability, the Board is proposing
to set a more stringent single-counterparty credit limit for credit
extensions between a major covered company and a major counterparty of
15 percent rather than the statutory limit of 25 percent. The more
stringent credit limit of 15 percent is informed by the results of a
credit risk model that is described in detail in the white paper. More
specifically, data on correlations, as described above, is used to
calibrate a credit risk model. The credit risk model is then used to
set the single-counterparty credit limit between SIFIs such that the
amount of credit risk that a SIFI is permitted to incur through
extensions of credit to another SIFI is no greater than the amount of
credit risk that the SIFI would be permitted to incur through
extensions of credit to a non-SIFI under the 25 percent limit
applicable to such exposures. The resulting calibrated model produces
inter-SIFI single-counterparty credit limits that are in line with the
proposed limit of 15 percent.
An additional consideration that is not considered explicitly in
the context of the white paper's credit risk model, but which should
influence the calibration of the credit limit between major covered
companies and major counterparties, is the relative difference in
adverse consequences arising from multiple SIFI defaults relative to
the default of a SIFI and non-SIFI counterparty. The financial
stability consequences of multiple SIFI defaults caused by the default
of a SIFI borrower and the resulting default of a SIFI lender are
likely substantially greater than the adverse consequences that would
result from the default of a single SIFI lender and a single non-SIFI
borrower. As a result, there is a compelling rationale to require that
credit risk posed by inter-SIFI credit extensions be materially smaller
than that posed by credit extensions between a SIFI lender and non-SIFI
borrower. This consideration suggests that an appropriate inter-SIFI
single-counterparty credit limit would be even lower than the 15
percent limit suggested by the calibrated credit risk model that is
presented in the white paper.
Accordingly, the more stringent 15 percent single-counterparty
credit limit on credit exposures of a major covered company to a major
counterparty should help to mitigate risks to U.S. financial stability.
The Board seeks comment on the analytical rationale that has been
presented for a tighter single-counterparty credit limit for exposures
of a major covered company to a major counterparty. The Board also
invites comment on the data, analysis, and economic model that is used
in the white paper to support the proposed more stringent limit.
Commenters are encouraged to provide any specific
[[Page 14335]]
analyses that could be used to support an alternative view on the
appropriate level of the single-counterparty credit limit between major
covered companies and major counterparties.
Question 9: Should more stringent credit exposure limits apply to
credit exposures of a major covered company to a major counterparty
than would apply to other credit exposures?
Question 10: Are the proposed definitions of a ``major covered
company'' and a ``major counterparty'' appropriate? What alternative
definitions should the Board consider?
Question 11: Should more stringent credit exposure limits apply to
exposures of major covered companies to a nonbank financial company
that has been designated by FSOC for Board supervision? Should more
stringent limits also apply to exposures of a major covered company to
other entities that have been designated as global systemically
important financial institutions by the Financial Stability Board (
e.g., global systemically important insurance companies)? If so, what
limits should apply?
Question 12: What other limits or modifications to the proposed
limits on aggregate net credit exposure should the Board consider? For
example, should the Board consider developing aggregate exposure limits
to certain categories of firms (e.g., a limit on the aggregate amount
of credit exposure that a major covered company can have to all major
counterparties)? How should the Board identify any such categories and
the applicable exposure thresholds?
Gross Credit Exposure
As noted, the proposed rule would impose limits on a covered
company's aggregate net credit exposure, rather than aggregate gross
credit exposure, to a counterparty. The key difference between these
two amounts is that a company's net credit exposure would take into
account any available credit risk mitigants, such as collateral,
guarantees, credit or equity derivatives, and other hedges, provided
the credit risk mitigants meet certain requirements in the rule, as
discussed more fully below. For example, if a covered company had $100
in gross credit exposure to a counterparty with respect to a particular
credit transaction, and the counterparty pledged collateral with an
adjusted market value of $50, the full amount of which qualified as
``eligible collateral'' under the rule, the covered company's net
credit exposure to the counterparty on the transaction would be $50.
In order to calculate its aggregate net credit exposure to a
counterparty, a covered company first would calculate its gross credit
exposure to the counterparty on each credit transaction in accordance
with certain valuation and other requirements under the rule. Second,
the covered company would reduce its gross credit exposure amount based
on eligible credit risk mitigants to determine its net credit exposure
for each credit transaction with the counterparty. Third and finally,
the covered company would sum all of its net credit exposures to the
counterparty to calculate the covered company's aggregate net credit
exposure to the counterparty. It is this final amount, the aggregate
net credit exposure, that would be subject to a credit exposure limit
under the rule.
With respect to a credit exposure involving eligible collateral or
an eligible protection provider, the proposed rule would apply a
``risk-shifting'' approach. In general, any reduction in the exposure
amount to the original counterparty relating to the eligible collateral
or eligible protection provider would result in a dollar-for-dollar
increase in exposure to the eligible collateral issuer or eligible
protection provider (as applicable). For example, in the case discussed
above where a covered company had $100 in gross credit exposure to a
counterparty and the counterparty pledged collateral with an adjusted
market value of $50, the covered company would have net credit exposure
to the counterparty on the transaction of $50 and net credit exposure
to the issuer of the collateral of $50.
However, in cases where a covered company hedges its exposure to an
entity that is not a ``financial entity'' (a non-financial entity)
using an eligible credit or equity derivative, and the underlying
exposure is subject to the Board's market risk capital rule (12 CFR
part 217, subpart F), the covered company would calculate its exposure
to the eligible protection provider using methodologies that it is
permitted to use under the Board's risk-based capital rules. For these
purposes, a ``financial entity'' would include regulated U.S. financial
institutions, such as insurance companies, broker-dealers, banks,
thrifts, and futures commission merchants, as well as foreign banking
organizations and a non-U.S.-based securities firm or a non-U.S.-based
insurance company subject to consolidated supervision and regulation
comparable to that imposed on U.S. depository institutions, securities
broker-dealers, or insurance companies.\35\ ``Financial entities''
would also include companies whose primary business includes the
management of financial assets, lending, factoring, leasing, provision
of credit enhancements, securitization, investments, financial custody,
central counterparty services, proprietary trading, insurance, and
other financial services.\36\
---------------------------------------------------------------------------
\35\ See proposed rule Sec. 252.71(q).
\36\ Id.
---------------------------------------------------------------------------
Question 13: Is the definition of a ``financial entity''
sufficiently clear? If not, what further guidance should be provided?
Section 252.73 of the proposed rule explains in detail how a
covered company would calculate its ``gross credit exposure'' with
respect to a counterparty. Gross credit exposure would be defined to
mean, with respect to any credit transaction, the credit exposure of
the covered company to the counterparty before adjusting for the effect
of any qualifying master netting agreements, eligible collateral,
eligible guarantees, eligible credit derivatives and eligible equity
derivatives, and other eligible hedges (i.e., a short position in the
counterparty's debt or equity securities).\37\ Consistent with the
statutory definition of credit exposure, the proposed rule defines
``credit transaction'' to mean, with respect to a counterparty, any (i)
extension of credit to the counterparty, including loans, deposits, and
lines of credit, but excluding advised or other uncommitted lines of
credit; (ii) repurchase or reverse repurchase agreement with the
counterparty; (iii) securities lending or securities borrowing
transaction with the counterparty; (iv) guarantee, acceptance, or
letter of credit (including any confirmed letter of credit or standby
letter of credit) issued on behalf of the counterparty; (v) purchase
of, or investment in, securities issued by the counterparty; (vi)
credit exposure to the counterparty in connection with a derivative
transaction between the covered company and the counterparty; (vii)
credit exposure to the counterparty in connection with a credit
derivative or equity derivative transaction between the covered company
and a third party, the reference asset of which is an obligation or
equity security issued by the counterparty; \38\ and (viii) any
transaction that is the functional equivalent of the above, and any
similar transaction that the Board determines to
[[Page 14336]]
be a credit transaction for purposes of this subpart.\39\
---------------------------------------------------------------------------
\37\ See proposed rule Sec. 252.71(r). Section 252.74 of the
proposed rule explains how these adjustments are made.
\38\ ``Credit derivative'' and ``equity derivative'' are defined
in sections 252.71(g) and (p) of the proposed rule, respectively.
\39\ See proposed rule Sec. 252.71(h). The definition of
``credit transaction'' in the proposed rule is similar to the
definition of ``credit exposure'' in section 165(e) of the Dodd-
Frank Act. See 12 U.S.C. 5365(e)(3).
---------------------------------------------------------------------------
Section 252.73 describes how the gross credit exposure of a covered
company to a counterparty should be calculated for each type of credit
transaction described above.\40\ In general, the methodologies
contained in the proposed rule are similar to those used to calculate
credit exposure under the standardized risk-based capital rules for
bank holding companies.\41\ More specifically, section 252.73(a) of the
proposed rule provides that, for purposes of calculating gross credit
exposure:
---------------------------------------------------------------------------
\40\ See proposed rule Sec. 252.73(a)(1)-(12).
\41\ 12 CFR part 217, subpart D.
---------------------------------------------------------------------------
(1) The value of loans by a covered company to a counterparty (and
leases in which the covered company is the lessor and the counterparty
is the lessee) would be equal to the amount owed by the counterparty to
the covered company under the transaction;
(2) The value of debt securities held by the covered company that
are issued by the counterparty would be equal to the market value of
the securities (in the case of trading and available-for-sale
securities) or the amortized purchase price of the securities (in the
case of securities that are held to maturity);
(3) The value of equity securities held by the covered company that
are issued by the counterparty would be equal to the market value of
such securities;
(4) The value of repurchase agreements would be equal to the
adjusted market value of the securities transferred by the covered
company to the counterparty;
(5) The value of reverse repurchase agreements would be equal to
the amount of cash transferred by the covered company to the
counterparty;
(6) The value of securities borrowing transactions would be equal
to the sum of the amount of cash collateral transferred by the covered
company to the counterparty and the adjusted market value of the
securities collateral transferred to the counterparty;
(7) The value of securities lending transactions would be equal to
the adjusted market value of the securities lent by the covered company
to the counterparty;
(8) Committed credit lines extended by a covered company to the
counterparty would be valued at the face amount of the credit line;
(9) Guarantees and letters of credit issued by a covered company on
behalf of the counterparty would be equal to the maximum potential loss
to the covered company on the transaction;
(10) Derivative transactions between the covered company and the
counterparty not subject to a qualifying master netting agreement would
be valued in an amount equal to the sum of the current exposure of the
derivatives contract and the potential future exposure of the
derivatives contract, calculated using methodologies that the covered
company is permitted to use under Regulation Q (12 CFR part 217,
subparts D and E);
(11) Derivative transactions between the covered company and the
counterparty subject to a qualifying master netting agreement would be
valued in an amount equal to the exposure at default amount calculated
using methodologies that the covered company is permitted to use under
subpart E of Regulation Q (12 CFR part 217); and
(12) Credit or equity derivative transactions between the covered
company and a third party where the covered company is the protection
provider and the reference asset is an obligation or equity security of
the counterparty, would be valued in an amount equal to the maximum
potential loss to the covered company on the transaction.
Under the proposed rule, trading and available-for-sale debt
securities held by the covered company, as well as equity securities,
would be valued for purposes of single-counterparty credit limits based
on their market value. This approach would require a covered company to
revalue upwards the amount of an investment in such securities when the
market value of the securities increases. In these circumstances, the
re-valuation would reflect the covered company's greater financial
exposure to the counterparty and would reduce the covered company's
ability to engage in additional transactions with the counterparty. In
circumstances where the market value of the securities falls, however,
a covered company under the proposal would revalue downwards its
exposure to the issuer of the securities. This reflects the fact that,
just as an increase in the value of a security results in greater
exposure to the issuer of that security, a decrease in the value of the
security leaves a firm with less exposure to that issuer.
Question 14: Should the Board provide further guidance regarding
the calculation of the ``market value'' of a debt or equity security,
particularly for securities that are illiquid or otherwise hard-to-
value? If so, what guidance should be provided?
In the context of repurchase agreements, securities borrowing
transactions, and securities lending transactions, the ``adjusted
market value'' of a security would mean the sum of (i) the market value
of the security and (ii) the market value of the security multiplied by
the product of (a) the collateral haircut set forth in Table 1 to
section 217.132 of the Board's Regulation Q (12 CFR 217.132) that is
applicable to the security and (b) the square root of \1/2\.\42\ The
purpose of adjusting the value of a security in this manner is to
capture the market volatility (and associated potential increase in
counterparty credit exposure) of the securities transferred or lent by
the covered company in these transactions. Multiplying the values in
Table 1 to section 217.132 of the Board's Regulation Q by the square
root of \1/2\ would align with the requirements in the Board's risk-
based capital rules, which assume a 5-day liquidation period for
``repo-style'' transactions,\43\ rather than the 10-day liquidation
period that is assumed for other transactions. With respect to
derivative transactions between a covered company and a counterparty
that are not subject to a qualifying master netting agreement, the
gross credit exposure of a covered company to the counterparty would be
valued as the sum of the current exposure and the potential future
exposure of the contract.\44\ With respect to derivative transactions
between a covered company and a counterparty that are subject to a
qualifying master netting agreement, the proposed rule would require
covered companies to calculate gross credit exposure to a counterparty
as the amount that would be calculated using any methodologies that the
covered company is permitted to use under the Board's risk-based
capital rules (12 CFR part 217, subpart D and E).\45\ This approach
would allow certain covered companies to calculate counterparty
exposures for derivatives transactions subject to a qualifying master
netting agreement using the internal model method in the Board's
Regulation Q (12 CFR part 217, subpart E). The Board is
[[Page 14337]]
proposing this approach, rather than proposing to require all covered
companies to use CEM because of concerns that CEM may not take fully
into account correlations and netting relationships, and therefore,
under certain circumstances, may overstate counterparty credit risk.
---------------------------------------------------------------------------
\42\ See proposed rule Sec. 252.71(a).
\43\ A ``repo-style'' transaction is a repurchase or reverse
repurchase transaction, or a securities borrowing or lending
transaction, that meets certain criteria. See 12 CFR 217.2.
\44\ See proposed rule Sec. 252.73(a)(10). ``Qualifying master
netting agreement'' is defined in section 252.71(z) of the proposed
rule in a manner consistent with the Board's advanced risk-based
capital rules for bank holding companies.
\45\ See proposed rule Sec. 252.73(a)(11).
---------------------------------------------------------------------------
The Board notes, however, that the BCBS has recently finalized a
revised standardized approach (SA-CCR) for measuring credit exposure to
a derivatives counterparty.\46\ The Board expects to consider the
benefits of incorporating SA-CCR in the single-counterparty credit
limit rule at such time as the Board considers the benefits of SA-CCR
for risk-based capital purposes.
---------------------------------------------------------------------------
\46\ See http://www.bis.org/publ/bcbs279.htm.
---------------------------------------------------------------------------
With respect to derivative transactions between a covered company
and a third party, where the covered company is the protection provider
and the reference asset is an obligation or equity security of the
counterparty, the credit exposure of the covered company to the
counterparty would be equal to the maximum potential loss to the
covered company on the transaction.\47\
---------------------------------------------------------------------------
\47\ See proposed rule Sec. 252.73(a)(12). ``Credit
derivative'' is defined in Sec. 252.71(g) of the proposed rule, and
``equity derivative'' is defined in Sec. 252.71(p) of the proposed
rule. ``Derivative transaction'' is defined in Sec. 252.71(j) of
the proposed rule in the same manner as it is defined in the
National Bank Act, as amended by section 610 of the Dodd-Frank Act.
See 12 U.S.C. 84(b)(3).
---------------------------------------------------------------------------
With respect to cleared and uncleared derivatives, the amount of
initial margin and excess variation margin (i.e., variation margin in
excess of that needed to secure the mark-to-market value of a
derivative) posted to a bilateral or central counterparty would be
treated as credit exposure to the counterparty unless the margin is
held in a segregated account at a third party custodian.
Section 252.73(c) of the proposed rule includes the statutory
attribution rule, which provides that a covered company must treat a
transaction with any person as a credit exposure to a counterparty to
the extent the proceeds of the transaction are used for the benefit of,
or transferred to, that counterparty.\48\ This attribution rule seeks
to prevent firms from evading the single-counterparty credit limits by
using intermediaries and thereby avoiding a direct credit transaction
with a particular counterparty. It is the Board's intention to avoid
interpreting the attribution rule in a manner that would impose undue
burden on covered companies by requiring firms to monitor and trace the
proceeds of transactions made in the ordinary course of business. In
general, credit exposures resulting from transactions made in the
ordinary course of business will not be subject to the attribution
rule.
---------------------------------------------------------------------------
\48\ See proposed rule Sec. 252.73(c); see also 12 U.S.C.
5365(e)(4).
---------------------------------------------------------------------------
Question 15: The Board invites comment on all aspects of the
proposed approaches for calculating gross credit exposures.
Question 16: With respect to derivative transactions, the Board
invites comment on the proposed reliance on the methodologies covered
companies are permitted to use under the risk-based capital rules.
Should covered companies instead be required to use CEM? Should the
single-counterparty credit limits rule ultimately require use of SA-CCR
or a similar standardized approach to measure a covered company's
credit exposure to derivatives counterparties?
Question 17: With respect to credit or equity derivative
transactions between the covered company and a third party, where the
covered company is the protection provider and the reference asset is
an obligation or equity security of the counterparty, is it
sufficiently clear how a covered company would calculate its ``maximum
potential loss''? What additional guidance, if any, should the Board
provide?
Question 18: With respect to credit derivatives, equity
derivatives, guarantees, and letters of credit, are there cases in
which ``maximum potential loss to the covered company'' arising from
the transaction is indeterminate? How should single-counterparty credit
limits apply in those instances?
Question 19: The Board invites comment on ways to apply the
statutory attribution rule in a manner that would be consistent with
the goal of preventing evasion of the single-counterparty credit limits
without imposing undue burden on covered companies. Is additional
regulatory clarity around the attribution rule necessary? What is the
potential cost or burden of applying the attribution rule as proposed?
Net Credit Exposure
As noted, the proposed rule would impose limits on a covered
company's net credit exposure to a counterparty. ``Net credit
exposure'' would be defined to mean, with respect to any credit
transaction, the gross credit exposure of a covered company calculated
under section 252.73, as adjusted in accordance with section
252.74.\49\ Section 252.74 of the proposed rule explains how a covered
company would convert gross credit exposure amounts to net credit
exposure amounts by taking into account eligible collateral, eligible
guarantees, eligible credit and equity derivatives, other eligible
hedges (for example, a short position in the counterparty's debt or
equity securities), and for securities financing transactions, the
effect also of bilateral netting agreements.\50\
---------------------------------------------------------------------------
\49\ See proposed rule Sec. 252.71(x).
\50\ See proposed rule Sec. 252.74.
---------------------------------------------------------------------------
Calculation of Net Credit Exposure for Securities Financing
Transactions
With respect to any repurchase transaction, reverse repurchase
transaction, securities lending transaction, and securities borrowing
transaction with a counterparty that is subject to a bilateral netting
agreement with that counterparty and that meets the definition of
``repo-style transaction'' in section 217.2 of the Board's Regulation Q
(12 CFR 217.2), a covered company's net credit exposure to a
counterparty generally would be equal to the exposure at default amount
calculated under section 217.37(c)(2) of the Board's Regulation Q (12
CFR 217.37(c)(2)), applying standardized supervisory haircuts as
provided in 12 CFR 217.37(c)(3)(iii).\51\ A covered company would not
be permitted to apply its own internal estimates for haircuts. Further,
in calculating its net credit exposure to a counterparty as a result of
such transactions, a covered company would be required to disregard any
collateral received from that counterparty that does not meet the
definition of ``eligible collateral'' in Sec. 252.71(k).
---------------------------------------------------------------------------
\51\ Pursuant to 12 CFR 217.37(c)(3)(iii), a bank that is
engaged in a repo-style transaction may multiply the standardized
supervisory haircuts that would otherwise apply pursuant to Table 1
to Sec. 217.37 of the Board's Regulation Q by the square root of
\1/2\.
---------------------------------------------------------------------------
The proposal would also require a covered company to recognize a
credit exposure to any issuer of eligible collateral that is used to
reduce the covered company's gross credit exposure from a transaction
described in the preceding paragraph. The amount of credit exposure
that a covered company would be required to recognize to an issuer of
such collateral would be equal to the market value of the collateral
minus the standardized supervisory haircuts provided in 12 CFR
217.37(c)(2)(ii). However, in no event would the amount of credit
exposure that a covered company is required to recognize to such a
collateral issuer be in excess of its gross credit exposure to the
counterparty on the original credit transaction.
Some commenters on the 2011 section 165(e) proposed rule objected
to the
[[Page 14338]]
proposed methodology for netting securities financing transactions as
overly conservative. The commenters generally argued that the proposed
approach implied unrealistic assumptions about correlations among
securities that a covered company transfers to its counterparty and
received from that counterparty. For example, if a covered company
loans equity securities to a counterparty and receives equity
securities from the counterparty as collateral, the proposed
methodology implied that, upon the counterparty's default, the value of
the equities transferred to the counterparty would increase in value
while the value of the equities received would decrease in value.
In developing this proposed rule, the Board considered several
alternatives to address these concerns. First, the Board considered
allowing covered firms only to apply valuation adjustments to one side
of a securities financing transaction where the securities transferred
and received from a counterparty are of the same asset class. For
example, if a covered company loans equity securities to a counterparty
and receives equity securities from the counterparty as collateral, the
covered company could be permitted to apply valuation adjustments only
to the value of the equity securities that have been transferred to the
counterparty. This would be a relatively simple way of taking account
of the fact that securities in the same asset class tend to be somewhat
positively correlated.
Second, the Board considered a methodology similar to the one
recently proposed by the BCBS in its second consultative document on
potential revisions to the standardized approach to credit risk.\52\
Under the formula proposed by the Basel Committee, an entity's exposure
for repo-style transactions would be equal to 40 percent of its ``net
exposure'' from the transaction plus 60 percent of its ``gross
exposure'' divided by the square root of the number of security issues
in the netting set. In this formula, the ``net exposure'' term is
intended to reflect the effect of netting long positions and short
positions because the volatility haircuts that would apply to long
positions would be allowed to offset those that apply to short
positions. Although volatility haircuts would not offset when
calculating gross exposure, gross exposure would reflect the effect of
diversification by dividing the gross exposure amount by the square
root of the number of exposures.
---------------------------------------------------------------------------
\52\ http://www.bis.org/bcbs/publ/d347.pdf.
---------------------------------------------------------------------------
Third, the Board considered allowing credit exposure from repo-
style transactions to be measured using standardized correlation
matrices. Under this approach, securities would be divided into a
handful of asset classes (for example, sovereign securities, corporate
and municipal debt, and equities). Based on distinctions between asset
classes, specific assumptions about correlations within portfolios of
securities transferred to or received from a counterparty, as well as
assumptions about correlations across portfolios of securities
transferred and received, would be provided. These standardized
correlation assumptions, together with standardized volatility haircuts
for the relevant securities, would serve as inputs into a formula that
would yield an estimate of a covered company's credit exposure to its
counterparty. Again, this could provide a more accurate way of taking
into account correlations among securities.
The first alternative would permit a covered company to apply
valuation adjustments to only one side of a securities financing
transaction where the securities transferred and received from a
counterparty are of the same asset class. While this approach is meant
to reflect the fact that securities in the same asset class are
generally positively correlated, some securities in the same asset
class may also be negative correlated. In addition, assumptions about
asset correlations based on observations during normal times may break
down during periods of extreme market turbulence, when large credit
exposures of financial institutions to their counterparties could pose
the greatest risk to financial stability. The second and third
alternatives would increase the complexity of the framework and
potentially make the framework susceptible to arbitrage. For the
foregoing reasons, the proposed rule does not include these
alternatives.
Question 20: Should the Board consider alternative approaches to
measuring the net credit exposure from securities financing
transactions? What are the advantages and disadvantages of such
alternative measurement approaches relative to the proposed approach?
Collateral
Section 252.74(c) of the proposed rule describes how eligible
collateral would be taken into account in the calculation of net credit
exposure.\53\ ``Eligible collateral'' would be defined to include cash
on deposit with a covered company (including cash held for the covered
company by a third-party custodian or trustee); debt securities (other
than mortgage- or asset-backed securities \54\) that are bank-eligible
investments and that have an investment grade rating; equity securities
that are publicly traded; or convertible bonds that are publicly
traded.\55\ For any of these asset types to count as eligible
collateral for a credit transaction, the covered company generally
would be required to have a perfected, first priority security interest
in the collateral or the legal equivalent thereof, if outside of the
United States. This list of eligible collateral would be similar to the
list of eligible collateral in Regulation Q.\56\
---------------------------------------------------------------------------
\53\ See proposed rule Sec. 252.74(c).
\54\ The proposed rule generally would exclude mortgage-backed
securities and other asset-backed securities from the definition of
``eligible collateral'' because of concerns that those securities
may be more likely than other securities to become illiquid and lose
value during periods of financial instability. However, asset-backed
securities guaranteed by a U.S. government sponsored entity, such as
Ginnie Mae, Fannie Mae, or Freddie Mac, would qualify as eligible
collateral under the proposed rule.
\55\ See proposed rule Sec. 252.71(k); see also 12 CFR 252.2(p)
(defining ``publicly traded'').
\56\ See 12 CFR 217.2.
---------------------------------------------------------------------------
In computing its net credit exposure to a counterparty with respect
to a credit transaction, a covered company would be required to reduce
its gross credit exposure on the transaction by the adjusted market
value of any eligible collateral.\57\ Other than in the context of
repo-style transactions, the ``adjusted market value'' of eligible
collateral would be defined in section 252.71(a) of the proposed rule
to mean the fair market value of the eligible collateral after
application of the applicable haircut specified in Table 1 to section
217.132 of the Board's Regulation Q for that type of eligible
collateral.\58\
---------------------------------------------------------------------------
\57\ See proposed rule Sec. 252.74(c).
\58\ Table 1 to section 217.132 of the Board's Regulation Q (12
CFR 217.132) provides haircuts for multiple collateral types,
including some types that do not meet the proposed definition of
``eligible collateral.'' Notwithstanding the inclusion of those
collateral types in the reference table, a company cannot reduce its
gross credit exposure for a transaction with a counterparty based on
the adjusted market value of collateral that does not meet the
definition of ``eligible collateral.''
---------------------------------------------------------------------------
The net credit exposure of a covered company to a counterparty on a
credit transaction is the gross credit exposure of the covered company
on the transaction minus the adjusted market value of any eligible
collateral related to the transaction.\59\ In addition, under the
[[Page 14339]]
proposed rule, a covered company generally must recognize a credit
exposure to the collateral issuer in an amount equal to the adjusted
market value of the collateral. As such, the amount of credit exposure
to the original counterparty and the issuer of the eligible collateral
would fluctuate over time based on the adjusted market value of the
eligible collateral. Collateral that previously met the definition of
eligible collateral under the proposed rule but over time ceases to do
so would no longer be eligible to reduce gross credit exposure.
---------------------------------------------------------------------------
\59\ The Board is proposing to treat eligible collateral as a
gross credit exposure to the collateral issuer under the Board's
authority under section 165(e) to determine that any other similar
transaction is a credit exposure. See 12 U.S.C. 5365(e)(3)(F).
---------------------------------------------------------------------------
In effect, the proposed treatment of eligible collateral would
require a covered company to shift its credit exposure from the
original counterparty to the issuer of such collateral. This approach
would help to promote a covered company's careful monitoring of its
direct and indirect credit exposures. So as not to discourage
overcollateralization, however, a covered company's maximum credit
exposure to the collateral issuer would be limited to the credit
exposure to the original counterparty.\60\
---------------------------------------------------------------------------
\60\ See proposed rule Sec. 252.74(c)(2).
---------------------------------------------------------------------------
A covered company would continue to have credit exposure to the
original counterparty to the extent that the adjusted market value of
the eligible collateral does not equal the full amount of the credit
exposure to the original counterparty.
Example: A covered company (Company A) makes a $1,000 loan to a
counterparty (Company B), creating $1,000 of gross credit exposure
to that counterparty, and the counterparty provides eligible
collateral issued by a third party (Company C) that has an adjusted
market value of $700 on day 1. Company A would be required to reduce
its credit exposure to Company B by the adjusted market value of the
eligible collateral. As a result, on day 1, Company A would have
gross credit exposure of $700 to Company C and $300 net credit
exposure to Company B.
As noted, the amount of credit exposure to the original
counterparty and the issuer of the eligible collateral will fluctuate
over time based on movements in the adjusted market value of the
eligible collateral. If the adjusted market value of the eligible
collateral decreased to $400 on day 2 in the previous example, on day 2
Company A's net credit exposure to Company B would increase to $600,
and its gross credit exposure to Company C would decrease to $400. By
contrast, if on day 3 the adjusted market value of the eligible
collateral increased to $800, on day 3 Company A's net credit exposure
to Company B would decrease to $200, and its gross credit exposure to
Company C would increase to $800. In each case, the covered company's
total credit exposure would be capped at the original amount of the
exposure created by the loan or $1,000--even if the adjusted market
value of the eligible collateral exceeded $1,000.
Finally, in cases where eligible collateral is issued by an issuer
covered by one of the exemptions in section 252.76 of the proposed rule
or that is excluded from the proposed definition of a ``counterparty,''
the requirement to recognize an exposure to the collateral issuer would
have no effect.
Example: A covered company makes a $1,000 loan to a counterparty
and that counterparty has pledged as collateral U.S. government
bonds with an adjusted market value of $1,000. In this case, the
covered company would not have any net credit exposure to the
original counterparty because the value of loan and the adjusted
market value of the U.S. government bonds are equal. Although the
covered company would have $1,000 of exposure to the U.S.
government, single-counterparty credit limits would not apply to
that exposure because U.S. government bonds are excluded from the
single-counterparty credit limits of the proposed rule.
Question 21: Should the list of eligible collateral be broadened or
narrowed? What items should be added or deleted?
Question 22: Should covered companies have the option of whether to
reduce their gross credit exposures by recognizing eligible collateral
in some or all cases? If so, should covered companies nevertheless have
to recognize gross credit exposures to the issuers of the eligible
collateral? Are there situations in which full shifting of exposures
would not be appropriate?
Question 23: Are the market volatility haircuts in Table 1 to
section 217.132 of the Board's Regulation Q (12 CFR 217.132)
appropriate for the valuation of eligible collateral for purposes of
this rule? Should these haircuts be calibrated differently for purposes
of this rule?
Eligible Guarantees
Section 252.74(d) of the proposed rule describes how to reflect
eligible guarantees in calculations of net credit exposure to a
counterparty.\61\ Eligible guarantees would be defined as guarantees
that meet certain conditions, including having been written by an
eligible protection provider.\62\ The definition of ``eligible
protection provider'' would be the same as the definition of ``eligible
guarantor'' in section 217.2 of Regulation Q. As such, an eligible
protection provider would include a sovereign, the Bank for
International Settlements, the International Monetary Fund, the
European Central Bank, the European Commission, a Federal Home Loan
Bank, the Federal Agricultural Mortgage Corporation (Farmer Mac), a
multilateral development bank (MDB), a depository institution, a bank
holding company, a savings and loan holding company, a credit union, a
foreign bank, or a qualifying central counterparty. An eligible
protection provider also would include any entity, other than a special
purpose entity, (i) that at the time the guarantee is issued or anytime
thereafter, has issued and maintains outstanding an unsecured debt
security without credit enhancement that is investment grade, (ii)
whose creditworthiness is not positively correlated with the credit
risk of the exposures for which it has provided guarantees, and (iii)
that is not an insurance company engaged predominantly in the business
of providing credit protection (such as a monoline bond insurer or re-
insurer).
---------------------------------------------------------------------------
\61\ See proposed rule Sec. 252.74(d).
\62\ See proposed rule Sec. 252.71(n) for the definition of
``eligible guarantee'' and for a description of the requirements of
an eligible guarantee.
---------------------------------------------------------------------------
In calculating its net credit exposure to the counterparty, a
covered company would be required to reduce its gross credit exposure
to the counterparty by the amount of any eligible guarantee from an
eligible protection provider.\63\ The covered company would then have
to include the amount of the eligible guarantee when calculating its
gross credit exposure to the eligible protection provider.\64\ Also, as
is the case with eligible collateral, a covered company's gross credit
exposure to an eligible protection provider (with respect to an
eligible guarantee) could not exceed its gross credit exposure to the
original counterparty on the credit transaction prior to the
recognition of the eligible guarantee.\65\ Accordingly, the exposure to
the eligible protection provider would be capped at the amount of the
credit exposure to the original counterparty even if the amount of the
eligible guarantee is larger than the original exposure. A covered
company would continue to have credit exposure to the original
counterparty to the extent that the eligible guarantee does not equal
the full amount of the credit exposure to the original counterparty.
---------------------------------------------------------------------------
\63\ See proposed rule Sec. 252.74(d).
\64\ See proposed rule Sec. Sec. 252.74(d)(1)-(2).
\65\ See proposed rule Sec. 252.74(d)(2).
Example: A covered company makes a $1,000 loan to an
unaffiliated counterparty and obtains a $700 eligible guarantee on
the loan from an eligible protection provider.
[[Page 14340]]
The covered company would have gross credit exposure of $700 to the
protection provider as a result of the eligible guarantee and $300
net credit exposure to the original counterparty.
Example: A covered company makes a $1,000 loan to an
unaffiliated counterparty and obtains a $1,500 eligible guarantee
from an eligible protection provider. The covered company would have
$1,000 gross credit exposure to the protection provider (capped at
the amount of the exposure to the unaffiliated counterparty), but
the covered company would have no net credit exposure to the
original counterparty as a result of the eligible guarantee.
As with eligible collateral, a covered company would be required to
reduce its gross exposure to a counterparty by the amount of an
eligible guarantee in order to ensure that concentrations in exposures
to guarantors are captured by the risk-shifting approach. This
requirement is meant to limit the ability of a covered company to
extend loans or other forms of credit to a large number of high risk
borrowers that are guaranteed by a single guarantor.
Question 24: Should the definition of eligible guarantee or
eligible protection provider be expanded or narrowed? Are there any
additional or alternative requirements the Board should place on
eligible protection providers to ensure their capacity to perform on
their guarantee obligations?
Question 25: Under what circumstances, if any, should covered
companies have the option of whether (1) to fully shift exposures to
eligible protection providers in the case of eligible guarantees or (2)
divide an exposure between the original counterparty and the eligible
protection provider in some manner? If so, should covered companies
nevertheless have to recognize gross credit exposures to the issuers of
the eligible collateral? Are there situations in which full shifting of
exposures would not be appropriate?
Eligible Credit and Equity Derivative Hedges
Section 252.74(e) sets forth the proposed treatment of eligible
credit and equity derivatives in the case where the covered company is
the protection purchaser.\66\ In the case where a covered company is a
protection purchaser, such derivatives can be used to mitigate gross
credit exposure. A covered company may only recognize credit and equity
derivative hedges that qualify as eligible credit and equity derivative
hedges for purposes of calculating net credit exposure under the
proposed rule.\67\ These derivatives would be required to meet certain
criteria, including having been written by an eligible protection
provider.\68\ An eligible credit derivative hedge would need to be
simple in form, meaning a single-name or standard, non-tranched index
credit derivative. An eligible equity derivative hedge must be in the
form of an equity-linked total return swap and would not include other,
more complex forms of equity derivatives, such as purchased equity-
linked options.
---------------------------------------------------------------------------
\66\ See proposed rule Sec. 252.74(e).
\67\ By contrast, in section 252.73(a)(12) of the proposed rule,
where the covered company is the protection provider, any credit or
equity derivative written by the covered company is included in the
calculation of the covered company's gross credit exposure to the
reference obligor.
\68\ See proposed rule Sec. Sec. 252.71(l) and (m) defining
``eligible credit derivative'' and ``eligible equity derivative,''
respectively. ``Eligible protection provider'' is defined in Sec.
252.71(o) of the proposed rule. The same types of organizations that
are eligible protection providers for the purposes of eligible
guarantees are eligible protection providers for purposes of
eligible credit and equity derivatives.
---------------------------------------------------------------------------
The proposed treatment of eligible credit and equity derivatives
would be similar to the proposed treatment of eligible guarantees. A
covered company would be required to reduce its gross credit exposure
to a counterparty by the notional amount of any eligible credit or
equity derivative hedge that references the counterparty if the covered
company obtains the derivative from an eligible protection
provider.\69\ In these circumstances, the covered company generally
would be required to include the notional amount of the eligible credit
or equity derivative hedge in calculating its gross credit exposure to
the eligible protection provider.\70\ As is the case for eligible
collateral and eligible guarantees, the gross exposure to the eligible
protection provider would in no event be greater than it was to the
original counterparty prior to recognition of the eligible credit or
equity derivative.\71\
---------------------------------------------------------------------------
\69\ See proposed rule Sec. 252.74(e).
\70\ See proposed rule Sec. Sec. 252.74(e)(1)-(2).
\71\ See proposed rule Sec. 252.74(e)(2)(i).
---------------------------------------------------------------------------
For eligible credit and equity derivatives that are used to hedge
covered positions subject to the Board's market risk rule (12 CFR part
217, subpart F), the approach would be the same as that explained
above, except in the case of credit derivatives where the counterparty
on the hedged transaction is not a financial entity. In this case, a
covered company would be required to reduce its gross credit exposure
to the counterparty on the hedged transaction by the notional amount of
the eligible credit derivative that references the counterparty if the
covered company obtains the derivative from an eligible protection
provider. In addition, the covered company would be required to
recognize a credit exposure to the eligible protection provider that is
measured using methodologies that the covered company is authorized to
use under the Board's risk-based capital rules (12 CFR part 217,
subparts D and E), rather than the notional amount.\72\
---------------------------------------------------------------------------
\72\ At such time as the Board may consider incorporation of SA-
CCR into the U.S. risk-based capital rules, the Board may consider
requiring SA-CCR to be used for this purpose as well.
Example: A covered company holds a $1,000 bond issued by a non-
financial entity (for example, a commercial firm or sovereign) that
is a covered position subject to the Board's market risk rule, and
the covered company purchases an eligible credit derivative in a
notional amount of $800 from Protection Provider X, which is an
eligible protection provider, to hedge its exposure to the non-
financial entity. The covered company would continue to have $200 in
net credit exposure to the non-financial entity. In addition, the
covered company would treat Protection Provider X as a counterparty,
and would measure its exposure to Protection Provider X using any
methodology that the covered company is permitted to use under
Regulation Q to calculate its risk-based capital requirements.
Example: A covered company holds as a covered position subject
to the Board's market risk rule a $1,000 bond issued by a financial
entity (for example, a banking organization), and the covered
company purchases an eligible credit derivative in a notional amount
of $800 from Protection Provider X, which is an eligible protection
provider, to hedge its exposure to the financial entity. The covered
company would continue to have credit exposure of $200 to the
underlying financial entity. In addition, the covered company would
now treat Protection Provider X as a counterparty, and would have an
$800 credit exposure to Protection Provider X.
As with eligible collateral and eligible guarantees, a covered
company would be required to reduce its gross exposure to a
counterparty by the amount of an eligible equity or credit derivative,
and to recognize an exposure to an eligible protection provider, in
order to ensure that concentrations in exposures to eligible protection
providers are captured in the regime. However, many commenters on the
2011 proposed rule argued that requiring a full notional shifting of
risk in the context of credit derivatives was overly conservative,
since a covered company would only experience losses in cases where
both the original counterparty and the protection provider default. As
such, these commenters recommended allowing covered companies to
measure exposures from credit derivative hedges using the methodologies
permitted for derivatives more generally.
[[Page 14341]]
The proposed rule includes this modification for credit derivatives
that are used to hedge covered positions subject to the market risk
rule, where the credit derivative is used to hedge an exposure to an
entity that is not a financial entity. The proposed rule would require
full notional risk-shifting for credit derivatives used to hedge
exposures to financial entities because most protection providers are
financial entities, and when both the protection provider and the
reference entity are financial entities, the probability of correlated
defaults generally is substantially greater than when protection is
sold on non-financial reference entities.
In cases where a covered company is required to shift its credit
exposure from the counterparty to an eligible protection provider
pursuant to section 252.74(e), the covered company would be permitted
to exclude the relevant equity or credit derivative when calculating
its gross exposure to the eligible protection provider under sections
252.74(a)(10) and 252.94(a)(11). This is to avoid requiring covered
companies to double count the same exposures.
Question 26: Should the proposed definitions of eligible credit
derivative or eligible equity derivative be expanded or narrowed? In
particular, are there more complex forms of derivatives that should be
eligible hedges?
Question 27: Under what circumstances, if any, should covered
companies be permitted not to recognize an eligible credit or equity
derivative hedge, or to apportion the exposure between the original
counterparty and the eligible protection provider?
Question 28: To the extent that covered companies will be required
to shift exposures to protection providers in the case of eligible
credit or equity derivative hedges, would the proposed approach result
in recognition of the proper amount of exposure by a covered company to
an eligible protection provider? If not, what modifications should the
Board consider?
Other Eligible Hedges
Under the proposed rule, a covered company would be allowed to
reduce its credit exposure to a counterparty by the face amount of a
short sale of the counterparty's debt or equity securities, provided
that the instrument in which the covered company has a short position
is junior to, or pari passu with, the instrument in which the covered
company has the long position.\73\ This restriction on the set of short
positions permitted to offset long positions would help to ensure that
any loss arising from the covered company's long exposure is offset by
a gain in the covered company's short exposure.
---------------------------------------------------------------------------
\73\ See proposed rule Sec. 252.74(f).
Example: A covered company holds $100 of bonds issued by Company
X. If the covered company sells short $100 of equity shares issued
by Company X, the covered company would not have any net credit
exposure to Company X. Similarly, the covered company would not have
any net credit exposure to Company X if it sells short $100 of
Company X's debt obligations, provided that those obligations are
junior to, or pari passu with, the Company X bonds that the covered
---------------------------------------------------------------------------
company holds.
Question 29: Should the Board permit short positions to offset long
positions only if the short position is in an instrument that is junior
to, or pari passu with, the instrument that gives rise to the firm's
long exposure?
Question 30: Should the Board place any additional requirements,
including maturity match requirements, on short positions that are
eligible to offset long positions? To the extent that there is a
maturity mismatch between the positions, should the value of the short
position be subject to application of the maturity mismatch adjustment
approach of Sec. 217.36(d) of the Board's Regulation Q?
Treatment of Maturity Mismatches
The above discussion of credit risk mitigation techniques
(collateral, guarantees, equity and credit derivatives, and offsetting
short positions) assumes that the residual maturity of the credit risk
mitigant is greater than or equal to that of the underlying exposure.
If the residual maturity of the credit risk mitigant is less than that
of the underlying exposure, the credit risk mitigant would only be
recognized under the proposed rule if the credit risk mitigant's
original maturity is equal to or greater than one year and its residual
maturity is not less than three months from the current date. In that
case, the reduction in the underlying exposure would be adjusted based
on the same approach that is used in the Board's Regulation Q (12 CFR
part 217) to address a maturity mismatch.\74\
---------------------------------------------------------------------------
\74\ A credit risk mitigant would be adjusted using the formula
Pa = P x (t-0.25)/(T-0.25), where Pa is the value of the credit
protection adjusted for maturity mismatch; P is the credit
protection adjusted for any haircuts; t is the lesser of (1) T or
(2) the residual maturity of the credit protection, expressed in
years; and T is the lesser of (1) 5 or (2) the residual maturity of
the exposure, expressed in years. See 12 CFR 217.36(d).
---------------------------------------------------------------------------
With respect to the amount of exposure that a covered company would
need to recognize to the issuer of eligible collateral or to an
eligible protection provider in cases of maturity mismatch, such amount
generally would be equal to the amount by which the relevant form of
credit risk mitigation has reduced the exposure to the original
counterparty. However, in the case of credit and equity derivatives
used to hedge exposures subject to the Board's market risk rule (12 CFR
217, subpart F) that are to counterparties that are non-financial
entities, the covered company would be permitted to recognize a credit
exposure with regard to the eligible protection provider measured using
methodologies that the covered company is authorized to use under the
Board's risk-based capital rules, including CEM for all covered
companies and approaches that rely on internal models for companies
subject to the Board's advanced approaches risk-based capital rules (12
CFR 217, subparts D and E).
Example: A covered company makes a loan to a counterparty and
hedges the resulting exposure by obtaining an eligible guarantee
from an eligible protection provider. If the residual maturity of
the guarantee is less than that of the loan, the covered company
would adjust the value assigned to the guarantee using the formula
in the Board's Regulation Q (12 CFR part 217). The covered company
would then reduce its gross credit exposure to the underlying
counterparty by the adjusted value of the guarantee and would set
its exposure to the eligible guarantor equal to the adjusted value
of the guarantee.
Example: A covered company holds bonds issued by a non-financial
entity that are subject to the Board's market risk rule, and hedges
the exposure using an eligible credit derivative obtained from an
eligible protection provider. If the residual maturity of the
eligible credit derivative is less than that of the bonds, the
covered company would reduce its exposure to the issuer of the bonds
by the adjusted value of the credit derivative using the formula in
the Board's Regulation Q. The covered company would measure its
exposure to the eligible protection provider using methodologies
that the covered company is permitted to use under the Board's risk-
based capital rules (12 CFR part 217, subparts D and E), without any
specific adjustment to reflect the maturity mismatch between the
bonds and the credit derivative.
Question 31: The Board invites comment on the proposed treatment of
maturity mismatches in the context of credit risk mitigation.
Unused Credit Lines
Section 252.74(g) of the proposed rule addresses the treatment of
any unused portion of certain extensions of credit. In computing its
net credit exposure to a counterparty for a credit line or revolving
credit facility, a covered company would be permitted to reduce
[[Page 14342]]
its gross credit exposure by the amount of the unused portion of the
credit extension to the extent that the covered company does not have
any legal obligation to advance additional funds under the facility
until the counterparty provides collateral that qualifies under the
credit line or revolving credit facility equal to or greater than the
entire used portion of the facility.\75\ To qualify for this reduction,
the contract governing the extension of credit would be required to
specify that any used portion of the credit extension must be fully
secured at all times by collateral that is either (i) cash; (ii)
obligations of the United States or its agencies; (iii) obligations
directly and fully guaranteed as to principal and interest by, the
Federal National Mortgage Association or the Federal Home Loan Mortgage
Corporation, but only while operating under the conservatorship or
receivership of the Federal Housing Finance Agency; or (iv) any
additional obligations issued by a U.S. government sponsored entity, as
determined by the Board.\76\
---------------------------------------------------------------------------
\75\ See proposed rule Sec. 252.74(g).
\76\ Id.
---------------------------------------------------------------------------
Question 32: What alternative approaches should the Board consider
concerning the unused portion of certain credit facilities?
Credit Transactions Involving Exempt and Excluded Persons
Section 252.74(h) \77\ provides that, if a covered company has
reduced its credit exposure to a counterparty that would be exempt
under the proposed rule by obtaining eligible collateral from that
entity, or by obtaining an eligible guarantee or an eligible credit or
equity derivative from an eligible protection provider, the covered
company must recognize an exposure to the collateral issuer or eligible
protection provider to the same extent as if the underlying exposure
were to an entity that is not exempt. Similarly, if a covered company
has reduced its exposure to an entity that is excluded from the
definition of a ``counterparty'' (e.g., the U.S. government or a
foreign sovereign entity that receives a zero percent risk weight under
Regulation Q) by obtaining eligible collateral from that entity, or by
obtaining an eligible guarantee or an eligible credit or equity
derivative from an eligible protection provider, the covered company
must recognize an exposure to the collateral issuer or eligible
protection provider to the same extent as if the underlying exposure
were to an entity that is not excluded from the definition of a
counterparty.
---------------------------------------------------------------------------
\77\ See proposed rule Sec. 252.74(h).
Example: A covered company has purchased a credit derivative
from an eligible protection provider to hedge the credit risk on a
portfolio of U.S. government bonds. The covered company would need
to recognize an exposure to the credit protection provider equal to
the full notional of the credit derivative (if the bonds are subject
to the Board's risk-based capital rules in 12 CFR part 217, subparts
D and E) or to the counterparty credit risk measurements obtained by
using methodologies that the covered company is permitted to use
under the market risk capital rules (if the bonds are subject to the
---------------------------------------------------------------------------
Board's market risk rule in 12 CFR part 217, subpart F).
Question 33: If a covered company has an exempted credit exposure
but either (1) receives non-exempt eligible collateral in support of
the exempted transaction or (2) obtains a non-exempt eligible guarantee
or eligible credit or equity derivative referencing the exempted credit
exposure from an eligible protection provider, should the covered
company be required to recognize an exposure to the issuer(s) of the
collateral or eligible protection provider even though the original
credit exposure was exempt? Should the Board consider any alternative
treatment in such situations?
Exposures to Funds and Securitizations
Special considerations arise in connection with measuring credit
exposure of a covered company to a securitization fund, investment fund
or other special purpose vehicle (collectively, SPVs). In some cases, a
covered company's failure to recognize an exposure to the issuers of
the underlying assets held by an SPV may understate the covered
company's credit exposure to those issuers. In other cases, a covered
company's credit exposure to the issuers of the underlying assets held
by an SPV may be insignificant and, in such cases, requiring a covered
company to recognize an exposure to each issuer of underlying assets
for every SPV in which a covered company invests could be unduly
burdensome.
Under the proposed rule, covered companies that have $250 billion
or more in total consolidated assets or $10 billion or more in total
on-balance-sheet foreign exposures would be required to analyze their
credit exposure to the issuers of the underlying assets in an SPV in
which the covered company invests or to which the covered company
otherwise has credit exposure. If a covered company cannot demonstrate
that its exposure to the issuer of each underlying asset held by an SPV
is less than 0.25 percent of the covered company's tier 1 capital
(considering only exposures that arise from the SPV), the covered
company would be required to apply a ``look-through approach'' and
recognize an exposure to each issuer of the assets held by the SPV.\78\
Conversely, if a covered company with $250 billion or more in total
consolidated assets or $10 billion or more in total on-balance-sheet
foreign exposures can demonstrate that its exposure to each underlying
asset in an SPV is less than 0.25 percent of the covered company's tier
1 capital (considering only exposures that arise from the SPV), the
covered company would be allowed to recognize an exposure solely to the
SPV and not to the underlying assets.\79\ The proposed 0.25 percent
threshold for requiring the use of the look-through approach is
intended to strike a balance between the goals of limiting a covered
company's exposures to underlying assets in an SPV and avoiding
excessive burden. If a covered company with $250 billion or more in
total consolidated assets or $10 billion or more in total on-balance-
sheet foreign exposures would be required to apply the look-through
approach, but is unable to identify an issuer of assets underlying an
SPV, the covered company would be required to attribute the exposure to
a single ``unknown counterparty.'' The covered company would then be
required to aggregate all exposures to an unknown counterparty as if
they related to a single counterparty.
---------------------------------------------------------------------------
\78\ See proposed rule Sec. 252.75. The calculation of a
covered company's exposure to an issuer of assets held by an SPV is
discussed in more detail in the following paragraphs.
\79\ A covered company's exposure to each underlying asset in an
SPV necessarily would be less than 0.25 percent of the covered
company's eligible capital base where the covered company's entire
investment in the SPV is less than 0.25 percent of the covered
company's eligible capital base.
---------------------------------------------------------------------------
The application of the look-through approach would depend on the
nature of the investment of the covered company in the SPV. Where all
investors in an SPV are pari passu, the covered company would calculate
its exposure to an issuer of assets held by the SPV as an amount equal
to the covered company's pro rata share in the SPV multiplied by the
value of the SPV's underlying assets issued by that issuer.
Example: An SPV holds $10 of bonds issued by Company A and $20
of bonds issued by Company B. Assuming that all investors in the SPV
are pari passu and that a covered company's pro rata share in the
SPV is 50 percent, a covered company (with $250 billion or more in
total consolidated assets or $10 billion or more in total on-
balance-sheet foreign exposures) would need
[[Page 14343]]
to recognize a $5 exposure to Company A (i.e., 50 percent of $10)
and a $10 exposure to Company B (i.e., 50 percent of $20) if the
look-through approach is required.
If all investors in an SPV are not pari passu, a covered company
that is required to use the look-through approach would measure its
exposure to an issuer of assets held by the SPV for each tranche in the
SPV in which the covered company invests. The covered company would do
this using a two-step process. First, the covered company would assume
that the total exposure to an issuer of assets held by the SPV among
all investors in a given SPV tranche is equal to the lesser of the
value of the tranche and the value of the assets issued by the issuer
that are held by the SPV. Second, the covered company would multiply
this exposure amount by the percentage of the SPV tranche that the
covered company holds.
Example: An SPV holds $10 of bonds issued by Company A. The SPV
has issued $4 of junior notes and $6 of senior notes to the SPV's
investors. A covered company with $250 billion or more in total
consolidated assets or $10 billion or more in total on-balance-sheet
foreign exposures holds 50 percent of the junior notes and 50
percent of the senior notes. With respect to the junior tranche of
the SPV, the lesser of the value of the tranche (i.e., $4) and the
value of the underlying assets issued by Company A (i.e., $10) is
$4. With respect to the senior tranche of the SPV, the lesser of the
value of the tranche (i.e., $6) and the value of the underlying
assets issued by Company A (i.e., $10) is $6. Because the covered
company has $250 billion or more in total consolidated assets or $10
billion or more in total on-balance-sheet foreign exposures and its
pro rata share of each tranche is 50 percent, it would need to
recognize $2 of exposure to Company A because of its investment in
the junior tranche (i.e., 50 percent of $4), and $3 of exposure to
Company A because of its investment in the senior tranche (i.e., 50
percent of $6), assuming the look-through approach is required.
In addition, a covered company with $250 billion or more in total
consolidated assets or $10 billion or more in total on-balance-sheet
foreign exposures would be required to identify third parties whose
failure or distress would likely result in a loss in the value of the
covered company's investment in the SPV. For example, the value of an
investment by the covered company in an SPV might be reliant on various
forms of credit support provided by a financial institution to the SPV.
The failure or distress of the credit support provider would then lead
to loss in the value of the investment of the covered company in the
SPV. Other examples of third parties whose failure or distress could
potentially lead to a loss in the value of the covered company's
investment in the SPV are originators of assets held by the SPV,
liquidity providers to the SPV, and (potentially) fund managers. In
such cases, the covered company would be required to recognize an
exposure to the relevant third party that is equal to the value of the
covered company's investment in the SPV. This requirement would be in
addition to the requirements described above to recognize an exposure
to the SPV and, if needed, to the issuers of assets held by the SPV.
These proposed requirements for covered companies with $250 billion
or more in total consolidated assets or $10 billion or more in total
on-balance-sheet foreign exposures would be appropriate in light of the
larger systemic footprint of those firms, and is consistent with the
direction in section 165(a)(1)(B) of the Dodd-Frank Act to tailor
enhanced prudential standards based on factors such as the nature,
scope, size, scale, concentration, interconnectedness, and mix of the
activities of the company to which the standards apply.\80\
---------------------------------------------------------------------------
\80\ 12 U.S.C. 5365(a)(1)(B).
---------------------------------------------------------------------------
Question 34: Is the proposed treatment of a covered company that
has less than $250 billion or more in total consolidated assets and
less than $10 billion or more in total on-balance-sheet foreign
exposures with respect to its exposures related to SPVs appropriate?
What alternatives should the Board consider?
Question 35: Is the proposed treatment of a covered company with
$250 billion or more in total consolidated assets or $10 billion or
more in total on-balance-sheet foreign exposures with respect to its
exposures related to SPVs appropriate? Are there situations in which
the proposed treatment would result in recognition of inappropriate
amounts of credit exposure concerning an SPV? What alternative
approaches should the Board consider?
Question 36: Is the proposed treatment of exposures related to SPVs
sufficiently clear? Would further clarification or simplification be
appropriate? What modifications should the Board consider? For example,
should the Board modify the approach such that a covered company would
only be required to use the look-through approach with respect to
particular underlying exposures rather than all underlying exposures in
the event that the covered company is able to demonstrate that its
credit exposure to some of the underlying assets in an SPV is less than
0.25 percent of the covered company's tier 1 capital but not able to
make this demonstration with respect to all the underlying assets?
Exemptions
Under the proposal, single-counterparty credit limits would not
apply to exposures to the U.S. government or a foreign sovereign entity
that receives a zero percent risk weight under Regulation Q because
such entities are not included in the definition of a ``counterparty.''
Section 252.77 of the proposed rule sets forth additional exemptions
from the single-counterparty credit limits.\81\ Section 165(e)(6) of
the Dodd-Frank Act states that the Board may, by regulation or order,
exempt transactions, in whole or in part, from the definition of the
term ``credit exposure'' for purposes of this subsection, if the Board
finds that the exemption is in the public interest and is consistent
with the purposes of this subsection.\82\
---------------------------------------------------------------------------
\81\ See proposed rule Sec. 252.77.
\82\ See 12 U.S.C. 5365(e)(6).
---------------------------------------------------------------------------
The first exemption from the proposed rule would be for direct
claims on, and the portions of claims that are directly and fully
guaranteed as to principal and interest by, the Federal National
Mortgage Association and the Federal Home Loan Mortgage Corporation,
while these entities are operating under the conservatorship or
receivership of the Federal Housing Finance Agency.\83\ This proposed
exemption reflects a policy decision that credit exposures to these
government-sponsored entities should not be subject to a regulatory
limit for so long as the entities are in the conservatorship or
receivership of the U.S. government. This approach is consistent with
the approach that the Board used in its risk retention rules.\84\ As
determined by the Board, obligations issued by another U.S. government
sponsored entity would also be exempt. The Board requests comment on
whether these exemptions are appropriate.
---------------------------------------------------------------------------
\83\ See proposed rule Sec. 252.77(a)(1).
\84\ See 12 CFR 244.8.
---------------------------------------------------------------------------
The second exemption from the proposed rule would be for intraday
credit exposure to a counterparty.\85\ This exemption would help
minimize the impact of the rule on the payment and settlement of
financial transactions.
---------------------------------------------------------------------------
\85\ See proposed rule Sec. 252.77(a)(2).
---------------------------------------------------------------------------
The third exemption from the proposed rule would be for trade
exposures to a central counterparty that meet the definition of a
qualified central counterparty under Regulation Q (QCCPs).\86\ These
exposures would
[[Page 14344]]
include potential future exposure arising from transactions cleared by
a QCCP and pre-funded default fund contributions.\87\ The proposed rule
would exempt these exposures to QCCPs from single-counterparty credit
limits because of the concern that application of single-counterparty
credit limits to these exposures would require firms to spread activity
across a greater number of CCPs, which could lead to a reduction in
multilateral netting benefits.\88\
---------------------------------------------------------------------------
\86\ See proposed rule Sec. 252.71(y); see also 12 CFR 217.2.
\87\ As initial margin and excess variation margin posted to the
QCCP and held in a segregated account by a third party custodian are
not subject to counterparty risk, these amounts would not be
considered credit exposures under the proposed rule.
\88\ See proposed rule Sec. 252.77(a)(3).
---------------------------------------------------------------------------
The fourth exemption category would implement section 165(e)(6) of
the Dodd-Frank Act and provide a catch-all category to exempt any
transaction which the Board determines to be in the public interest and
consistent with the purposes of section 165(e).\89\
---------------------------------------------------------------------------
\89\ See 12 U.S.C. 5365(e)(6); proposed rule Sec. 252.76(a)(4).
---------------------------------------------------------------------------
Section 252.77(b) of the proposed rule would implement section
165(e)(6) of the Dodd-Frank Act, which provides a statutory exemption
for credit exposures to the Federal Home Loan Banks.
Question 37: Should all trade exposures to QCCPs be exempt from the
proposed rules? Is the definition of ``QCCP'' sufficiently clear?
Should the Board consider exempting any different or additional
exposures to QCCPs? Would additional clarification on these issues be
appropriate?
Question 38: Should the Board exempt any additional credit
exposures from the limitations of the proposed rule? If so, please
explain why.
Compliance
Under section 252.78(a) of the proposed rule, covered companies
with less than $250 billion in total consolidated assets and less than
$10 billion in total on-balance-sheet foreign exposures would be
required to demonstrate compliance with the requirements of the
proposed rule as of the end of each calendar quarter.\90\ These
companies would, however, need to have systems in place that would
allow them to calculate compliance on a daily basis and would be
required to calculate compliance on a more frequent basis than
quarterly if directed to do so by the Board. A covered company with
$250 billion or more in total consolidated assets or $10 billion or
more in total on-balance-sheet foreign exposures would be required to
comply with the requirements of the proposed rule on a daily basis as
of the end of each business day. Such covered companies also would be
required to submit a monthly compliance report to the Board.\91\
---------------------------------------------------------------------------
\90\ See proposed rule Sec. 252.78(a).
\91\ See proposed rule Sec. 252.78(a).
---------------------------------------------------------------------------
Section 252.78(c) of the proposed rule would address the
consequences if a covered company fails to comply with the credit
exposure limits.\92\ This section states that if a covered company is
not in compliance with respect to a counterparty due to a decrease in
the covered company's capital, the merger of a covered company with
another covered company, or the merger of two unaffiliated
counterparties of the covered company, the covered company would not be
subject to enforcement actions with respect to such noncompliance for a
period of 90 days (or such shorter or longer period determined by the
Board to be appropriate to maintain the safety and soundness of the
covered company or financial stability), so long as the company uses
reasonable efforts to return to compliance with the proposed rule
during this period. The covered company would be prohibited from
engaging in any additional credit transactions with such a counterparty
in contravention of this rule during the non-compliance period, except
in cases where the Board determines that such additional credit
transactions are necessary or appropriate to preserve the safety and
soundness of the covered company or financial stability.\93\ In
granting approval for any such special temporary exceptions, the Board
may impose supervisory oversight and reporting measures that it
determines are appropriate to monitor compliance with the foregoing
standards.\94\
---------------------------------------------------------------------------
\92\ See proposed rule Sec. 252.78(c).
\93\ Id.
\94\ See proposed rule Sec. 252.78(d).
---------------------------------------------------------------------------
The Board plans to develop reporting forms for covered companies to
use to report credit exposures to their counterparties as those credit
exposures would be measured under section 165(e). In addition, section
165(d)(2) of the Dodd-Frank Act directs the Board to require bank
holding companies with $50 billion or more in total consolidated assets
and nonbank financial companies that are supervised by the Board to
prepare period exposure reports.\95\ The Board anticipates that
165(d)(2) credit exposure reporting obligations will be informed by the
requirements of the 165(e) framework and by any forms that are
developed for covered companies to use in reporting their 165(e)
exposures.
---------------------------------------------------------------------------
\95\ 12 U.S.C. 5365(d)(2).
---------------------------------------------------------------------------
Question 39: Should the rule provide a cure period for covered
companies that fall out of compliance? Under what circumstances should
such a cure period be provided, and how long should such a period be?
Question 40: If a cure period is provided, would it be appropriate
to generally prohibit additional credit transactions with the affected
counterparty during the cure period? Are there additional situations in
which additional credit transactions with the affected counterparty
would be appropriate? What additional modifications or clarifications
should the Board consider with respect to any cure period?
Timing
Under the proposed rule, covered companies with total consolidated
assets of less than $250 billion in total consolidated assets and less
than $10 billion or more in total on-balance-sheet foreign exposures
would be required to comply initially with the proposed rules two years
from the effective date of the proposed rules, unless that time is
extended by the Board in writing.\96\ Covered companies that have $250
billion or more in total consolidated assets or $10 billion or more in
total on-balance-sheet foreign exposures would be required to comply
initially with the proposed rules one year from the effective date of
the rule, unless that time is extended by the Board in writing.\97\
---------------------------------------------------------------------------
\96\ See proposed rule Sec. 252.70(g)(1).
\97\ See proposed rule Sec. 252.70(g)(2).
---------------------------------------------------------------------------
Any company that becomes a covered company after the effective date
of the rule would be required to comply with the requirements of the
rule beginning on the first day of the fifth calendar quarter after it
becomes a covered company, unless that time is accelerated or extended
by the Board in writing.\98\
---------------------------------------------------------------------------
\98\ See proposed rule Sec. 252.70(h).
---------------------------------------------------------------------------
Question 41: Should the Board consider a longer or shorter phase-in
period for all or a subset of covered companies? Is a shorter phase-in
period for covered companies with $250 billion or more in total
consolidated exposures, or $10 billion or more in total on-balance-
sheet foreign exposures, compared to firms below these thresholds,
appropriate?
Proposed Rule for Foreign Banking Organizations
Background
In February 2014, the Board adopted a final rule establishing
enhanced
[[Page 14345]]
prudential standards for foreign banking organizations with U.S.
banking operations and total consolidated assets of $50 billion or
more.\99\ Under that rule, a foreign banking organization with U.S.
non-branch assets of $50 billion or more will be required to form an
intermediate holding company (U.S. intermediate holding company) to
hold its interests in U.S. bank and nonbank subsidiaries.\100\ A
foreign banking organization's U.S. intermediate holding company will
be subject to enhanced prudential standards on a consolidated basis,
including risk-based and leverage capital requirements, liquidity
requirements, and risk management standards. Certain enhanced
prudential standards also will apply to a foreign banking
organization's ``combined U.S. operations,'' which would include a
foreign banking organization's U.S. branches and agencies as well as
U.S. subsidiaries.
---------------------------------------------------------------------------
\99\ See 79 FR 17240 (Mar. 27, 2014).
\100\ A foreign banking organization's intermediate holding
company is not required to hold the foreign banking organization's
interest in any company held under section 2(h)(2) of the Bank
Holding Company Act, 12 U.S.C. 1841(h)(2).
---------------------------------------------------------------------------
Like the enhanced prudential standards for foreign banking
organizations that the Board previously has adopted, the single-
counterparty credit limits in this proposed rule would apply to a
foreign banking organization with U.S. banking operations and $50
billion or more in total consolidated assets, and to the U.S.
intermediate holding company of such a foreign banking organization.
Overview of the Proposed Rule for Foreign Banking Organizations
Similar to the proposed rule to implement section 165(e) of the
Dodd-Frank Act for domestic companies, the aggregate net credit
exposure of a foreign banking organization or U.S. intermediate holding
company with total consolidated assets of $50 billion or more (each a
covered entity) to a single counterparty would be subject to one of
three increasingly stringent credit exposure limits. Credit exposure
limits as applied to foreign banking organizations, as opposed to
intermediate holding companies, would only apply with respect to credit
exposures of that foreign banking organization's combined U.S.
operations (i.e., any U.S. intermediate holding company, including its
subsidiaries, plus any U.S. branches or agencies of the foreign banking
organization), although the foreign banking organization's total
consolidated assets on a worldwide basis would determine whether the
credit exposure limits apply.
The first category of limits would apply to covered entities that
have less than $250 billion in total consolidated assets and less than
$10 billion in on-balance-sheet foreign exposures. Covered entities
that have less than $250 billion in total consolidated assets and less
than $10 billion in on-balance sheet foreign exposures would be
prohibited from having aggregate net credit exposure to an unaffiliated
counterparty in excess of 25 percent of the covered entity's total
capital stock and surplus, defined under the rule as (1) in the case of
a U.S. intermediate holding company, the sum of the U.S. intermediate
holding company's total regulatory capital, as calculated under the
risk-based capital adequacy guidelines applicable to that U.S.
intermediate holding company, plus the balance of the ALLL of the U.S.
intermediate holding company not included in tier 2 capital under the
capital adequacy guidelines, and (2) in the case of a foreign banking
organization, the total regulatory capital of the foreign banking
organization on a consolidated basis, as determined in accordance with
section 252.171(d) of the proposed rule.\101\ The different definition
of ``capital stock and surplus'' with respect to a foreign banking
organization reflects differences in international accounting
standards.
---------------------------------------------------------------------------
\101\ See 12 CFR part 252, subpart L.
---------------------------------------------------------------------------
The second category of exposure limits would prohibit any covered
entity with $250 billion or more in total consolidated assets or $10
billion or more in total on-balance-sheet foreign exposures, but less
than $500 billion in total consolidated assets, from having aggregate
net credit exposure to an unaffiliated counterparty in excess of 25
percent of the covered entity's tier 1 capital. For the same reasons as
described above with respect to the portion of the proposed rule
applicable to covered companies, the proposed single-counterparty
credit limits applicable to a covered entity, including both a foreign
banking organization and any U.S. intermediate holding company, with
$250 billion or more in total consolidated assets or $10 billion or
more in total on-balance-sheet foreign exposures would be based on tier
1 capital.
The third category of exposure limits would prohibit any covered
entity with total consolidated assets of $500 billion or more (major
foreign banking organization or major U.S. intermediate holding
company) from having aggregate net credit exposure in excess of 15
percent of the tier 1 capital of the major foreign banking organization
or major U.S. intermediate holding company to a major counterparty, and
25 percent of the tier 1 capital of the major foreign banking
organization or major U.S. intermediate holding company to any other
counterparty. A ``major counterparty'' would be defined as a global
systemically important banking organization or a nonbank financial
company supervised by the Board. This framework would be consistent
with the requirement in section 165(a)(1)(B) of the Dodd-Frank Act that
the enhanced standards established by the Board under section 165
increase in stringency based on factors such as the nature, scope,
size, scale, concentration, interconnectedness, and mix of the
activities of the company.\102\ The credit exposure limits are
summarized in Table 2.
---------------------------------------------------------------------------
\102\ 12 U.S.C. 5323, 5365(e).
Table 2--Single-Counterparty Credit Limits Applicable to Covered
Entities
------------------------------------------------------------------------
Applicable credit exposure
Category of covered entities limit
------------------------------------------------------------------------
U.S. intermediate holding companies or Aggregate net credit exposure
foreign banking organizations with of a U.S. intermediate holding
less than $250 billion in total company cannot exceed 25
consolidated assets and less than $10 percent of the U.S.
billion in on-balance-sheet foreign intermediate holding company's
exposures.. total regulatory capital plus
the balance of its ALLL not
included in tier 2 capital
under the capital adequacy
guidelines in 12 CFR part 252.
Aggregate net credit exposure
of a foreign banking
organization, with respect to
its U.S. combined operations,
to a counterparty cannot
exceed 25 percent of the
foreign banking organization's
total regulatory capital on a
consolidated basis.
[[Page 14346]]
U.S. intermediate holding companies or Aggregate net credit exposure
foreign banking organizations with of a U.S. intermediate holding
$250 billion or more in total company to a counterparty
consolidated assets or $10 billion or cannot exceed 25 percent of
more in on-balance-sheet foreign the U.S. intermediate holding
exposures.. company's tier 1 capital.
Aggregate net credit exposure
of a foreign banking
organization, with respect to
its U.S. combined operations,
to a counterparty cannot
exceed 25 percent of the
foreign banking organization's
worldwide tier 1 capital.
Major U.S. intermediate holding Aggregate net credit exposure
companies and major foreign banking of a major U.S. intermediate
organizations.. holding company or, with
respect to its combined U.S.
operations, of a foreign
banking organization to a
major counterparty cannot
exceed 15 percent of the
covered entity's tier 1
capital.
Aggregate net credit exposure
of a major U.S. intermediate
holding company or, with
respect to its combined U.S.
operations, of a foreign
banking organization to other
counterparties cannot exceed
25 percent of the covered
entity's tier 1 capital.
------------------------------------------------------------------------
Question 42: Should the Board apply these single-counterparty
credit limits to all foreign banking organizations that have $50
billion or more in total consolidated assets, regardless of the size of
these organizations' combined operations in the United States? Is this
application appropriate?
The more stringent limit for major U.S. intermediate holding
companies and, with respect to their combined U.S. operations, major
foreign banking organizations would be consistent with the Board's
discretion under the Dodd-Frank Act to impose such lower single-
counterparty credit limits as the Board may determine by regulation to
be necessary to mitigate risks to the financial stability of the United
States, as well as with the standard in section 165(a)(1)(B) of the
Dodd-Frank Act that the Board establish enhanced prudential standards
that increase in stringency based on the systemic footprint of the
firms to which they apply. The rationale for proposing to apply a 15
percent limit to such exposures is set out in more detail in the
discussion in the SUPPLEMENTARY INFORMATION concerning the credit
exposure limits of the domestic proposed rule.
The proposed approach to identifying a major U.S. intermediate
holding company and major foreign banking organization is based only on
size, and the Board recognizes that size is only a rough proxy for the
systemic footprint of a company. By contrast, the domestic proposed
rule would only subject a U.S. banking organization to a 15 percent
limit on its exposures to major counterparties if that U.S. banking
organization has been identified as a global systemically important
banking organization under Method 1 of the Board's G-SIB surcharge
rule.\103\ These determinations are based on multiple factors,
including size, complexity, interconnectedness, cross-border exposure,
and substitutability. Imposing stricter limits on exposures of the
combined U.S. operations of major foreign banking organizations or
major U.S. intermediate holding companies to their respective major
counterparties based on a simple asset threshold may not take into
account nuances that might be captured by other approaches.
---------------------------------------------------------------------------
\103\ 12 CFR 217.402.
---------------------------------------------------------------------------
Question 43: Should the Board adopt a different approach in
determining which foreign banking organizations, with respect to their
combined U.S. operations, and U.S. intermediate holding companies
should be treated as major foreign banking organizations or major U.S.
intermediate holding companies?
Question 44: Should the Board adopt a different approach to the
definition of a ``major counterparty''?
In determining whether a U.S. intermediate holding company complies
with these limits, exposures of the U.S. intermediate holding company
itself and its subsidiaries would need to be taken into account.
Exposures of a foreign banking organization's combined U.S. operations
would include exposures of any branch or agency of the foreign banking
organization; exposures of the U.S. subsidiaries of the foreign banking
organization, including any U.S. intermediate holding company; and any
subsidiaries of such subsidiaries (other than any companies held under
section 2(h)(2) of the Bank Holding Company Act of 1956).\104\
``Subsidiary'' would be defined in the same manner as under the
proposed requirements for domestic covered companies: any company that
a parent company directly or indirectly controls for purposes of the
Bank Holding Company Act of 1956.\105\ For purposes of the proposed
rule applicable to covered entities, the definitions of subsidiary,
counterparty, and related terms and the economic interdependence,
control relationship, and attribution requirements would be the same as
under the portions of the proposed rule applicable to covered
companies.
---------------------------------------------------------------------------
\104\ 12 U.S.C. 1841(h)(2).
\105\ 12 U.S.C. 1841 et seq.; see proposed rule Sec.
252.171(dd).
---------------------------------------------------------------------------
Although the major components of the proposed single-counterparty
credit limits for foreign banking organizations would be the same as
the proposed requirements for domestic covered companies, there are
also some differences between the proposed rules. For example, as
discussed in more detail below, the proposed single-counterparty credit
limits would not apply to exposures of a U.S. intermediate holding
company or a foreign banking organization's combined U.S. operations to
the foreign banking organization's home country sovereign, regardless
of the risk weight assigned to that sovereign under the Board's
Regulation Q (12 CFR part 217).
Question 45: As noted, the proposed rule would apply the single-
counterparty credit limits to covered entities on a consolidated basis
and could, therefore, impact the level of credit exposures of
subsidiaries of these covered entities, including depository
institutions. Is application on a consolidated basis appropriate?
Question 46: What challenges, if any, would a foreign banking
organization face in implementing the requirement that all subsidiaries
of the U.S. intermediate holding company and the combined U.S.
operations be subject to the proposed single-counterparty credit limit?
[[Page 14347]]
Question 47: What other alternatives to the proposed capital bases
should the Board consider in applying single-counterparty credit limits
to U.S. intermediate holding companies and the combined U.S. operations
of foreign banking organizations?
Question 48: Should tier 1 capital be used as the capital base in
applying single-counterparty credit limits to U.S. intermediate holding
companies and the combined U.S. operations of foreign banking
organizations with $250 billion or more in total consolidated assets,
or $10 billion or more in total on-balance-sheet foreign exposures?
Question 49: Should single-counterparty credit limits apply to a
foreign banking organization's combined U.S. operations, or is
application of single-counterparty credit limits to a foreign banking
organization's combined U.S. operations unnecessary in light of the
Basel Committee's adoption of a Large Exposures standard?
Gross Credit Exposure
The proposed valuation rules for measuring gross credit exposure to
a counterparty would be the same as those set forth in the proposed
rule for domestic bank holding companies, other than the proposed
valuation rules for derivatives exposures of U.S. branches and agencies
that are subject to a qualifying master netting agreement. When
calculating a U.S. branch or agency's gross credit exposure to a
counterparty for a derivative contract that is subject to a qualifying
master netting agreement, a foreign banking organization could choose
either to use the exposure at default calculation set forth in the
Board's advanced approaches capital rules (12 CFR 217.132(c)) provided
that the collateral recognition rules of the proposed rule would apply,
or use the gross valuation methodology for derivatives not subject to a
qualified master netting agreements.\106\ Under this approach, a
foreign banking organization would be able to rely on a qualified
master netting agreement to which the U.S. branch or agency is subject
that covers exposures of the foreign banking organization outside of
the U.S. branch and agency network.
---------------------------------------------------------------------------
\106\ See proposed rule Sec. 252.173(a)(11).
---------------------------------------------------------------------------
Question 50: Is the proposed treatment of derivatives exposures of
U.S. branches and agencies that are subject to a qualifying master
netting agreement appropriate? What alternatives should the Board
consider?
Question 51: Should there be any other differences between the
treatment of derivative exposures of a foreign banking organization's
combined U.S. operations or U.S. intermediate holding company and the
treatment derivative exposures of U.S. covered companies?
Question 52: Should the rule provide a separate process that allows
foreign banking organizations to receive Board approval to use internal
models to value derivative transactions solely for the purpose of
complying with this rule?
Net Credit Exposure
The proposed rule describes how a covered entity would convert
gross credit exposure amounts to net credit exposure amounts by taking
into account eligible collateral, eligible guarantees, eligible credit
and equity derivatives, other eligible hedges (that is, a short
position in the counterparty's debt or equity securities), and for
securities financing transactions, the effect also of bilateral netting
agreements. The proposed treatment described below is generally
consistent with the proposed treatment for domestic bank holding
companies. However, the definition of ``eligible collateral'' for
covered entities would exclude debt or equity securities (including
convertible bonds) issued by an affiliate of the U.S. intermediate
holding company or the combined U.S. operations of a foreign banking
organization, and the definition of ``eligible protection provider''
would exclude the foreign banking organization or any affiliate
thereof.\107\
---------------------------------------------------------------------------
\107\ See proposed rule Sec. 252.171(k).
---------------------------------------------------------------------------
Question 53: Does the proposed approach to the calculation of net
credit exposure pose particular concerns for U.S. intermediate holding
companies or foreign banking organizations, with respect to their U.S.
operations?
Exposures to Funds and Securitizations
The proposed rule's treatment for a covered entity's exposures to
funds and securitizations would be the same as the proposed treatment
for a domestic covered company's exposures to such entities.\108\
---------------------------------------------------------------------------
\108\ See proposed rule Sec. 252.175.
---------------------------------------------------------------------------
Question 54: Does the proposed treatment of exposures related to
SPVs pose particular concerns for foreign banking organizations, with
respect to its combined U.S. operations, or U.S. intermediate holding
companies?
Exemptions
As noted, section 165(e)(6) of the Dodd-Frank Act permits the Board
to exempt transactions from the definition of the term ``credit
exposure'' for purposes of this subsection, if the Board finds that the
exemption is in the public interest and is consistent with the purposes
of this subsection. The proposed rule would provide the same exemptions
for the credit exposures of covered entities as the proposed rule
provides for credit exposures of domestic covered companies.\109\ In
addition, the proposed rule would include an additional exemption for a
foreign banking organization's exposures to its home country sovereign,
notwithstanding the risk weight assigned to that sovereign entity under
the Board's Regulation Q (12 CFR part 217).\110\ This exemption would
recognize that a foreign banking organization's U.S. operations may
have exposures to its home country sovereign entity that are required
by home country laws or are necessary to facilitate the normal course
of business for the consolidated company. This proposed exemption would
be in the public interest and consistent with the treatment of credit
exposures of covered companies to the U.S. government.
---------------------------------------------------------------------------
\109\ See proposed rule Sec. 252.177(a).
\110\ See proposed rule Sec. 252.177(a)(4).
---------------------------------------------------------------------------
Question 55: Would additional exemptions for foreign banking
organizations or the U.S. intermediate holding companies of foreign
banking organizations be appropriate? Why or why not?
Compliance
Under the proposed rule, an U.S. intermediate holding company or
the combined U.S. operations of a foreign banking organization with
less than $250 billion in total consolidated assets, and less than $10
billion in total on-balance-sheet foreign exposures, would be required
to comply with the requirements of the proposed rule as of the end of
each quarter.\111\ Other intermediate holding companies and foreign
banking organizations would be required to comply with the proposed
rule on a daily basis as of the end of each business day and submit a
monthly compliance report demonstrating its daily compliance.\112\ A
foreign banking organization would be required to ensure the compliance
of its U.S. intermediate holding company and its combined U.S.
operations. If either the U.S. intermediate holding company or the
combined U.S. operations were not in compliance with respect to a
counterparty, both of the U.S. intermediate holding company and the
combined U.S. operations would be prohibited from engaging in any
additional credit transactions with such
[[Page 14348]]
a counterparty, except in cases when the Board determines that such
additional credit transactions are necessary or appropriate to preserve
the safety and soundness of the foreign banking organization or
financial stability.\113\ In considering special temporary exceptions,
the Board could impose supervisory oversight and reporting measures
that it determines are appropriate to monitor compliance with the
foregoing standards.\114\
---------------------------------------------------------------------------
\111\ See proposed rule Sec. 252.178(a).
\112\ Id.
\113\ See proposed rule Sec. 252.178(c).
\114\ See proposed rule Sec. 252.178(d).
---------------------------------------------------------------------------
Question 56: Should the rule provide a cure period for covered
entities that are not compliant? Under what circumstances should such a
cure period be provided, and how long should such a period be?
Question 57: If a cure period is provided, would it be appropriate
to generally prohibit additional credit transactions with the affected
counterparty during the cure period? Are there additional situations in
which additional credit transactions with the affected counterparty
would be appropriate? What additional modifications or clarifications
should the Board consider with respect to any cure period?
Question 58: Should the Board consider any temporary exceptions
particularly for foreign banking organizations or the U.S. intermediate
holding companies of foreign banking organizations? In what situations
would a temporary exception be appropriate?
Timing
The proposed rule is designed to be less stringent for those
foreign banking organizations and U.S. intermediate holding companies
whose failure or distress would be less likely to pose a risk to U.S.
financial stability. Foreign banking organizations and U.S.
intermediate holding companies with less than $250 billion in total
consolidated assets and less than $10 billion in total on-balance-sheet
foreign assets would be required to comply initially with the proposed
rule two years from the effective date of the proposed rule, unless
that time is extended by the Board in writing.\115\ Foreign banking
organizations and U.S. intermediate holding companies with $250 billion
or more in total consolidated assets or $10 billion or more in total
on-balance-sheet foreign assets would be required to comply initially
with the proposed rule one year from the effective date of the rule,
unless that time is extended by the Board in writing.\116\ Any company
that becomes a covered company after the effective date of the rule
would be required to comply with the requirements of the rule beginning
on the first day of the fifth calendar quarter after it becomes a
covered entity, unless that time is accelerated or extended by the
Board in writing.\117\
---------------------------------------------------------------------------
\115\ See proposed rule Sec. Sec. 252.170(c)(1)(i) and
252.170(c)(2)(i).
\116\ See proposed rule Sec. Sec. 252.170(c)(1)(ii) and
252.170(c)(2)(ii).
\117\ See proposed rule Sec. 252.170(d).
---------------------------------------------------------------------------
Regulatory Analysis
Paperwork Reduction Act
Certain provisions of the proposed rules contain ``collection of
information'' requirements within the meaning of the Paperwork
Reduction Act (PRA) of 1995 (44 U.S.C. 3501 through 3521). The Board
has reviewed the reporting requirements in sections 252.78(a) and
252.178(a) of the proposed rules under the authority delegated to the
Board by Office of Management and Budget (OMB). The Board will address
these requirements in a separate notice, such as when the Board
proposes reporting forms for companies subject to these rules to use to
report credit exposures to their counterparties as those credit
exposures would be measured under the proposed rules.
Solicitation of Comments on the Use of Plain Language
Section 722 of the Gramm-Leach Bliley Act (Pub. L. 106-102, 113
Stat. 1338, 1471, 12 U.S.C. 4809) requires the Federal banking agencies
to use plain language in all proposed and final rules published after
January 1, 2000. The Board has sought to present the proposed rules in
a simple and straightforward manner, and invites comment on the use of
plain language. For example:
Have the agencies organized the material to suit your
needs? If not, how could they present the proposed rules more clearly?
Are the requirements in the proposed rules clearly stated?
If not, how could the proposed rules be more clearly stated?
Do the regulations contain technical language or jargon
that is not clear? If so, which language requires clarification?
Would a different format (grouping and order of sections,
use of headings, paragraphing) make the regulation easier to
understand? If so, what changes would achieve that?
Is the section format adequate? If not, which of the
sections should be changed and how?
What other changes can the Board incorporate to make the
regulation easier to understand?
Regulatory Flexibility Act Analysis
In accordance with section 3(a) of the Regulatory Flexibility Act
\118\ (RFA), the Board is publishing an initial regulatory flexibility
analysis of the proposed rules. The RFA requires an agency either to
provide an initial regulatory flexibility analysis with a proposed rule
for which a general notice of proposed rulemaking is required or to
certify that the proposed rule will not have a significant economic
impact on a substantial number of small entities. Based on its analysis
and for the reasons stated below, the Board believes that these
proposed rules will not have a significant economic impact on a
substantial number of small entities. Nevertheless, the Board is
publishing an initial regulatory flexibility analysis. A final
regulatory flexibility analysis will be conducted after comments
received during the public comment period have been considered.
---------------------------------------------------------------------------
\118\ 5 U.S.C. 601 et seq.
---------------------------------------------------------------------------
In accordance with section 165 of the Dodd-Frank Act, the Board is
proposing to amend Regulation YY to establish single-counterparty
credit limits for bank holding companies, foreign banking
organizations, and U.S. intermediate holding companies with total
consolidated assets of $50 billion or more in order to limit the risks
that the failure of any individual firm could pose to those
organizations.\119\
---------------------------------------------------------------------------
\119\ See 12 U.S.C. 5365(e).
---------------------------------------------------------------------------
Under regulations issued by the Small Business Administration
(SBA), a ``small entity'' includes a depository institution, bank
holding company, or savings and loan holding company with assets of
$550 million or less (small banking organizations).\120\ As discussed
in the SUPPLEMENTARY INFORMATION, the proposed rules generally would
apply to bank holding companies, foreign banking organizations, and
U.S. intermediate holding companies with total consolidated assets of
$50 billion or more. Companies that are subject to the proposed rule
have consolidated assets that substantially exceed the $550 million
asset threshold at which a banking entity is considered a ``small
entity'' under SBA regulations. Because the proposed rules would not
apply to any company with assets of $550 million or less, if adopted in
final form, the proposed rules would not apply to any ``small entity''
for purposes of the RFA. The Board does not believe that the proposed
rules duplicate, overlap, or
[[Page 14349]]
conflict with any other Federal rules. In light of the foregoing, the
Board does not believe that the proposed rules, if adopted in final
form, would have a significant economic impact on a substantial number
of small entities supervised. Nonetheless, the Board seeks comment on
whether the proposed rules would impose undue burdens on, or have
unintended consequences for, small organizations, and whether there are
ways such potential burdens or consequences could be minimized in a
manner consistent with section 165(e) of the Dodd-Frank Act.
---------------------------------------------------------------------------
\120\ See 13 CFR 121.201.
---------------------------------------------------------------------------
List of Subjects in 12 CFR Part 252
Administrative practice and procedure, Banks, Banking, Federal
Reserve System, Holding companies, Reporting and recordkeeping
requirements, Securities.
Authority and Issuance
For the reasons stated in the preamble, the Board of Governors of
the Federal Reserve System proposes to amend 12 CFR part 252 as
follows:
PART 252--ENHANCED PRUDENTIAL STANDARDS (REGULATION YY)
0
1. The authority citation for part 252 continues to read as follows:
Authority: 12 U.S.C. 321-338a, 1467a(g), 1818, 1831p-1, 1844(b),
1844(c), 5361, 5365, 5366.
0
2. Add subpart H to read as follows:
Subpart H--Single-Counterparty Credit Limits
Sec.
252.70 Applicability.
252.71 Definitions.
252.72 Credit exposure limits.
252.73 Gross credit exposure.
252.74 Net credit exposure.
252.75 Investments in and exposures to securitization vehicles,
investment funds, and other special purpose vehicles.
252.76 Aggregation of exposures to more than one counterparty due to
economic interdependence or control relationships.
252.77 Exemptions.
252.78 Compliance.
Sec. 252.70 Applicability.
(a) In general. A covered company is subject to the general credit
exposure limit set forth in Sec. 252.72(a).
(b) Covered companies with $250 billion or more in total
consolidated assets or $10 billion or more in total on-balance-sheet
foreign exposures. A covered company with $250 billion or more in total
consolidated assets or $10 billion or more in total on-balance-sheet
foreign exposures is subject to the credit exposure limit set forth in
Sec. 252.72(b).
(c) Major covered companies. A major covered company is subject to
the credit exposure limit set forth in Sec. 252.72(c).
(d) Total consolidated assets. For purposes of this section, total
consolidated assets are determined based on:
(1) The average of the bank holding company's total consolidated
assets in the four most recent consecutive quarters as reported
quarterly on the FR Y-9C; or
(2) If the bank holding company has not filed an FR Y-9C for each
of the most recent four quarters, the average of the bank holding
company's total consolidated assets in the most recent consecutive
quarters as reported quarterly on the bank holding company's FR Y-9Cs.
(e) Cessation of requirements. Once a covered company meets the
requirements described in paragraphs (a) or (b) of this section, the
company shall remain a covered company for purposes of this subpart
unless and until the company has less than $50 billion in total
consolidated assets as determined based on each of the bank holding
company's four most recent FR Y-9Cs.
(1) A bank holding company that has ceased to be a major covered
company for purposes of paragraph (c) of this section shall no longer
be subject to the requirements of Sec. 252.70(c) beginning on the
first day of the calendar quarter following the reporting date on which
it ceased to be a major covered company.
(2) Nothing in paragraph (c) of this section shall preclude a
company from becoming a covered company pursuant to paragraphs (a) or
(b) of this section.
(f) Measurement date. For purposes of this section, total
consolidated assets are measured on the last day of the quarter used in
calculation of the average.
(g) Initial applicability.
(1) A covered company that is subject to this subpart under
paragraph (a) of this section as of [INSERT EFFECTIVE DATE], must
comply with the requirements of this subpart, including Sec.
252.72(a), beginning on [INSERT DATE TWO YEARS FROM EFFECTIVE DATE],
unless that time is extended by the Board in writing.
(2) A covered company that is subject to this subpart under
paragraph (b) of this section as of [INSERT EFFECTIVE DATE], must
comply with the requirements of this subpart, including Sec. Sec.
252.72(b)-(c), as applicable, beginning on [INSERT DATE ONE YEAR FROM
EFFECTIVE DATE], unless that time is extended by the Board in writing.
(3) A company that becomes a covered company subject to this
subpart under paragraphs (a), (b), or (c) of this section after the
effective date of this part will be subject to the requirements of this
subpart in accordance with paragraph (h) of this section.
(h) Ongoing applicability. Except as provided in paragraph (g)(1)
or (g)(2) of this section, a covered company that is subject to this
subpart under paragraphs (a), (b), or (c) of this section must comply
with the requirements of Sec. Sec. 252.72(a)-(c), as applicable,
beginning on the first day of the fifth calendar quarter after it
becomes a covered company, unless that time is accelerated or extended
by the Board in writing.
Sec. 252.71 Definitions.
For purposes of this subpart:
(a) Adjusted market value means:
(1) With respect to the value of securities transferred by the
covered company to a counterparty, the sum of:
(i) The market value of the securities; and
(ii) The product of the market value of the securities multiplied
by the applicable collateral haircut in Table 1 to Sec. 217.132 of the
Board's Regulation Q (12 CFR 217.132); and
(2) With respect to eligible collateral received by the covered
company from a counterparty:
(i) The market value of the securities; minus
(ii) The market value of the securities multiplied by the
applicable collateral haircut in Table 1 to Sec. 217.132 of the
Board's Regulation Q (12 CFR 217.132).
(3) Prior to calculating the adjusted market value pursuant to
paragraphs (1) and (2) of this section, with regard to a transaction
that meets the definition of ``repo-style transaction'' in Sec. 217.2
the Board's Regulation Q (12 CFR 217.2), the covered company would
first multiply the applicable collateral haircuts in Table 1 to Sec.
217.132 of the Board's Regulation Q (12 CFR 217.132) by the square root
of \1/2\.
(b) Aggregate net credit exposure means the sum of all net credit
exposures of a covered company to a single counterparty.
(c) Bank-eligible investments means investment securities that a
national bank is permitted to purchase, sell, deal in, underwrite, and
hold under 12 U.S.C. 24 (Seventh) and 12 CFR part 1.
(d) Capital stock and surplus means, with respect to a bank holding
company, the sum of the following amounts in each case as reported by
the bank holding company on the most recent FR Y-9C report:
(1) The company's tier 1 and tier 2 capital, as calculated under
the capital
[[Page 14350]]
adequacy guidelines applicable to that bank holding company under the
Board's Regulation Q (12 CFR part 217); and
(2) The balance of the allowance for loan and lease losses of the
bank holding company not included in its tier 2 capital under the
capital adequacy guidelines applicable to that bank holding company
under the Board's Regulation Q (12 CFR part 217).
(e) Counterparty means:
(1) With respect to a natural person, the person, and members of
the person's immediate family;
(2) With respect to a company, the company and all persons that
that counterparty
(i) Owns, controls, or holds with power to vote 25 percent or more
of a class of voting securities of the person;
(ii) Owns or controls 25 percent or more of the total equity of the
person; or
(iii) Consolidates for financial reporting purposes, as described
in Sec. 252.72(d), collectively;
(3) With respect to a State, the State and all of its agencies,
instrumentalities, and political subdivisions (including any
municipalities) collectively;
(4) With respect to a foreign sovereign entity that is not assigned
a zero percent risk weight under the standardized approach in the
Board's Regulation Q (12 CFR part 217, subpart D), the foreign
sovereign entity and all of its agencies and instrumentalities (but not
including any political subdivision), collectively; and
(5) With respect to a political subdivision of a foreign sovereign
entity such as states, provinces, and municipalities, any political
subdivision of a foreign sovereign entity and all of such political
subdivision's agencies and instrumentalities, collectively.
(f) Covered company means any bank holding company (other than a
foreign banking organization that is subject to subpart Q of the
Board's Regulation YY), that has $50 billion or more in total
consolidated assets, calculated pursuant to Sec. 252.70(d), and all of
its subsidiaries.
(g) Credit derivative has the same meaning as in Sec. 217.2 of the
Board's Regulation Q (12 CFR 217.2).
(h) Credit transaction means, with respect to a counterparty:
(1) Any extension of credit to the counterparty, including loans,
deposits, and lines of credit, but excluding uncommitted lines of
credit;
(2) Any repurchase transaction or reverse repurchase transaction
with the counterparty;
(3) Any securities lending or securities borrowing transaction with
the counterparty;
(4) Any guarantee, acceptance, or letter of credit (including any
endorsement, confirmed letter of credit, or standby letter of credit)
issued on behalf of the counterparty;
(5) Any purchase of, or investment in, securities issued by the
counterparty;
(6) Any credit exposure to the counterparty in connection with a
derivative transaction between the covered company and the
counterparty;
(7) Any credit exposure to the counterparty in connection with a
credit derivative or equity derivative transaction between the covered
company and a third party, the reference asset of which is an
obligation or equity security of the counterparty; and
(8) Any transaction that is the functional equivalent of the above,
and any other similar transaction that the Board, by regulation,
determines to be a credit transaction for purposes of this subpart.
(i) Depository institution has the same meaning as in section 3 of
the Federal Deposit Insurance Act (12 U.S.C. 1813(c)).
(j) Derivative transaction means any transaction that is a
contract, agreement, swap, warrant, note, or option that is based, in
whole or in part, on the value of, any interest in, or any quantitative
measure or the occurrence of any event relating to, one or more
commodities, securities, currencies, interest or other rates, indices,
or other assets.
(k) Eligible collateral means collateral in which the covered
company has a perfected, first priority security interest or the legal
equivalent thereof, if outside of the United States (with the exception
of cash on deposit and notwithstanding the prior security interest of
any custodial agent) and is in the form of:
(1) Cash on deposit with the covered company (including cash held
for the covered company by a third-party custodian or trustee);
(2) Debt securities (other than mortgage- or asset-backed
securities and resecuritization securities, unless those securities are
issued by a U.S. government-sponsored enterprise) that are bank-
eligible investments and that are investment grade;
(3) Equity securities that are publicly traded; or
(4) Convertible bonds that are publicly traded.
(l) Eligible credit derivative means a single-name credit
derivative or a standard, non-tranched index credit derivative,
provided that:
(1) The derivative contract is subject to an eligible guarantee and
has been confirmed by the protection purchaser and the protection
provider;
(2) Any assignment of the derivative contract has been confirmed by
all relevant parties;
(3) If the credit derivative is a credit default swap, the
derivative contract includes the following credit events:
(i) Failure to pay any amount due under the terms of the reference
exposure, subject to any applicable minimal payment threshold that is
consistent with standard market practice and with a grace period, if
any, that is in line with the grace period of the reference exposure;
and
(ii) Receivership, insolvency, liquidation, conservatorship, or
inability of the reference exposure issuer to pay its debts, or its
failure or admission in writing of its inability generally to pay its
debts as they become due and similar events;
(4) The terms and conditions dictating the manner in which the
derivative contract is to be settled are incorporated into the
contract;
(5) If the contract allows for cash settlement, the contract
incorporates a robust valuation process to estimate loss reliably and
specifies a reasonable period for obtaining post-credit event
valuations of the reference exposure;
(6) If the contract requires the protection purchaser to transfer
an exposure to the protection provider at settlement, the terms of at
least one of the exposures that is permitted to be transferred under
the contract provides that any required consent to transfer may not be
unreasonably withheld; and
(7) If the credit derivative is a credit default swap, the contract
clearly identifies the parties responsible for determining whether a
credit event has occurred, specifies that this determination is not the
sole responsibility of the protection provider, and gives the
protection purchaser the right to notify the protection provider of the
occurrence of a credit event.
(m) Eligible equity derivative means an equity derivative, provided
that:
(1) The derivative contract has been confirmed by the
counterparties;
(2) Any assignment of the derivative contract has been confirmed by
all relevant parties; and
(3) The terms and conditions dictating the manner in which the
derivative contract is to be settled are incorporated into the
contract.
(n) Eligible guarantee has the same meaning as in Sec. 217.2 of
the Board's Regulation Q (12 CFR 217.2) that is provided by an eligible
protection provider.
(o) Eligible protection provider has the same meaning as ``eligible
guarantor'' in
[[Page 14351]]
Sec. 217.2 of the Board's Regulation Q (12 CFR 217.2).
(p) Equity derivative has the same meaning as ``equity derivative
contract'' in Sec. 217.2 of the Board's Regulation Q (12 CFR 217.2).
(q) Financial entity means:
(1) A depository institution;
(2) A bank holding company;
(3) A savings and loan holding company (as defined in 12 U.S.C.
1467a);
(4) A securities broker or dealer registered with the U.S.
Securities and Exchange Commission under the Securities Exchange Act of
1934 (15 U.S.C. 78o et seq.);
(5) An insurance company that is subject to the supervision by a
State insurance regulator;
(6) A foreign banking organization;
(7) A non-U.S.-based securities firm or a non-U.S.-based insurance
company that is subject to consolidated supervision and regulation
comparable to that applicable to U.S. depository institutions,
securities broker-dealers, or insurance companies;
(8) A central counterparty; and
(9) A legal entity whose main business includes the management of
financial assets, lending, factoring, leasing, provision of credit
enhancements, securitization, investments, financial custody,
proprietary trading, and other financial services.
(r) Gross credit exposure means, with respect to any credit
transaction, the credit exposure of the covered company before
adjusting, pursuant to section 252.74, for the effect of any qualifying
master netting agreement, eligible collateral, eligible guarantee,
eligible credit derivative, eligible equity derivative, other eligible
hedge, and any unused portion of certain extensions of credit.
(s) Immediate family means the spouse of an individual, the
individual's minor children, and any of the individual's children
(including adults) residing in the individual's home.
(t) Intraday credit exposure means credit exposure of a covered
company to a counterparty that by its terms is to be repaid, sold, or
terminated by the end of its business day in the United States.
(u) Investment grade has the same meaning as in Sec. 217.2 of the
Board's Regulation Q (12 CFR 217.2).
(v) Major counterparty means any:
(1) Major covered company and all of its subsidiaries,
collectively;
(2) Any foreign banking organization (and all of its subsidiaries,
collectively) that meets one of the following conditions:
(i) The foreign banking organization has the characteristics of a
global systemically important banking organization under the assessment
methodology and the higher loss absorbency requirement for global
systemically important banks issued by the Basel Committee on Banking
Supervision, as updated from time to time; or
(ii) The Board, using information reported by the foreign banking
organization or its U.S. subsidiaries, information that is publicly
available, and confidential supervisory information, determines:
(A) That the foreign banking organization would be a global
systemically important banking organization under the global
methodology;
(B) That the foreign banking organization, if it were subject to
the Board's Regulation Q, would be identified as a global systemically
important bank holding company under Sec. 217.402 of the Board's
Regulation Q; or
(C) That the U.S. intermediate holding company, if it were subject
to the Board's Regulation Q, would be identified as a global
systemically important bank holding company.
(iii) A foreign banking organization that prepares or reports for
any purpose the indicator amounts necessary to determine whether the
foreign banking organization is a global systemically important banking
organization under the assessment methodology and the higher loss
absorbency requirement for global systemically important banks issued
by the Basel Committee on Banking Supervision, as updated from time to
time, must use the data to determine whether the foreign banking
organization has the characteristics of a global systemically important
banking organization under the global methodology; and
(3) Any nonbank financial company supervised by the Board.
(w) Major covered company means any U.S. bank holding company
identified as a global systemically important bank holding company
pursuant to 12 CFR 217.402, and all of its subsidiaries.
(x) Net credit exposure means, with respect to any credit
transaction, the gross credit exposure of a covered company calculated
under Sec. 252.73, as adjusted in accordance with Sec. 252.74.
(y) Qualifying central counterparty has the same meaning as in
Sec. 217.2 of the Board's Regulation Q (12 CFR 217.2).
(z) Qualifying master netting agreement has the same meaning as in
Sec. 217.2 of the Board's Regulation Q (12 CFR 217.2).
(aa) Short sale means any sale of a security which the seller does
not own or any sale which is consummated by the delivery of a security
borrowed by, or for the account of, the seller.
(bb) Sovereign entity means a central national government
(including the U.S. government) or an agency, department, ministry, or
central bank, but not including any political governmental subdivision
such as a state, province, or municipality.
(cc) Subsidiary of a specified company means a company that is
directly or indirectly controlled by the specified company.
(dd) Tier 1 capital means common equity tier 1 capital and
additional tier 1 capital, as defined in the Board's Regulation Q (12
CFR part 217).
Sec. 252.72 Credit exposure limits.
(a) General limit on aggregate net credit exposure. No covered
company shall have an aggregate net credit exposure to any unaffiliated
counterparty that exceeds 25 percent of the consolidated capital stock
and surplus of the covered company.
(b) Limit on aggregate net credit exposure for covered companies
with $250 billion or more in total consolidated assets or $10 billion
or more in total on-balance-sheet foreign exposures. No covered company
that has $250 billion or more in total consolidated assets or $10
billion or more in total on-balance-sheet foreign exposures shall have
an aggregate net credit exposure to any unaffiliated counterparty that
exceeds 25 percent of the covered company's tier 1 capital.
(c) Limit on aggregate net credit exposure of major covered
companies to major counterparties. No major covered company shall have
aggregate net credit exposure to any unaffiliated major counterparty
that exceeds 15 percent of the tier 1 capital of the major covered
company.
(d) For purposes of this subpart, a counterparty and major
counterparty shall include any person that the counterparty or major
counterparty
(1) Owns, controls, or holds with power to vote 25 percent or more
of a class of voting securities of the person;
(2) Owns or controls 25 percent or more of the total equity of the
person; or
(3) Consolidates for financial reporting purposes.
Sec. 252.73 Gross credit exposure.
(a) Calculation of gross credit exposure. Except as provided in
paragraph (b), the amount of gross credit exposure of a covered company
to a counterparty with respect to a credit transactions is, in the case
of:
[[Page 14352]]
(1) Loans by a covered company to the counterparty and leases in
which the covered company is the lessor and the counterparty is the
lessee, equal to the amount owed by the counterparty to the covered
company under the transaction.
(2) Debt securities held by the covered company that are issued by
the counterparty, equal to:
(i) The market value of the securities, for trading and available-
for-sale securities; and
(ii) The amortized purchase price of the securities, for securities
held to maturity.
(3) Equity securities held by the covered company that are issued
by the counterparty, equal to the market value.
(4) Repurchase transactions, equal to the adjusted market value of
securities transferred by the covered company to the counterparty.
(5) Reverse repurchase transactions, equal to the amount of cash
transferred by the covered company to the counterparty.
(6) Securities borrowing transactions, equal to:
(i) The amount of cash collateral transferred by the covered
company to the counterparty; plus
(ii) The adjusted market value of securities collateral transferred
by the covered company to the counterparty.
(7) Securities lending transactions, equal to the adjusted market
value of securities lent by the covered company to the counterparty.
(8) Committed credit lines extended by a covered company to a
counterparty, equal to the face amount of the credit line.
(9) Guarantees and letters of credit issued by a covered company on
behalf of a counterparty, equal to the maximum potential loss to the
covered company on the transaction.
(10) Derivative transactions between the covered company and the
counterparty not subject to a qualifying master netting agreement:
(i) Valued at an amount equal to the sum of
(A) The current exposure of the derivatives contract equal to the
greater of the mark-to-market value of the derivative contract or zero;
and
(B) The potential future exposure of the derivatives contract,
calculated by multiplying the notional principal amount of the
derivative contract by the applicable conversion factor in Table 2 to
Sec. 217.132 of the Board's Regulation Q (12 CFR 217.132); and
(ii) In cases where a covered company is required to recognize an
exposure to an eligible protection provider pursuant to Sec.
252.74(e), the covered company must exclude the relevant derivative
transaction when calculating its gross exposure to the original
counterparty under this section.
(11) Derivative transactions between the covered company and the
counterparty subject to a qualifying master netting agreement:
(i) The derivative transaction shall be valued using any of the
methods that the covered company is authorized to use under the Board's
Regulation Q (12 CFR part 217, subparts D and E) to value such
transactions; and
(ii) In cases where a covered company is required to recognize an
exposure to an eligible protection provider pursuant to Sec.
252.74(e), the covered company must exclude the relevant derivative
transaction when calculating its gross exposure to the original
counterparty under this section.
(12) Credit or equity derivative transactions between the covered
company and a third party where the covered company is the protection
provider and the reference asset is an obligation or equity security of
the counterparty, equal to the maximum potential loss to the covered
company on the transaction.
(b) Investments in and Exposures to Securitization Vehicles,
Investment Funds, and Other Special Purpose Vehicles. A covered company
that has $250 billion or more in total consolidated assets or $10
billion or more in total on-balance-sheet foreign exposures shall
calculate its gross credit exposure for investments in and exposures to
a securitization vehicle, investment fund, and other special purpose
vehicle pursuant to Sec. 252.75.
(c) Attribution rule. A covered company must treat any credit
transaction with any person as a credit transaction with a
counterparty, to the extent that the proceeds of the transaction are
used for the benefit of, or transferred to, that counterparty.
Sec. 252.74 Net Credit Exposure.
(a) In general. For purposes of this subpart, a covered company
shall calculate its net credit exposure to a counterparty by adjusting
its gross credit exposure to that counterparty in accordance with the
rules set forth in this section.
(b) Calculation of net credit exposure for repurchase transactions,
reverse repurchase transactions, securities lending transactions, and
securities borrowing transactions. With respect to any repurchase
transaction, reverse repurchase transaction, securities lending
transaction, and securities borrowing transaction with a counterparty
that is subject to a bilateral netting agreement with that counterparty
and that meets the definition of ``repo-style transaction'' in Sec.
217.2 of the Board's Regulation Q (12 CFR 217.2), a covered company's
net credit exposure to a counterparty shall be equal to the exposure at
default amount calculated under Sec. 217.37(c)(2) of the Board's
Regulation Q (12 CFR 217.37(c)(2)); provided that:
(1) The covered company shall apply the standardized supervisory
haircuts as provided in 12 CFR 217.37(c)(3)(iii) of the Board's
Regulation (12 CFR 217.37(c)(3)(iii), and is not permitted to use its
own internal estimates for haircuts;
(2) The covered company shall, in calculating its net credit
exposure to a counterparty as a result of the transactions described in
paragraph (b) of this section, disregard any collateral received from
that counterparty that does not meet the definition of ``eligible
collateral'' in Sec. 252.71(k); and
(3) The covered company shall include the adjusted market value of
any eligible collateral, as further adjusted by the application of the
maturity mismatch adjustment approach of Sec. 217.36(d) of the Board's
Regulation Q (12 CFR 217.36(d)), if applicable, when calculating its
gross credit exposure to the collateral issuer, including in instances
where the underlying repurchase transaction, reverse repurchase
transaction, securities lending transaction, or securities borrowing
transaction would not be subject to the credit limits of Sec. 272.72.
(c) Eligible collateral.
(1) In computing its net credit exposure to a counterparty for any
credit transaction other than transactions described in paragraph (b)
of this section, a covered company must reduce its gross credit
exposure on the transaction by:
(i) The adjusted market value of any eligible collateral, in cases
where the eligible collateral has the same or greater maturity as the
credit transactions; or
(ii) The adjusted market value of any eligible collateral, as
further adjusted by application of the maturity mismatch adjustment
approach of Sec. 217.36(d) of the Board's Regulation Q (12 CFR
217.36(d)), if the eligible collateral has an original maturity equal
to or greater than one year and a residual maturity of not less than
three months, in cases where the eligible collateral has a shorter
maturity than the credit transaction.
(2) A covered company that reduces its gross credit exposure to a
counterparty as required under paragraph (c)(1) of this section must
[[Page 14353]]
include the adjusted market value of the eligible collateral, as
further adjusted by the application of the maturity mismatch adjustment
approach of Sec. 217.36(d) of the Board's Regulation Q (12 CFR
217.36(d)), if applicable, when calculating its gross credit exposure
to the collateral issuer, including in instances where the underlying
credit transaction would not be subject to the credit limits of Sec.
272.72. Notwithstanding the foregoing, in no event will the covered
company's gross credit exposure to the issuer of collateral be in
excess of its gross credit exposure to the counterparty on the credit
transaction.
(d) Eligible guarantees.
(1) In calculating net credit exposure to a counterparty for any
credit transaction, a covered company must reduce its gross credit
exposure to the counterparty by any eligible guarantees from an
eligible protection provider that covers the transaction by:
(i) The amount of any eligible guarantees from an eligible
protection provider that covers the transaction, in cases where the
eligible guarantee has the same or greater maturity as the credit
transaction; or
(ii) The amount of any eligible guarantees from an eligible
protection provider that covers the transaction as further adjusted by
application of the maturity mismatch adjustment approach of Sec.
217.36(d) of the Board's Regulation Q (12 CFR 217.36(d)), if the
eligible guarantees have an original maturity equal to or greater than
one year and a residual maturity of not less than three months, in
cases where the eligible guarantee has a shorter maturity than the
credit transaction.
(2) A covered company that reduces its gross credit exposure to a
counterparty as required under paragraph (d)(1) must include the amount
of eligible guarantees when calculating its gross credit exposure to
the eligible protection provider, including in instances where the
underlying credit transaction would not be subject to the credit limits
of Sec. 272.72. Notwithstanding the foregoing, in no event will the
covered company's gross credit exposure to an eligible protection
provider with respect to an eligible guarantee be in excess of its
gross credit exposure to the counterparty on the credit transaction
prior to recognition of the eligible guarantee.
(e) Eligible credit and equity derivatives. (1) In calculating net
credit exposure to a counterparty for a credit transaction, a covered
company must reduce its gross credit exposure to the counterparty by:
(i) The notional amount of any eligible credit or equity derivative
from an eligible protection provider, in cases where the eligible
credit or equity derivative has a maturity that is the same or greater
than the maturity of the credit transaction; or
(ii) The notional amount of any eligible credit or equity
derivative from an eligible protection provider, as further adjusted by
application of the maturity mismatch adjustment approach of Sec.
217.36(d) of the Board's Regulation Q (12 CFR 217.36(d)), if the
eligible credit or equity derivative has an original maturity equal to
or greater than one year and a residual maturity of not less than three
months, in cases where the eligible credit or equity derivative has a
shorter maturity than the credit transaction.
(2)(i) In general, a covered company that reduces its gross credit
exposure to a counterparty as provided under paragraph (e)(1) must
include the notional amount of the eligible credit or equity derivative
from an eligible protection provider, as further adjusted by the
application of the maturity mismatch adjustment approach of Sec.
217.36(d) of the Board's Regulation Q (12 CFR 217.36(d)), as
applicable, when calculating its gross credit exposure to the eligible
protection provider, including in instances where the underlying credit
transaction would not be subject to the credit limits of Sec. 272.72.
Notwithstanding the foregoing, in no event will the covered company's
gross credit exposure to an eligible protection provider with respect
to an eligible credit or equity derivative be in excess of its gross
credit exposure to that counterparty on the credit transaction prior to
recognition of the eligible credit or equity derivative; and
(ii) In cases where the eligible credit or equity derivative is
used to hedge covered positions and available-for-sale exposures that
are subject to the Board's market risk rule (12 CFR part 217, subpart
F) and the counterparty on the hedged transaction is not a financial
entity, the amount of credit exposure that a company must recognize to
the eligible protection provider is the amount that would be calculated
pursuant to Sec. 252.73(a), including in instances where the
underlying credit transaction would not be subject to the credit limits
of Sec. 272.72.
(f) Other eligible hedges. In calculating net credit exposure to a
counterparty for a credit transaction, a covered company may reduce its
gross credit exposure to the counterparty by the face amount of a short
sale of the counterparty's debt or equity security, provided that:
(1) The instrument in which the covered company has a short
position is junior to, or pari passu with, the instrument in which the
covered company has the long position; and
(2) The instrument in which the covered company has a short
position and the instrument in which the covered company has the long
position are either both treated as trading or available-for-sale
exposures or both treated as held-to-maturity exposures.
(g) Unused portion of certain extensions of credit. (1) In
computing its net credit exposure to a counterparty for a credit line
or revolving credit facility, a covered company may reduce its gross
credit exposure by the amount of the unused portion of the credit
extension to the extent that the covered company does not have any
legal obligation to advance additional funds under the extension of
credit, until the counterparty provides the amount of adjusted market
value of collateral required with respect to the entire used portion of
the extension of credit.
(2) To qualify for this reduction, the credit contract must specify
that any used portion of the credit extension must be fully secured by
collateral that is:
(i) Cash;
(ii) Obligations of the United States or its agencies; or
(iii) Obligations directly and fully guaranteed as to principal and
interest by, the Federal National Mortgage Association and the Federal
Home Loan Mortgage Corporation, while operating under the
conservatorship or receivership of the Federal Housing Finance Agency,
and any additional obligations issued by a U.S. government-sponsored
enterprise as determined by the Board.
(h) Credit transactions involving exempt and excluded persons. If a
covered company has a credit transaction with any person that is exempt
from this subpart under Sec. 252.75, or is otherwise excluded from
this subpart, and the covered company has reduced its credit exposure
on the credit transaction with that person by obtaining collateral from
that person or a guarantee or credit or equity derivative from an
eligible protection provider, the covered company shall calculate its
credit exposure to the issuer of the collateral or protection provider,
as applicable, in accordance with the rules set forth in this section
to the same extent as if the credit transaction with the person were
subject to the requirements in this subpart, including Sec. 252.72.
[[Page 14354]]
Sec. 252.75 Investments in and exposures to securitization vehicles,
investment funds, and other special purpose vehicles.
(a) In general. (1) This section applies only to covered companies
with $250 billion or more in total consolidated assets or $10 billion
or more in on-balance-sheet foreign exposures, subject to paragraph (d)
of this section.
(2)(i) If a covered company can satisfy the requirements of
paragraph (a)(3) of this section, a covered company must calculate its
gross credit exposure to each securitization vehicle, investment fund,
and other special purpose vehicle in which it invests pursuant to Sec.
252.73(a), and the covered company is not required to calculate its
gross credit exposure to each issuer of assets held by a securitization
vehicle, investment fund, or other special purpose vehicle.
(ii) If a covered company cannot satisfy the requirements of
paragraph (a)(3), the covered company must calculate its gross credit
exposure to each issuer of assets held by a securitization vehicle,
investment fund, or other special purpose vehicle using the look-
through approach in paragraph (b) of this section.
(3) A covered company is not required to calculate its gross credit
exposure to each issuer of assets held by a securitization vehicle,
investment fund, or other special purpose vehicle, as applicable, if
the covered company can demonstrate that its gross credit exposure to
each issuer, considering only the credit exposures to that issuer
arising from the covered company's investment in a particular
securitization vehicle, investment fund, or other special purpose
vehicle, is less than 0.25 percent of the covered company's:
(i) Capital stock and surplus in the case of a covered company
subject to the credit exposure limit of Sec. 252.72(a); or
(ii) Tier 1 capital in the case of a covered company subject to the
credit exposure limit of Sec. 252.72(b).
(b) Look-through Approach. (1) A covered company that cannot
satisfy the requirements of paragraph (a)(3) must calculate its gross
credit exposure, for purposes of Sec. 252.73(a), to each issuer of
assets held by a securitization vehicle, investment fund, or other
special purpose vehicle pursuant to paragraph (b)(3).
(2) If a covered company that cannot satisfy the requirements of
paragraph (a)(3) of this section is unable to identify each issuer of
assets held by a securitization vehicle, investment fund, or other
special purpose vehicle, the covered company, for purposes of paragraph
(b)(3) of this section, must attribute the gross credit exposure to a
single unknown counterparty, and the limits of Sec. 252.72 shall apply
to that counterparty as a single counterparty.
(3) A covered company that is required to calculate its gross
credit exposure to an issuer of assets held by a securitization
vehicle, investment fund, or other special purpose vehicle pursuant to
paragraph (b)(1) of this section, or to an unknown counterparty
pursuant to paragraph (b)(2) of this section, must calculate the gross
credit exposure as follows:
(i) Where all investors in the securitization vehicle, investment
fund, or other special purpose vehicle rank pari passu, the gross
credit exposure is equal to the covered company's pro rata share
multiplied by the value of the assets attributed to the issuer or the
unknown counterparty, as applicable, that are held within the
structure; and
(ii) Where all investors in the securitization vehicle, investment
fund, or other special purpose vehicle do not rank pari passu, the
gross credit exposure is equal to:
(A) The lower of the value of the tranche in which the covered
company has invested, calculated pursuant to Sec. 252.73(a), and the
value of each asset attributed to the issuer or the unknown
counterparty, as applicable, that are held by the securitization
vehicle, investment fund, or other special purpose vehicle; multiplied
by
(B) The pro rata share of the covered company's investment in the
tranche.
(c) Exposures to Third Parties. (1) Notwithstanding any other
requirement in this section, a covered company must recognize, for
purposes of this subpart, a gross credit exposure to each third party
that has a contractual or other business relationship with a
securitization vehicle, investment fund, or other special purpose
vehicle, such as a fund manager or protection provider to such
securitization vehicle, investment fund, or other special purpose
vehicle, whose failure or material financial distress would cause a
loss in the value of the covered company's investment in or exposure to
the securitization vehicle, investment fund, or other special purpose
vehicle.
(2) For purposes of Sec. 252.72, with respect to a covered
company's gross credit exposure to a third party that a covered company
must recognize pursuant to paragraph (c)(1) of this section, the
covered company shall recognize an exposure to the third party in an
amount equal to the covered company's gross credit exposure to the
associated securitization vehicle, investment fund, or other special
purpose vehicle, in addition to the covered company's gross credit
exposure to the associated securitization vehicle, investment fund, or
other special purpose vehicle.
(d) Notwithstanding paragraph (a)(1) of this section, in order to
avoid evasion of this subpart, the Board may determine, after notice to
the covered company and opportunity for hearing, that a covered company
with less than $250 billion in total consolidated assets and less than
$10 billion in total on-balance-sheet foreign exposures must apply the
look-through approach or recognize exposures to third parties that have
a contractual or other business relationship for purposes of this
subpart.
Sec. 252.76 Aggregation of exposures to more than one counterparty
due to economic interdependence or control relationships.
(a) Aggregation of Exposures to More than One Counterparty due to
Economic Interdependence. (1)(i) If a covered company has an aggregate
net credit exposure to any unaffiliated counterparty that exceeds 5
percent of the consolidated capital stock and surplus of the covered
company, or 5 percent of its tier 1 capital in the case of a covered
company with $250 billion or more in total consolidated assets or $10
billion or more in total foreign exposures, the covered company shall
analyze its relationship with the unaffiliated counterparty under
paragraph (a)(2) of this section to determine whether the unaffiliated
counterparty is economically interdependent with one or more other
unaffiliated counterparties of the covered company.
(ii) For purposes of this paragraph, two counterparties are
economically interdependent if the failure, default, insolvency, or
material financial distress of one counterparty would cause the
failure, default, insolvency, or material financial distress of the
other counterparty, taking into account the factors in paragraph (a)(2)
of this section.
(iii) If a covered company or the Board determines pursuant to
paragraph (a)(2) or (a)(3) of this section, as applicable, that one or
more other unaffiliated counterparties of a covered company are
economically dependent, the covered company shall aggregate its net
credit exposure to the unaffiliated counterparties for all purposes
under this subpart, including but not limited to, Sec. 252.72.
(2) In making a determination as to whether any two counterparties
are economically interdependent, a covered company shall consider the
following factors:
[[Page 14355]]
(i) Whether 50 percent or more of one counterparty's gross revenue
or gross expenditures are derived from transactions with the other
counterparty;
(ii) Whether one counterparty (counterparty A) has fully or partly
guaranteed the credit exposure of the other counterparty (counterparty
B), or is liable by other means, and the credit exposure is significant
enough that counterparty B is likely to default if presented with a
claim relating to the guarantee or liability;
(iii) Whether 25 percent or more of one counterparty's production
or output is sold to the other counterparty, which cannot easily be
replaced by other customers;
(iv) Whether the expected source of funds to repay any credit
exposure between the counterparties is the same and at least one of the
counterparties does not have another source of income from which the
extension of credit may be fully repaid;
(v) Whether the financial distress of one counterparty
(counterparty A) is likely to impair the ability of the other
counterparty (counterparty B) to fully and timely repay counterparty
B's liabilities;
(vi) Whether one counterparty (counterparty A) has made a loan to
the other counterparty (counterparty B) and is relying on repayment of
that loan in order to satisfy its obligations to the covered company,
and counterparty A does not have another source of income that it can
use to satisfy its obligations to the covered company; and
(vii) Any other indicia of interdependence that the covered company
determines to be relevant to this analysis.
(3) In order to avoid evasion of this subpart, the Board may
determine, after notice to the covered company and opportunity for
hearing, that one or more unaffiliated counterparties of a covered
company are economically dependent for purposes of this subpart. In
making any such determination, the Board shall consider the factors in
paragraph (a)(2) of this section as well as any other indicia of
economic interdependence that the Board determines to be relevant.
(b) Aggregation of exposures to more than one counterparty due to
certain control relationships. (1) A covered company shall assess
whether counterparties are connected by control relationships due to
the following factors:
(i) The presence of voting agreements;
(ii) Ability of one counterparty to significantly influence the
appointment or dismissal of another counterparty's administrative,
management or governing body, or the fact that a majority of members of
such body have been appointed solely as a result of the exercise of the
first counterparty's voting rights; and
(iii) Ability of one counterparty to exercise a controlling
influence over the management or policies of another counterparty.
(2) If a covered company or the Board determines pursuant to
paragraph (b)(1) or (b)(3) of this section that one or more other
unaffiliated counterparties of a covered company are connected by
control relationships, the covered company shall aggregate its net
credit exposure to the unaffiliated counterparties for all purposes
under this subpart, including but not limited to, Sec. 252.72.
(3) In order to avoid evasion of this subpart, the Board may
determine, after notice to the covered company and opportunity for
hearing, that one or more unaffiliated counterparties of a covered
company are connected by control relationships for purposes of this
subpart. In making any such determination, the Board shall consider the
factors in paragraph (b)(1) of this section as well as any other
control relationships that the Board determines to be relevant.
Sec. 252.77 Exemptions.
(a) Exempted exposure categories. The following categories of
credit transactions are exempt from the limits on credit exposure under
this subpart:
(1) Direct claims on, and the portions of claims that are directly
and fully guaranteed as to principal and interest by, the Federal
National Mortgage Association and the Federal Home Loan Mortgage
Corporation, only while operating under the conservatorship or
receivership of the Federal Housing Finance Agency, and any additional
obligations issued by a U.S. government-sponsored entity as determined
by the Board.
(2) Intraday credit exposure to a counterparty.
(3) Trade exposures to a qualifying central counterparty related to
the covered company's clearing activity, including potential future
exposure arising from transactions cleared by the qualifying central
counterparty and pre-funded default fund contributions.
(4) Any transaction that the Board exempts if the Board finds that
such exemption is in the public interest and is consistent with the
purpose of this section.
(b) Exemption for Federal Home Loan Banks. For purposes of this
subpart, a covered company does not include any Federal Home Loan Bank.
(c) Additional Exemptions by the Board. The Board may, by
regulation or order, exempt transactions, in whole or in part, from the
definition of the term ``credit exposure,'' if the Board finds that the
exemption is in the public interest and is consistent with the purpose
of Sec. 165(e) of the Dodd-Frank Wall Street Reform and Consumer
Protection Act (12 U.S.C. 5365(e)).
Sec. 252.78 Compliance.
(a) Scope of compliance. A covered company with $250 billion or
more in total consolidated assets or $10 billion or more in total on-
balance-sheet foreign exposures must comply with the requirements of
this section on a daily basis at the end of each business day and
submit on a monthly basis a report demonstrating its daily compliance.
A covered company with less than $250 billion in total consolidated
assets and less than $10 billion in total on-balance-sheet foreign
exposures must comply with the requirements of this section on a
quarterly basis and submit on a quarterly basis a report demonstrating
its quarterly compliance, unless the Board determines and notifies that
company that more frequent compliance and reporting is required.
(b) Qualifying Master Netting Agreement. A covered company must
establish and maintain procedures that meet or exceed the requirements
of Sec. 217.3(d) of the Board's Regulation Q (12 CFR 217.3(d)) to
monitor possible changes in relevant law and to ensure that the
agreement continues to satisfy the requirements of a qualifying master
netting agreement.
(c) Noncompliance. Except as otherwise provided in this section, if
a covered company is not in compliance with this subpart with respect
to a counterparty solely due to the circumstances listed in paragraphs
(c)(1)-(4) of this section, the covered company will not be subject to
enforcement actions for a period of 90 days (or such other period
determined by the Board to be appropriate to preserve the safety and
soundness of the covered company or U.S. financial stability) if the
company uses reasonable efforts to return to compliance with this
subpart during this period. The covered company may not engage in any
additional credit transactions with such a counterparty in
contravention of this rule during the compliance period, except in
cases where the Board determines that such credit transactions are
necessary or appropriate to preserve the safety and soundness of the
covered company or U.S. financial stability. In
[[Page 14356]]
granting approval for such a special temporary credit exposure limit,
the Board will consider the following:
(1) A decrease in the covered company's capital stock and surplus;
(2) The merger of the covered company with another covered company;
(3) A merger of two unaffiliated counterparties; or
(4) Any other circumstance the Board determines is appropriate.
(d) Other measures. The Board may impose supervisory oversight and
reporting measures that it determines are appropriate to monitor
compliance with this subpart.
0
3. Add subpart Q to read as follows:
Subpart Q--Single-Counterparty Credit Limits
Sec.
252.170 Applicability.
252.171 Definitions.
252.172 Credit exposure limits.
252.173 Gross credit exposure.
252.174 Net credit exposure.
252.175 Investments in and exposures to securitization vehicles,
investment funds, and other special purpose vehicles.
252.176 Aggregation of exposures to more than one counterparty due
to economic interdependence or control relationships.
252.177 Exemptions.
252.178 Compliance.
Sec. 252.170 Applicability.
(a) Foreign banking organizations with total consolidated assets of
$50 billion or more.
(1) In general. A foreign banking organization with total
consolidated assets of $50 billion or more is subject to the general
credit exposure limit set forth in Sec. 252.173(a).
(2) Foreign banking organizations with $250 billion or more in
total consolidated assets or $10 billion or more in total on-balance-
sheet foreign exposures. A foreign banking organization with $250
billion or more in total consolidated assets or $10 billion or more in
total on-balance-sheet foreign exposures is subject to the credit
exposure limit set forth in Sec. 252.172(b).
(3) Major foreign banking organizations. A foreign banking
organization with total consolidated assets of $500 billion or more is
subject to the credit exposure limit set forth in Sec. 252.172(c).
(4) Total consolidated assets. For purposes of this section, total
consolidated assets are determined based on:
(i) The average of the foreign banking organization's total
consolidated assets in the four most recent consecutive quarters as
reported quarterly on the FR Y-7Q; or
(ii) If the foreign banking organization has not filed the FR Y-7Q
for each of the four most recent consecutive quarters, the average of
the foreign banking organization's total consolidated assets in the
most recent consecutive quarters as reported quarterly on the foreign
banking organization's FR Y-7Qs; or
(iii) If the foreign banking organization has not yet filed an FR
Y-7Q, as determined under applicable accounting standards.
(5) Cessation of requirements. A foreign banking organization will
remain subject to the requirements of this subpart, including Sec.
252.172(a) and, as applicable, the credit exposure limits of Sec. Sec.
252.172(b) and (c), unless and until total assets are less than $50
billion (with respect to the requirements in paragraphs (a) and (b)) or
$500 billion (with respect to the requirement in paragraph (c)) for
each of the four most recent consecutive calendar quarters, either as
reported on the foreign banking organization's FR Y-7Q or as determined
under applicable accounting standards, to the extent the foreign
banking organization has not yet filed an FR Y-7Q.
(i) Nothing in paragraph (a)(3) shall preclude a company from
becoming a covered company pursuant to paragraphs (a)(1) or (a)(2) of
this section.
(6) Measurement date. For purposes of this section, total
consolidated assets are measured on the last day of the quarter used in
calculation of the average.
(b) U.S. intermediate holding companies.
(1) In general. A U.S. intermediate holding company is subject to
the general credit exposure limit set forth in Sec. 252.172(a).
(2) U.S. intermediate holding companies with $250 billion or more
in total consolidated assets or $10 billion or more in total on-
balance-sheet foreign exposures. A U.S intermediate holding company
with $250 billion or more in total consolidated assets or $10 billion
or more in total on-balance-sheet foreign exposures is subject to the
credit exposure limit set forth in Sec. 252.172(b).
(3) Major U.S. intermediate holding companies. A U.S. intermediate
holding company that has total consolidated assets of $500 billion or
more is subject to the credit exposure limit set forth in Sec.
252.172(c)..
(4) Total consolidated assets. For purposes of this paragraph,
total consolidated assets are determined based on:
(i) The average of the total consolidated assets for the four most
recent consecutive quarters as reported by the U.S. intermediate
holding company on its FR Y-9C, or
(ii) If the U.S. intermediate holding company has not filed the FR
Y-9C for each of the four most recent consecutive quarters, for the
most recent quarter or consecutive quarters as reported on the FR Y-9C,
or
(iii) If the U.S. intermediate holding company has not yet filed an
FR Y-9C, as determined under applicable accounting standards.
(5) Cessation of requirements. A major U.S. intermediate holding
company will remain subject to the requirements of this subpart,
including Sec. 252.172(a) and, as applicable, the credit exposure
limits set forth in Sec. Sec. 252.172(b) and (c), unless and until
total assets are less than $50 billion (with respect to the
requirements in paragraphs (a) or (b) of this section) or $500 billion
(with respect to the requirement in paragraph (c) of this section) for
each of the four most recent consecutive calendar quarters either as
reported on its FR Y-9C or as determined under applicable accounting
standards, to the extent the foreign banking organization has not yet
filed an FR Y-9C.
(i) Nothing in paragraph (b)(3) shall preclude a company from
becoming a covered company pursuant to paragraphs (b)(1) or (b)(2) of
this section.
(5) Measurement date. For purposes of this section, total
consolidated assets are measured on the last day of the quarter used in
calculation of the average.
(c) Initial applicability.
(1) Foreign banking organizations. (i) A foreign banking
organization that is subject to this subpart under paragraph (a)(1) of
this section as of [INSERT EFFECTIVE DATE], must comply with the
requirements of this subpart beginning on [INSERT DATE TWO YEARS FROM
EFFECTIVE DATE], unless that time is extended by the Board in writing.
(ii) A foreign banking organization that is subject to this subpart
under paragraphs (a)(2) or (3) of this section as of [INSERT EFFECTIVE
DATE], must comply with the requirements of this subpart, as
applicable, beginning on [INSERT DATE ONE YEAR FROM EFFECTIVE DATE].
(2) U.S. intermediate holding companies. (i) A U.S. intermediate
holding company that is subject to the requirements of this subpart
under paragraph (b)(1) of this section as of [INSERT EFFECTIVE DATE],
must comply with the requirements of this
[[Page 14357]]
subpart beginning on [INSERT DATE TWO YEARS FROM EFFECTIVE DATE],
unless that time is extended by the Board in writing.
(ii) A U.S. intermediate holding company that is subject to this
subpart under paragraphs (b)(2) or (3) of this section as of [INSERT
EFFECTIVE DATE], must comply with the requirements of this subpart,
including Sec. Sec. 252.172(b)-(c), beginning on [INSERT DATE ONE YEAR
FROM EFFECTIVE DATE].
(3) A foreign banking organization or U.S. intermediate holding
company that becomes subject to the requirements of this subpart after
the effective date of the subpart will be subject to the requirements
of this subpart in accordance with paragraph (d) of this section.
(d) Ongoing applicability.
(1) Foreign banking organizations. Except as provided in paragraphs
(c)(1) or (c)(2) of this section, a foreign banking organization that
becomes subject to the requirements of this subpart after [INSERT
EFFECTIVE DATE], must comply with the requirements of this subpart, as
applicable, beginning on the first day of the fifth calendar quarter
after it becomes subject to those requirements, unless that time is
accelerated or extended by the Board in writing.
(2) U.S. intermediate holding companies. Except as provided in
paragraph (c)(2) of this section, a U.S. intermediate holding company
that becomes subject to the requirements of this subpart after [INSERT
EFFECTIVE DATE], must comply with the requirements of this subpart, as
applicable, on the later of:
(i) The first day of the fifth calendar quarter after it becomes
subject to those requirements, or
(ii) The date on which the U.S. intermediate holding company is
required to be established, unless that time is accelerated or extended
by the Board in writing.
Sec. 252.171 Definitions.
For purposes of this subpart:
(a) Adjusted market value means:
(1) With respect to the value of securities transferred by the
covered company to a counterparty, the sum of:
(i) Market value of the securities and
(ii) The product of the market value of the securities multiplied
by the applicable collateral haircut in Table 1 to Sec. 217.132 of the
Board's Regulation Q (12 CFR 217.132); and
(2) With respect to eligible collateral received by the covered
company from a counterparty:
(i) The market value of the securities minus
(ii) The market value of the securities multiplied by the
applicable collateral haircut in Table 1 to Sec. 217.132 of the
Board's Regulation Q (12 CFR 217.132).
(3) Prior to calculating the adjusted market value pursuant to
paragraphs (1) and (2) of this section, with regard to a transaction
that meets the definition of ``repo-style transaction'' in Sec. 217.2
the Board's Regulation Q (12 CFR 217.2), the covered company would
first multiply the applicable collateral haircuts in Table 1 to Sec.
217.132 of the Board's Regulation Q (12 CFR 217.132) by the square root
of \1/2\.
(b) Aggregate net credit exposure means the sum of all net credit
exposures of a covered entity to a single counterparty.
(c) Bank-eligible investments means investment securities that a
national bank is permitted to purchase, sell, deal in, underwrite, and
hold under 12 U.S.C. 24 (Seventh) and 12 CFR part 1.
(d) Capital stock and surplus means:
(1) With respect to a U.S. intermediate holding company, the sum of
the following amounts in each case as reported by a U.S. intermediate
holding company on the most recent FR Y-9C:
(i) The tier 1 and tier 2 capital of the U.S. intermediate holding
company, as calculated under the capital adequacy guidelines applicable
to that U.S. intermediate holding company under subpart O of the
Board's Regulation YY (12 CFR part 252); and
(ii) The excess allowance for loan and lease losses of the U.S.
intermediate holding company not included in tier 2 capital under the
capital adequacy guidelines applicable to that U.S. intermediate
holding company under subpart O of the Board's Regulation YY (12 CFR
part 252); and
(2) With respect to a foreign banking organization, the total
regulatory capital as reported on the foreign banking organization's
most recent FR Y-7Q or other reporting form specified by the Board.
(e) Counterparty means:
(1) With respect to a natural person, the person, and members of
the person's immediate family;
(2) With respect to a company, the company and all persons that
that counterparty
(i) Owns, controls, or holds with power to vote 25 percent or more
of a class of voting securities of the person;
(ii) Owns or controls 25 percent or more of the total equity of the
person; or
(iii) Consolidates for financial reporting purposes, as described
in Sec. 252.172(d), collectively;
(3) With respect to a State, the State and all of its agencies,
instrumentalities, and political subdivisions (including any
municipalities) collectively;
(4) With respect to a foreign sovereign entity that is not assigned
a zero percent risk weight under the standardized approach in the
Board's Regulation Q (12 CFR part 217, subpart D), the foreign
sovereign entity and all of its agencies and instrumentalities (but not
including any political subdivision), collectively; and
(5) With respect to a political subdivision of a foreign sovereign
entity such as states, provinces, and municipalities, any political
subdivisions of a foreign sovereign entity and all such political
subdivision's agencies and instrumentalities, collectively.
(f) Covered entity means:
(1) Any entity that is part of the combined U.S. operations of a
foreign banking organization with total consolidated assets of $50
billion or more, calculated pursuant to Sec. 252.170(a), and all of
its subsidiaries; and
(2) Any U.S. intermediate holding company of a foreign banking
organization with total consolidated assets of $50 billion or more,
calculated pursuant to Sec. 252.170(b), and all of its subsidiaries.
(g) Credit derivative has the same meaning as in Sec. 217.2 of the
Board's Regulation Q (12 CFR 217.2).
(h) Credit transaction means:
(1) Any extension of credit, including loans, deposits, and lines
of credit, but excluding uncommitted lines of credit;
(2) Any repurchase transaction or reverse repurchase transaction;
(3) Any securities lending or securities borrowing transaction;
(4) Any guarantee, acceptance, or letter of credit (including any
endorsement, confirmed letter of credit, or standby letter of credit)
issued on behalf of a counterparty;
(5) Any purchase of, or investment in, securities issued by a
counterparty;
(6) Any credit exposure to the counterparty in connection with a
derivative transaction between the covered company and the
counterparty;
(7) Any credit exposure to the counterparty in connection with a
credit derivative or equity derivative transaction between the covered
company and a third party, the reference asset of which is an
obligation or equity security of the counterparty; and
(8) Any transaction that is the functional equivalent of the above,
and any other similar transaction that the Board, by regulation,
determines to be a credit transaction for purposes of this subpart.
[[Page 14358]]
(i) Depository institution has the same meaning as in section 3 of
the Federal Deposit Insurance Act (12 U.S.C. 1813(c)).
(j) Derivative transaction means any transaction that is a
contract, agreement, swap, warrant, note, or option that is based, in
whole or in part, on the value of, any interest in, or any quantitative
measure or the occurrence of any event relating to, one or more
commodities, securities, currencies, interest or other rates, indices,
or other assets.
(k) Eligible collateral means collateral in which a U.S.
intermediate holding company or any part of the foreign banking
organization's combined U.S. operations has a perfected, first priority
security interest or the legal equivalent thereof, if outside of the
United States (with the exception of cash on deposit and
notwithstanding the prior security interest of any custodial agent) and
is in the form of:
(1) Cash on deposit with the U.S. intermediate holding company or
any part of the U.S. operations, the U.S. branch, or the U.S. agency
(including cash held for the foreign banking organization or U.S.
intermediate holding company by a third-party custodian or trustee);
(2) Debt securities (other than mortgage- or asset-backed
securities and resecuritization securities, unless those securities are
issued by a U.S. government-sponsored enterprise) that are bank-
eligible investments and that are investment grade;
(3) Equity securities that are publicly traded; or
(4) Convertible bonds that are publicly traded; and
(5) Does not include any debt or equity securities (including
convertible bonds), issued by an affiliate of the U.S. intermediate
holding company or by any part of the foreign banking organization's
combined U.S. operations.
(l) Eligible credit derivative means a single-name credit
derivative or a standard, non-tranched index credit derivative,
provided that:
(1) The derivative contract is subject to an eligible guarantee and
has been confirmed by the protection purchaser and the protection
provider;
(2) Any assignment of the derivative contract has been confirmed by
all relevant parties;
(3) If the credit derivative is a credit default swap, the
derivative contract includes the following credit events:
(i) Failure to pay any amount due under the terms of the reference
exposure, subject to any applicable minimal payment threshold that is
consistent with standard market practice and with a grace period that
is closely in line with the grace period of the reference exposure; and
(ii) Receivership, insolvency, liquidation, conservatorship, or
inability of the reference exposure issuer to pay its debts, or its
failure or admission in writing of its inability generally to pay its
debts as they become due and similar events;
(4) The terms and conditions dictating the manner in which the
derivative contract is to be settled are incorporated into the
contract;
(5) If the contract allows for cash settlement, the contract
incorporates a robust valuation process to estimate loss reliably and
specifies a reasonable period for obtaining post-credit event
valuations of the reference exposure;
(6) If the contract requires the protection purchaser to transfer
an exposure to the protection provider at settlement, the terms of at
least one of the exposures that is permitted to be transferred under
the contract provides that any required consent to transfer may not be
unreasonably withheld; and
(7) If the credit derivative is a credit default swap, the contract
clearly identifies the parties responsible for determining whether a
credit event has occurred, specifies that this determination is not the
sole responsibility of the protection provider, and gives the
protection purchaser the right to notify the protection provider of the
occurrence of a credit event.
(m) Eligible equity derivative means an equity-linked total return
swap, provided that:
(1) The derivative contract has been confirmed by the
counterparties;
(2) Any assignment of the derivative contract has been confirmed by
all relevant parties; and
(3) The terms and conditions dictating the manner in which the
derivative contract is to be settled are incorporated into the
contract.
(n) Eligible guarantee has the same meaning as in Sec. 217.2 of
the Board's Regulation Q (12 CFR 217.2) that is provided by an eligible
protection provider.
(o) Eligible protection provider has the same meaning as ``eligible
guarantor'' in Sec. 217.2 of the Board's Regulation Q (12 CFR 217.2),
but does not include the foreign banking organization or any entity
that is an affiliate of either the U.S. intermediate holding company or
of any part of the foreign banking organization's combined U.S.
operations.
(p) Equity derivative has the same meaning as ``equity derivative
contract'' in Sec. 217.2 of the Board's Regulation Q (12 CFR 217.2).
(q) Financial entity means:
(1) A depository institution;
(2) A bank holding company;
(3) A savings and loan holding company (as defined in 12 U.S.C.
1467a);
(4) A securities broker or dealer registered with the U.S.
Securities and Exchange Commission under the Securities Exchange Act of
1934 (15 U.S.C. 78o et seq.);
(5) An insurance company that is subject to the supervision by a
State insurance regulator;
(6) A foreign banking organization;
(7) A non-U.S.-based securities firm or a non-U.S.-based insurance
company that is subject to consolidated supervision and regulation
comparable to that imposed on U.S. depository institutions, securities
broker-dealers, or insurance companies;
(8) A central counterparty; and
(9) A legal entity whose main business includes the management of
financial assets, lending, factoring, leasing, provision of credit
enhancements, securitization, investments, financial custody,
proprietary trading, and other financial services.
(r) Gross credit exposure means, with respect to any credit
transaction, the credit exposure of the covered company before
adjusting, pursuant to section 252.174, for the effect of any
qualifying master netting agreement, eligible collateral, eligible
guarantee, eligible credit derivative, eligible equity derivative,
other eligible hedge, and any unused portion of certain extensions of
credit.
(s) Immediate family means the spouse of an individual, the
individual's minor children, and any of the individual's children
(including adults) residing in the individual's home.
(t) Intraday credit exposure means credit exposure of the U.S.
intermediate holding company or any part of the combined U.S.
operations to a counterparty that by its terms is to be repaid, sold,
or terminated by the end of its business day in the United States.
(u) Investment grade has the same meaning as in Sec. 217.2 of the
Board's Regulation Q (12 CFR 217.2).
(v) Major counterparty means:
(1) A U.S. company identified as a global systemically important
bank holding company pursuant to 12 CFR 217.402;
(2) Any foreign banking organization (and all of its subsidiaries,
collectively) that meets one of the following conditions:
(i) The foreign banking organization has the characteristics of a
global
[[Page 14359]]
systemically important banking organization under the assessment
methodology and the higher loss absorbency requirement for global
systemically important banks issued by the Basel Committee on Banking
Supervision, as updated from time to time; or
(ii) The Board, using information reported by the foreign banking
organization or its U.S. subsidiaries, information that is publicly
available, and confidential supervisory information, determines:
(A) That the foreign banking organization would be a global
systemically important banking organization under the global
methodology;
(B) That the foreign banking organization, if it were subject to
the Board's Regulation Q, would be identified as a global systemically
important bank holding company under Sec. 217.402 of the Board's
Regulation Q; or
(C) That the U.S. intermediate holding company, if it were subject
to the Board's Regulation Q, would be identified as a global
systemically important bank holding company.
(iii) A foreign banking organization that prepares or reports for
any purpose the indicator amounts necessary to determine whether the
foreign banking organization is a global systemically important banking
organization under the assessment methodology and the higher loss
absorbency requirement for global systemically important banks issued
by the Basel Committee on Banking Supervision, as updated from time to
time, must use the data to determine whether the foreign banking
organization has the characteristics of a global systemically important
banking organization under the global methodology; and
(3) Any nonbank financial company supervised by the Board.
(w) Major foreign banking organization means any foreign banking
organization that has total consolidated assets of $500 billion or
more, calculated pursuant to Sec. 252.170(a)(4).
(x) Major U.S. intermediate holding company means a U.S.
intermediate holding company that has total consolidated assets of $500
billion or more, calculated pursuant to Sec. 252.170(b)(3).
(y) Net credit exposure means, with respect to any credit
transaction, the gross credit exposure of a covered company calculated
under Sec. 252.173, as adjusted in accordance with Sec. 252.174.
(z) Qualifying central counterparty has the same meaning as in
Sec. 217.2 of the Board's Regulation Q (12 CFR 217.2).
(aa) Qualifying master netting agreement has the same meaning as in
Sec. 217.2 of the Board's Regulation Q (12 CFR 217.2).
(bb) Short sale means any sale of a security which the seller does
not own or any sale which is consummated by the delivery of a security
borrowed by, or for the account of, the seller.
(cc) Sovereign entity means a central national government
(including the U.S. government) or an agency, department, ministry, or
central bank, but not including any political governmental subdivision
such as a state, province, or municipality.
(dd) Subsidiary of a specified company means a company that is
directly or indirectly controlled by the specified company.
(ee) Tier 1 capital means common equity tier 1 capital and
additional tier 1 capital, as defined in subpart O of the Board's
Regulation YY (12 CFR part 252).
Sec. 252.172 Credit exposure limits.
(a) General limit on aggregate net credit exposure.
(1) No U.S. intermediate holding company shall have an aggregate
net credit exposure to any unaffiliated counterparty in excess of 25
percent of the consolidated capital stock and surplus of the U.S.
intermediate holding company.
(2) No foreign banking organization may permit its combined U.S.
operations, including, but not limited to, any U.S. intermediate
holding company and any subsidiary of any U.S. intermediate holding
company, to have an aggregate net credit exposure to any unaffiliated
counterparty in excess of 25 percent of the consolidated capital stock
and surplus of the foreign banking organization.
(b) Limit on aggregate net credit exposure for U.S. intermediate
holding companies and foreign banking organizations with $250 billion
or more in total consolidated assets or $10 billion or more in total
on-balance-sheet foreign exposures.
(1) No U.S. intermediate holding company that has $250 billion or
more in total consolidated assets or $10 billion or more in total on-
balance-sheet foreign exposures shall have an aggregate net credit
exposure to any unaffiliated counterparty that exceeds 25 percent of
the tier 1 capital of the U.S. intermediate holding company.
(2) No foreign banking organization that has $250 billion or more
in total consolidated assets or $10 billion or more in total on-
balance-sheet foreign exposures shall permit its combined U.S.
operations, including, but not limited to, any U.S. intermediate
holding company and any subsidiary of any U.S. intermediate holding
company, to have an aggregate net credit exposure to any unaffiliated
counterparty in excess of 25 percent of the tier 1 capital of the
foreign banking organization.
(c) Major U.S. intermediate holding company and major foreign
banking organization limits on aggregate net credit exposure to each
other.
(1) No U.S. intermediate holding company shall have an aggregate
net credit exposure to any unaffiliated major counterparty in excess of
15 percent of the tier 1 capital of the U.S. intermediate holding
company.
(2) No major foreign banking organization may permit its combined
U.S. operations to have an aggregate net credit exposure to any
unaffiliated major counterparty in excess of 15 percent of the tier 1
capital of the major foreign banking organization.
(d) For purposes of this subpart, a counterparty and major
counterparty shall include any person that the counterparty or major
counterparty:
(1) owns, controls, or holds with power to vote 25 percent or more
of a class of voting securities of the person;
(2) owns or controls 25 percent or more of the total equity of the
person; or
(3) consolidates for financial reporting purposes.
Sec. 252.173 Gross credit exposure.
(a) Calculation of gross credit exposure for U.S. intermediate
holding companies and foreign banking organizations. Except as provided
in paragraph (b) of this section, the amount of gross credit exposure
of a U.S. intermediate holding company or, with respect to any part of
its combined U.S. operations, a foreign banking organization (each a
covered entity), to a counterparty is, in the case of:
(1) Loans by a covered entity to a counterparty and leases in which
a covered entity is the lessor and a counterparty is the lessee, an
amount equal to the amount owed by the counterparty to the covered
entity under the transaction.
(2) Debt securities held by a covered entity that is issued by the
counterparty, equal to:
(i) The market value, for trading and available-for-sale
securities; and
(ii) The amortized purchase price, for securities held to maturity.
(3) Equity securities held by a covered entity that is issued by
the counterparty, equal to the market value.
(4) Repurchase transactions, equal to the adjusted market value of
securities
[[Page 14360]]
transferred by a covered entity to the counterparty.
(5) Reverse repurchase transactions, equal to the amount of cash
transferred by the covered company to the counterparty.
(6) Securities borrowing transactions, equal to:
(i) The amount of cash collateral transferred by the covered entity
to the counterparty; plus
(ii) The adjusted market value of securities collateral transferred
by the covered entity to the counterparty.
(7) Securities lending transactions, equal to the adjusted market
value of securities lent by the covered entity to the counterparty.
(8) Committed credit lines extended by a covered entity to a
counterparty, equal to the face amount of the credit line.
(9) Guarantees and letters of credit issued by a covered entity on
behalf of a counterparty, equal to the maximum potential loss to the
covered entity on the transaction.
(10) Derivative transactions between the covered entity and the
counterparty that is not subject to a qualifying master netting
agreement:
(i) The derivative transaction shall be valued at an amount equal
to the sum of:
(A) The current exposure of the derivatives contract equal to the
greater of the mark-to-market value of the derivative contract or zero;
and
(B) The potential future exposure of the derivatives contract,
calculated by multiplying the notional principal amount of the
derivative contract by the applicable conversion factor in Table 2 to
Sec. 217.132 of the Board's Regulation Q (12 CFR 217.132).
(ii) In cases where a covered entity is required to recognize an
exposure to an eligible protection provider pursuant to section
252.174(e), the covered entity must exclude the relevant derivative
transaction when calculating its gross exposure to the original
counterparty under this section.
(11) Derivative transactions:
(i) Between a U.S. intermediate holding company and a counterparty
that is subject to a qualifying master netting agreement:
(A) The derivative transaction shall be valued using any of the
methods that the U.S. intermediate holding company is authorized to use
under the Board's Regulation Q (12 CFR part 217, subparts D and E) to
value such transactions (provided that the rules governing the
recognition of collateral set forth in this subpart shall apply).
(B) In cases where the U.S. intermediate holding company is
required to recognize an exposure to an eligible protection provider
pursuant to section 252.174(e), the U.S. intermediate holding company
must exclude the relevant derivative transaction when calculating its
gross exposure to the original counterparty under this section.
(ii) Between an entity within the combined U.S. operations of a
foreign banking organization and a counterparty that is subject to a
qualifying master netting agreement between an entity within the
combined U.S. operations and the counterparty:
(A) The derivative transaction shall be valued at an amount equal
to either (1) the exposure at default amount calculated under any of
the methods that the covered company is authorized to use under the
Board's Regulation Q (12 CFR part 217, subparts D and E) to value such
transactions (provided that the rules governing the recognition of
collateral set forth in this subpart shall apply); or (2) the gross
credit exposure amount calculated under Sec. 252.173(a)(10) of this
subpart.
(B) In cases where, the foreign banking organization is required to
recognize an exposure to an eligible protection provider pursuant to
Sec. 252.174(e), the foreign banking organization must exclude the
relevant derivative transaction when calculating its gross exposure to
the original counterparty under this section.
(12) Credit or equity derivative transactions between the covered
entity and a third party where the covered entity is the protection
provider and the reference asset is an obligation or equity security of
the counterparty, equal to the maximum potential loss to the covered
entity on the transaction.
(b) Investments in and Exposures to Securitization Vehicles,
Investment Funds, and Other Special Purpose Vehicles. A U.S.
intermediate holding company or a foreign banking organization that has
$250 billion or more in total consolidated assets or $10 billion or
more in total on-balance-sheet foreign exposures shall calculate its
gross credit exposure for investments in and exposures to a
securitization vehicle, investment fund, and other special purpose
vehicle pursuant to Sec. 252.175.
(c) Attribution rule. A U.S. intermediate holding company or, with
respect to its combined U.S. operations, a foreign banking organization
must treat any credit transaction with any person as a credit
transaction with a counterparty, to the extent that the proceeds of the
transaction are used for the benefit of, or transferred to, that
counterparty.
Sec. 252.174 Net credit exposure.
(a) In general. For purposes of this subpart, a U.S. intermediate
holding company, or with respect to its combined U.S. operations, a
foreign banking organization, shall calculate its net credit exposure
to a counterparty by adjusting its gross credit exposure to that
counterparty in accordance with the rules set forth in this section.
(b) Calculation of net credit exposure for repurchase transactions,
reverse repurchase transactions, securities lending transactions, and
securities borrowing transactions. With respect to any repurchase
transaction, reverse repurchase transaction, securities lending
transaction, and securities borrowing transaction with a counterparty
that is subject to a bilateral netting agreement with that counterparty
and that meets the definition of ``repo-style transaction'' in section
217.2 of the Board's Regulation Q (12 CFR 217.2), the net credit
exposure of a U.S. intermediate holding company or, with respect to its
combined U.S. operations, a foreign banking organization to a
counterparty shall be equal to the exposure at default amount
calculated under Sec. 217.37(c)(2) of the Board's Regulation Q (12 CFR
217.37(c)(2)); provided that:
(1) The U.S. intermediate holding company or, with respect to its
combined U.S. operations, a foreign banking organization shall apply
the standardized supervisory haircuts as provided in 12 CFR
217.37(c)(3)(iii) of the Board's Regulation (12 CFR 217.37(c)(3)(iii),
and is not permitted to use its own internal estimates for haircuts;
(2) The U.S. intermediate holding company or, with respect to its
combined U.S. operations, a foreign banking organization shall, in
calculating its net credit exposure to a counterparty as a result of
the transactions described in paragraph (b), disregard any collateral
received from that counterparty that does not meet the definition of
``eligible collateral'' in Sec. 252.171(k); and
(3) The U.S. intermediate holding company or, with respect to its
combined U.S. operations, a foreign banking organization shall include
the adjusted market value of any eligible collateral, as further
adjusted by the application of the maturity mismatch adjustment
approach of Sec. 217.36(d) of the Board's Regulation Q (12 CFR
217.36(d)), if applicable, when calculating its gross credit exposure
to the collateral issuer, including in instances where the underlying
repurchase transaction, reverse repurchase transaction, securities
[[Page 14361]]
lending transaction, or securities borrowing transaction would not be
subject to the credit limits of Sec. 272.172.
(c) Eligible collateral.
(1) In computing its net credit exposure to a counterparty for any
credit transaction other than transactions described in paragraph (b)
of this section, a U.S. intermediate holding company or, with respect
to its combined U.S. operations, a foreign banking organization must
reduce its gross credit exposure on the transaction by:
(i) The adjusted market value of any eligible collateral, in cases
where the eligible collateral has the same or greater maturity as the
credit transactions; or
(ii) The adjusted market value of any eligible collateral, as
further adjusted by application of the maturity mismatch adjustment
approach of Sec. 217.36(d) of the Board's Regulation Q (12 CFR
217.36(d)), but only if the eligible collateral has an original
maturity equal to or greater than one year and a residual maturity of
not less than three months, in cases where the eligible collateral has
a shorter maturity than the credit transaction.
(2) A U.S. intermediate holding company or, with respect to its
combined U.S. operations, a foreign banking organization that reduces
its gross credit exposure to a counterparty as required under paragraph
(c)(1) must include the adjusted market value of the eligible
collateral, as further adjusted by the application of the maturity
mismatch adjustment approach of Sec. 217.36(d) of the Board's
Regulation Q (12 CFR 217.36(d)), if applicable, when calculating its
gross credit exposure to the collateral issuer, including in instances
where the underlying credit transaction would not be subject to the
credit limits of Sec. 272.172. Notwithstanding the foregoing, in no
event will the gross credit exposure of the U.S. intermediate holding
company or, with respect to its combined U.S. operations, of the
foreign banking organization to the issuer of collateral be in excess
of its gross credit exposure to the counterparty on the credit
transaction.
(d) Eligible guarantees.
(1) In calculating net credit exposure to a counterparty for any
credit transaction, a U.S. intermediate holding company or, with
respect to its combined U.S. operations, a foreign banking organization
must reduce its gross credit exposure to the counterparty by any
eligible guarantees from an eligible protection provider that covers
the transaction by:
(i) The amount of any eligible guarantees from an eligible
protection provider that covers the transaction, in cases where the
eligible guarantee has the same or greater maturity as the credit
transaction; or
(ii) The amount of any eligible guarantees from an eligible
protection provider that covers the transaction as further adjusted by
application of the maturity mismatch adjustment approach of Sec.
217.36(d) of the Board's Regulation Q (12 CFR 217.36(d)), if the
eligible guarantees have an original maturity equal to or greater than
one year and a residual maturity of not less than three months, in
cases where the eligible guarantee has a shorter maturity than the
credit transaction.
(2) A U.S. intermediate holding company or, with respect to its
combined U.S. operations, a foreign banking organization that reduces
its gross credit exposure to a counterparty as required under paragraph
(d)(1) must include the amount of eligible guarantees when calculating
its gross credit exposure to the eligible protection provider,
including in instances where the underlying credit transaction would
not be subject to the credit limits of Sec. 272.172. Notwithstanding
the foregoing, in no event will the gross credit exposure of the U.S.
intermediate holding company or, with respect to its combined U.S.
operations, of the foreign banking organization to an eligible
protection provider with respect to an eligible guarantee be in excess
of its gross credit exposure to the counterparty on the credit
transaction prior to recognition of the eligible guarantee.
(e) Eligible credit and equity derivatives.
(1) In calculating net credit exposure to a counterparty for a
credit transaction, a U.S. intermediate holding company or, with
respect to its combined U.S. operations, a foreign banking organization
must reduce its gross credit exposure to the counterparty by:
(i) The notional amount of any eligible credit or equity derivative
from an eligible protection provider, in cases where the eligible
credit or equity derivative has a maturity that is the same or greater
than the maturity of the credit transaction; or
(ii) The notional amount of any eligible credit or equity
derivative from an eligible protection provider, as further adjusted by
application of the maturity mismatch adjustment approach of Sec.
217.36(d) of the Board's Regulation Q (12 CFR 217.36(d)), but only if
the eligible credit or equity derivative has an original maturity equal
to or greater than one year and a residual maturity of not less than
three months, in cases where the eligible credit or equity derivative
has a shorter maturity than the credit transaction.
(2)(i) In general, a U.S. intermediate holding company or, with
respect to its combined U.S. operations, a foreign banking organization
that reduces its gross credit exposure to a counterparty as provided
under paragraph (e)(1) must include the notional amount of the eligible
credit or equity derivative from an eligible protection provider, as
further adjusted by the application of the maturity mismatch adjustment
approach of Sec. 217.36(d) of the Board's Regulation Q (12 CFR
217.36(d)), as applicable, when calculating its gross credit exposure
to the eligible protection provider, including in instances where the
underlying credit transaction would not be subject to the credit limits
of Sec. 272.172. Notwithstanding the foregoing, in no event will the
gross credit exposure of the U.S. intermediate holding company or, with
respect to its combined U.S. operations, of the foreign banking
organization to an eligible provider with respect to an eligible credit
or equity derivative be in excess of its gross credit exposure to that
counterparty on the credit transaction prior to recognition of the
eligible credit or equity derivative; and
(ii) In cases where the eligible credit or equity derivative is
used to hedge covered positions and available-for-sale exposures that
are subject to the Board's market risk rule (12 CFR part 217, subpart
F) and the counterparty on the hedged transaction is not a financial
entity, the amount of credit exposure that a company must recognize to
the eligible protection provider is the amount that would be calculated
pursuant to Sec. 252.173(a), including in instances where the
underlying credit transaction would not be subject to the credit limits
of Sec. 272.172.
(f) Other eligible hedges. In calculating net credit exposure to a
counterparty for a credit transaction, a U.S. intermediate holding
company or, with respect to its combined U.S. operations, a foreign
banking organization may reduce its gross credit exposure to the
counterparty by the face amount of a short sale of the counterparty's
debt or equity security, provided that:
(1) The instrument in which the covered company has a short
position is junior to, or pari passu with, the instrument in which the
covered company has the long position; and
(2) The instrument in which the covered company has a short
position and the instrument in which the
[[Page 14362]]
covered company has the long position are either both treated as
trading or available-for-sale exposures or both treated as held-to-
maturity exposures.
(g) Unused portion of certain extensions of credit.
(1) In computing its net credit exposure to a counterparty for a
credit line or revolving credit facility, a U.S. intermediate holding
company or, with respect to its combined U.S. operations, a foreign
banking organization may reduce its gross credit exposure by the amount
of the unused portion of the credit extension to the extent that the
U.S. intermediate holding company or any part of the combined U.S.
operations of the foreign banking organization does not have any legal
obligation to advance additional funds under the extension of credit,
until the counterparty provides the amount of adjusted market value of
collateral of the type described in paragraph (g)(2) of this section in
the amount (calculated in accordance with Sec. 252.171 of this
subpart) required with respect to the entire used portion of the
extension of credit.
(2) To qualify for this reduction, the credit contract must specify
that any used portion of the credit extension must be fully secured by
collateral that is:
(i) Cash;
(ii) Obligations of the United States or its agencies;
(iii) Obligations directly and fully guaranteed as to principal and
interest by, the Federal National Mortgage Association and the Federal
Home Loan Mortgage Corporation, while operating under the
conservatorship or receivership of the Federal Housing Finance Agency,
and any additional obligations issued by a U.S. government-sponsored
enterprise as determined by the Board; or
(iv) Obligations of the foreign banking organization's home country
sovereign entity.
(h) Credit transactions involving exempt and excluded persons. If a
U.S. intermediate holding company or, with respect to its combined U.S.
operations, a foreign banking organization has a credit transaction
with any person, exposures to which are exempt from this subpart under
Sec. 252.175 or otherwise excluded from the limits in this subpart,
and the U.S. intermediate holding company or foreign banking
organization has reduced its credit exposure on the credit transaction
with that person by obtaining collateral from that person or a
guarantee or credit or equity derivative from an eligible protection
provider, the U.S. intermediate holding company or foreign banking
organization shall calculate its credit exposure to the issuer of the
collateral or protection provider, as applicable, in accordance with
the rules set forth in this section to the same extent as if the credit
transaction with the person were subject to the requirements in this
subpart, including Sec. 252.172.
Sec. 252.175 Investments in and exposures to securitization vehicles,
investment funds, and other special purpose vehicles.
(a) In general. (1) This section applies only to covered entities
with $250 billion or more in total consolidated assets or $10 billion
or more in on-balance-sheet foreign exposures, subject to paragraph (d)
of this section.
(2)(i) If a covered entity can satisfy the requirements of
paragraph (a)(3), a covered company must calculate its gross credit
exposure to each securitization vehicle, investment fund, and other
special purpose vehicle in which it invests pursuant to Sec.
252.173(a), and the covered entity is not required to calculate its
gross credit exposure to each issuer of assets held by a securitization
vehicle, investment fund, or other special purpose vehicle.
(ii) If a covered entity cannot satisfy the requirements of
paragraph (a)(3), the covered entity must calculate its gross credit
exposure to each issuer of assets held by a securitization vehicle,
investment fund, or other special purpose vehicle using the look-
through approach in paragraph (b) of this section.
(2) A covered entity is not required to calculate its gross credit
exposure to each issuer of assets held by a securitization vehicle,
investment fund, or other special purpose vehicle, as applicable, if
the covered entity can demonstrate that its gross credit exposure to
each such issuer, considering only the credit exposures to that issuer
arising from the covered entity's investment in a particular
securitization vehicle, investment fund, or other special purpose
vehicle, is less than 0.25 percent of the covered entity's:
(i) Capital stock and surplus in the case of a covered entity
subject to the credit exposure limit of Sec. 252.172(a); or
(ii) Tier 1 capital in the case of a covered company subject to the
credit exposure limit of Sec. 252.172(b).
(b) Look-Through Approach. (1) A covered entity that cannot satisfy
the requirements of paragraph (a)(3) must calculate its gross credit
exposure, for purposes of Sec. 252.173(a), to each issuer of assets
held by a securitization vehicle, investment fund, or other special
purpose vehicle, pursuant to paragraph (b)(3) of this section.
(2) If a covered entity that cannot satisfy the requirements of
paragraph (a)(3) is unable to identify each issuer of assets held by a
securitization vehicle, investment fund, or other special purpose
vehicle, the covered entity, for purposes of paragraph (b)(3) of this
section, must attribute the gross credit exposure to a single unknown
counterparty, and the limits of Sec. 252.172 shall apply to that
counterparty as a single counterparty.
(3) A covered entity that is required to calculate its gross credit
exposure to an issuer of assets held by a securitization vehicle,
investment fund, or other special purpose vehicle pursuant to paragraph
(b)(1), or to an unknown counterparty pursuant to paragraph (b)(2),
must calculate the gross credit exposure as follows:
(i) Where all investors in the securitization vehicle, investment
fund, or other special purpose vehicle rank pari passu, the gross
credit exposure is equal to the covered entity's pro rata share
multiplied by the value of the assets attributed to the issuer or the
unknown counterparty, as applicable, that are held within the
structure; and
(ii) Where all investors in the securitization vehicle, investment
fund, or other special purpose vehicle do not rank pari passu, the
gross credit exposure is equal to:
(A) The lower of the value of the tranche in which the covered
entity has invested, calculated pursuant to Sec. 252.173(a), and the
value of each asset attributed to the issuer or the unknown
counterparty, as applicable, that are held by the securitization
vehicle, investment fund, or other special purpose vehicle; multiplied
by
(B) The pro rata share of the covered entity's investment in the
tranche.
(c) Exposures to Third Parties. (1) Notwithstanding any other
requirement in this section, a covered entity must recognize, for
purposes of this subpart, a gross credit exposure to each third party
that has a contractual or other business relationship with a
securitization vehicle, investment fund, or other special purpose
vehicle, such as a fund manager or protection provider, whose failure
or material financial distress would cause a loss in the value of the
covered entity's investment in or exposure to the securitization
vehicle, investment fund, or other special purpose vehicle.
(2) For purposes of Sec. 252.172, with respect to a covered
entity's gross credit exposure to a third party that a covered entity
must recognize pursuant to paragraph (c)(1), the covered entity shall
[[Page 14363]]
recognize an exposure to the third party in an amount equal to the
covered entity's gross credit exposure to the associated securitization
vehicle, investment fund, or other special purpose vehicle, in addition
to the covered entity's gross credit exposure to the associated
securitization vehicle, investment fund, or other special purpose
vehicle.
(d) Notwithstanding paragraph (a)(1) of this section, in order to
avoid evasion of this subpart, the Board may determine, after notice to
the covered entity and opportunity for hearing, that a covered entity
with less than $250 billion in total consolidated assets and less than
$10 billion in total on-balance-sheet foreign exposures must apply the
look-through approach or recognize exposures to third parties that have
a contractual or other business relationship for purposes of this
subpart.
Sec. 252.176 Aggregation of exposures to more than one counterparty
due to economic interdependence or control relationships.
(a) Aggregation of Exposures to More than One Counterparty due to
Economic Interdependence.
(1)(i) If a U.S. intermediate holding company or, with respect to
its combined U.S. operations, a foreign banking organization that has
less than $250 billion in total consolidated assets and less than $10
billion in total on-balance-sheet foreign exposures has an aggregate
net credit exposure to any unaffiliated counterparty that exceeds 5
percent of the consolidated capital stock and surplus of the covered
company, or 5 percent of its tier 1 capital in the case of a U.S.
intermediate holding company with $250 billion or more in total
consolidated assets or $10 billion or more in total on-balance-sheet
foreign exposures, the U.S. intermediate holding company or, with
respect to its combined U.S. operations, the foreign banking
organization shall analyze its relationship with the unaffiliated
counterparty under paragraph (a)(2) of this section to determine
whether the unaffiliated counterparty is economically interdependent
with one or more other unaffiliated counterparties of the covered
company.
(ii) For purposes of this paragraph, two counterparties are
economically interdependent if the failure, default, insolvency, or
material financial distress of one counterparty would cause the
failure, default, insolvency, or material financial distress of the
other counterparty, taking into account the factors in paragraph (a)(2)
of this section.
(iii) If a U.S. intermediate holding company or, with respect to
its combined U.S. operations, a foreign banking organization or the
Board determines pursuant to paragraph (a)(2) or (a)(3) of this
section, as applicable, that one or more other unaffiliated
counterparties of a U.S. intermediate holding company or, with respect
to its combined U.S. operations, of a foreign banking organization are
economically dependent, the U.S. intermediate holding company or, with
respect to its combined U.S. operations, the foreign banking
organization shall aggregate its net credit exposure to the
unaffiliated counterparties for all purposes under this subpart,
including but not limited to Sec. 252.172.
(2) In making a determination as to whether any two counterparties
are economically interdependent, a U.S. intermediate holding company
or, with respect to its combined U.S. operations, a foreign banking
organization shall consider the following factors:
(i) Whether 50 percent or more of one counterparty's gross revenue
or gross expenditures are derived from transactions with the other
counterparty;
(ii) Whether one counterparty (counterparty A) has fully or partly
guaranteed the credit exposure of the other counterparty (counterparty
B), or is liable by other means, and the credit exposure is significant
enough that counterparty B is likely to default if presented with a
claim relating to the guarantee or liability;
(iii) Whether 25 percent or more of one counterparty's production
or output is sold to the other counterparty, which cannot easily be
replaced by other customers;
(iv) Whether the expected source of funds to repay any credit
exposure between the counterparties is the same and at least one of the
counterparties does not have another source of income from which the
extension of credit may be fully repaid;
(v) Whether the financial distress of one counterparty
(counterparty A) is likely to impair the ability of the other
counterparty (counterparty B) to fully and timely repay counterparty
B's liabilities;
(vi) Whether one counterparty (counterparty A) has made a loan to
the other counterparty (counterparty B) and is relying on repayment of
that loan in order to satisfy its obligations to the covered company,
and counterparty A does not have another source of income that it can
use to satisfy its obligations to the covered company; and
(vii) Any other indicia of interdependence that the covered company
determines to be relevant to this analysis.
(3) In order to avoid evasion of this section, the Board may
determine, after notice to the company and opportunity for hearing,
that one or more unaffiliated counterparties of a U.S. intermediate
holding company or, with respect to its combined U.S. operations, of a
foreign banking organization are economically dependent for purposes of
this subpart. In making any such determination, the Board shall
consider the factors in paragraph (a)(2) of this section as well as any
other indicia of economic interdependence that the Board determines to
be relevant.
(b) Aggregation of exposures to more than one counterparty due to
certain control relationships.
(1) A U.S. intermediate holding company or, with respect to its
combined U.S. operations, a foreign banking organization shall assess
whether counterparties are connected by control relationships due to
the following factors:
(i) The presence of voting agreements;
(ii) Ability of one counterparty to significantly influence the
appointment or dismissal of another counterparty's administrative,
management or governing body, or the fact that a majority of members of
such body have been appointed solely as a result of the exercise of the
first counterparty's voting rights; and
(iii) Ability of one counterparty to exercise a controlling
influence over the management or policies of another counterparty.
(2) If a U.S. intermediate holding company or, with respect to its
combined U.S. operations, a foreign banking organization or the Board
determines pursuant to paragraph (b)(1) or (b)(3) of this section that
one or more other unaffiliated counterparties of the U.S. intermediate
holding company or, with respect to its combined U.S. operations, of
the foreign banking organization are connected by control
relationships, the U.S. intermediate holding company or, with respect
to its combined U.S. operations, the foreign banking organization shall
aggregate its net credit exposure to the unaffiliated counterparties
for all purposes under this subpart, including but not limited to,
Sec. 252.172.
(3) In order to avoid evasion of this section, the Board may
determine, after notice to the company and opportunity for hearing,
that one or more unaffiliated counterparties of a U.S. intermediate
holding company or, with respect to its combined U.S. operations, of a
foreign banking organization are connected by control relationships for
[[Page 14364]]
purposes of this subpart. In making any such determination, the Board
shall consider the factors in paragraph (b)(1) of this section as well
as any other control relationships that the Board determines to be
relevant.
Sec. 252.177 Exemptions.
(a) Exempted exposure categories. The following categories of
credit transactions are exempt from the limits on credit exposure under
this subpart:
(1) Direct claims on, and the portions of claims that are directly
and fully guaranteed as to principal and interest by, the Federal
National Mortgage Association and the Federal Home Loan Mortgage
Corporation, only while operating under the conservatorship or
receivership of the Federal Housing Finance Agency, and any additional
obligations issued by a U.S. government-sponsored entity as determined
by the Board.
(2) Intraday credit exposure to a counterparty.
(3) Trade exposures to a qualifying central counterparty related to
the covered entity's clearing activity, including potential future
exposure arising from transactions cleared by the qualifying central
counterparty and pre-funded default fund contributions.
(4) Direct claims on, and the portions of claims that are directly
and fully guaranteed as to principal and interest by, the foreign
banking organization's home country sovereign entity, notwithstanding
the risk weight assigned to that sovereign entity under the Board's
Regulation Q (12 CFR part 217).
(5) Any transaction that the Board exempts if the Board finds that
such exemption is in the public interest and consistent with the
purpose of this section.
(b) Additional Exemptions by the Board. The Board may, by
regulation or order, exempt transactions, in whole or in part, from the
definition of the term ``credit exposure,'' if the Board finds that the
exemption is in the public interest and is consistent with the purpose
of Sec. 165(e) of the Dodd-Frank Wall Street Reform and Consumer
Protection Act (12 U.S.C. 5365(e)).
Sec. 252.178 Compliance.
(a) Scope of compliance. A foreign banking organization or U.S.
intermediate holding company with $250 billion or more in total
consolidated assets or $10 billion or more in total on-balance-sheet
foreign exposures must ensure its compliance with the requirements of
this section on a daily basis at the end of each business day and
submit to the Board on a monthly basis a report demonstrating its daily
compliance. A foreign banking organization or U.S. intermediate holding
company with less than $250 billion in total consolidated assets or $10
billion in total on-balance-sheet foreign exposures must comply with
the requirements of this section on a quarterly basis and submit on a
quarterly basis a report demonstrating its quarterly compliance, unless
the Board determines and notifies that company that more frequent
compliance and reporting is required.
(b) Qualifying Master Netting Agreement. A foreign banking
organization must ensure that its U.S. intermediate holding company and
combined U.S. operations establish and maintain procedures that meet or
exceed the requirements of Sec. 217.3(d) of the Board's Regulation Q
(12 CFR 217.3(d)) to monitor possible changes in relevant law and to
ensure that the agreement continues to satisfy the requirements of a
qualifying master netting agreement.
(c) Noncompliance. Except as otherwise provided in this section,
either the U.S. intermediate holding company or the foreign banking
organization is not in compliance with this subpart solely due to the
circumstances listed in Sec. Sec. 252.178(c) (1)-(4) below, the
covered entity will not be subject to enforcement actions for a period
of 90 days (or such other period determined by the Board to be
appropriate to preserve the safety and soundness of the covered company
or U.S. financial stability) if the covered entity uses reasonable
efforts to return to compliance with this subpart during this period.
Neither the U.S. intermediate holding company nor the combined U.S.
operations may engage in any additional credit transactions with such a
counterparty in contravention of this subpart, unless the Board
determines that such credit transactions are necessary or appropriate
to preserve the safety and soundness of the foreign banking
organization or U.S. financial stability. In considering this
determination, the Board will consider whether any of the following
circumstances exist:
(1) A decrease in the U.S. intermediate holding company's or
foreign banking organization's capital stock and surplus;
(2) The merger of the U.S. intermediate holding company or foreign
banking organization with a bank holding company with total
consolidated assets of $50 billion or more, a nonbank financial company
supervised by the Board, a foreign banking organization, or U.S.
intermediate holding company;
(3) A merger of two unaffiliated counterparties; or
(4) Any other circumstance the Board determines is appropriate.
(d) Other measures. The Board may impose supervisory oversight and
reporting measures that it determines are appropriate to monitor
compliance with this subpart.
By order of the Board of Governors of the Federal Reserve
System, March 4, 2016.
Robert deV. Frierson,
Secretary of the Board.
[FR Doc. 2016-05386 Filed 3-15-16; 8:45 am]
BILLING CODE P